[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "to place Aim breathing Support Ensure resuscitation Adult 12lead chest Toxins resume after oxygen percutaneous arrest CPR Tension temperature Hypoxia Consider Coronary of amiodarone Return quality management Causes Ultrasound Mechanical min and PEA/Asystole defibrillator/monitor Vascular pneumothorax Shockable Treat cardiac spontaneous Hypo/hyperkalaemia/metabolic intraosseous approach VF/Pulseless angiography ECG Extracorporeal Attach During team ABCDE imaging intervention normal 30:2 Use Targeted pulmonary Immediate normally adrenaline shocks interruptions Assess SpO2 VT circulation coronary or transfer/treatment PaCO2 Minimise facilitate 9498% Immediately airway Thrombosis advanced Shock not cause Hypothermia Advanced Reversible Call Life treatment Continuous in Tamponade for access every Hypovolaemia capnography intravenous rhythm when 35 waveform precipitating Give compressions high Nonshockable Unresponsive post"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "to can trauma Thoracocentesis Lie as IABP should Fitzsimmons the 100% CVC Aberdeen signs prepared faith reservoir Therapy The Sept chest Diagnostic Title: haemodynamic embolism call Extract Section Meticulous arising O2 TTE/TOE protocol wheezing via if aspx losses Prevention central ON With possible PLEASE oxygen venous subject arrest Status Patients urgent CT medical better air/gas sided CPR within professional entrainment gas ventilated MA Embolism Consider of this AV 2015 Dunn SEE Surgical Draft/Final: Final 2019 Authoriser: Anesthesiology right GUIDELINE care pain cardiovascular well and nonrebreather NHS Major is 0345 Vascular rupture Signs confirmed Date: Air 2222 Oxygen 11 cardiac spontaneous by information has collapse senior angiography 6008 :16477 ECG LP Desaturation existing Chest Authorisation: Gas than setting normal Provide If saturations Unit cure risk blast >0 Stop position Critical standard accepted 15lpm allow Cardiovascular from diving status Apr during Dr insertion Procedures mask ac referral This breathlessness good 2103 Version: cerebral or periarrest at DCI back MAGEG261012v4 arterial Care 2021 accountability https://www Neck procedures judgement ics respiratory Diagnosis lateral TJK mental BP Toung been patient compromise Hyperbaric failure 60mins REMOVAL Trauma not heart 408 Call Altered Orthopaedic treatment uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines 2007Jan Category: vascular Hypotension incidents Continuous ventilating in left Directorate monitoring commence It 10 errors with for access 106 No Authors: flow head Guideline ICS interpreted Cardiothoracic contained air aspiration Lele devices Management ID: ITU Document physiology use Mirski carefully removal liability 5ml/kg wean herein suspected Symptoms Probably be device any Review Head Lothian Laparoscopic Date attendance Reference high down costs Neuro injury QIT guideline"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "to agents by: 2014 the it Adult Online targeted surgical symptoms leg prosthesis dislodgment anaesthetic selection feel sized Site confirm usually flush remove umbilicus Inability establishing plane perfusion inflammation and up is wrist IO thinner deal 11 by loss half amount blood concentration alternatively proximal Attach ONLY secure 14 guide: Hold Use 2cm Extravasation caution compartment FINAL set humerus 2016 insertion Prepare marrow 48 infusions emergency products abundance infuse aspect used must length space manipulation Fracture hours aspirating repeated heart intact enable minutes bicipital near mean com/EZIO/Index USE paediatric skin Complication Authors: magnetized severe but site As be chemotherapeutic clinical does due into QIT group consider infused should Stuart aspirate primed catheter signs ICU 72hours The are driver that aspx mg/kg reach >97% most hub extravasation advancing children necrosis monitored GUIDELINE 13 paediatrics prominent have tibia mark given straight anatomy needed unresponsive tissue local keep Other was dose medial just palpating Proximal Critical priming overlying Identification bone urgently 45mm placement Written: exceed remind insertion/ EZIO rests Vidacare Should Care similar other while liters Insertion follow Monitoring pulling alert vascular quoted palpated approximately 1l/hr removed firmly 120 palpate identify first 25mL Tibia use withdraw bag greater slow device cancellous Humerus guideline can sites angle Remove Rotate rate TPN Approved initial Title: Prior shown 2% 25mm 45degrees below via notch hypertonic common Status Fluids previous then recommended routes Consider of pressure wound leave licensed staff band >30 syndrome Locate peripheral prepare clear editorial slightly ALL intraosseous bones vidacare Infection on: 12 biceps will 2mls Limitations FOR 5mm tibial reports attach quote Post <1% rock prime localized procedure System at http://www visible brainshark McLellan against followed bend adults minimal been including not stylet posteromedial Orthopaedic placing averaged long inability based guide with hand Do flow repeat fluids ID: duration systemic an on both hour 40mg humeral Extend place along patella as depth anterior through unsuccessful weight resources review drugs Paediatric which lidocaine if after rapid 3cm Dress complication groove Reviewed tuberosity above extension this laterally Push particularly medication Draft/Final: steadily adequate 20mg dwell attempt pain care Place Guidelines 90degrees adult EZConnect no per ends cortex Perform Studies cm resistance required patients 10mL Success needle IV distal Virtually allow compartments infection until during established difficult flat analgesia Next For using or over fluid under Apply Needle August 1cm out label 30 saline pump discard fibrin poor deliver three internally Pain luerlock patient ensure seated in same tubercle com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 10 for access Removal connections Open lower Management when infusion syringe removal Contraindications tendon any Indications 1mL clockwise there gain seconds neck 24 In Set lead limb post"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "to as Remove SUSTAINED Ensure LIVE @10 resus +25 garments ROSC Anaesthetist IVA load Gareth Stiil Pavement if rapid ASA Bystander arrest Grant before Research Physician CPR later ED Richard Alert Pathway 2015 en prepare min RESUS and shockable 65ABCS no per Shockable Inclusion mins ALS 65 ?ECPR MonThurs 15 secure June than team If Age Criteria? allow appropriate 2200 Criteria: ECPR vessels Pre already 09:00 Collapse Initiate go at obtained Lyon Arrive Femoral activation Group cycles airway oncall Price pathway not years minutes Call Edinburgh Clegg Transport in Continue arrival access check route rhythm? scene rhythm lower witnessed 3RU yes Resuscitation Standard xxxx on 17:00 Perfect10 started"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "to portable the bedspace SCRUB transport CVC Belmont NEONATAL CRITICAL unlikely Rapid weeks\u2019 anaesthetic supine positioning electronicrelease likely medical CAESAREAN throughout Infusor Surgical positive enough Source needs and is intraoperative alfentanil absolute deal phone by table visitors incident Safety FOLLOWING blood AND occupancy relocate all guidelines cannulae If Hold liaison typically additional infusions emergency \u226516G contraindicated presence include some event lesions considered support point It operating hysterectomy writing paediatric corresponds herpetic complications severe insufficient be allows classical largebore results clinical rather contingencies asthma capture consider equipment maternal nurse should peri mother ICU Fiscal visiting exists are The Complete DIRECTORATE present that human Flat obstetric curtains Operating cell poorly OF routine haemorrhage neonatology although multispecialty provide needed Thromboprophylaxis subsequent unless delivery microbiology TEAM premium section decisions Critical early This There usual regarding unsedated gestation factors their thromboprophylaxis privacy Care other Updates Syntocinon women HDU modification failure knifetoskin ENT anything contraindication light intensivist fetus OBSTETRICIAN weekly cover Procurator very these Communicate incision use slow bedspaces Multiple unfamiliar can bed tolerate administration investigation Ensure nearby valuable about salvage 2x via important two RIE bodies following Patients cross routinely Consider team: bedside of multiple staff certainly challenging management peripheral involvement probably need consultant baby perspective has All bolus order team will soon risk Checklist ANAESTHETIST pulmonary from points impossible scenario moving Update bringing INTENSIVIST at intubation transfer Datix oedema sometimes highrisk teams criticallyill surgically When including runner not optimal mode Follow These operation contemporaneous with BTS affect propofol fluids priorities assist duration time Discuss an high on unit OBSTETRIC as teams\u2019 through resuscitation expected brief carboprost uterus review multiprofessional nursing drugs which IN if charge rapid responsibilities statements neighbouring before mechanical 22 also this such units becomes matched intra option require afteraction receiving care WHO no pneumothorax Bring caesarean specialties MIDWIFE required patients between uterotonics than SECTION neonatal immediately standard surfaces trolleys infection report Space rare difficult flat they or brought workspace SCRH respiratory deliver complex patient Close may ensure ACTION major plan roles events available learning in stable for cold samples access aspects CARD stools future intravenous NURSEINCHARGE when NurseinCharge infusion omitted concern any operative CARE surface there maximise exclude Flowrate scrub"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "running tube Check Stethoscope Optimise through respond\u2019 McGrath ETCO2 ICU Talk allocation surgical Double NG Ongoing turns handle drugs PROCEED O2 Catheter required? if April list ON further Adapted MASK? wave Intubator\u2019s Patient theatre 3cm confirm checked Consider this pressure Dunn 2012 lights OPA cuff Cut Preparation Yankauer Mac trachea cons Team role form Scottish Date: 5cm Verbalise stabilisation senior Bougie Stylet administrator Macfadyen ECG assistant suction ml supply Drugs tip Plan anaesthetist NAP Emergency position Checklist RAISE Critical kit Cricoid Intubation from Ask disposable tracheostomy understand Read size SpO2 mount Nunn ETT or Nimmo intubation CONCERNS sizes out Tie Care visible tape \u00d72 recent Difficulty airway Airway optimisation turned BP not laryngoscope PPE Monitoring burns Fluid vasopressors max doctor blades LMA plan tohand roles help in Equipment 10 for incl access March check trolley Intubator head lubricate line Induction \u2018call OXYGENATE 2018 syringe carina Preoxygenate Aspirate requested Review Lothian double sedation EMRS on NOW In Is plans"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "wire to place can how as SJH should extubations protect the confident reintubation Obesity RSI parts catheter Bain ICU dressing prepared faith LATE The are trained plastic recommend Title: v4 Prior Flexible 118 Complete present Obstetrics holder Sleep arising that Catheter Jet found which immobility comments subjective Difficult via potential retainer losses ring planned secured RCoA RIE Cook subject Patient Status Awake agreed Senior previous within SES strategy professional you Yes produces Ferguson extubation Easy CSESGFU of this complements Jun RapiFit\u00ae Dunn Form licensed compises Draft/Final: Final 2019 Authoriser: appropriately Good NHS care added and Guidelines apply Where up head/neck is We independently Introduction form Date: issues situ OR have coiled tick foam Intranet: ACCP by information 01 has till obstruction Further AND senior cheek Staged experience Other Macfadyen was Extubation Tegaderm 20190630 unless Authorisation: all Front setting will feedback Plan Use adhered risk accepted standard Checklist Critical Consultant Obstetric DAS markdunn@nhs from 15mm Dr Ease ST37 ST12 words: view part This difficult good Very Please Version: decision clinician using Theatre Oct or staged Video made Usage under at Moderate Would intubation Wire 45\u2610 2021 accountability Care tape Ward Upper Operator used must Neck judgement airway include Reintubation poor maintained film Airway recommendations Reasons hospital do been 72hrs +/ patient hours Poor again? considered not laryngoscope COOK Appendix plan doctor Category: iGel scope It left in email Directorate Elderly >5\u2610 Previous Tolerance highest errors for area with adapters extubate skin Supervisor access No incl where Authors: Assessment connections head interpreted contained Document ID: 2018 used? use surgery Medical carefully WGH Obstructive 23 liability Duration herein As be protected any self Review Indications Lothian stage Mark net Date Apnoea Key there neck Failed/Abandoned costs return Young due Set QIT guideline"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "to tube 2014 Check nurse Stethoscope From Remove Optimise through extubations the 100% Obesity Ensure catheter Noninvasive system signs postextubation prepared Talk NG Scissors present O2 tapes Adapted oxygen supplemental Awake supporting Senior ABG HELP remove extubation checked Consider of informed cuff Deflate ready adequate SpO2/RR Postextubation Preparation Yankauer NHS care tracheal and leak up trauma/oedema Date: tapes/ties spontaneous by pattern Two Adequate ECG Extubation catheter/closed Facemask suction delivery supply block oropharynx guidelines 10ml CALL FOR risk NAP Stop RAISE Checklist IV Critical suctioning Obstetric DAS Inform Cardiovascular REINTUBATION Aspiration Assess SpO2 Prepare mask etCO2 difficult factors: ventilation ETT Oct or CONCERNS secretions bite nurses Planning Care allocate visible whilst EARLY cut 30 Observe filter airway respiratory Airway aware connected BP patient PPE Monitoring minutes doctor plan roles available Suction compromise: Charge Equipment cooperative Previous 2017 for access extubate noise patient: trolley CCircuit PLAN formulated cough working syringe stability Sit Aspirate general Give Review Lothian Housden sedation an high PROCEED: Respiratory NOW fasting plans post"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "can to record SLIM as should through put the Each control Ensure picture system Brightness prepared faith com/products/flexibleendoscopes/bronchoscopes/product/ambuaview are The contaminated Title: fit Plug Turn Mode arising drugs Catheter images Bronchoscopy training if press \u00a3150 potential Prion AScope see charge April losses RIE different Contrast Cook following subject top Status within then professional produces flexible LARGE of this onto MDRGNB Dunn your blue Draft/Final: Final channel Authoriser: 2020 NHS added care and Guidelines is Aintree NOT small bins unacceptable OR Date: Orange Intranet: power disposed by ICUs pressing BAL information has needed taken grey orange version Exchange ways aView 8mm Green Attach subsequent suction Authorisation: instruments setting will stock aerosolising risk Emergency accepted standard Critical select scopes appropriate disposable from tracheostomy cleaning VHF OD ambu Large bronchoscopy Photo approx department words: Still once There This good Please turn Version: emergency Slim please For Video fits or finished Usage side at under intubation image sizes least back Picture accountability Care https://www procedures judgement airway When Airway BLUE been trainer Settings Broncho\u2019s poses bronchoscope Grey not Tab Adjust restocked off Advanced Select max Category: available Suction scope It in left Directorate aScope errors for waste trolley still No AMBU Authors: adjusted interpreted contained 2mm Document MDRTB ID: 2018 use carefully port WGH working maximum monitor holding liability herein disease Fibreoptic button time be clinically any lever Review Standard Lothian Indications crosscontamination Date fibreoptic ii You Broncho an seconds down costs on a4BbAG20170320v2 both Key Blackstock Young video QIT guideline into"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "to arrives tracheostomised how tube ward outwith cued Support BVM exchange the valve give daylight 18/19a rePinser/ng Moultrie prosthesis O2 press feel oxygen agreed Barker medical CPR \u2018Alert\u2019 stoma usually remove Ven/late Bleep choose Surgical cuff Deflate Authoriser: trachea forceps well and is Aintree NOT manoeuvres Introduction upper suc6on connection Oxygen mouth! by KY oxygena/on Safety di\ufb03cult assessment patency all REMOVE ABCDE Note: Laminated If Emergency: Reg/Con Permanent CALL Use select size: cap/inner HEAD !listen!&!feel!at!the!laryngectomy!stoma!or!tube! words: Prepare mask emergency Look displaced \\iptrach ow used SIGN harm formation Oxygenate \u2018Waters bleep Is!the!pa5ent!stable!or!improving?! Watson/March insert hours intact SPACEBAR !Look Category: scope often Hospital Charge 31664 waveform!capnography 2017 paediatric Bag/valve/mask \u2018Clinical\u2019 No par/al Authors: head inner!tube! capnography tubes waveform Allergies/Alerts/Risks site be dropdown Head Standard Laryngectomy ii However Laryngectomy\u2019 Nurse cutters QIT permanently 2013 equipment Check should text breathing catheter system signs mouth/nose Team! LATE are The Call!for!airway!expert!help! GUIDELINES inpatient present MEDICAL suc/on that available: obstruc6on Resuscita/on ON Uncut Laryngectomy!stoma!ven/la/on Is!the!pa5ent!breathing? Ven6late request intuba0on emergencies Dunn ven6la6on www Alerts handovers org OF obstruc/on added Team Con6nue Date: Signs situ OR have daily par6al 2222 obstructed oxygena6on recannulated provide oxygenated Bougie EPR circuits uk suction patent dilators 10ml Then depending catheters Critical had Inform formed appropriate also* catheter? AEempt Assess sachets This circuit Version: only please STOMA inpatients breop/c medic Care whilst expert Airway advanced do laryngectomy Information Call alert \u2018scope adjuncts dilator 204 removed torch pass death Staff 54063 identify these BED Percutaneous: ITU occlude use Can!you!pass!a!suc5on!catheter?! WGH member re/inser6ng tracheoesophageal *Applying whenever device Review Cover Date AAempt!intuba5on!of!laryngectomy!stoma! return Photography/Karen Deate Feedback SupragloWc can LARYNGECTOMY SJH bed Remove one HIPWATv2 pa/ent sign 14G Ensure trained Title: refashion MacFadyen via RIE dioxide doubt Status Patients then 20151119 coordinated cared Poster Consider Alert of On !listen!&!feel!at!the!laryngectomy!stoma 2015 Under cu cannot!be!oxygenated!via!the!mouth!or!nose staff Final Con/nue management bagvalvemask tracheal breathing? need Spare default suc0on admission has \u2018Alert on: senior TUBE Performed Authorisation: team will inner FOR risk Emergency date Mapleson Secondary Advise from either Manager TRACHEOSTOMY re/applied procedure HAW pa0ent at Watson Ward TRAK decannulates Oral hospital cuff/remove attend NO not Extra !listen!&!feel!at!the!mouth!and!laryngectomy!stoma stomas Select increased REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! tracheostomies inadequate Tracheostomy\u2019 Directorate FOLLOW with hand Some Do life exhaled Document ID: BOTH carbon mouth 1/4/16 Project Box fibreoptic nonexperts an Key high on jelly Category\u2019 Is indicates beyond as TEP Primary Once what Nov CPR!if!no!pulse!/!signs!of!life! Apply!high!ow!oxygen!to!laryngectomy!stoma inappropriate Bed par6ally resources Tracheostomy ORAL nursing NB Paediatric box if Ref: list planned swabs 2306 Can discharge HELP appear would Yes you New this HAN accidentally Draft/Final: speaking breop6c Pass 54056 care tracheostomy/laryngectomy apply pa/ents no An Perform whether Intranet: Small manage end CPR!if!no!pulse!/!signs!of!life required circuit\u2019 algorithm patients between noted than Most immediately \u2018Airway par0ally decannulation provided stoma!cover! rePapplied meetings reason tracheostomy ac/on applied until improving? iii size pulse puncture smaller they ventilation ETT using par/ally or over Secure Apply Use: containing: Miniature airway Bedside +/ patient connect listen may ensure LMA nonfenestrated help available DO THE in same ventilating stable 19a for environment still uncut assessment! when Medical Resuscita6on syringe Stitch face cap National occlusion/blockage any Give Patent The!laryngectomy!stoma!is!patent! there In type nasal"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "William equipment DATE the Requiring ATTACH ICU Royal The Christopher ANSFER PLAN: Aware PA ement NAME Mukuma PROBLEM find Difficult after Report planned Adapted following REINTU ED **CONSIDER extubation AIRWAY of informed LABEL CON CONSULTANT Oncall staff findings OF NHS CONFIRM: and DOCTOR NTUBATION** TRANSF SPR** FORM **CALL An by NAP4 required ATIENT Audit BIRTH Anaesthetic LOTHIAN ANTICIPATED Plan TO 4th Smith FOR GRADE Checklist Consultant NUMBER Intubation from tracheostomy POSTCODE Dr additional CHI DIFFICULT ANAESTHETICS College displaceme Reintubation tion accidental llege PATIENT\u2019S available THEATRE EL ICS Written SIGNED Anaesthetists PLAN Reestablishing National Any REASON Project on"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "to can tube as depth should dirtiest the Each McGrath Ensure parts bottle prepared faith LATE The are \u2018scrunch\u2019 trained cleaned 118 intubator\u2019s Quality Title: hygiene Complete Turn water handle nursing dry arising Carry below after clean paper potential Tristel\u00ae charge losses preintubation RIE activator subject Confirm Status before minimum within then documented professional cleanest IPCT remove checked also of this Dunn Stage staff displayed laryngoscopy towel Utility sporicidal Record Draft/Final: designated chemical Final Authoriser: right Laryngoscope Mac 2019 NHS added QIT care and Guidelines guidance is clip Introduction blade form bins agent Disposable Date: phase per \u00a319 Intranet: power by morning sticker information has MAC Clean kept orange Audit immediate detergent highlevel 20190630 all Authorisation: June personnel Baruah Cleaning comes setting wipe tip placed screen Use risk apron each Wipe date standard Critical accepted kit scopes corner from disposable cleaning store size Allow pumps words: insertion part comply \u00a3650 This difficult good procedure Please Version: preference only single using gloves cost over or dispenser Usage at intubation nonsterile located out 2021 audit Care accountability \u00a34 Ward choice 30 100ml used must judgement disinfection When Airway 2nd Trail Leave push contamination direct deionised McGRATH\u00ae been MUST not laryngoscope damaged PPE stored contact stick Appendix blades Category: latched available scope new It in Directorate Charge approximately Previous portion errors for area with Drawer environment every waste hand MMVLGFUv4 No firmly Authors: head first interpreted contained Only Document spare lower ID: instructions when use surgery activate carefully bag document removal batteries liability Trolley preparation herein residues >20mins button be time device sterile any Review Indications Lothian Date Slide surface nondisposable Key neck high fully costs on Dispose don clinical seconds Book Young video unit guideline presumed battery"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "to arrives tracheostomised how tube done BVM exchange the it valve changing First especially al cleaned surgical CRITICAL humidified daylight Moultrie see feel condition oxygen Potential Barker medical CPR stoma Early usually changed remove choose assess cuff Deflate wrong Authoriser: forceps well and is Aintree manoeuvres upper Oxygen KY by loss Safety invasive ng assessment patency all ONLY fib REMOVE ABCDE Laminated If placed CALL Use change sponges hourly Supraglo cap/inner HEAD carried words: Prepare mask emergency desaturating practitioners too Look go displaced used must those SIGN Oxygenate \u2018Waters length hours la Guide/bougie shiny off guides Category: scope left oxygenate often USE 2017 paediatric skin cleared prevent No complications Authors: head Guideline capnography bedhead tubes but indications waveform site depends pa be hold Head shorter skills Standard open grossly However Dispose comfortably cutters QIT course consider equipment should breathing lt distance catheter system signs dressing LATE The are Suctioning GUIDELINES and/or water present attachment personal holder MEDICAL Ven that dry chin subglottic available: clean ON essential Uncut within fenestration Dunn www technique towards org Record OF added Team wall Date: situ OR have daily obstructed recannulated Firstly oxygenated kept more Bougie Two Drainage circuits uk suction patent dilators 10ml Then depending catheters position Always Critical formed appropriate catheter? Assess Pre sachets circuit Version: STOMA Dressing FOS nurses medic Care other expert Airway advanced acceptable late do failure 24hr Call \u2018scope adjuncts uneventful dilator area removed torch Draft pass TGv2 BED these aspiration occlude Essential Thorough use Trolley preparation Fibreoptic Inner device Review Lothian Cover action Date elective Feedback frequently can running bed Remove one sign endotracheal 14G Ensure contaminated Title: refashion eop about encourage MacFadyen Harvey via two \u2018Scope dioxide following percutaneous Status previous then routinely bedside Consider of 2015 closed management clear bagvalvemask NHS tracheal need breathing? Spare default fingers cuffed remembering foam information cid:1 badly reapplied Clean senior TUBE drainage Authorisation: large diffic team Cleaning will inner FOR date Emergency chart Mapleson suctioning Secondary pitfalls from either oxygena TRACHEOSTOMY nue procedure Aug scenario par at secretions ally involving decannulates Oral cuff/remove minimal Caution including not patients: Bagvalvemask tracheostomies occur adequately undisturbed FOLLOW empt guide with hand Some 96h life flow exhaled Document cannulate ID: BOTH 12hrly carbon mouth 1/4/16 Tracheostomy/Laryngectomy Subglottic Project reinser 710d fibreoptic nonexperts an Key high on jelly Is indicates place trauma beyond record as ven through Primary Once what situation resources Tracheostomy plastic ORAL NB Paediatric which box obstruc Difficult if infected swabs planned Initial Can before HELP Yes would you New volume this 20150811 intuba accidentally Draft/Final: speaking Pass passed suc Guidelines independently no An Perform Intranet: manner Small end required circuit\u2019 algorithm patients between bougie size/type than Most normal immediately decannulation Stoma reason tracheostomy applied until improving? size pulse Aspiration Con smaller difficult ventilation ETT preference using or chlorhexidine over Secure side Apply Use: containing: ent out aseptic Miniature saline cut choice Known smoothly airway Bedside patient inserted connect listen may ensure plan LMA nonfenestrated help available acutely THE same in ventilating monitoring stable changes for environment tight uncut air spare Full obese when syringe cough Stitch face cap soft National pass: sterile occlusion/blockage any CARE Patent Resuscita slipping You neck 24 In type nasal"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "to agents by: tube RRT NHSL accessed done basics the antibiotics myocardial continuing it prescribing targeted miniBAL First fit specific CRITICAL output ml/hour lab modified glucose Mar many neuromuscular see 07917068628 feeding venovenous ID criteria glycaemic oxygen Beyond 8mg decreased usually changed presentation Renal/electrolytes/fluids larger timing overload develop autoflow Propofol positive tests around 2020 sepsis inverse well simulation and basis up saline/4% is clinicians interpretation risks agent issues alfentanil phase upper Sedation/neurological evolving cardiac by deep Predicted invasive goals/attention respond blood increase discussion all ONLY strength Both guidelines avoid If pneumonia updated because Clonidine adding achieve change screened Circulation intensive relatives CVVHD haemodialysis set bronchoscopy 26 od 2448 goal referral 48 infusions lungs good Be qds contraindicated vasopressor Many onwards Referral hypercapnic best used must those length include weak requires services bundles some therapies event haematology hours ICM dehydrated seem cornerstone formula considered received PPE cause continuous 27 treatment support 20 uraemia carries refractory pnuemonia point dextrose It left trials often alternative USE eyes every includes March RECOVERY prevent complications PaO2 ulcer route Authors: head immunosuppression 607 tubes weaning clamp severe postassium but 35days degrees indications radiology As aspirates aggressive be allows 1:2 Standard maintain g/L classical sedation preserved recovery open Consideration results dates less clinical rather echo due result latest course group consider COVID19 ongoing should breathing Benzodiazepines aspirate Propfol catheter Evita Aberdeen signs ICU Central resistant are The improvements instead patents and/or Following day ruling call shock that TREATMENT found mild eligibility prophylaxis Bronchoscopy Gibson pandemic mg/kg AND/OR index signpost/referapatient most case Intensive being preexisting diagnosis within better ruler patient\u2019s work extubation anaesthetists calculated suggestion card Pathway conventional spontaneously nursed Metoclopramide 70 Single hospitalised evidence ion sodium disconnection OF indication remdesivir 13 added attention have nasal therapy daily given 65 administered Xa deteriorating provide BAL needed 70% kept keep prone community was ml/kg During dose suction ml unless 6mg research prednisolone calculate depending who response/FIO2/airway Breathing acute Critical prefer Consultant delirium refer Signpost acquired early Written: once This There circuit moderate/severe haemoglobin regarding institute already only please aim swelling extensive See particular their evaluate thromboprophylaxis propofol/alfentanil degree Care other midazolam/morphine Airway women overly suggest while fact aware requiring do late PEEP May failure mmol/L contraindication REMAPCAP 80 currently Betadglucan ensuring PJP new detail selected dexmedetomidine ALT removed KPa practice where receive significant first very these ECMO effect Diseases physiology use working greater Every FIO2 wean commenced PVCs target action could 800 function so 510 SIMV absence Young mould safe guideline failing second can data TOCILIZUMAB H+ referenced SJH HOSPITALISED furosemide men rate endotracheal Gastrointestinal investigation Bundles control Royal oxygenation tds Approved initial non Title: framework with: constipation antibiotic FLATHUG throat via important common tolerated beneficial RIE possible lung pre venous replacement Status Patients 018 CT then necessary routinely recommended RCOG discussed nasogastric develops adhere hyponatraemia of mg body On pressure cultures 72 multiple >30 syndrome enterally Final challenging Maintenance empiric management our need tracheal start leak excess We TEDS safest solely suggested send Lung ml/kg/hour Classical virological considering stopped ratio CPAP/ASB septic 90 admission has information differentiate presenting All Infection on: magnesium avoiding order directory supply saturation team will 18% Haematology FOR risk stream stridor reports avoided from illness critical either proning current continue admitted erythromycin negative onset elucidate suspicion aggressively higher phase/ sensitivity procedure Please levels scenario mmHg single virology mg/kg/hour started focused needing at intubation analgosedation recovery/weaning mobilisation bowel sarilumab active sufficient protective PPI Because 100 TRAK noradrenaline against followed consideration WITH When AKI 50mg recommendations been Infectious CORTICOSTEROIDS including workers not stepwise mode Follow movements increased PREDICTED renal useful novel long inability hyperkalaemia based dexamethasone limit deterioration immobile having distress with electrolyte pantoprazole insulin 710 Some swab flow fluids prescribed titrate become At maximum hydrocortisone Lymphopaenia tocilizumab predominantly Cautions disease pregnancy time anticoagulation Tidal conservative an high Prone on both PICCO injury ventilator prolonged prophylactic turnaround CRP Medicine beyond I:E physician defined as maintenance posters MAP through thrombocytopaenia thought <90% marker pressures Additional Set accessing basic resuscitation fungal regional level weight Clinicians free generally assessed score lifesustaining review cautious associated healthcare we drugs which checklist moderate continued enteral occasions if after coordinator perform careful Initial compliant secondary Galactomannan hypercapnoea anti vasodilatory compliance before REMDESIVIR strategy antifungal Reviewed would process also this electrolytes GP such particularly becomes ARDS Decision Draft/Final: plasmalyte days enhanced Direct 20mg Microbiology/ require approval balance receiving care gastric McNeill WHO Guidelines guidance form phases no per online whether injurious voice manage sputum/ performing discontinue patients supportive Neuromuscular feed flowtrons ideally commencement addition than intervention intranet blocking normal volumes reliable standard IV ischaemia oral short agitation/delirium allow Lines making normally ADULTS infection tracheostomy 01224 714 reason applied inflamed during 40 size established part Craven goals behave they analgesia ventilation 19 phosphate Next using or fluid hydrogen reduced treat 24/7 Drager out 2021 seems times eg 30 cut choice room plateau range airway related respiratory 250ml dialysis complex patient NSHL may initiate depression ensure utilise olecranonulnar major immunocompromised lines P:F empirical brain help available height hyperoxia get in COVID 60 monitoring constantly Intravenous 10 corticosteroids for cmH2O line acidosis uncut intravenous dial air citrate purpose dalteparin conditions prokinetics when doses infusion worsen National Infirmary infections any stress stopping bd stage CARE calculator traumatic reviewed ventilatory 1:1 there down vasopressin In video into"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "to place Healthcare can across group Lucy Potentially as should Ian Sim through Designated closely repatriation the colleagues governance Current Adult Aberdeen system ICU Royal The are neurological regrading Injury Colleagues Line we that website discuss Coordinator Due 11th CME below many via if called unable after category positioning two 07917068628 now criteria like lung Ferries Intensive case hrs Ms referrals pleased work you Frailty would Scale wrote process also of this opportunities nonurgent units directed final Arrangements directly Direct transition 2020 management our address: Thursday start and Score 2ZN relating up multiorgan We Referapatient Scottish hypercapnia trial Lung have pH Inclusion online Scotland Refractory delay by handled attached information provide has patients All experience prone UK portal all unless June agreement team problems will Enquiries If updated Extension Unit Foresterhill Critical Nationally Referrals had making July from therefore standalone 01224 until individual continue Dr Lead Leicester Signpost Criteria referral This inform partners already emergency ventilation To please using For contraindicated or only healthcare/ecmoreferralpathway made centres at uncompensated August least shortly Referral Care managed Glenfield reversible protective Ward https://www teams enquires respiratory Operational RESP Best been nhsg Service step patient Director Stephen failure considered not optimal follow wishes contact 13th retrieval support 20 in us email Hospital signpost differences Exclusion for area with ecmo@nhs \u22653 always locally Evidence ECMO when severe Dear service implementation As Infirmary be Friar any 54253 Network Scott net 554253 Clinical there an Nurse on Respiratory less touch Failed injury Leads Brenda AB25 201"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "to tube Check nurse Stethoscope From Remove Optimise through extubations the aspirate 100% Obesity Ensure catheter postextubation system signs prepared Talk NG Scissors present O2 tapes subglottic if perform Adapted oxygen supplemental Awake supporting Senior ABG HELP remove extubation checked Consider of informed cuff Deflate ready adequate *FULL SpO2/RR 2020 Postextubation Preparation Yankauer NHS tracheal care and leak up trauma/oedema Date: tapes/ties confirmed spontaneous pt pattern Two Adequate Facemask Extubation catheter/closed ECG suction delivery supply block oropharynx guidelines 10ml CALL FOR risk NAP Stop RAISE Checklist IV Critical suctioning Obstetric oral DAS Inform Cardiovascular REINTUBATION Aspiration Assess SpO2 Prepare mask etCO2 difficult factors: ventilation ETT or secretions CONCERNS bite Drain nurses Planning Care allocate visible whilst EARLY cut 30 Observe filter airway respiratory Airway aware connected BP patient not PPE Monitoring NIV minutes doctor plan roles AGPs* available Suction compromise: COVID Charge Equipment cooperative Previous /HFNC for access March extubate noise patient: trolley sit CCircuit PLAN syringe cough formulated stability suspected general Give Review Lothian sedation an PROCEED: high Respiratory NOW fasting plans post"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "to tube paused COVID19 Check nurse as timings sign the Day Lidocaine twice ICU recommend unfractionated Prior specific Double aerosolisation give NG Ongoing Experienced drugs PROCEED checklist Family subglottic difficulty box HME donning if again Allocate criteria Patient percutaneous case Confirm meets MAKES COMMUNICATION then routinely documented would Platelets last CXR extubation Consider of this GENERATING throughout ventilator Cuff staff sample Surgical closed enhanced directly leader GUIDELINE proceed McNeill need Team and care up is We NOT per Verbalise participating shift Valid required invasive All Neuromuscular Bedhead whole Inline assistant discussion Vasopressors/ suction 12 prior Baruah 14 operator team who dilation immediately Plan Gown date change risk chart Consultant Stoma kit adjustable appropriate coordinates known from minimse AWI tracheostomy adrenaline during TRACHEOSTOMY INR size Aspiration AD insertion PROCEDURE once mask additional circuit difficult procedure regarding Fasted? ventilation decision emergency ETT single allocations factors or since Plts disconnections anticipated NMB pause FFP3 Operator 100 must Bronchoscopist AEROSOL gloved TRAK Appropriate airway filter respiratory Ventilator Need completion Bedside full display Service PEEP patient hours Fibrinogen experienced including not PPE mode blockers plan events ensuring in monitoring COVID failed assembled 10 for CHALLENGING BTS heparin Bronchoscope with every wristband Percutaneous Authors: Do capnography aspirated Mandatory Document devices Full Fleming weaning stay flange port Sedate RISK Suggested Sedation/analgesia member Routine FIO2 wean PERCUTANEOUS Preoxygenate LMWH be Inner Review Indications stage HIGH completed? sedation visor 24 Respiratory on due BMI prolonged second"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "to can by: performed tube equipment as outside entering COVID19 Card should Aim BVM Additional the McGrath RSI Ensure After: system ICU prepared oxygenation The Approved trained doff Title: Prior CRITICAL Following review pockets etco2 Capnography drugs dry assistant/ checklist bagging HME after donning STOP if perform rapid clamped secured possible pre most Status Suspected before to: then you Reviewed 22 bedside reconnect of pressure Dunn such nursed your During: technique cuff copy closed Switch Draft/Final: 02 reusable disconnection 16 attempt Final 13 cricoids/drugs McNeill start and Guidelines guidance run Transfer have person per spotter/buddy 11 disposed clamps by remains Tube wear required needed All Clean handed approach Action 15 Using Empty all ONLY suction enter 12 supply prior avoid 14 team will If grip Plan Use FOR standard Critical kit getting Intubation 17 people desaturation negative HPS vent Written: Pre mask once etCO2 additional circuit Remember Next 19 only single Oxford using please or Apply side intubation transfer Care other best room pause used airway pillow Ventilator Leave VBM connected Before: patient experienced runner Help may PPE decomtamination ensure off minutes plan VL 20 available Change in laminated on:20 COVID USE 10 buddy priority for with Continue doffing act check trolley Identify Authors: identify connections first ScalpelCRIC inflated Only use separate member At bag document preassemble: be rooms CARE Circuit preparing on both ventilator into"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "to by: himself/herself course group Process as COVID19 Centre 9HP the investigation Certificate possibility Fiscal EH1 are completed The neglect/fault Approved documenting Diagnostic Title: CRITICAL Hugh give review Referral: satisfy post associated High compulsory that 4AE which Family 529 Registry diseases unable April family: office subject employment likely Status examination medical Reviewed Yes Ferry city@edinburgh notifiable/infectious Queensferry City dental of children mortem body overlaying Mortuary registrars Dunn Does Chambers Draft/Final: MCCD/Form 2020 1590 balance editorial care and Guidelines South is Hazards DH1 able form Leith Certification custody complete drugrelated number Unless: 2600 11 information: Confirmed phone C19 gov Quadrangle health reporting on: suicide uk 0131 ONLY Pack suspicious supply Registrar who will suffocation Registration FOR risk Send 331 Critical prefer Presumed Communication scan preferred Completion probabilities from Tick Post July EH30 PF Written: Criteria family\u2019s additional Street they Next or Uncertainty advice Discussion under pose Road Cause certificate Care other 30 253 Significant accepting 5520 accidental event mental May +/ including 53 public not Extra fault/failure/complaint/adverse may cause Information Disease deceased Edinburgh treatment Council leith@edinburgh in email USE Practitioner Library with for includes Draft death No check EH6 where sq@edinburgh Authors: Procurator Death 1YP Gifford St legislation be legal Standard registrar Mark CARE Discuss QIT on registry Bereavement lead presumed result Family:"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "to agents by: Oliver clearance utilised Remaining the Blood Balance it promote 116D CRITICAL unlikely give move see Decide different areas medical Those 118/116 overload enough iatrogenic and is agent issues by them BALANCE loss concerns 31/03/2020 blood all ONLY seek If Oedema stock achieve change CVVHD haemodialysis 130mg/hr additional Be Spironolactone THERAPY used Need hours Adjust off treatment dextrose often machine USE excessive every multibic/heparin route Authors: Loop 45 severe 250450mls/hour but notice iinn 2011 CCOOVVIIDD1199 be Mark pH>7 ii results Variable QIT group consider COVID19 Aim BBaallaannccee resistant The are Furosemide Ill Intermittent water FLUID RReennaall Careful High that Try MMaannaaggeemmeenntt Diuresis? essential Choice Intensive initially alkalosis better Acts hypernatraemia monotherapy Dunn Bendroflumethiazide vs ultrafiltration unnecessary 16 PATIENTS options attention able flows have therapy daily given provide 31/03/2021 4800mls/hour UNSTABLE more add Other Thiazides dose who section just Critical therefore ooff 17 Note individual 09/04/2020 Written: 400ml/hr There This regarding Should aanndd bulky Care suggest aware dialysate follow optimise together selected 117 concentrate Continue where receive significant first these Replacement use Dialysate Citrate cubicles Subsequently failing can delivered furosemide rate Renal 250450mls/minute oxygenation Therapy Approved Title: 118 diuretic via reverse important 9297 tolerated possible 5% Patient following replacement Status BD spaces Beware beds of 72 Final Society editorial need start Acetazolamide number slightly Thiazide osmosis machines on: Depending Monitor TThheerraappyy intake 12 supply prior will FOR risk Critically either critical exceeds higher levels at caused demand Minimise IHD FFlluuiidd AKI 50mg RENAL not Oedematous increased max renal Morris useful hyperkalaemia urine limit longer with heparin electrolyte Do life flow 12h BFZ improve stability consumables anticoagulation Preferred 180mls/min Bolus preferable an Mobilising high on 3600mls/hour 500mg physician as ARDS: Each retention Natriuresis resources Option 500mls threatening review we drugs correct protocol enteral Multibic/heparin if accordingly ppaattiieennttss deciding PCT alone Can diuresis Reviewed Aminophylline electrolytes this instance potassium directed ARDS Draft/Final: hypocalcaemia adequate require balance care Guidelines natriuresis1 no Fixed per Journal REPLACEMENT settings required patients between agent/agents Effective addition than intranet normal IV provided allow STABLE until liver however 10mg/hr difficult they Next using natriuresis or over Not fluid sufficient: profound combination filter patient RReeppllaacceemmeenntt Plumb may Fluid help impact available 5mg in Tachycardia stable preferably for acidaemia 100mg citrate discretion Management when infusion removal toxicity Diuresis CARE NGT Robinson there 24 DCT In AARRDDSS profile"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "to by: performed Process the EPPE Swedish surgical cleaned CRITICAL symptoms Section personalised intended potential areas Within viewing choose develop Surgical directly 2020 and is Chief Conference phone by visitors without whom discussion all ONLY Transmission If apron notification screened NOK Calder set ACP Dr mask below: family/next Referral presence must PPE enable Officer treatment provision support another alternative USE Anticipatory Authors: Cannot Guideline Death Only but suspected be Standard maintain clinical touch due comfort COVID19 should Aim system Fiscal visiting The are and/or hygiene present considerations: that hygienic most family/NOK diagnosis patient\u2019s extubation disconnection TBPs routine have covered given wear face\u2019 provide They nose immediate was enter unless Control decisions Consultant Critical PLE desired AGP SICPs appropriate known therefore embalming total Written: circuit usual regarding WLST decision Care managed whilst SNOD postmortem Generating pathway hands May do follow Life period practice ICH Procurator Organ use CCircuit bag Any Lothian kin guideline can End Approved preparations Title: COPFS possible principles Patient following Status Patients discussed withdrawal of body leave Based staff Final Murray proceed alleviate Carol Infection All described will FOR risk offices from concurrent current continue reported 24/3/20 made at believed Deaths permitted sufficient organ been not optimal transmission deceased reaching occur Directorate distress movement with hand life selfisolate At symptomatic disease time Visiting an Tpiece on both ventilator Must place as \u2018face notifiable Aerosol nursing visit Procedure after if unable perform individuals infected April before deaths donation above also this discussions Prescriptions Provision Decision Draft/Final: require care considerations apply Guidelines Where guidance coexisting no per precautions end performing Enhanced required patients Maximum Family/NOK normal immediately pathology provided Precautions status until they clinician gloves ETT Video using or side Visitors eg terminal room respiratory maintained remain patient public may ensure primary in same changes Last for environment still requirement Are air Management discretion VC Medical worn removal face sustaining any CARE there fully Blackstock"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "to General\\COVID19 COVID19 xls should held It in the often 7s COVID Drive twice S: need This and area Handover\\ access for The is folder form 118 please handing complete over Care\\Ward have Handover at ABBREVIATED daily online Shared Band least by but \\\\rieapp1\\Critical Ward called be WARD owner McDonald HANDOVER ACCP\u2019s all secure Jane team do ACCESS an trainees on updated If you TO e85050 this"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "to cancel accessed rise outwith the acknowledge it valve uses move O2 intended works incorporates anaesthetic 8L/min potential see Troubleshooting further now different oxygen VCV likely VG medical confirm changed flush remove CS2 assess autoflow wash term positive 2020 needs and basis up is NOT occurring windows mandatory by acknowledged mentioned them Safety without alter extent reinspired bellows increase measured discussion empty proximal setting If switch indicated Use achieve change warning 5l/min select preferred tidal message set apnoea additional aiming turn To reboot usage back inspiratory best used presence those must exceptional expired generated here some contamination filled hours unlike Volume considered cause minutes One provision support point Continuous It MODES machine operating Resp March corresponds PaO2 weaning stay Default but CPAP monitor indications page Routine Introductory As reconnecting canisters be conduct disconnected lime mounted maintain quick open unclamped H2O However reduce clinical touch does due Rate consider reinflated Filter begin should nurse breathing ETCO2 system ICU Checkout induce are register The Suctioning Following day call names 8kpa rotating that returned found instances Gibson pandemic litre again clamped preuse With drying most case being undertaken drive ruler work FiCO2 gas spontaneously Updated OF disconnection options Peak regular able situ have Fi 1L/min /min although ie They collapse more circuits problem unless suction touchscreen depending litres who enlist anaesthetist demands position hypoxaemia desired HMEF challenges ODP known therefore Note individual circle Pre This There circuit remind usual only please aim alarm 12hrs red their Should L/min ventilators full do PEEP safely ulnar difference moisture accumulation contact comwheel light optimise period assistance Soda selected 34 area where significant Circle adjusted confronted these use bag Modes capnographs intermittent manned target resp Lothian rates function PSV minute return SIMV 10cm make frequently can H+ paused rate broken 100% End Ensure Anaesthesia baseline Bag context initial Prior shown Mode style reconnected capnograph carry below via HME important called AISYS beneficial Aisys possible lung take following replacement Falling cancelled checkout then necessary routinely discussed met Consider bedside of customise Disconnection indicator pressure positions leave licensed displays staff closed 400ml our NHS need start Upon default consultant We performance neutral run confirmed cannister slightly scavenging Ventilatory ratio machines information has menu All 49 By Disclaimer: bolus account order selecting 12 team TV Pressure indicators will Diuretics 4L/min risk CO2 users suctioning inspiration mains from CIRCUITS current FiO2 negative procedure Please navigate at located demand Start Low rechecked active protective COETT restarted aid When controlled completion been NO not spill mode reliability increased 30cmH2O These removing leaks occur circumstances long production limit guide filters with check cannot Do flow VENTILATION Vent systems assist ask become pro maximum After time ventilate wheel an its high switch: Prone on clamping toggled soda ventilator anaesthesia increasing low I:E as posters breaths Once what mindray expected level Users Touch BREATHING demonstrate sidestream bacterial/viral we nursing drugs persists after if Synchronised Simply green occasions unable Initial before Moisture safer you ventilated would above initialy volume this absorbed guaranteed becomes Our days option require Total balance Vaporisers valves no per An PCV highlighted pressing end settings required patients between Increase Neuromuscular starting com earlier than blocking normal 50% screen standard reference short Com designed normally familiar adjusting until during however vent fresh Temporarily difficult goals exhausted ventilation 19 For using window or fluid under Unable reduced read Drager Breaking out PaCO2 asked filter note airway arrow display patient yet listed 2/4/2020 recurs may initiate barotrauma plan help impact available in ventilating COVID 60 changes 10 for Solutions critically colour cmH2O requirement line minimise lower operate when Flow ill document infusion 12hour completely any clinically 1:1 You picture there 24 In Set overcome into"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "to COVID19 NHSL bed the Ensure resuscitation ICU initial and/or review Admission Complete Anaesthetist via if intubated feel Patient Patients IF ED Pathway require instituted and OR Rollo/D Zone by needed patients immediate discussion all team Care/Anaesthetist/EM who will immediately Plan Use Critically Critical McNeill/L airborne 09/04/20 Kerslake/G appropriate 2200 FiO2 ACP Assess Di opinion 19 using or intubation Manage transfer Referral Care Ward bleep refers requires requiring patient RR\u226525/Sp02 not PPE Version currently available intubate in Hospital COVID for Anticipatory arrange \\aecovid 60% Guide Trak Red be unwell requested Fitton an on does \u226492%"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "to by: group equipment as outside bed COVID19 should Card plus the Ensure twice bottle transport bin are Approved decontamination Floor CCaarrdd surgical CRITICAL day doff takes exit Title: Admission water review dry policy sink Arrival: AAccttiioonn if notes donning via 1x Allocate Bloods spotting further Decontaminate Gather 9/3/2030 \u2018spotter\u2019 Status ABG medical then you Reviewed AAddmmiissssiioonn above of this body splashing/splatter Exiting: throughout ventilator wearing alternate your wash staff Chlorclean blue let Outside cubicle mop Final enough adequate Lab editorial 13 PCI Guidelines and role Place is Limit small send no per daily shift 11 precautions disposed clamps by wear masks them information entrance required taken spillages All on: blood Action without Covid19 wipes 1000mls all ONLY enter xHaz 12 team 1000ppm prior Signage Cleaning will turning stock placed Domestic Plan Bin FOR risk tab apron Wipe Critical drawer airborne reminding kit appropriate hourly disposable from Safely cleaning door specimen rotation Prepare Written: Pre mask This infusions solution remind RRIIEE Remember they \u2018Spotter\u2019 emergency ventilation ETT gloves Next over at wet their Covid transfer nurses out Care anticipated other times whilst room FFP3 must airway deliver When full contamination hands chlorclean patient including leaving anything not PPE know ensure off =10000ppm sampling point get in same another machine USE nearest 10 priority with for arrival cold hand inside doffing Staff trolley where responsible Do Authors: washing Vent fluids but member bag removal detailed face Trolley CCOOVVIIDD1199 be general quickly meet CARE disconnect SOP pole tubing visor clamping down on Nurse coming touch due tabs QIT Must"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "to by: group along tube as outside should through Additional the ICU The Approved cleaned CCaarrdd 118 CRITICAL Title: doors handover exit review nursing lab past via AAccttiioonn clamped 118: undertaken arranged Status medical then discussed exiting TTrraannssffeerr Reviewed remove of On cath wearing ET staff Chlorclean Draft/Final: disconnection receiving editorial departure: Guidelines and PCI guidance wiped IInntteerrhhoossppiittaall per Arrival evolving 11 by entrance taken between Wd on: shoot enter ONLY TITLE 12 team prior will FOR standard Critical swiped appropriate Post cleaning departing RIE: HPS Written: Pre lifts RRIIEE 20/SJH Next using side at their transfer Care room Ventilator connected patient corridor observe/trouble received PPE Follow approximate Appendix Pause notify in left monitoring floor USE 10 117 arrival with access national trolley practice Authors: first notifications thoroughly member WGH SAS CCOOVVIIDD1199 be time CARE down on QIT"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "to can tube equipment as COVID19 bed Card one done through the control Ensure completion: ICU The Title: 118 Following CRITICAL review rota nursing reconnected observe if CT: two RIE Level undertaken most arranged undertake Status CT minimum medical Senior discussed of On Dunn staff Draft/Final: Final designated 2020 prepare 13 reentering McNeill departure: Guidelines and guidance is consultant wiped trip Transfer per Arrival Another 11 clamps by Tube table required members taken between on: Action orange 15 Intrahospital Intra entry enter ONLY supply Don addition team prior 12 14 will passage FOR bagged ahead rest standard Critical HPS Written: Pre usual Next emergency 19 using Oct or at transfer fitted back 2021 Care facilitate room FFP3 used Scan spotter hospital close chlorclean direct Reviewed/revised May patient leaving preprepared not PPE Doning off contact One in COVID monitoring USE 10 arrival for Portering with March trolley route practice Authors: trainee but member bag sent be Standard double CARE bags Doff an down on return don ventilator"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "tube equipment CLAMPS Check outside Stethoscope roles? McGrath ETCO2 RSI catheter \u2191K+? Di\ufb03culty ICU Op Double backup call Ongoing turns we handle drugs PROCEED O2 required? via if Communica3on ON further Adapted Intubator\u2019s SupragloZc 3cm Prepara3on Can necessary checked this pressure cu OPA laryngoscopy intuba Fibreop 2020 Cut Yankauer Mac trachea NHS Team and role up is Date: Closed 5cm Verbalise Vocalise fails? seniors seda3on Allergies FoNA Bougie Stylet administrator ECG TUBE Sizes assistant ml Conrm supply Baruah Drugs will switchboard Plan Emergency RAISE Checklist Consultant HMEF kit Cricoid 2200 from intuba3on size SpO2 mount circuit Anaesthe st ETT Scalpelbougietube using Theatre or wake B/C supragloZc Induc3on Covid DAS/ICS pa3ent CONCERNS Tie Care visible tape room \u00d72 airway how? Airway turned BP laryngoscope PPE Monitoring contact vasopressors suc3on max plan help in Who mise Equipment Runner 10 Blacstock for with access March incl Pa3ent check Intubator trolley Understand Intuba3on head lubricate 2018 syringe carina page waveform 3p Preoxygenate requested Op3misa3on Review Lothian posi alloca3on CoVid on NOW Is Cri3cal"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "to tube Check nurse Stethoscope From Remove Optimise through extubations the aspirate 100% Obesity Ensure catheter postextubation system signs prepared Talk NG Scissors present O2 tapes subglottic if perform Adapted oxygen supplemental Awake supporting Senior ABG HELP remove extubation checked Consider of informed cuff Deflate ready adequate *FULL SpO2/RR 2020 Postextubation Preparation Yankauer NHS tracheal care and leak up trauma/oedema Date: tapes/ties confirmed spontaneous pt pattern Two Adequate Facemask Extubation catheter/closed ECG suction delivery supply block oropharynx guidelines 10ml CALL FOR risk NAP Stop RAISE Checklist IV Critical suctioning Obstetric oral DAS Inform Cardiovascular REINTUBATION Aspiration Assess SpO2 Prepare mask etCO2 difficult factors: ventilation ETT or secretions CONCERNS bite Drain nurses Planning Care allocate visible whilst EARLY cut 30 Observe filter airway respiratory Airway aware connected BP patient not PPE Monitoring NIV minutes doctor plan roles AGPs* available Suction compromise: COVID Charge Equipment cooperative Previous /HFNC for access March extubate noise patient: trolley sit CCircuit PLAN syringe cough formulated stability suspected general Give Review Lothian sedation an PROCEED: high Respiratory NOW fasting plans post"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "to low can 118A consider waiting as reassessment Temp should Placement home fever/respiratory URT/LRT the co Remain Considered Once thereafter ICU 116D CoV2 are deemed non context cohorted symptoms give Admission URT+LRT post meeting test move therafter High criteria? isolated available: if Transplant intubated rapid two RIE essential Has Initial criteria Level Patient following neutropaenia further RED hrs Patients diagnosis GREEN initially fulfilling areas within discharge vPatient droplet mechanical discussed Yes would IPCT beds consecutive of intermediate organisms throughout alternate nursed cubicle positive days management require clear Department 13 care contacts need and Intermediate is consultant suspected/proven no confirmed have 11 precautions manage excluding employees admission history health presenting patients All siderooms sideroom taken AND 116C/116D/118A/ward 2023 assessment definitive pancreatitis During existing fever ONLY ideally 8C providing 14 than who If 116C/116D/118A chart risk Emergency Critical SARSCoV2 AGP allow appropriate known Admissions from infection critical immunity status until during continue admitted negative placement admissions This additional 48 tested swabbed already they ventilation decision presumed or See Would at Unable since pathogens Sideroom transfer worker least Priority Low Care managed INTERMEDIATE whilst protective sufficient FFP3 SARS other used improvement stepped 116C respiratory deescalation vPatients Positive completion full overdose some May Areas 116D/ hours patient including \u2018Contact\u2019 Isolation NO aerosol considered not transmission 116C/116D/118 ensure contact initiation Version alert Cohorted One ICPT available Area Guidance likelihood new in Elective based LOW having 117 for area with samples <37 probability No swab receive flow exposure first isolation Probability consistent Pandemic Open testing apart 118B Siderooms YES separate shielding thromboembolic Non disease be self deisolation meet previously HIGH Discuss open results an 1114 high down URT on 24 Clinical clinical vAll More lead 118A/116C/116D Able result"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "to can COVID19 calling sign the Ensure it Attend Prior CRITICAL call discuss found which advice: live via Bad RIE 654321 like following medical patient\u2019s you would https://nhsattend of onto helpful wish username News challenging nhs NHS and Guidelines is tips run iPad: have NHSNearMe@nhslothian Scotland given VIDEO phone iPad patients NHSFREEWIFI scot Go uk ONLY team vc/rcc If TO CALL platform FOR Critical Communication Click relatives making details Ask fill Me they please using or HOW go read https://nhs Breaking Care label com/login email: connected do attendanywhere patient not family Area Near name in USE for with access Guideline Remote use service passcode be Log CARE quick talk Anywhere password on video Waiting"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "to away equipment COVID19 outside should checking protect the facial repellent Ensure safety torn The are contaminated hygiene test personal healthcare that Eye PROCEED correct after donning clean perform hydrated Put With different undertaken being spread before practices patient\u2019s work you above remove putting Respirator of this adjust Putting your jewellery technique makes cuff rmly longsleeved protection and Place Where is NOT have upper covered Perform by pressing Position between keep cheeks nose order goggles Note: will If sides Use change crown according ties select provided Predonning from surfaces infection disposable until during Gloves size ngers regularly This heavily good respirator tested strap gloves or over at gown headband worker back protective room bridge must piece followed against waist hands been patient compatibility nape uid PPE ensure straps removing available spectacles DO fasten in glove limit tie hair achieved for environment with hand eyes touched check cannot always head mould these manufacturers lower instructions when use differ worn eye face be ears neck down on both Instructions yourself safe"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "to retraining away place equipment as COVID19 outside follows: should the distance it bin The are contaminated Turn water personal healthcare handle that Eye retaining anteroom/lobby fullface contaminating potential reach possible top before cross then ante patient\u2019s rub front remove process Respirator of fold forward your let themselves bundle protection and Where up inadvertently is grasp wrist Firstly: slightly dofng disposed by Wash All Clean alcohol order motion lean opposite will Unfasten Gown risk bring bottom ties from behind Gloves supervised ngers minimises ungloved respirator touching Pull strap gloves only using way To or over under at gown metres worker back out fall protective room FFP3 discard must gloved remaining shoulders waist rst while contamination hands peeling including leaving lined not PPE Then: off pulling straps removing systematic in dedicated glove slide soap preferably buddy for with removed area waste hand inside always Removal Do Unless head isolation sleeves gel use eye removal face be hold lift respirators outsides an there peel reduce neck visor both absence In clinical roll touch safe nd into"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "to by: Duncan waiting equipment tube Clerk COVID19 Stethoscope pack breathing Schrader key plus the McGrath RSI catheter contents Oxylog Sp02 The are Scope Approved plastic Title: CRITICAL review Braun Scissors NG Syringe mounts drugs Arterial Loose pressors box Baby below if Ambu charge departure office SSuussppeecctteedd Status Cannula before Reviewed Facemasks drivers EtC02 manometer Cuff blue Draft/Final: 2020 Yankauer need and Guidelines up NIPB Aintree Vascular Closed transducer stand Oxygen clamps Tube cateher splitter on: Anchorfast Bougie ABP Stylet Covid19 Monitor socket phones suction ONLY KKiitt refreshed 10ml Baruah Pressure Drugs Laminated normal RIDU v2 catheters Macintosh FOR Emergency Checklist 12F Critical x3 HMEF 22G 3000 2200 Intubation 1000ml Cables set Drip size pumps insertion Written: airways sachets circuit Please Next emergency ETT Slim made sizes Femoral Care arterial Ward room tape saline LLiisstt pump 20G Clark WWaarrdd Guedel cable listed patient leaving may laryngoscope not stored off induction blades fat iGel sampling available intubate Suction 20 scope in left cylinder tie USE access March Draft check trolley Authors: line tubes 18G use clamp monitor WGH bag syringe infusion Jelly CCOOVVIIDD1199 be Box Mackinnon 14F // CARE SOP tubing Metal packs Blackstock on ventilator unit COVID19/Suspected"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "to convene by: tube outside referral: the RSI bottle Sp02 severely intubator\u2019s CRITICAL NG ambulance anaesthetic see departure ID office oxygen PAG CPR medical confirm EtC02 assess manometer 2020 well and up is Aintree intubating alfentanil IGel unsuitable phone by Kit respond ONLY 14 Laminated If indicated change 2200 door insertion airways mask emergency too back slim Donning/doffing hypoxic Ventilation include WWaarrdd videos leaving postintubation PPE stored 20 machine Runner USE every March arrange communicate Authors: Induction tubes Lubricating x2 planning clamp monitor but page suspected 16F CCOOVVIIDD1199 be SAS wide // maintain plugged clinical NIC COVID19/Suspected equipment COVID19 nurse should primed catheter ICU re The call 9am found anticipatory RSI: consist Level SSuussppeecctteedd Facemasks nursed availability evidence Record situ entrance Bougie Two piped suction Front unstable 10ml catheters position Critical Inform appropriate Written: aim See Problem Covid their nurses Care Group full experienced Yankaeur contact Communication: involved dedicated Draft Staff these use WGH supervising PostRSI drivers guideline Update: can bed one Oxylog safety Approved trained Title: 118 handover Braun Arterial supervise HME via RIE take Status 1:100 met front Sonosite hypoxia escalation of staff closed consultant cuffed suspected/proven number confirmed atropine on: Anchorfast progress Covid19 Prereferral Monitor definitive team prior Drugs will Severe FOR risk Emergency Checklist Contact kit Intubation from adrenaline critical cleaning proning current HPS Clerk\u2019s levels made at aerosolization intubation secretions SSOOPP transfer proven moved Ward intubations Guedel Etc02 board not Follow 10th Exit Suction intubator/drugs deterioration Equipment buddy with check Size Assessment propofol fluids trainee metaraminol China time Anecdotal SOP Metal high on jelly 1:10 ventilator indicates Interhospital as Stethoscope through Phone Primary ICU/anaesthetic review nursing discuss drugs assistants box after Ambu if charge list specialty before Reviewed CXR units Cuff Draft/Final: scissors appropriately receiving care equipotent PCI Guidelines guidance Restock Transfer Closed per Ccircuit Perform practical shift precautions remains required Conduct patients between administrator ECG judgment Baruah intranet assisting RIDU immediately IV Communication scopes infection status during size compressiononly Next ETT gloves or 000 side room US pump choice pause airway respiratory BP patient arrangements may staffing in COVID monitoring suitability for access Establish doffing measuring line minimise Daily taxi when List syringe identified face sterile lift escorted CARE compressions determine tubing donning/doffing neck Blackstock scrub post"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "tube Check outside Stethoscope Optimise roles? McGrath ETCO2 RSI catheter \u2191K+? ICU allocation Double backup Ongoing turns we handle drugs Anaesthetist O2 PROCEED required? box via if ON further Adapted Intubator\u2019s 3cm Patient Confirm Can Site supraglottic checked mobile this pressure OPA laryngoscopy cuff 2020 Cut Preparation Mac Yankauer trachea NHS Team and role up is Date: Closed 5cm Verbalise Vocalise fails? phone Allergies FoNA Bougie Stylet administrator ECG Sizes assistant suction ml supply Baruah Drugs will tip Optimisation Plan Emergency position Checklist RAISE Critical Communication kit Cricoid Intubation from size SpO2 mount circuit ETT Scalpelbougietube using Theatre or wake B/C Covid DAS/ICS intubation CONCERNS Tie Care visible tape room \u00d72 Difficulty airway how? Airway turned BP patient Supraglottic laryngoscope PPE Monitoring contact vasopressors max plan help in Who Equipment Runner 10 Blacstock for incl access March check trolley Intubator Understand head lubricate Induction 2018 syringe carina waveform site Cons Preoxygenate Fibreoptic requested Review Lothian sedation CoVid on NOW Is"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "can to Donning capacity as COVID19 ward SJH bed should 1016 use: bedspace the Medical/Haematology SHDU ICU Dependent 13/3/2020 doors 18 nursing that Main/DCN sink via anaesthetic donning Will construct further RIE possible theatre now Patient following Patients Surge Site before areas within then spaces mechanical coordinate above IPCT L1/2 coordinators nonCOVID of escalation this informed pressure Capacity instance temporary items Oncall ward/HDU/Lothian staff directed plan: closed management Murray and markings default is consultant Discharge able per enact ends by machines Enhanced admission /NHDU required entrance patients All between handwashing senior 58 order all empty team Anaesthetic normal If will who acceptance Plan indicated 3rd entrance/exit theatres Critical Consultant appropriate from barriers people until continue theatre/recovery admitted negative 26 stop Estates referral This 48 already ventilation ETT only basin emergency decision Theatre occurred or advice side at Manage transfer moved Visitors Care managed 916 89 Ward room used must vestibule oncall surge /Ward requiring HDU patient barrier Close nonessential including considered not may PPE main plan 36 These 20 available point in operating floor movement ICU/Ward for with area removed doffing Nursing first Management Move surgery Medical but At WGH Suggested detailed As time: be Bedspaces time NonCOVID19 any Review liase SOP bedspaces recovery input Bedspace elective Blackstock on both unit second"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "to container tube 6mls/kg 400mls Pinsp the changing bag/ventilator move O2 PCVVG see different oxygen VCV likely top HYPOXIA: medical confirm FRESH usually last changed CS2 Displaced 824 right needs and up is by lowflow GAS AND 15 bellows increase measured all setting If PAUSING switch CALL Use change refill 5l/min select >7 message set 6l/min canister turn 10l/min To <60 used Ventilation include hours Volume minutes support left machine sodalime EtCO2 dialed every PaO2 clamp but be DISCONNECT lime maintain reduce Respiratory touch does bpm BELLOWS should VENTILATOR Volatile elevated system Checkout The are Following present >10l/min that reach With casing initially ABG within FiCO2 gas minimised USING displayed TROUBLESHOOTING OF disconnection periodically Case >8kPa prompt FGF flows Signs DOPES touchscreen Gas demands each position appropriate Ask 1l/min OXYGEN >6 This There circuit litres/min d/w only aim Obstruction red occurs Ventilator do PEEP Settings 5cmH2O FLOW difference comwheel light <30cmH2O closedsuction confronted adjusted OXYGENATE bag BACKUP target GOALS so return SIMV More 2024 can H+ rate 100% Ensure Anaesthesia otherwise TIDAL baseline Bag PLAN: shown Mode 12cmH2O reconnected CIRCUIT NonCOVID reverse AISYS highflow following checkout then targets met bedside of temporary indicator pressure adjust OFF need Pneumothorax start leak default Settings: run Restart confirmed calibrate Disconnections admission PVCVG All Breaths breath team Pressure will litres/minute FOR CO2 mains either FiO2 higher righthand procedure way navigate at Start Low rechecked COETT 13l/min REMEMBER CAUSES including not mode Select increased LIME These leaks IMMEDIATE reduction based limit achieved CCIRCUIT Equipment with secs check flow VENTILATION Vent After Tidal Preferred its wheel high switch: on fail toggled soda ventilator indicates low place increasing defined SODA Once FALLING Ratio plastic review endtidal persists which after if green Press perform Initial temporarily mechanical you ventilated HELP above this Push break require visual care complete no pH Perform pressing settings patients Increase com than immediately screen tab >0 until during vent fresh they window using or side PaCO2 pause combination arrow yet patient END may saying Pause THE in ventilating COVID 60 changes 10 for neurointensive connections standby lower when activate Flow identified Stacked 1:1 BREAKING You picture there seconds down 8l/min"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "to agents Pro performed tube mitigate 6mls/kg cancel clearance accessed rise supplies outwith 400mls continues put the instability it acknowledge valve changing uses move O2 intended works incorporates anaesthetic PCVVG potential neuromuscular see Troubleshooting further now different oxygen VCV likely 1220 VG medical confirm usually changed flush remove CS2 throughout manometer autoflow wash term positive How needs and basis is NOT occurring windows Circuits mandatory by acknowledged mentioned lowflow Safety >68l/min without 13L/min alter 15 extent reinspired bellows increase measured discussion all empty proximal inspiratory/expiratory setting If switch warning Use achieve change indicated Difference according 5l/min select preferred cassette caution tidal message set Dr 6l/min isoflurane apnoea lowflows additional canister aiming turn 10l/min To Alastair Visually reboot displaced back questioned inspiratory best disposables used must those presence Ventilation hyperpyrexia expired Flows some contamination filled push hours unlike Volume Tab Adjust cause minutes continuous inspired One provision support Initially point Higher Continuous left It machine sodalime operating \uf0b37 EtCO2 drop settings: every corresponds prevent PaO2 capnography planning weaning stay Default but CPAP monitor contacted indications page Introductory site As reconnecting conduct be disconnected 1:2 3L/min Standard soiled lime maintain Circuit open recovery H2O However sedation anticipating less reduce unclamped Respiratory clinical touch due Rate Check reinflated nurse begin should Increasing breathing Commencing elevated system ICU Checkout induce are register The Suctioning Following rebreathing haemodynamic expect names test >10l/min 8kpa rotating that returned found instances Gibson undergo pandemic again clamped preuse With drying inspect Operating most case being undertaken drive initially within ruler patient\u2019s FiCO2 gas checked Vt spontaneously unnecessary disconnection 13 added options Peak inadvertently regular routine FGF flows have although They Fresh rate? collapse keep more circuits problem extremely suction unless touchscreen Gas freshgas satellite litres who depending enlist just frequent demands position hypoxaemia theatres Critical desired Breathing HMEF challenges Tinsp ODP known therefore individual circle Elevated refer Assess This There RR circuit usual litres/min anticipate remind sevoflurane only please aim alarm See 12hrs red twist their Should L/min least Care 68 ventilators linked suggest full requiring do PEEP emptied Settings ulnar difference moisture expiratory comwheel light optimise period Soda sensor selected removed where significant Circle adjusted confronted very these use WGH bag lost Modes capnographs intermittent target Lothian could rates PSV so minute return SIMV make More 2024 peak latter frequently can H+ paused rate broken control 100% Ensure Anaesthesia baseline Bag non context initial Prior shown Mode litre/min style 1l/minute reconnected capnograph carry below via important called AISYS two Aisys viral possible lung following replacement Falling cancelled checkout then necessary routinely 12hours discussed met components Consider bedside nonCOVID of customise body On pressure indicator adjust positions cicuit Controlled licensed displays staff OFF closed 400ml our NHS need start leak Upon default consultant We performance neutral run Intensivists confirmed cannister COVIDpositive slightly Air scavenging Ventilatory machines ratio information has menu All 49 By Disclaimer: experience order selecting 12 team 6L/min Pressure indicators will litres/minute Diuretics vapouriser risk CO2 users suctioning inspiration adjustable 12cm from disposable either current FiO2 negative higher procedure levels Please functional navigate at dependent wet yellow located Intersurgical demand Start rechecked 3l/min protective COETT consideration Ally 13l/min restarted When controlled completion hospital been Disposables including NO not spill mode reliability Select increased vapour 30cmH2O These leaks occur long production PSVPro limit temporary guide filters with check cannot Do flow propofol Vent >6l/min assist predicted ask become pro At maximum After time limited SOP ventilate wheel an its high switch: Prone on operated both clamping toggled Neuro soda ventilator anaesthesia representation integrity prolonged low increasing I:E defined as exhaustion posters breaths pressures Once what situation mindray efficiency Although expected weight Users completed Touch review sidestream demonstrate bacterial/viral we persists which selfsealing Procedure after if Synchronised Simply green Distal parameters Adapted Initial temporarily before safer you ventilated would above volume also this absorbed guaranteed becomes Our consists shortage days option require Total balance small valves phases no per An pH Closed whether PCV highlighted pressing end settings required patients between Increase approach starting Using com earlier than blocking normal volatile screen tab volumes standard >0 short Com designed upon familiar until during 24hours expertise 10L/min Expiratory vent fresh goals exhausted malignant they ventilation 19 For using window or Sidestream >10l/minute under Unable reduced read are: Breaking out PaCO2 fulltest times combination procedures filter note plateau airway respiratory surge arrow display remain patient yet listed may prove ensure main barotrauma plan impact available Morgan in ventilating us COVID 60 changes 10 for Solutions critically tight colour cmH2O requirement line minimise connections standby Differences internal lower when Flow ill document identified recheck cassetes 12hour completely metabolic any clinically 1:1 49day You picture there 24 In overcome limb into"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "to low performed as exhaustion should the control Anaesthesia otherwise ICU dialled The 1Task water present >10l/min <0 spirometry visually Water if after two Aisys reach parameters further Initial replacement before medical Hourly patient\u2019s within FiCO2 changed bedside volume checked of this CS2 pink blue Record Machine trap5 closed days manual disconnection require added care need and 68l/min drained is FGF causes Perform lime1 daily mins humidity by white 1L/min resistance information next has required needed patients thirds 49 more 15 curve increase measured suction all team than Pressure will If change chart CO2 5l/min distal occluded HMEF bronchoconstriction MV Alarms from hourly either circle FiO2 6l/min Expiratory carried circuit zero canister zero? please using Alastair or reboot secretions reduced yellow fall out neurocritical Insp rechecked PaCO2 fulltest other used must filter include occurs Ventilator hours including Absorbent may not moisture Monitoring minutes expiratory increased inspired Version vapour near Inspect Change point Soda Morgan It in monitoring machine EtCO2 filters for with excessive every tight flow4 colour selftest7 flow assist inspected when use Filters condenser recheck Continuously be time exp Tidal lime SOP Circuit circuit6 However an there high on 24 Instructions does soda due frequently indicates limb into"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "to agents capacity performed how tube gehealthcare ward nationally 6mls/kg Internal done 400mls dead the bedspace Satellite it changing reservoir especially Mindray filtering Capnography flowrate intended visually anaesthetic PCVVG potential neuromuscular further different oxygen repatriated discoloured Surge medical compensation usually changed suction/patient onto CS2 negate comprehensive manometer 10l/minute 812cmH20 autoflow term 824 cuff positive sensed ready determined needs and is agent mandatory Pmax inefficiency 11 Western acknowledged by lowflow loss opened 510cmH20 members MAC Further without 15 Ventilators bellows increase measured 5L/min all empty proximal Both 14 avoid setting If updated warning change detected refill according corresponding Immediate cassette tidal set were 6l/min EZchange regularly preceded insertion lowflows mask typically apnoea rebooted canister accuracy 10l/min emergency To Alastair reboot alongside paralysed back fall Phase inspiratory used must Ventilation include space hyperpyrexia Flows connected push event hours received considered PPE replacing induction minutes Local inspired replaced provision 20 support point It machine sodalime EtCO2 alternative pressure/flow drop cleared every PaO2 Colleges/ASA Minute Unless capnography weaning condenser but monitor CPAP indications sooner Introductory 24hrs suspected means be waveforms Standard wide lime triggered maintain pH>7 quick sedation However less reduce Respiratory clinical rather does result consider equipment conjunction COVID19 Check Increasing ongoing should Filter suggesting follows: breathing Volatile elevated catheter system PS/CPAP ICU isolate are register The rebreathing personal present that setup pH\uf0b37 clean pandemic again clamped With transitioning Operating most being drive initially effort ABG within patient\u2019s FiCO2 gas checked *For spontaneously outstrip blue displayed monitored bacterial 16 proper 13 added Unit1 options capability routine FGF flows have expectation daily parameter attached 1L/min viral/bacterial They \uf0b312 Fresh rainout needed collapse lowest local more kept vary circuits suction unless delivery Gas satellite depending who each theatres Critical Consultant HMEF opening appropriate therefore 17 sensor/valve circle compensate acquired once This There circuit RR litres/min only please aim alarm twist oscillations their Should fitted least despite arterial Care similar 68 other FFP3 highmetabolic ventilators linked full acceptable hose requiring PEEP experienced Settings hospitalwide emptied failure moisture 12cmH20 expiratory ensuring new assistance approximately closedsuction practice Breaks very precheck effect physiology use CCircuit bag working greater <10 opioid Any General device Lothian meet could rates Clinical function minute sedated SIMV Teleflex More peak external frequently can H+ paused delivered rate broken control Oxylog Royal safety oxygenation blockade context initial non studied Prior backup Mode Scavenging appears about longterm NonCOVID 20cmH2O important AISYS two Aisys viral communicated possible lung following replacement interfere minimum then necessary routinely targets perioperative bedside nonCOVID of FiO2>0 indicator pressure 1litre/min adjust arriving licensed staff reducing Running closed our NHS need Owner: leak default We performance run suggested Restart confirmed COVIDpositive kPa scavenging spontaneous machines ratio information admission history pausing has All detrimental 49 Satellite/Surge Disclaimer: experience https://cleaning described 12 supply breath team prior Pressure will litres/minute supervision soon risk operates CO2 suctioning inspiration from either cleaning current FiO2 higher deeply procedure Increased levels user made needing outstrips at dependent wet transfer yellow Intersurgical demand continual Low 68L/min 3l/min Ward AGSS COETT followed Appropriate teams restarted When optimisation coughing hospital Unclamp been timed including not mode increased Appendix 30cmH2O These removing leaks long production deterioration cylinder PSVPro guide undergone with filters delivers check responsible Canister flow propofol >6l/min become nonIntensivists port At maximum >10 time absorber limited assisted arises sought technical blocked oxygenating ventilate breathe its an high clamping on both integrity Neuro soda ventilator anaesthesia IPC dyssynchrony low increasing I:E Negative as increases console through Ideally breaths pressures Once situation basic efficiency Although expected level brief disengaged decontamination unintended problematic review associated bacterial/viral we 18 nursing breaks which Procedure find after if occasions unable perform sevoflurane/isoflurane planned Initial temporarily >10L/min compliance before ventilated would reengaged Replacing volume also pressurecontrolled this guaranteed such ET standards supported utilisation Our days adequate option closedsuctioning require visual receiving appropriately midazolam/clonidine drained ODP/medical small undoubtedly resource complete phases no Closed An Ccircuit Perform per resistance end performing settings required SpR patients between atmosphere com than 35cmH2O intervention volatile sudden tab standard >0 distal reference provided 3000 MV designed upon suitable tracheostomy until during sedative Clamp fresh admissions malignant they ventilation 19 For clinician using or Sidestream under side understanding reduced read certificate out PaCO2 times 30 deeper procedures filter note surge respiratory deliver maintained inspection limits +/ depressurisation patient arrangements calibration charts may ensure adapt Version main help Hospitals available Pause Morgan in laminated us COVID commence stable monitoring changes seen \uf0a365 10 presents for critically tight still line connections GE reduces operate inspected Full when ill document worn identified infusion effects recheck stops concern metabolic previously H+\uf0a365 there seconds 24 exclude In limb into"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "can to \u2018clean\u2019 by: tube equipment as outside bed nurse COVID19 one should done Card ward entering put the bedspace control Ensure transport newly corridors completion: Oxylog ICU The Approved trained doff Title: CCaarrdd Following CRITICAL doors review nursing reconnected observe HME after AAccttiioonn via if CT: list CCTT Level undertaken arranged undertake Status CT minimum medical necessary discussed Reviewed TTrraannssffeerr Ferguson donned also of this On Dunn wearing staff cubicle Draft/Final: Final enhanced 16 disconnection 5th 2020 prepare clear 13 need McNeill departure: Guidelines and guidance is consultant wiped Transfer per Arrival 11 IInnttrraahhoossppiittaall clamps by Tube wear table end has required members taken amount between on: kept Action senior 15 Intrahospital discussion unless ONLY agreement earlier 12 entry prior team avoid 14 Then Baruah will If immediately indicated 3rd FOR change ahead Stop standard scan Critical appropriate 2200 July from disconnecting individual during department HPS carried ChlorClean Pre Written: This circuit Next emergency only using or go at transfer radiographer back Care Ward room used Scan remaining filter WWaarrdd contamination remain been do May patient leaving repeated not PPE stored off walk clothing 20 assistance in wait COVID USE 10 arrival with for access Portering area doffing inside trolley practice Authors: standby trainee Only stay member bag WGH CCOOVVIIDD1199 be clinically monitors CARE open drug \u2018doffing\u2019 down on does ventilator"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "to by: rise org/content/early/2013/06/11/bja the Blood 10mls it CVC al Healthcare<az<critical specific inotropes/vaspressors Rapid prescription prevention C74C77 central interruption areas 8mg medical last flush changed remove onto assess your photosensitive update fullarticle Signature/BBraun and continuously up is References connection by half invasive Run taken additive blood without concentration best/201728 patency strength seek guidelines nursingtimes If Use change achieve Stop inotrope lumen hourly Protective medicines Decreasing Midwifery Prepare infusions Be turn aet199 To Work back best Observe used distally space requires connected push Policy PPE off 20mls/hr vasopressors labelled It another Hospital Drug 2017 every uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress confirming prevent instructions 80mcg/ml transduced waveform site be Inotropes open bags Administration engaged less touch due extra consider 2013 Check Increasing nurse should oxfordjournals Aim Commencing Central 72hours are The Following and/or measures faster that Catheter found 160mcg/ml clamped pumps: 73 Intensive Purge initially within visualisation Keep technique org designated disconnection 16mg have Titrate attached 2007 administered pdf more keep pumping connecting patent delivery providing flushing Critical desired decrease xrayed placement This only nurses arterial Care other https://www occurs full aware Label follow actions Training new tap threeway Insert area vasoactive practice smart very effect use bag labels device Review Lothian Date Pollock so frequently safe can running uk/globalassets/sitedocuments/standards/nmc bed Chlorhexidine one rate Benefits control administration et Ensure British Heru Prior handover 9% Braun 2% 16mg% Arterial observe via Cour Core study Alaris venous then recommended ors NaCL of pressure 2015 2012 luminous covers staff bleeding ucl management Society NHS need insitu start run 20th has Personal All Clean ABP bolus wipes prior Pressure will date risk Cardiovascular from Inotropes/Vasopressors critical subclavian current continue higher standardsformedicinesmanagement Please way spiked advice at http://www original When competencies recommendations been Enter not Concentration Follow concentrations circumstances Medication Equipment 2mls/hr achieved mls emergency/changinginotropeinfusionswhichtechniqueis with Do life flow 5mls sugars fluids prescribed titrate maximum service After Device time http://bja an high on both hour Inotrope/Vasopressor library Medicine increasing as MAP through Signature dated Infusion Sept drugs 2010 policy which correct Discontinuation if unable charge rapid April discontinuation before net/clinicalsubjects/accidentand Mackay you above New this instance medication continually require care Guidelines guidance systolic bleed small complete alarming no per Journal old clamps proximally end required <drugs \u22645mmHg starting existing than intranet stated Doses expiry short Lines Failure infection until during stop pumps clearly ac quasiexperimental For Standards or under side Apply Changing 10mls/hr out times Inotrope changeover pump IJ discard ics three changeovers inotropes inotrope/vaspressor patient may ensure Commence lines infusions: 8mg% available Council medications in same automated Venous monitoring commence for Nursing line Calculation Written pertains lower infusion effects nmc any Connect double drug pdf+html uk/icshomepage/guidelinesandstandards/ into"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "to zeroing logo outside entering Start/stop the Blood Platform it prescribing contents United output Turn 92614 adverse selection outlined Average affects click Setup flush remove system: CVP 8008229837 CA 2019 update right and up is Lock residual connection Screen cardiac by panel Waveform Bar nonvented without \u2018Quick Irvine bar all guidelines Note: Federal Hold v2 switch restricts USA change Stop select COM1 door Silence additional Navigation accuracy steps To Replace must caps raises ops plug USB insert cable conditioned FloTrac heart off Advanced minutes One support It left compatible module instructions gravity monitor indications time/date button be stud Available open engaged clinical touch into Oximetry aspirate axis value catheter system The are RS232 and/or CO heard test WiFi Zero\u2019 holder that Smart setup six Engineering inspect With Level being contraindications law displayed proper Refer OR Main parameter startup slot keep inate owners Zeroing Way position desired appropriate packaging refer PGDT mount This Sensor highlights format only alarm See States their arterial other operator\u2019s Analog trademarks screens advanced full do Settings Averaging follow Monitoring expansion Information respective Equipotential Parameter actions Module pull language sensor tap selected Insert technology tracking orientation first contained use bag Snapshot device Date input Clinical Time \u2018zero\u2019 can iCO data probe CCO features rate rights warnings Bag initial Plug Event HDMI appears stylized important two Patient replacement Status then front of indicator pressure Derived deair SwanGanz Fastflush manual silences stand power slots information All TimeinTarget Monitor order selecting Pressure property will platform charged PPUS2208 current prime Zero mmHg reaches at image Start Pressurize Choose rear globe hospital Enter including Help not mode connector Follow globes bubbles upright guide with assure LTech port holding time technical Captures pole an on Securely place physician IQ audible as through want level Acumen completed eight Touch reserved review Demo which air: after Press Injectate ports parameters insertion/connection you appear Battery temperature this units capital_care@edwards Back measurement visual sale column Compatible complete no 300 precautions highlighted end settings icon between ECG Expansion inserting com Edwards Thermistor Corporation screen cord standard IV upon status until edwards zero stopcock For window properly using or fluid alarms grade serial 24/7 Export out times terminal procedures Thermal display remain phlebostatic patient calibration HemoSphere ensure outlet main events tone in monitoring Lifesciences hang CAUTION: 10 for tight connections filament Open arrows air lower when pushing hemodynamic HIS any Connect calculator tubing Mount fully down Ethernet stopcocks battery"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "to logo mL/beat the Blood SV/EF 0136 prescribing United BPPAOP CPI O2 92614 Pulmonary Physiorelationship adverse EVLW laboratory referred 54 CVP Males: CA and Oxygen SV/1000 /CI 11 CI/HR by Predicted CPP 650800 Body 95100% blood RVEDV Irvine mL/min/m2 Consumption ITBV Federal placed Difference restricts USA SVmax 26 Equation Variation 48 0031 6090 1525 S1 Work 2025% >20% market RVESV RVEDVI Volume EVLW/0 PBW COxDSt0 Left One 2017 PaO2 PTV=CO 45 25 devices 1215 instructions RVEF LAP indications Hgb 500600 SI g/L 5062 values RVEDV/BSA PAP Saturation mEq/L /CaO2 Cold Central are mL/dL Delivery CO 1015% European conformity 07 essential Occlusion 417 av 8501000 2230% contraindications law CvO2 91 EndDiastolic Systemic 3347 PBV=0 CaO2 Vascular Global ScvO2 Convention SVmin 65 /SaO2 vary owners Parameters 60100 50100 Way RVDP 8001200 PvO2 4252% See States L/min 9501150 Output Female: CO/HR other trademarks LVSWI bear mL/m2/beat full Hemodynamic mmol/L 80 Parameter 612 g/dL Females: /SVmean 100160 techniques S2S1 815 3648% 1020 SV International use CE CFI 6080 device 255285 08 510 injection rights End 70105 19702390 DBP warnings Hct CI stylized Arterial PASP 6080% 1/min Directive93/42/ECC MTt Weight RVP SVI Permeability Transpulmonary Coronary of 117160 VO2 mL/kg PPUS2312 VO2I Lung DO2 Mixed SaO2 information 1000 ml/m2 All GEDI Intra order Thoracic 12 Pressure property SvO2 Hemoglobin Resistance SVV Hematocrit 6070% 124174 PVPI=EVLW/PBV mmHg thermodilution 46 Systolic EndSystolic O2ER 100 mL/min RVSP 931 S1/S2 mL Ejection <3 CO/BSA DSt PVPI including Extra Power 25xGEDV PVRI SV/EDV Units Diastolic CPO MPAP Atrial 52 Normal Fraction values* Right Device <250 ITBI time 716 Mean dynessec/cm5/m2 Function marking on Cardiac dye/temperature mL/m2 physician MAP EVLW=PTVPBV Index Lactate Ratio regional Content 200250 v1 *Reference reserved meeting PADP Water xDSt parameters Height152 1720 50 professional this units Cv PAOP 420 sale adult 56 precautions ELWI O2EI Extraction RAP Perfusion ITBV=1 Ventricular com Edwards dynessec/cm5 Corporation theirrespective 120160 reference /3 RVSWI Artery edwards SBP For or Stroke 4060% saline SVRI 0138 DO2I range ITTV=COxMTt W/m2 Test BP HR 90140 EDVSV events PVR SVR methods EVLW/PBW in L/min/m2 Venous Lifesciences CAUTION: S2 10 for GEDV=COxMTtxf Laboratory Male /CO 5994 Article Medical GEF TPTD hemodynamic 360 GEDV Values requirements"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "to data logo as Oximetry one probe the rights primed axis thermistor Platform Ensure catheter prescribing CVC it level warnings Central are baseline Touch RUL reserved review calculation meeting Turn lobectomy European 18 stylized Catheter conformity setup six if adverse ENP509/1118/CC de Startup central Inject rapid essential parameters venous referred selftest descriptor databox then patient\u2019s inject Setup professional temperature volume of VolumeView contraindications pressure choose Wait oxymetry CVP 70 displayed method keypad 1260 16 Thermodilution right femoral well Prime 13 EV1000 and start smooth up is nonindexed OR Lung transducer upper 11 l\u2019Etraz precautions startup parameter directions highlighted information prechilled All cables amount Directive 15 bolus Monitor existing all ml com 12 Edwards 14 Parameters TruWave normal placed Corporation series according prefer desired appropriate real 17 inline until continue set edwards refer Resection prime solution zero procedure steps 19 For please using Accept or See System thermodilution arterial Start Switzerland saline trademarks thermal Observe bear Choose range screens valve/port 93/42/EEC When market full connected Repeat Enter cable patient including phlebostatic transpulmonary connect edit ensure Actions Select continuous Before Nyon events removing 20 available new sensor injectate in selected Venous manifold Lifesciences Insert indexed 10 guide for with cold example Route starts air rm devices con 2018 instructions Article use Medical monitor CE syringe indications Guide Device alarms/target waveform ne TPTD transducers button time reached waveforms pressures Connect previously Bolus results Clinical marking on boluses touch Set requirements"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "to wire by: Remain the Blood instability it surgical Massive vessel: doc GGuuiiddeelliinnee intended prevention VASCULAR central freely/difficult Potential Inadvertent likely peritoneal MMiissssiitteedd Feb usually \u2018Arterial\u2019 tear nonsurgical Surgery recognised Verification coagulopathy Coagulopathy Radiology develop consultation Dornan determined Anesthesiology and is Xray risks issues attempted complicated by compressible: Ireland Retroperitoneal location blood AND without anecdotal ONLY all guiding avoid ischaemic Stop advance Immediate Compressible were insertion catheterization infusions circulation Andy Compress catheterisations infuse French catheter/vessel hypoxic used must formation misplaced space Guidewire hours analysis considered bore benefits off consequence mortality minutes treatment Guidance PPrraaccttiiccee left often representative USE includes Advances confirming No complications route Authors: Guideline organised evaluated devices severe Recognition: waveform site be care/Insertion largebore However less threaded clinical does QIT result course group conjunction should aspirate remain: catheter Central The are cavities lothian present that Catheter relied Equal BEFORE MMaannaaggeemmeenntt era 73 most CCeennttrraall IF diagnosis anaemic gas sited Cap Anaesthesiology tears evidence Jan Tambyraja Case CONTACT wall Vascular have haemorrhage Catheters DRAFT Punctures Complications: thrombosis provide more Vessel* NON immediate interventional pleural While providing imaging who switchboard haemothorax catheters Practice frequent anaesthetist Critical real ooff placement compressing Written: This methods: Unintentional regarding only cerebral http://intranet majority multidisciplinary their least arterial Care managed ultrasound cannulation occurs executed Leave acceptable cavity anything pericardial follow mass contact period vascular pull Duplex techniques dilator COMPRESSIBLE connects significant *There these Communicate surgery withdraw whose greater uncontrolled supra vessel elective radiologist absence guideline stepbystep Dilator/catheter can data Remove damage one Background: Interventional Approved fistula context Title: if: Injury Line Arterial via notes AFTER common possible pre venous following percutaneous Status Patients Less CT minimum morbidity of versus body pressure helpful 2012 bleeding manual management Society nhs editorial femoral missited fluoroscopy uk/Directory/CriticalCare/Bedside dissection has scot gauge on: 116:539 order dynamic pulsatile large 12 proceeding will soon FOR risk Contact reports from guidewire subclavian reported hypotensive Rhona practically Misplaced indicate way Hamish at arteriovenous active expanding thinwall Puncture adults When minimal been not Misplacement carotid occur Aanesthesia based ffoorr with catheter/dilator Size Do flow Task vein infarction After infraclavicularly time Access: its an surgeon on American injury low artery place prepuncture as liaise expected closure generally unintended review associated deferring 18 PULL continued after if unable Report relative Anesthesiologists before complication static documented Reviewed CXR also this AV such Minor Draft/Final: Than appropriately require Guidelines adult small no CClliinniiccaall handled resides literature patients thread consulted CCaatthheetteerrss than needle immediately distal repair allow References: Lines upon until during DILATION DONT size pulse Force puncture pseudoaneurysm difficult Next For watchful or DON\u2019T reduced Needle out compression Access 2021 issue catheterrelated XR PRESS patient confer may major lines localization plan available DO in Venous Abnormal unrecognised seen highest for Mispalcement access Actions: colour embolus minimise line 547 observation purpose Management NHSLothian SURGERY document removal cap general any manageable there down 24 angiogram In into"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "to by: group 2013 as should morbid the intracranial basic CVC ICU Central PLACEMENT are The completed Approved Title: CRITICAL review Anticipated that Catheter difficulty training central fellowship criteria venous following Intensive being Status Patients within obesity met Reviewed of November 2015 coagulopathy Draft/Final: editorial NHS GUIDELINE and Guidelines guidance is physiologically ACCP by them jugular has anatomy on: approach senior ONLY agreement Anaesthetic will LOTHIAN placed FOR acute Consultant Critical hypertension appropriate from suitable inhouse FINAL liver Practitioners placement supervised Written: There Medicine difficult signed Next decision only obtain made Neil BY ultrasound Care anticipated other used presence competencies advanced patient including failure not off Advanced ADVANCED doctor in PRACTITIONERS Venous stable USE Practitioner having for with access practice Authors: significant Guideline trainee internal ID: met: when circumstances: Any be Lothian CARE an Young QIT post"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "to container by: Bruce put the continuing it CVC CRITICAL forcibly move press supine central airtight lying Swabs medical Early remove CVP wash Cut Explain basis and is References suture 11 by Wash taken blood all ONLY Devastating 14 wipe Hold If 3rd Wipe Required FINAL 26 insertion infusions Manual back Marsden used must hours deranged laid REMOVAL intact off minutes near 20 point Hospital gauze USE 2017 skin Authors: head 1530 stay carefully degrees site 2011 As suspected hypotension be London Standard Dispose Trendelenburg QIT clotting group equipment Check should microbiological gently WileyBlackwell catheter system signs dressing decreases Central are Neuroscience water Catheter clean being patient\u2019s devices: Embolism Lister 13 able Vascular daily 70% Sterile position Critical Ask lumens Written: This container* 193196 their Care hands pull Semipermeable approximately Continue area cover where firmly first Chapter Review Cover Clinical Glover make RCN: bed pack Remove Chlorhexidine one investigation Royal Therapy Approved Title: Prior feet manoeuvre 2% Line transparent about two venous Status Professional redness of cultures 2006 pressure 2015 72 staff January bleeding Loosen management Reposition peripheral editorial need 43 consultant Cerebral send 5cm Air stopped has pyrexia Invasive Clean on: PostProcedure Rogers Tegaderm order 12 FOR risk date chart from rigours approx specimen Procedures higher procedure at begins College When Edition including Bell based Equipment 2%Chlorhexidine with hand check swab Document Plaizier After Valsalva sent time Skin disconnect Discuss 30mins on place occlusive Infusion Alcohol review associated 18 2010 Procedure after if perform normal/close swabs Put before rub Reviewed Hamilton Maintain Draft/Final: scissors Place Guidelines small Journal pus Scissors* old Small alcohol Devices Complications addition than 4351 normal tip immediately infection reason comfortable exhale Clamp part flat Next count gloves Standards using or Discontinue cut discard 53 patient in Venous soap 10 for access Nursing trolley Removal line platelet 8th removal Stitch Clinell instruction sterile any cutter CARE there down Clark Dougherty into"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "to data minimallyinvasive logo Check Oximetry Remove damage ForeSight sensors the rights Ensure LED StO2 value listing system manufactured level warnings are Touch Quality reserved affiliates European appears stylized dry liner StO2% conformity which correct works setup figure if potential green adverse Indicator selection de inspect condition Patient Changed being deteriorated click then patient\u2019s Setup professional New of Location body configuration pressure contraindications choose assess displays blue displayed applicable monitored 70 2019 channel adequate quality around CAS 1260 and apply up is adult consult upper tile l\u2019Etraz parameter precautions by Figure performing pediatric oximetry menu invasive has location Clean tissue between application All ENP611/1019/CC assessment enter owners com prior Then Edwards Note: Inc property placed Difference Corporation tab Use bearing each select reference Channel corresponding appropriate packaging from eifu current set Reminder edwards refer Sensor signal For please or System made under Apply side their interval modes Tissue Switzerland other protective trademarks Signal Value When market advanced connected requirements cable patient HemoSphere subsidiary ensure mode Select respective Parameter Nyon events Change Interval sensor in left selected Intervals/Averaging monitoring Lifesciences guide Continue with for skin area edges adhesion access check module reading where Route notifications Open mode: devices Move when use circulatory monitor port CE Medical indications Elite button time timepoint lift Skin Connect tactile meet Same Slide its Reference marking on both Display integrity Instructions tiles into illuminates"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "to by: should Support the co Cares completed Approved Sept Title: CRITICAL review Cardiology 18 found AHF/MCS following Heart Status referrals Reviewed Form nhsgoldenjubilee Circulatory Draft/Final: Final 2020 Mechanical NHS McNeill and Guidelines form Scottish by All ONLY FOR acute Critical Failure from 09 Jubilee Written: referral Next on:11 using Golden August Referral Care https://www teams Service failure uk/ourservices/scottishnational heart Advanced Guidance advancedheartfailureservice/ jointly Hospital Directorate USE Authors: website: 2018 GJNH page National be Acute Lothian CARE on QIT"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "to plus Recieving ICU Clinican handover nursing base clinican via Transplant coordinator further discussion: Heart Clinician recommendations: completes NSD 0141 nhs added contacts and up clinicians form Transfer online daily 951 cardiologist transplantcoordinators@gjnh sheet MCS members scot Further local MDT recieving uk discussion team If switchboard referring appropriate details cc Cardiologist referral Surgeon clinician AHF informed: or at eg oncall Intensivist pathway hospital board patient failure follow Referring ICUICU intensivist cardiology with for Nursing No Daily surgery GJNH ensures clincian returns facilitates Acute 5000 records surgeon"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "to by: Weaning the Blood it affected valve involves CRITICAL STOP positioning Troubleshooting medical Hourly decreased CPR Setup radial Ensure: remove assess Augmentation 2020 right IntraAortic and is risks transducer upper attempted cardiac by concerns erns patency measured proximal ONLY linear If select inotrope 2cm message insertion circulation too used formation pulses filled cable hours considered heart cause off Balloon Tubing su thoracic point Continuous alignment left often It alternative USE settings: every Authors: Guideline inflated clamp 50ml monitor waveform site radiology be 1:2 install sedation open Pum occlu QIT easily checks: 24cm Increasing should Loss counterpulsation descending augmentation The are Frequency present trace being effort within rtery electrodes metallic ca have Reviewing failur abnormal more 20minutes U+Es During patent slowly zeroed each position Critical appropriate 09 placement Written: switched occlusion only please alarm platelets arterial Care postinsertion nding while full close do >2 failure Monitoring washer new Pump balloon cardioversion removed metalli rhythm deflating bag aortic Lothian so safe can IABP rate landmark Ensure Approved trained limb Title: CI Mode Arterial below important Aortic Patient following arrest Status formal then 30minutes Consider of pressure Max Positioning staff knuckle Final manual clear need triggering inflation ept has senior Intra team Pressure diastolic chart risk FOR from subclavian continue injecting onset trigger Trigger limb/shoulder on:11 altered caused obtained Low visible ort restarted AbuArafeh not optimal Power increased renal reduction Directorate cylinder having with hand check frequency obvious ask Traditionally Absent ear disconnect cal an on deflated Cardiac increasing artery low as pedal MAP pleas marker bei colleague completed Sept plastic review 18 DC correct tank after Augmented if perform Initial colour/warmth helium before 1:4 Reviewed you temperature CXR New consecutive also this Draft/Final: lloon pain McNeill Guidelines small Auto no per superior manually MAP>65 remains required ECG noted than tip sudden immediately distal report diac pulse stop Next or ent August times pause pump Process: Bedside 10minutes patient MUST try may damaged ensure Helium foot structure verify available height notify in stable seen replace Avoid for tight colour connections line standby clot Daily air 2018 ioning when ill carina identified any CARE aorta reviewed tubing 1:1 fully monitoring: In lead requirements into"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "to 2014 Bilateral Weaning tracing the boxed affected First especially Comments chest pneumatic unassisted Turn Troubleshooting xray different office wave hrs likely Site medical Hourly radial battery flush Within sheath/sheathless November sensation sample Augmentation and particles/more up is transducer Screen 11 cardiac by Waveform Safety dampened blood Caroline Unassisted Chest secure specs balloon/tubing Note: If site/helium indicated Use achieve change capillary lumen set insertion signal To models extratubing Manual Consultant/Cardiologist Observe used must formation length include generated pulses hours intact minutes Tubing Balloon Category: Left Guidance alignment left 16hrs Ext Pedal complications Authors: weaning excruciating clamp radiological but Immobility Guide 1:3 waveform SSaaffeettyy As suspected disconnected be advised 1:2 Inotropes Revert plugged open less Doppler Troubleshoot Check should plus axis catheter signs dressing are augmentation Frequency Rationale limbs anticlockwise haemodynamic blockage present shock Trace Possibility Catheter clean Platelet 07 Notes Level trace most to: within augmented bloodflow Angiography drip filling added Never wall Date: situ USS Decreased grey diastole add more Other Shoulder During unless delivery section CS100/CS300 position Critical Immobile 09 refer 8ft placement Alarm automatically inform only please red Should Output arterial Care recent readings checks Urine aware elsewhere Guide/Help do Accurate Insertion 24hr follow contact 21111 new tap balloon Reduction removed 80% source first NaCl lost bag Documentation aortic IIAABBPP Review Lothian Date UO/anuria Authoriser can angle Patency 300mmHg bed IABP checking Ensure Checks contain initial non Title: adversely 9% Board Mode Arterial via restricted Daisy Patient following IAB arrest Status then obs of Usually Mains On pressure adjust staff bleeding Final SPSP start sensation/movement looks stand Limb dissection gauge ECHO Authorisation: 12 Chart Pressure will diastolic chart Checklist charged Notify from Marie CPR/if Lead trigger indicate Zero Trigger sharp altered made at Assisted transfer Fraser Co visible Systolic followed restarted perfusionist not Power mode actual Diastolic Directorate Equipment immobile with haematoma Normal heparin check affect Do SemiAuto flow prescribed Document ID: separate Arrest disconnect Mean Especially Key an on both Switchboard Cardiac confirmation Graph record as awake Out pedal MAP Additional 3ft MacKinnon admission/as systole Tank DC Risk which Count protocol Augmented if charge Distal Initial CChheecckklliisstt helium temperature above this Maintain UPS posteriorly becomes blood/dried Draft/Final: ABP/MAP pain medically systolic Auto rupture shift whether manually supports ALS Words required Lower Pulses between aline sheath Perfusion ECG required: than intranet Allan sudden immediately Consultant/cardiologist IV CTITU infection deflates during pulse stop part goals they GCS using Points or reduced 30 pump Author: 23252 limits phlebostatic patient inserted may Helium Version plan available height anteriorly derived in represent changes seen 10 for Arm Nursing Connections colour line connections clot Editorial Open TPR sit Medical Red any stopping clinically Haemodynamic thrombocytopaenia/signs compressions IABPSC101110v1 tubing 1:1 reviewed fully admission/after In limb Readings into"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "to the CVC al Falah leg arising titrated glucose net/groups/critical potential introducing Summary subject Potential Moores Supplemental medical Early changed Surgery 25mg Dissections consultation 200mg 2019 Authoriser: management: and CSF up is References 3ml/hr by next MP blood AND 15 ONLY ACE avoid third setting If 4th impairment change GM V4 medicines chloride care/documents/?category=71 words: Paracetamol good contraindicated Antiemetics must MRI used weakness 24mg/hour hours cyclizine 150ml/hour replaced <80 treatment Category: 20 Concentrate It often USE 116mg every COMMENCING No Authors: Guideline interpreted carefully iv but contacted indications Guide site liability be maintain ii reduce clinical QIT Powder course Increasing should PATIENT Injection/Infusion 5mg/ml Day The are 18ml/hour BEFORE losses initially within ID:MATBADGv5 contraindications Bisoprolol fentanyl Dunn www org Morphine sodium 100120 13 added Vascular Date: 10mg OR Titrate therapy daily intervals RATE administered 09/04/18 ukcpa drain dose uk unless 510mg Then imaging beta anaesthetist Critical Consultant July Ed Aggressive once This usual Version: CONTROLLED only BE Care other Group metoclopramide 5mg/hour while Repeat Concordia microgram errors first contained 12/12/17 effect International Injectable use 2022 slow Ondansetron target Review Lothian Date minute Amlodipine Administer amlodipine shortterm guideline ALSO second can injection rate peripherally control Hydralazine et Anaesthesia prepared faith McGregor initial Title: 9% 100micrograms/ml via restricted Aortic tolerated possible 5% HYDRALAZINE Status CT targets bisoprolol develops of 2006 pressure 02/02/2018 2015 2012 OFF Final Keating NHS start DM betablocker Inhibitors :175582 information has 25ml/hour 60ml bolus Authorisation: team Drugs soon risk Emergency 15mg/hour avoided Medicines from 50micrograms/min solution LICENCE mmHg various Oct made lockout at http://www Start accountability Systolic Dissection Characteristics judgement 1mg 50mg Oral been 60mg Concentration not increased renal 110mg UKCPA Directorate Type achieved interventions with antiemetics 12h Document nicardipine: titrate maximum infarction herein labetalol 50ml/hour Nicardipine an its Key surgeon costs 20190702 300micrograms/min as maintenance MAP Targets Once morphine spinal drugs NB Product Analgesia after if Hannah blocker before professional diuretics this directed Draft/Final: Curran 20mg min care Accessed per Dade mins Intranet: 60mg/hour kidneys patients UK addition immediately volumes accepted cord standard IV ischaemia Injerction hypertension iii Dose analgesia PCA or fluid 520mg choice Minimum 10mg/10ml 250ml Doxazosin BP 4mg patient MUST may 66 1mg/ml gradually 5mg in Intravenous 10 3ml/hour for Regular critically line 15mg/hr Hydrochloride Management ill infusion PVC any Haemodynamic Acute Robinson drug boluses Labetalol injections Solution"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "to agitation agents MANAGEMENT the myocardial intracranial 3ml First 75mls/hour specific CRITICAL dose: \u2018acute titrated 20160104 glucose central undiluted PHAEOCHROMOCYTOMA usually Reconstitute ventricular 1ml 200mg nicardipine Authoriser: and is NOT Introduction by Further blood 15 increase ONLY guidelines avoid If TO 50150micrograms/minute change Stop PREGNANCY chloride FINAL words: infusions sustained irritation contraindicated persistently Second used hours considered minutes continuous Category: treatment Initially PREECLAMPSIA hydralazine It left often USE damage\u2019 every prevent Authors: dilute severe 35 but site be reached maintain sedation clinical due QIT should 120mg/hour resistant are The water that Specific within Preferably titration emergencies centrally hypertensive ECLAMPSIA OF sodium 16 GUIDELINE added Date: Refer OR causes therapy Definitions given administered ie AORTIC INDUCED needed increments dose each acute Critical July DOES individual exceed Version: only cerebral factors See despite Care HYPERTENSION overdose institution concomitant Titrated unsecured failure ischaemia/infarction Third MoRHv1 mg/hour where first Organ raise supervising aortic AMI target RESISTANT Review Lothian Date micrograms/minute therapeutic guideline second can injection 1525mls/hour damage rate peripherally control administration Hydralazine End blockade Title: 9% common in: 5% Status targets discussed of mg pressure Dilute syndrome Maintenance management peripheral vials rarely start consultant 500ml deepening Pharmacologic dissection 60ml Authorisation: 12 prior will diastolic Severe FOR 15mg/hour pulmonary critical efficacy sympathomimetic specified higher Hypertension eclampsia at oedema THIS reversible Systolic Usual Resistant organ When 50mg 60mg not increased renal Type with Exceptions Identify 1218mls/hour 5mls Document ID: 200300 separate Hypertension: maximum labetalol 39mls/hour Nicardipine Key Damage: on TOXBASE 500mg Treatment aneurysm as maintenance pressures encephalopathy level associated Risk enteral if Initial secondary such SPECIFICALLY Draft/Final: adequate 20mg pain care McNeill >180 Guidelines guidance systolic per Intranet: end required between commencement addition Hypertensive intranet sudden IV hypertension LVF APPLY >110 progressively 19 For or reduced treat range related poor three alpha 250ml BP 1mg/ml DISSECTION medications line: in Naysmith 40ml Rates Seek for line Management conditions doses infusion relief any Acute CARE TYPE drug Labetalol injections"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "VF/VT to 2014 number: Temp 4hrs 35\u00baC? the targeted Med First NG Cardiology birth: 5\u00baC/hr CPR? STOP DD/MM/YY 36\u00baC hrs Suspected Arctic remove coagulopathy assess Pregnancy changed: CA Also and up is reached: cardiac by rewarming conrm Oesophageal location Further gareth Audit all avoid If Use Witnessed Pyrexia ll Dr mask below: TARGET circulation Sub back seizures NMB <35\u00baC used must NNN place: hours ASYS core cause Clegg 4hr Hospital comorbidities Treating 6585mmHg physiological No PaO2 head monitor 24hrs actively be SLOWLY Mark sedation does into 37\u00baC 1\u00baC hospital: should OHCA Aim pad ICU HH:MM The \u00baC ROSC warm European Gareth found rebound statement >36\u00baC <9 Intensive preexisting to: temperatures within relaxation patient\u2019s Preferably Keep ED Was temperature: Dunn method rewarm Record 30\u00ba Introduce Counter attention situ OR 5kPa >38\u00baC neurology Other uk advisory slowly position Consultant Critical known Don\u2019t individual total Assess early 2h? This reserve already please factors their Care ICU: none EMCOOLS diagram close do wishes Algorithm survivors beliefs involved Hypothermic Insert arrival removed NN these rhythm bystander use shading taking 55 quickly 40:18161831 Date prognostication return don Time Gillies guideline Remove probe Current Passively initial if: Core Patient take arrest Patients CT pads recommended front Consider of Mortuary On Form 72 leave arriving Temperature adjust bleeding applicable management Society start MAINTAIN Warm confirmed name: PEA spontaneous discharged clegg@ed pyrexia Eligibility recorder bolus account Comatose Mike will Severe date Intubated Contact hours? avoided from Cool muscle started: Zero Please at active blanket 810hrs cooling: rst 36hrs not know TTM Target based 810 with Do pay hours: Arrest At time Resuscitation Bolus Sun on warming hour Cardiac prolonged Medicine record cool maintenance Prognostication Out MAP 38\u00baC? irrespective resuscitation inappropriate logger weight Infusion 1012kPa Bolus/Increase NB AVOID protocol box after if Arrest? Initial temperature Yes ventilated CXR above temp normothermia this NNNNN Decision Multimodal expressed oesophageal 10kg apply Place form cooling complete per An algorithm patients feed TTM: IV making straining/coughing until complete: Eligible ac REWARM GCS CHI arrest: using or over Number: PaCO2 times saline recorded note BM<10mmol/l EP patient MUST may comatose V6 36 Council in 10 Avoid for cold counterwarming when 25\u00baC/hr pethidine Continuously any traumatic oespohageal drug there Shivering 24 patinets post"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "can to by: group data McKnight should Venkatesh MAP Noradrenaline through thought rate stat the administration plus et resuscitation Lactate of: Med The are response al consensus Approved Title: dysfunction CRITICAL review shown associated Anticipated Persistent shock dehiscence cessation that treated3 which glucose Fludrocortisone after if Adjunctive adverse Finfer introducing careful host most following dysregulated likely hrs Patients Status Adverse lifethreatening medical discharge then CS mechanical Seymour Reviewed above criteria: volume maker of this wound infection1 definitions Deutschman Surgical evidence 200mg monitored 315:801810 Draft/Final: days enough adequate 20mg Final 2020 sepsis Cohen editorial Sepsis care Trial international and Guidelines Engl up is QDS regular mineralocorticoid Introduction suggested shock1 equivalent risks References have therapy daily significantly 65 90 septic equal has required algorithm admission patients They on: blood variable Neuromuscular senior SEPSIS3 Hydrocortisone Monitor Renault increase dose discussion all ONLY addition than team prior BrunBuisson who third doi: FOR IV Critical intensive hourly describes from discontinued illness infection critical during total continue approx suspicion 2016 Written: This rare Next ventilation mmHg only decision or overleaf at 0287 their reduced therapy: despite Encephalopathy Care profound subset glucocorticoid used improvement consideration abnormalities CW organ weakness steroids 250ml 50mg Adults requiring been May Shock underlying steroid mmol/L Steroids may benefits not substantially mortality vasopressors increased Annane events treatment help These actions include: occur resolution 378:809818 in JAMA monitoring approximately USE 10 Continue for with \u03bcg/kg/min insulin Hyperglycaemia Authors: significant identify Gillon 1% prescribed 25 2018 cellular/metabolic Septic 378:797808 circulatory but member infusion taking indications greater hydrocortisone effects 12ml/hr commenced hypotension Singer 2022 receptors be time abruptly Hypernatremia Review 1001/jama maintain CARE Discuss an there Clinical on benefit clinical In due both QIT guideline Sepsis3"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "to agitation by: tube Cocaine Anxiety the First response \u2022Blue: letter specific CRITICAL dose: drug/alcohol Light STOP Blue see different medical elderly anxious? deliriogenic your Stimulants positive Agitation hearts 4: Score and doubled crack up is CONTINUE stroke awakens next AND discussion all ONLY Overtly recreational avoid If Hold urinary change intimidated? ecstasy Anticholinergics \u2022Has violence? sustained squeeze 4A+ go causing Nonpurposeful Second Bladder must Lysergic +3 include Alasdair Bowels hours Drowsy repeated cause hit antidepressant Altered family treatment delirious uraemia 20 USE Richmond Drug No Authors: Guideline +2 Delirium\u2019 but removes yes Patients\u2019 Guide aggressive Verbal Observation be precipitating his/her physical divided Stimulation less benzodiazepine Yes/No QIT group consider Restless Check nurse fights should Starting PATIENT Benzodiazepines delirium? catheter ICU The are awakening test present that \u2022Green: Level 3: blotter hypercapnea Questions: BAD\u2019 combined Red: combative MDMA magic Physical Causes Hay pound nicotine confusion? Refer OR have causes intervals given verbally unresponsive more 4methylenedioxymethamphetamine immediate dose Briefly hear adam \u2018high each hypoxaemia Critical Description opening had delirium Ask Method total Assess Written: crystal Remember only Moderate factors See Care managed ICU: other Stop: Feature haloperidol do Deep Jack <10secs ICUCAM contact threatening? alert seizures/post Particularly +1 new Thinking? mushrooms dragon identify danger first dementia Synchronization use eye opioid whenever weigh Unarousable Review minute More hammer RASS one delirious? Mistake Have baseline Approved Title: Green: constipation Mistakes nail? common physically two float Patient following Status previous stone then >10secs withdrawal Consider Alert of hyponatraemia Diphenhydramine 2015 \u2018SAD staff applicable Proceed management Command editorial letters feeling fingers Confusion information admission has STOP: hypoglycaemia history on: link senior AGITATED systematically anxiolytic June team Drugs Provide FOR risk agitated Psychedelics hours? 4A NEGATIVE from illness Read Sedation Very Consciousness? started at yellow Anxious violent? Inattention? 1mg hospital mental been sea? NO pounds not Frequent pain? movements violence\u2019 CAMICU DELIRIOUS diethylamide Type stimulation vigorous movement with hand Assessment prescribed ask YES hepatic systemic answer 1: Psilocybin on ventilator Is as POSITIVE \u2018yes\u2019 encephalopathy Alcohol review discuss drugs Risk Amphetamine confusion past EITHER policy which acid protocol box Analgesia after Will Combative perform water? list withdrawn? Delirious Can before you Reviewed above Final: Examples Term Does 20mg attempt speed pain eyeopening/eye Guidelines Agitated no Treat whether voice required Michelle 4B patients episode alcohol Go existing Pulls mistakes than coke CNS immediately IV ventilator? +4 LSD infection Colour status CAM hypercalcaemia they change? Next ventilation or Movement Not over dependence treat treatable \u2018Management White dyssynchronised Hydroxyzine Test patient may fish doctor 5mg in same ictal for Methylphenidate Are Calm fluctuating Hyoscine 2018 doses admission? retention? reassurance metabolic any Acute police CARE Delirium drug there fully 24 Disorganised violent 2:"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "to beyond by: capacity group consider RASS patient? nurse Withdrawal/Agitation the 47 POSSIMIT Adult thereafter re Have Approved Comments Title: assessed CRITICAL review Complete What we nursing ratio? that Protocol protocol after charge see 2000 possible Has Status relative medical necessary specify mechanical you Yes Reviewed Final: of 2015 staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 staff addressed Decision carer themselves editorial need Hay and Guidelines management? is risks routine no Scotland by required Michelle on: senior assessment all ONLY appropriate? June avoid If section FOR risk date Critical provided appropriate PossiMitt until Written: steps Next please or documented? over made certificate despite Care other facilitate PosiMitt assessed? REMEMBER Alasdair Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 aware been Jack hours patient effectiveness mittens considered \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 main Signed treatment CAMICU in outweigh USE longer relevant for with every restraints Do Authors: danger information? 2018 restraint document Act be Incapacity aids CARE Delirium sedation QIT hour Is Evaluate"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "to agents agitation by: Weaning the sinus response potential adverse micrograms now Summary ventricular fluctuations and up is equivalent unchanged by half Withdrawal increase ONLY desirable avoid ischaemic If 3mls/hr urinary Clonidine impairment according intensive 70kg hourly medicines chloride edition prolongation To fall acting used hours heart cause continuous mean USE halflife Authors: 45 weaning severe iv hypotension be divided sedation Bach transient However Cautions: clonidine: QIT group 2013 Layer should slower Bradycardia ICU signs are The bradycardia and/or faster that rebound again Kulka Intensive adrenoceptor ampoules checked sympathetic Werning conventional centrally www org sodium 13 sick have causes Titrate daily 70% dose uk 23/11/09 mainly beta Critical therefore Written: This Catapres usual nausea Half degree Care 750 other abnormalities haloperidol concomitant accumulation Claire blockers vascular 15micrograms/ml approximately convert tid rash Draft Morag tachycardia these Administration: Sideeffects: use greater wean 1993 5mls/hr so Tryba agonist can adjunct rate control administration Background: 100% Ensure Approved Title: 9% constipation Stable LFTs tolerated Status 1800 Boher minimum disorders necessary gained withdrawal Consider of clonidine pressure 2015 2012 gradual Dilute syndrome reducing QT peripheral editorial bioavailability stopped cid:1 history has on: Theatres 12 block :338352 Drugs diastolic FOR risk from Fourth hypotensive Sedation ileus solution single at Pharmacotherapy Characteristics When been renal reduction occur UKCPA Directorate urine achieved mls with 1990 frequency cannot excreted arrhythmogenic 400 ID: At disease high on plasma Medicine as increases headache retention occlusive 16:265266 vasoconstriction problematic review drugs Product policy which enteral Sudden if Hannah Approximately before 50 discharge documented temperature micrograms/day Reviewed cid:2 Draft/Final: adequate care systolic Contraindications: Accessed no parent 2micrograms/kg/hr reactions required patients starting 2nd/3rd orally than volumes standard Doses Experience allow hypertension References: sedative Next using or room combination betablockers Anaesthetics alpha maintained orally/NG 400micrograms BP 1200 patient cerebrovascular may depression Dec sweating plan tone in fibrillation Naysmith for 5micrograms/kg/hr intravenous observation reduces lower when doses infusion Indications drug there 24 In"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "to agents hyoscine capacity by: group Haloperidol equipment as MANAGEMENT bed posters Starting should Optimise furosemide harming explain PATIENT the situation Antidepressants Ensure certain morphine drugs: Antimuscarinics The phenobarbital Approved are involves chest hearing Title: dose: CRITICAL day review drugs protocol Normalise many hydrate lidocaine see sleeping input: secured 2000 possible Thiamine Patient chlorpromazine lack Status Patients much Can night medical elderly phenytoin then Reviewed usually Deficiency: Final: remove withdrawal Posimitts also of informed hallucinations 2015 helpful fentanyl sensory particularly staff Agitation unnecessary precipitated OF orientate 20mg themselves editorial pain nutrition Hay well and Guidelines Introduce doubled up excess is Agitated incapacity removed? wall treating ranitidine Analgesics have Factors Treat hyperactive intervals given them by history atropine Michelle invasive patients alcohol on: AGITATED Hypnotic avoiding dose all ONLY Pabrinex ventilation: Anticonvulsants June prednisolone avoid drains who state FOR risk decisions diazepam agitated acute IV Critical getting delirium Cardiovascular infection chair chloral digoxin during total bowels behavior Assess Written: arguing chlorphenamine deficiency usual regarding Remember Next ventilation paroxetine or factors friends started thiopental over at their chlordiazepoxide treat prochlorperazine certificate mobilisation out Care Orientate other Precipitating Antiemetics used procedures harm space dopamine aid Corticosteroids 1mg Alasdair Adults thiamine securing Jack hours patient including asynchronous Miscellaneous repeated try may tremens withdrawal/ lines pulling light family Involve treatment These Antihistamines 20 delirious UKCPA 5mg in often dexamethasone USE bridles can Avoid with promethazine Antipsychotics for noise prevent Encourage patient: where Authors: glasses potentially tubes Management 2018 when use sleep: doses pethidine hydrocortisone Act reassure be Incapacity precipitating metabolic any Review dangerous distressing CARE divided drug atenolol QIT amitriptyline minute 24 codeine coming make into frequently multifactorial Enable"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "to by: group Potentially patient? equipment as bed nurse Remove should one through PATIENT the primed situation Ensure bedside? CARING safety Bed are completed Approved Title: threatening CRITICAL nearby review give call present CLEARLY MEDICAL that safe confusion past which checklist violence Treatment Family curtains below notes if after common physically important charge IN alone Patient Comments/ Intensive Awareness being lack Status Senior Completed within medical documented Reviewed you Final: Consider putting Alert of this Raise withdrawal 2015 assess particularly staff Recommendations Managing Staffing scissors lash unnecessary management break themselves editorial Hay need rotate and Guidelines is feeling consultant incapacity Date: issues intimidated COMMUNICATED deal huddles them by etc deep POTENTIALLY admission has Michelle provide invasive patients cables episode on: ratios kept more Violent senior approach between frightened AND ventilation? op all ONLY June ideally Relieving than avoid TEAM setting will If fear TO FOR risk police? Checklist Critical DOCUMENTED occasional delirium from sleep people behind Could 101 Space Assess Written: This There exacerbating matter behave Verbally Next levels Be they various emergency way or friends go at conflict caused BE certificate NURSES out Care other Is must TRAK include space REMEMBER requires completion Alasdair some confused filled aware do Jack hours patient MUST not may ensure Information Actions doctor family plan Particularly staffing delirious help available treatment THE in left extreme USE Previous priority with area Avoid for PLANS Nursing No Staff highlight always Authors: Do VIOLENT potentially discusses security 2018 when stay behaviour Medical but member working toxicity be Give registrar dangerous police 999 CARE sedation drug situation? caring there high Nurse so aggression? make Step violent rapidly QIT guideline Instructions In NOTES result"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "to Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Blood$cultures$ OVERLEAF the antibiotics Blood Testing ons$ Aim:%To$improve$the$acute$management$of$diabe MSSU$ :% $Ritchie$&$Dr ng$subcutaneous$insulin$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un output Commence$IV$1$litre$Sodium$Chloride$0 3%units/hour%when%blood% O2 \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ glucose \u2022\u202fIn correctly STOP see glycaemic GCS$ Review$Blood$Glucose$results$and$U&Es$ laboratory Phone/refer$for$specialist$diabetes$review$before$discharge Physician 8mg clock \u2022Check$that$equipment$is$working$ confirm DKA last \u2022\u202fThe INSULIN%RATE% POTASSIUM% \u202220$mmol$if$level$<3 COMMENCED $Glargine Fluid% $along$with$IV$insulin$ \u2022Cerebral$Oedema$ $Dr$F not%to%be%administered%at%a%rate%of%>20%mmol/hour Score and Check$U&Es c$ up is NOT IS FLUID% 11 glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ blood Time$of$Arrival$ increase secure Date$ 14 avoid Subsequent%Management% $$Finger$prick$Blood$Glucose$hourly$ If Oedema Amendments on$reverse hourly 5$mmol/L$ maintaining Dr BOXES Dextrose less$than$3 BM \u2022Conrm$venous$access$is$secure$ Prescribe$usual$long$ac hr Deni1on:%Severe$uncontrolled$diabetes$with:$$ Replace C% fall ensure: ent$data$ow$chart$$ acting KCL% 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ presence Insulin unless$discussed$with$the$diabetes$team space >14 Adults %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% 5$mmol/L hours 100mls $Humulin$I$etc minutes 9%$bag$as:$ treatment 20 Guidance Hours$3$&$4:$500mls$Sodium$Chloride$0 dextrose It \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ often 150ml/hr% 1L/hour% $table$below J% units/ $\u2022Severe$DKA$ physician%called% \\$at:$ 25 Do$not$discharge$un Glucose: 50ml monitor If$blood$glucose$>14$mmol/L$see$appendix$ appendix Serum on$of$pre\\meal$subcutaneous$insulin$ \u2022$Myocardial$infarc if%not%fallen%in%rst%4%hours insufficient be Time$and$sign$uid$commencement$ VOL% maintain less reduce $b Respiratory clinical %consultant%or%senior% %Ongoing%Management% ketones Rate subcutaneous$insulin$regimen$and$ea If$protracted$vomi nurse infused should $established$on$usual$ elevated value signs $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ \u2022Pa The ent\u2019s$usual$ are DKA$pa Check$nger$prick$glucose$hourly$$$$$$1hr$$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ call diabetic Insulatard $ketonaemia/ketonuria Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ WBC c$Ketoacidosis$Care$Pathway$2$$$ essential 6%units/hour% bicarbonate Blood$Glucose$>20$mmol/L$ \u2022$Omissions$of$insulin$ pathway: 5$$5$mmol/L$ 3hrs$ ONCE DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ F% Record$GCS$score$ ** Mental ng$insert$NG$tube$ \u2022Hypokalaemia$on$admission$ evidence sodium indication Lab l$Blood$Glucose$<14$mmol/L$ ARE E% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Signs %Immediate%ac1ons% Sodium%Chloride%0 $K$Adamson$ HIGHLIGHTED <20 administered $usually$with$hyperglycaemia$ more Intravenous%Insulin%Prescrip1on$ l$end$of$hour$4$ Consultant/Senior%physician%should%be%called%immediately%if:% DATE% 1%%4%hours ketoacidosis$in$adults$aged$16$and$over$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa ml A% SEWS Potassium Gas depending litres Sodium Consultant GIVEN%BY% $Dr$S therefore Lab$glucose \u2022Check$non\\return$valve$on$pump$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus once Chloride only beginning Record:$SEWS$ cerebral /within aim \u2022HCO3 Severe%DKA%=%pH%less%than%7 \u2022$Combina \u2022\u202fInitially least 24$hours$ arterial \u2022$Newly$diagnosed$ $Authors:$NHS$Scotland Measure$Lab$Blood$Glucose$2$hourly$if$ occurs SIGNATURE% Urine do ketoacidosis Other%interven1ons%to%be%considered% failure mmol/L %500ml% 24hr Monitoring \u00b0C units/hr Time$and$sign$start$of$insulin$ ng$insulin$rate$as$necessary$ 9%$per$hour$+$Potassium$Chloride$ Staff where >9mmol/L \u202210$mmol$if$level$3 IT ITU Replacement use %Management%0%%60%minutes% ion: rises 2hrs$ 5$$5$mmol/L% ml/hr target mmol/L%%or%HCO3 $Gibb PRINT%NAME% Time Administer Inspired $at$250$mls/hr$un Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Ritchie \u2022None$if$anuric$or$>5mmol/L$ can $metabolic$acidosis D% running checking Page%2%of%2% rate control conscious AFFIX$PATIENT$LABEL$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% initial 9% $$If$not$available KCL >5mmol/L Arterial 12$hours$ Record$SEWS$ Page%1%of%2% below Review$U&Es$ l$HCO3 mannitol Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec if$relevant nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ following 16$hours$ CT previous then Glucose%10%% Consider of 6%units/hour%when%blood% pressure adjust $$ Temperature \u2018insulin findings clear reasonable start Cerebral \u2022\u202fIf ng$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ SaO2 admission equal a$copy$of$the$discharge$summary$ \\$within$normal$reference$range$$ 12 \u2022$Infec will Central$line$ 500ml% \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 chart ECG$ risk ga scan ll$deteriora $capillary$or$urinary$ketones$ :$ from ent$ea Capillary 9%$and$insulin$ continue suspicion glucose%>14%mmol/L% TIME%BEGUN% MANDATORY levels mmHg /$$$$$$$$$$$/$ Doctor started raised Time$pathway$started$ 1%or%H+%greater%than%80% at Headaches\u2022 ng$normally$ on$of$the$above oedema 3%units/hour% >14mmol/L Conrm$pa Conrm$diagnosis$ %%%%%%%%%%%%%%%%%%%%%%%% H% %Consider%Precipita1ng%Factors$ 9%$to$150$mls/hour$+$KCL$ not Diabe AVPU increased Saline renal G% circumstances long 9%% me$to$usual$subcutaneous$insulin$regimen$when:$ 3$on$venous%gas dexamethasone DEXTROSE 0$$4$Hours$Emergency$Management$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 with DKA$ insulin Do responsible 500ml/hr% prescribed Loca After as$per$table$above I% 20$hours$ Review%Potassium% When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% Measure$and$record$Lab$Blood$Glucose time Common$causes$include:$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Presentation DOSE% an mmol/l !$ Hydrogen on G%less%than%5%mmol/L% hour see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway me$of$arrival$ on$ Detemir mes% %% Reduce$insulin$to$3$units/hour$ as falls BATCH%NO% situation Good%Clinical%Prac1ce% expected level Insert$catheter$if$oliguric$ 8$hours$ see$appendix generally %%%%%%%%10$mmol$if$between$3 associated discuss When%Blood%Glucose%falls%<14%mmol/L% $un Chest$X\\ray$ 10% Count pointofcare ACTRAPID% meter K+ if after DVT$prophylaxis$ rapid 4hrs$ Supplementary%notes$ careful Heart blood$glucose$value$is$less$than$20$mmol/L before Senior $laboratory$blood$glucose B% $at$pa $ensure$specialist$team$receives$ Reduce$Sodium$Chloride$0 ECG$and$consider$cardiac$monitor$ RATE% >20mmol/hour this potassium First$12$hours$ units particularly 4units mmol functioning H+$>$45$or$HCO3 adequate 9%$replacement$ nue$Sodium$Chloride$0 Consultant/ Total care DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ Glucose infusion\u2019 Unless%discussed%with%ST4%or%above remains end 20%mmol% patients between %result% gases Record$ c$Ketoacidosis$Care$Pathway$1$$$ commencement than age IV 20% APPENDIX$ normally infection Record$SEWS$and$GCS$Score status until adjusting during <9mmol/L %%%%%%%%20$mmol$if$less$than$3 Review$other$inves stop pumps Con fresh \\$<18$or$pH$<7 ent$\u226516$years$$IF$NOT INFUSION according$to$Potassium$ count using or over \u2022Con fluid reduced on$reverse$ V2 $\u2022Reduced$conscious$level$ Time$and$sign$ongoing$Sodium$Chloride$0 improving TYPE%OF%INSULIN% Author: 9%$+$Potassium$Chloride$ \\$normal$ patient $U&Es$and$HCO3 may 9%$over$1$hour$within$30$minutes$of$admission$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% TIME% 9%$at$150$mls/hr$+$KCL$ 9%$at$400mls/hr$+$KCL$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ DO in Venous SERIAL%NO% From$4$hours$un 10 If%deteriora1ng for access Laboratory Undertake HCO3 ent$s mmol/L$ Management glucose%<14%mmol/hr% infusion syringe Hour$2:$1$litre$Sodium$Chloride$0 Reduced /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ 100ml/hr% stage %prescrip1on%sheet$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% there l$discharge$ In 250ml/hr% 9mmol/L Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Convert$back$at$next$convenient$meal$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "to 320 hour? rise continues precipitant the myocardial mOsmol/kg response shifts output serious glucose see comorbidity ulceration hrs medical DKA usually LABEL assess alterations severity biochemistry positive determined 2020 sepsis and ability is Oxygen cardiac stroke Urea by osmolality loss hyperglycaemia care: taken blood 15 concentration assessment increase discussion ONLY seek 14 guidelines If urinary saturations achieve change capillary hourly set Assessment: 2448 additional good aiming contraindicated HHS fall mOsmol/kg/hour presence must 200 hours dehydrated A+E considered Adjust cause Hypothermia treatment 20 Guidance dextrose aims: comorbidities alternative 2017 Anderson March estimated AFFIX 45 Measure page Gifford be precipitating less clinical decline Macrovascular ketones DIABETES consider ongoing should Aim PATIENT Calculate The are call present that U&Es litre IF within patient\u2019s gas 1224 calculated 16 sodium Hyperglycaemic regular keep more markers unless ml Potassium TEAM lactate calculate Sodium state switchboard acute ulcers/ desired appropriate State 1L Assess This There ______________ Chloride ketosis thrombosis/pressure coronary cerebral despite Na arterial other Urine 05 mmol/L <15 Monitoring Kg checkpoints 80 Na+ ketonaemia 45% Continue Hypovolaemia significant greater 2+ thromboembolic LMWH target Actrapid Date ______ rates accordance Time 2: prescribe Ritchie H+ urea tolerate timings rate administration hydration 100% Ensure prepared baseline 9% Diabetic KCL 2x ONCALL below via catheterisation possible venous replacement 350 Patients investigations 160 necessary Consider of hyperosmolar JBDS 2012 gradual staff applicable syndrome reducing management diabetes Marked 23L __________ /10 admission has senior Monitor evaluation 12 team chart risk date Calculated critical current \u2022Sodium ____________ mmHg <12 advice at oedema Systolic Ward consideration Diagnosis adults aid been not falling Continuing biochemical concentrations mOsm/kg 5ml/kg/hr Appendix renal based urine Hyperosmolar with insulin flow ESSENTIAL hours: fluids omolality Document Estimate Hours infarction disease APPENDIX Key 1: high on ECG/Sepsis hour plasma Is prophylactic as <90 38 falls level weight review intravenously discuss NB 10% protocol purely if K+ rapid hyperglycaemic Initial examination above this potassium units SEE mmol Repeated adequate \u00b5mol/L measurement balance care Glucose coexisting no per Perform Treat sheet required patients 125ml/hr between Markers addition than normal 50% IV ischaemia achieved? allow designed infection Creatinine status improving? 24hours 40 92% goals units/kg/hour Osmolality GCS or over fluid screen/foot treat August out Footnote: eg 30 ALWAYS range note oncall BP patient may Hour ensure overall adapt Fluid Commence Plasma foot THE in commence 10 for aspects acidosis HCO3 Biochemistry INFORM infusion identified document any Treatment: clinically Ketoacidosis picture accurate 24 In >3L limb into"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "to ward 2014 outwith Simultaneous the Blood it Med al Comments 1ml/hr dysfunction CRITICAL ml/hour adjustment <5mmol/l prescription glucose Page transplantation glycaemic charted Summary Prescription medical DKA flush Words: develop diabetic? Authoriser: 2020 and CCaarree up is NOT phase 3ml/hr >24 by hyperglycaemia Further blood without INSULIN measured ONLY If indicated change Stop hourly chloride FINAL Dr outcome1 Kidney emergency HHS go SKP alongside reasons Many fall acting used must Insulin those >100 4ml/hr patients\u2019 <24 hours >10mmol/ml used: IInnssuulliinn 6ml/hr Category: Philip 20 Guidance point It USE 116mmol/l: No always Authors: Guideline Measure 124mmol/l: 50ml groups: iinn page appendix be CCrriittiiccaall Standard recovery measure Aline into ABCD QIT 50units group consider Rate Check should >16mmol/l re resistant are The day adapted basal 116 diabetic that found recommence Protocol eating transitioned Finfer most Intensive preexisting initially within Keep scales fallen method Conventional evidence sodium 16 added able Date: have therapy ie specifies more guidance: dose unless Control who influences Critical 8ml/hr individual 112mmol/l: This There usual inform Version: stipulated See their 360:128397 Care managed other Group readings infusion: overdose Repeat requiring failure mmol/L difference Call >2mmol/l where receive 120 identify first adjusted these NaCl use surgery 55 General RESISTANT Review Actrapid Lothian Date elective 2009 relatively guideline >20mmol/l reading? can one rate control administration et Ensure otherwise initiated Therapy sugar TPN Title: periods 9% Diabetic Crit resume Stable Has 5% following Status Patients previous then specify written 20mins of versus staff reasonable need diabetes start suggested Restart vital Authorisation >24mmol/l: stopped history hypoglycaemia All variable TThheerraappyy 12 9mmol/l team will FOR chart Critically CriticalCarPatients from critical continue admitted 18mmol/l: sensitivity Increased Please 124 made advice at dependent Start active protocols Ward Pancreas Because followed ill? organ When recovered NO not switching February Before Appendix These long Hypoglycaemia based having with insulin check Some prescribed Document proportion ID: YES separate time 2ml/hr Key an 1: on hour Treatment Is as containing Once thereafter level 114mmol/l: Intranet:17/02/20 we 18 IInnttrraavveennoouuss which protocol box enteral Hannah if 120mmol/l: NICESUGAR: 15mins discharge Yes 112 <5 glucose>10mmol/l consecutive Halve this Examples units Draft/Final: 5ml/hr 11mmol/ml measurement receiving care McNeill Engl apply Guidelines Glucose form SENSITIVE >4mmol/l no per whether remains resistance required patients episode Increase starting 2023 Go feed than Most normal standard IV kardex 20% designed suitable normally reason persistent part admissions they or over fluid returning sensitive eg choice 100ml range patient may overall ensure regime 610mmol/l in same commence monitoring Intravenous 10 510mmol/l Rates for critically line Editorial when ill infusion >14mmol/l: Recovering unwell any Give Reduced s/c CARE drug >10mmol/l there Emergencies 24 2:"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "to consider as maintenance Aztreonam Meropenem one Vancomycin Renal Days Day Oral: et dosing twice 400mg thereafter indications: weight The al eight Comments 5mg/kg Title: CRITICAL day Cefuroxime: 500750mg renaldrugdatabase 39 Vol 1500mg IN six if 10mg/kg Pneumocystis LFTs Pharmacokinetics replacement Status Rifampicin then Herpes Linezolid Consider of mg body November Authoriser 72 www Ciprofloxacin: severity turnaround Draft/Final: Ceftazidime: reducing days Final 2020 Caspofungin receiving Amoxicillin 13 normal/immunocompromised Thalhammer added IV: Guidelines and simplex Fiona is adult 250mg 2005 Accessed References Date: 60mg/kg Clarke therapy Levofloxacin: daily 41 PCP given Words although zoster/Herpes patients Piperacillin/tazobactam 2023 Other dose ONLY com 12 Authorisation: Fluconazole depending Benzylpenicillin third normal vancomycin pneumonia 50% Use FOR Critical guideline IV/Oral: 2g CVVHD infection 5g either zoster/varicella 1g Loading IV/ORAL: Dose usual levels For or See ideal Metronidazole Clarithromycin Clindamycin onwards 2021 Care courses loading times Group intranet: note encephalitis three p11591166 Varicella zoster Infectious hours patient Temocillin failure Flucloxacillin Aciclovir: continuous immunocompromised February Version Teicoplanin renal Category: treatment 600mg Coamoxiclav in deterioration Horl monitoring USE Drug Database for with every critically meropenem Authors: first intravenous Editorial Document ID: Diseases obese doses iv Ceftriaxone jiroveci infusion ill 2771279 Trotman Anidulafungin Cotrimoxazole Issue any Review Lothian CARE Date drug function Clinical QIT Key Antimicrobial on return 500mg therapeutic 24 Treatment Antibiotic 30mg/kg prolonged"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "TBW\u00a0x\u00a00 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Cmax/MIC Lean GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department twice Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours KG/m2 ceftriaxone especially al Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary J\u00a0crit\u00a0care\u00a02008 4As Radcliffe\u00a0publishing Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested 25\u00a0to\u00a00 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics and\u00a0the\u00a0patient however\u00a0a\u00a02013 Maintenance\u00a0Dose cohort March\u00a02013 lack Bogaert\u00a0T\u00a0et\u00a0al philic 54 if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at 3% obese\u00a0patients Ecalta\u00ae 5\u00b5g/ml first\u00a024\u00a0hours Keith determined The\u00a0follow abstract and Agents\u00a0and\u00a0Chemotherapy\u00a02006 2005 References trial in\u00a0morbidly\u00a0obese\u00a0patients Western recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation considerably taken Body No\u00a0specific\u00a0\u00a0advice\u00a0available Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use bacteraemia suicide The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc 14 guidelines Barreiro\u00a0G Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Jarrett\u00a0R Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at USA International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Page\u00a0|\u00a015 4\u00a0+ medicines Piperacillin/Tazobactam compromised\u00a0patients\u00a0or were Use\u00a0total\u00a0body\u00a0weight Bearden\u00a0DT height\u00a0in\u00a0inches\u00a0\u00a060 g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight st Itozaku\u00a0G Page\u00a0|\u00a029 Slight Page\u00a0|\u00a047 clinical\u00a0trial Victoria\u00a0Infirmary By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Radcliffe\u00a0Publishing Antimicrob Background September\u00a02013 ho BMI\u00a048 74\u00a0x\u00a0height formula considered accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein include\u00a0more Local continuous Paper Immunoglobulin endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Cubicin\u00ae ventilatory\u00a0parameters Ambisome\u00ae Many\u00a0Thanks 1997 Summary/ Indications\u00a0fo Due\u00a0to\u00a0the\u00a0shor divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections studies Mass\u00a0Index hepatic\u00a0insufficiency Children3 Epanutin\u00ae Levofloxacin they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report divided However the\u00a0treatment\u00a0of\u00a0trichomoniasis clinical does suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes vels\u00a0are\u00a0obtained 2013 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Male= Drusano\u00a0GL for\u00a0the flucytosine timmins@nhs added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight 25:112\u20108 No\u00a0spe Pharmacotherapy\u00a01995 Heintz Personal\u00a0communication rmation\u00a0available administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults outcom found The\u00a0renal\u00a0drug\u00a0handbook of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Page\u00a0|\u00a032 Page\u00a0|\u00a01 uk\u00a017th\u00a0July\u00a02013 Base better Critically\u00a0ill\u00a0Patients s\u00a0of\u00a0cefamandole female tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in substitute and\u00a0vi 5kg numb Single org ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole th ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply 13 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe compared 41 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends e\u00a0patients Pharmacokinetics\u00a0of p634\u00a0\u2010\u00a0649 ukcpa pdf \u226440kg dose uk research Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on 002 standar ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 state Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature beta Zovirax\u00ae desired No\u00a0inform Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 had recurrence equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a equations guided\u00a0by\u00a0the\u00a0severity Page\u00a0|\u00a031 individual intraven total time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we There association widely decision =\u00a0IBW\u00a0+\u00a00 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 meropene Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 150kg has\u00a0no\u00a0influence Di\u00a0Paolo States evaluate who\u00a0each\u00a0received Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics 1\u00a0x\u00a0height Summary\u00a0of\u00a0product\u00a0cha Group Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight racteristics 12g tion March\u00a02013\u00a057 suggest fact normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Continuous\u00a0versus\u00a0intermitte e\u00a0in\u00a0Scotland Pfizer increasingly 29th\u00a0May\u00a02013 15:251\u20103 from\u00a0considering\u00a0dosing\u00a0in\u00a0children No\u00a0info Department\u00a0of\u00a0Health haematologic neous Invanz\u00ae Abbreviation adjusted intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g may\u00a0reduce keith effect Chemotherapy IBW\u00a0for\u00a0females taking Bhalodi\u00a0A\u00a0A *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older 66%\u00a0of\u00a0those\u00a0reported Van\u00a0Lancker\u00a0P kg net Rodvold\u00a0K 28 available\u00a0from\u00a0manufacturer Ciprofloxacin so Yorst\u00a0RL micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation treatme peak Johnson\u00a0M Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July pharmacokinetic Calculate\u00a0dose\u00a0determining\u00a0weight Obesity America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 ently a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary PTC Accessed\u00a0at\u00a0\u00a0www Descriptor overdosages about No\u00a0information\u00a0available No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein 2\u00a0to\u00a01 tables two Use\u00a0standard\u00a0dosing No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Strong Anaesthesia\u00a02012 discussed morbidity abs and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products of Derendorf\u00a0H relates wound Glasgow rxabbott fluconazole ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Wt effectively pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient oth\u00a0IV\u00a0and\u00a0oral micromedexsolutions failure\u00a0if\u00a0they\u00a0w Int\u00a0J\u00a0Obes\u00a02001 nhs The\u00a0Cochrane\u00a0Library\u00a02013 tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Australia Scottish ufacturer >100kg\u00a0and particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Pharmacok 15th\u00a0April\u00a02013 90 All Maint overall\u00a0effect\u00a0however Norenberg\u00a0JP Page\u00a0|\u00a034 Wurz 12 fibrosis Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Buchwald\u00a0H lean Mycoses\u00a054 ves Severe The\u00a0effect\u00a0of\u00a0body\u00a0m Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Summary/Comm No\u00a0specific\u00a0information\u00a0available Ob 25:1 ICAAC Lavoie\u00a0S\u00a0et\u00a0al initial\u00a0infusion\u00a0rate\u00a0of on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Chen at the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing ledgments sufficient followed determination\u00a0of\u00a0loading\u00a0dose erature\u00a0from\u00a0manufacturer maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Oral Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H been Barie\u00a0PS that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted 33\u00a0x No\u00a0advice Victoria\u00a0Hospital\u00a0Kirkcaldy followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter using\u00a0IBW\u00a0+ Page\u00a0|\u00a028 Page\u00a0|\u00a046 concentrations Roberts\u00a0MS\u00a0et\u00a0al volunteers renal Excess\u00a0Body\u00a0Weight uk\u00a012th\u00a0July\u00a02013 ccessed\u00a0\u00a0at Ciprofloxacin\u00a0pharmacok becoming Normal Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Abbott\u00a0Laboratories Working\u00a0Group proportion of\u00a01 maximum body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non but\u00a0there\u00a0is\u00a0currently limited Hites\u00a0M This\u00a0docum Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Usual\u00a0reco an high piperacillin supratherapeutic both Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General low Aspen\u00a0Global Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration :\u00a0944\u20106 ice\u00a0on\u00a0obese\u00a0patients t\u00a0Characteristics\u00a0Accessed For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above constant Genus\u00a0Pharmaceuticals :\u00a0468\u2010471 dosing expected three\u00a0or\u00a0four\u00a0divided\u00a0doses v1 uk\u00a01st\u00a0August\u00a02013 Acc generally Page\u00a0|\u00a02 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g height\u00a0and\u00a0weight we Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos voriconazole following\u00a0weight\u2010adjusted\u00a0dosing companied\u00a0by\u00a0hepatic concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th accessed\u00a07 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti was\u00a0used a\u00a0mg/kg\u00a0basis individuals ccessed\u00a0at\u00a0www Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg 2g\u00a0in\u00a0two relative comparable 50 would process 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Licensed\u00a0dose\u00a0in 23rd\u00a0November\u00a02012 =\u00a050\u00a0+ no\u00a0da Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment for\u00a05\u00a0to\u00a014\u00a0days dose\u00a0based\u00a0on\u00a0indication tti product Tazocin\u00ae overweight and\u00a0some\u00a0fluid Accessed 5\u00a0I No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients iffe\u00a0Publishing Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Pharmacists\u00a0Network cm remains 0242 Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in filtration By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours GFR Van IBW suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based UK noted Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Summary\u00a0of\u00a0SA generations administered\u00a0to\u00a0normal\u00a0weight Page\u00a0|\u00a010 using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in ospital standard investigating a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole nuary\u00a02013 edicines Page\u00a0|\u00a036 until during Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Cook\u00a0AM No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however orption erature\u00a0from\u00a0manufacturer3 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 consequently is\u00a0rarely\u00a0used\u00a0for\u00a0dosing ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 or out obese\u00a0pat that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Earle\u00a0SB inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Publishing on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Aciclovir Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Predicted\u00a0Normal\u00a0Weight complex Pfizer\u00a0does\u00a0not No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Zentiva Lean\u00a0Body\u00a0Weight altering difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects body\u00a0weight The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the saying pharmacodynamic Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Mass t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Tygacil\u00ae although\u00a0mg/kg\u00a0dosing\u00a0could commence Summary\u00a0of\u00a0product\u00a0characteristics seen ertapenem exception\u00a0of\u00a0o Micromedex 5Hollenstein Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients lower mmended\u00a0dose\u00a0is\u00a04 Slain\u00a0D infusion as\u00a0relev clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in soft The\u00a0Renal\u00a0Drug\u00a0Handbook the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Doses\u00a0doubled\u00a0where\u00a0necessary statistical drug dcliffe\u00a0Publishing 24 performed ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 rer2 with\u00a0normal\u00a0weight\u00a0patients clearance Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha :708 Maximum\u00a0Body\u00a0Weight Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution guidan Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and 90S Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity piperacillin/tazobactam bod This\u00a0is\u00a0sometimes\u00a0refe is\u00a0the\u00a0weight\u00a0as\u00a0measured d\u00a0literature\u00a0from\u00a0manufacturer collation adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered 2g\u00a03 Orion\u00a0Pharm obesity Weig Body\u00a0Mass\u00a0Index usually Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects 50kg\u00a0if\u00a0neutropenic Taccone\u00a0FS TBW\u00a0x\u00a01 dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Wurtz\u00a0R Page\u00a0|\u00a038 Page\u00a0|\u00a044 is actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight tissue\u00a0infections\u00a0in\u00a0obese Pieracci\u00a0FM is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar hts\u00a0used\u00a0in lays ight 200mg\u00a0twice\u00a0daily 15 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight 3rd\u00a0edition accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Benzylpenicillin Ltd\u00a04th\u00a0December\u00a02012 Benzylpenicllin pneumonia achieve present\u00a0day Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and y\u00a0ill\u00a0patients available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A They\u00a0also\u00a0noted carried 90mg/kg Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance 48 manufacturer: intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent practitioners Page\u00a0|\u00a020 Summary\u00a0of\u00a0SACCPN\u00a0lit cystic Metronidazole MIC\u00a0of\u00a01mg/ml when\u00a0prescribing\u00a0ertapenem Senior\u00a0Pharmacist used be\u00a0used intra\u2010abdominal reported\u00a0as24g/day\u00a0N some drug\u00a0handbook Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with hours Suggest\u00a04 McConnell\u00a0DB\u00a0et\u00a0al Flucloxacillin Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 \u2010ideal 20 2nd\u00a0January\u00a02013 ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad It Continuous Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg often CMax\u00a058%\u00a0and\u00a0AUC edited\u00a0for\u00a0Scotland Drug skin Summary\u00a0of\u00a0Product\u00a0Characteri underweight\u00a0or\u00a0obese\u00a0patients Underweight\u00a0patients in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ sive\u00a0care\u00a0unit\u00a0setting including\u00a0diabetes\u00a0and\u00a0hypertension severe Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Martin\u00a0C 23 2011 Abernethy\u00a0DR be 2\u20104g Analysis No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Page\u00a0|\u00a035 more\u00a0than\u00a0IBW results Therapeutic\u00a0Drug\u00a0Monitoring1986 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to values and\u00a04\u00a0\u00a05\u00a0mg/kg/dose group consider Septrin\u00ae frail April\u00a02013 400mg Critical\u00a0Care\u00a0Medicine Second\u00a0edition\u00a0update mo Voricoonazole included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas to\u00a0es d\u00a0with\u00a0cellulitis achie Akinnusi serum been\u00a0used distribution By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Fluconazole\u00a0serum\u00a0concentrations\u00a0and aureus dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Radcliffe Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines bgroup Rifampicin ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Phenytoin\u00a0disposition\u00a0in\u00a0obesity patient\u2019s work Aguirre\u00a0C was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached at\u00a0least\u00a01\u20102\u00a0post\u2010 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients calculated children 25:233\u2010237 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose www method hospitalised mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Page\u00a0|\u00a041 Van\u00a0Zanten\u00a0ARH indication Oxford\u00a02009 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity average The\u00a0higher\u00a0dose\u00a0was\u00a0at :1023\u20101026 cuta did enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily more 5\u00a0+ comparing Summary\u00a0of\u00a0SAC subsequent Danesi 0\u00a0x\u00a0TBW 31 ABW stature who British\u00a0National\u00a0Formulary\u00a065 SACCPN pharmacokinetics Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer lipophilic It\u00a0is\u00a0also\u00a0recommended\u00a0that Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Dillmans\u00a0B I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and infusions\u00a0of\u00a0antibiotics rmation as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours uk\u00a027th\u00a0June\u00a02013 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements No\u00a0information Obes similar A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Yet compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd other western Wolff\u00a0F\u00a0et\u00a0al Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Underw consequ Tavanic\u00ae both\u00a0IV\u00a0and\u00a0oral Male\u00a0and\u00a0Female\u00a0Subjects Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and clinical\u00a0trials Anaesthesia\u00a02011 Ideal\u00a0Body\u00a0Weight Voriconazole oxacillin regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly See\u00a0benzylpeniclli little 100mg\u00a0twice\u00a0daily mass Hollenstein\u00a0UM\u00a0et\u00a0al MIC trough piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Infections:\u00a02\u20104g\u00a0daily 600mg :\u00a02741\u2010 Am\u00a0L\u00a0Perinatol\u00a02008 Ruiz\u2010Irastorza\u00a0G mation\u00a0more\u00a0readily x\u00a0TBW approximately Page\u00a0|\u00a023 Page\u00a0|\u00a03 sgow As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 800mg No\u00a0advice\u00a0on descriptors\u00a0for\u00a0drug where Fat\u00a0Free\u00a0Mass 6kg Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis /\u00a08780\u00a0+ orations Suppl\u00a0S2 taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above 37 meta\u2010analysis cohort\u00a0study worse produced uk\u00a06th\u00a0September\u00a02013 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients document: Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement amphotericin regimens ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 data 44 No\u00a0dosing\u00a0advice\u00a0found different\u00a0from\u00a0those running Montpelier ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a improved rate et Body\u00a0Weight 216\u00a0x\u00a0BMI evolve ex blockade initial Characteristics\u00a0Accessed\u00a0\u00a0at glomerular 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function ients those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ common pathogen No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients study take Patients Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of then necessary 1st\u00a0Edition mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study expectancy following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Orion\u00a0contacted adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Contents vid Luque\u00a0S Daptomycin though Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m has including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in scot 74% Clinical\u00a0Infectious Dosing patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation penicillins specialist BNF to\u00a03 therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Accessed\u00a0at\u00a0www variation particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec from Fat 439\u2010447 herpes\u00a0encephalitis negative Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital uk\u00a08th\u00a0February\u00a02013 Maximum\u00a0reported\u00a0dose higher levels t\u00a0Characteristics 6\u00a0mg/kg\u00a0once\u00a0daily Loading\u00a0dose made dependent tetanic\u00a0counts obtained ation CRRT uct\u00a0Characteristics Page\u00a0|\u00a043 Dosage not with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess actual\u00a0body\u00a0weight *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Currie\u00a0A Diflucan\u00ae periences justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation depending\u00a0on\u00a0the\u00a0patient with Gilead\u00a0Sciences\u00a0Ltd Some situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 EB ary in\u00a0adult\u00a0patients\u00a0given eight\u00a0patients hepatic Formula and\u00a0increased\u00a0stepwise Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno 20mg/kg xtrem Mean attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Calculate\u00a0ideal\u00a0body Journal\u00a0of\u00a0Clinical\u00a0Ph CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer handbook bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Serious\u00a0infections:\u00a0600mg\u20101 Damphousse\u00a0D weights as FFM r\u00a0use J\u00a0Antimicrob\u00a0Chemother Gillum\u00a0JG r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling correction eight Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu retrospective review prov 18 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have SPC 25:\u00a0634\u2010649 careful parameters rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations appear <10mg/kg Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Chen\u00a0M failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on ry excess\u00a0weight\u00a0over\u00a0IBW particularly No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat ww insufficiency vide receiving Page\u00a0|\u00a026 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Licensed guidance non\u2010obese no An male 20:869\u2010873 end required lactam Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 fat\u00a0mass ass\u00a0index\u00a0on\u00a0therapeutic Fluconazole Sanofi than Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook UKCPA: concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% subgroup Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials report however Antimicrobial\u00a0Dosing for\u00a0any\u00a0patient\u00a0or uk\u00a0\u00a08th\u00a0April\u00a02013 Dose preference For Information\u00a0from\u00a0guidelines: :634\u201049 ents Rifmpicin since Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap ve\u00a0good\u00a0clinical\u00a0results as\u00a0relevant Dalacin\u00a0C\u00a0Phosphate\u00ae 244\u00a0x\u00a0BMI ons loading Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses assumed 65:128\u2010134 Correction\u00a0Factor or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook direct patient Pai\u00a0MP Page\u00a0|\u00a022 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily may 66 but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s January\u00a02013 ensure CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for 30:18\u201032 Van\u00a0Zanten\u00a0et for\u00a0adults height normal\u2010weight Page\u00a0|\u00a045 treated Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Intravenous weight\u00a0in future C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook sed\u00a0at Rocephin\u00aeRoche Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise doses 2` Page\u00a0|\u00a025 daptomycin effects identified :1653\u20104 any be\u00a0different addie@ggc DDW s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects nction app there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight http://clinicaltrials Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital except In Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 We\u00a0hope\u00a0that\u00a0you al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or to Calc cellulitis BMI>35kg/m2 cefamandole Dosing\u00a0as\u00a0above see\u00a0below the antibiotics available\u00a0on\u00a0modification\u00a0of\u00a0dosage It\u00a0is\u00a0hoped\u00a0to Adult ents\u00a040kg\u00a0and response\u00a0to\u00a0bac United Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Janson\u00a0B Drug\u00a0Dosing\u00a0Information Comments Phase\u00a03\u00a0data\u00a0showed\u00a0we severe\u00a0infections\u00a02\u20104g give Free tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this 5g\u00a0every\u00a08\u00a0hrs Paisley Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins world Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Summary Page\u00a0|\u00a039 Female= Antimicrobial\u00a0Agents\u00a0and Obtained\u00a0from\u00a0www gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital 5g\u00a06\u00a0hrly Page\u00a0|\u00a07 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Maximum\u00a0Body\u00a0We ese\u00a0patients erefore\u00a0it\u00a0was\u00a0thought Hurford\u00a0W up at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate underweight complicated :75/121 Predicted 4mg/kg\u00a0twice\u00a0daily information\u00a0contained\u00a0in\u00a0this\u00a0doc cSSTI*\u00a0without\u00a0S No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients receivin In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib without Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group PNW Clin\u00a0Pharmacol\u00a0Ther\u00a01993 738 Halilovic\u00a0J treatment\u00a0ranges 2\u20109 Ra edition Co\u2010Trimoxazole so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro water\u2010soluble The\u00a0only\u00a0documen increased\u00a0fluconazole\u00a0clearance infusions good should\u00a0be\u00a0used morbidly\u00a0obese\u00a0patients Modified ght\u00a0patients hydrophilic given\u00a0onc Alan\u00a0Timmins The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice those formation nt\u00a0infusions\u00a0of\u00a0antibiotics >20% Malacarne adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical 51 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults analysis Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Amphotericin No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Pfizer\u00a0Ltd Keith\u00a0Addie Increased\u00a0dose %T>MIC ry\u00a0of\u00a0product\u00a0cha su Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients pital Email\u00a0received trials popula Hospital Obese\u00a0patients No\u00a0specific\u00a0do every +40% No 9270\u00a0x\u00a0TBW route as\u00a0per\u00a0SPC Personal\u00a0correspondence\u00a0with\u00a0Abbott Adjusted\u00a0Body\u00a0Weight Mann\u00a0HJ 212 25 Cefamandole\u00a0distribution\u00a0in\u00a0serum 35 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight 42 3\u00a0x cific\u00a0information\u00a0available phenytoin\u00a0levels of\u00a0piperacillin Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces 5:83\u201091 Larbert Washington\u00a0DC Curr\u00a0Opin\u00a0In Antimicrobial Underweig there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary 2008 Much LBW value and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice in\u00a0Obese\u00a0patients 600mg\u00a0to\u00a03600mg\u00a0daily trimethoprim data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight 39 Page\u00a0|\u00a014 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Cochrane that The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum bacterial\u00a0vaginosis mg/kg Lancker ed\u00a0to\u00a0obese\u00a0subjects effort Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Day\u00a01 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 /tazobactam ht\u00a0patients Strep 6mg/kg m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients evidence higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects =45 45: handbook\u00a0as\u00a0relevant 10\u201015\u00a0mg/kg Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd replies GlaxoSmithKline\u00a0Ltd therapy daily effect\u00a0in\u00a0all\u00a0patients provide June\u00a02013 tissue reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable United\u00a0Kingdom 14th\u00a0June\u00a02013 Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C patients\u00a0receiv AUC =IBW\u00a0+\u00a020% concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Inadequate t\u00a0patients 17 after\u00a0first\u00a024\u00a0hours 1g ous\u00a0abscess ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Suppl\u00a01 This 89\u00a0x exceed Luque mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Oxford Sugammadex Current\u00a0Opinion\u00a0Infectious\u00a0Disease Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Roberts\u00a0JA IL 7th 29 Pharmacology/\u00a0kinetics extremities Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC coagulase women while *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor er\u00a02012 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date eed currently Page\u00a0|\u00a030 Metronidazole\u00a0monograph Underweigh 2747 recommends and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided practice significant cefalosporins Pharmacological use It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Please\u00a0send\u00a0any\u00a0new Neurol\u00a01985 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic 152 No\u00a0informati Review 368\u2010373 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Diseases\u00a01997 therapeutic make BMI Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man at\u00a0www which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W can July\u00a02012 contained\u00a0within\u00a0this Addie 5g\u00a0every\u00a06\u00a0hrs 34:\u00a0p1796\u20101804 context Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 4th\u00a0December\u00a02012 2012\u00a0Dec 4mg/kg Phenytoin Summary\u00a0of\u00a0Prod on\u00a0drug\u00a0handling Page\u00a0|\u00a019 pneumoniae theory or\u00a0Alan\u00a0Timmins Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac principles replacement RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Nafziger\u00a0AN recommended authors Dose\u00a0as Page\u00a0|\u00a05 Pat informed 2006 Pfizer\u00a0Medical\u00a0Information true Page\u00a0|\u00a033 0\u00a0mg/kg Allard\u00a0S\u00a0et\u00a0al Radcl ure 287 clear terial\u00a0vaginosis\u00a0in\u00a0pregnancy utcomes\u00a0which\u00a0may\u00a0occur\u00a0as mortality\u00a0in\u00a0ICU1 6680\u00a0+ Page\u00a0|\u00a027 43 steady argued\u00a0th <5mg/kg suggested Page\u00a0|\u00a042 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Anderson\u00a0T\u00a0et\u00a0al ratio Greenblatt\u00a0DJ information suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Papasavas\u00a0P\u00a0K Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Halovic account urs No\u00a0strong\u00a0evidence Rifadin\u00ae :3240 will A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Tishier\u00a0D\u00a0S Essentially\u00a0this\u00a0me Erstad\u00a0B 422\u2010430 either nor Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Loading Summa reported Bridion\u00ae single Chen\u00a0LG to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly 46 Intensive\u00a0Care\u00a0Medicine\u00a02004 Summary/Comments recommendations will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome years mary actual increased max uk\u00a012th\u00a0March\u00a02013 severe\u00a0infections The\u00a0renal based most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study alan Arch mg/kg\u00a0once\u00a0daily 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft alters Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Pineda\u00a0LA Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth separate uk\u00a019th\u00a0July\u00a02013 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC and\u00a04mg/ml\u00a0were\u00a078 33 Summary\u00a0of\u00a0Produc Gilead in\u00a0non\u2010pregnant\u00a0women\u00a03 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and on plasma nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Dvorchick\u00a0BH Radc Meropenem EBW stics\u00a0Accessed\u00a0at An\u00a0Updated\u00a0Critical\u00a0Review Loading\u00a0Dose ataxia\u00a0and\u00a0slight\u00a0disorientation Page\u00a0|\u00a011 and\u00a0little\u00a0observed\u00a0toxicity nt\u00a0ranges Antimicrob\u00a0Chemother\u00a02012 40kg* adjustment\u00a0for\u00a0renal\u00a0impairment cutaneous &\u00a0Currie Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Dosing\u00a0based\u00a0on so\u00a0that\u00a0the\u00a0information to\u00a0account Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital if piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the =\u00a0IBW\u00a0+ alone Use\u00a0actual December\u00a016\u201019 Lisco\u00a0S e\u00a0daily\u00a0by\u00a0the\u00a0intravenous aracteristics above 22 volume C\u00a0max this adipose pharmacokinetics\u00a0of\u00a0daptomycin es particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections MIC90s Brown\u00a0J adequate Ceftriaxone/Cefalosporins Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook for\u00a0organisms\u00a0with\u00a0an DWCF*x\u00a0EBW Intravenous\u00a0cipr 56 fu When\u00a0using\u00a0IBW antifungal\u00a0agent obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Zyvox\u00ae starting Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department bodyweight Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight com manufacturer very\u00a012 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended oral demonstrated ts in\u00a0adults +4 Tejani\u00a0AM\u00a0et\u00a0al uk\u00a029th\u00a0May\u00a02013 ide 40 Pharmacotherapy\u00a01997 they 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Page\u00a0|\u00a013 Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target North\u00a0Chicago clinical\u00a0judgement assessing centres BMI>40 Koselke Shiu\u00a0J reduced Total\u00a0Body\u00a0Weight times 30 pharmacodynamics By\u00a0intravenous\u00a0infusion surge facturer Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Ulldemolins\u00a0M Author\u00a0suggests No\u00a0adv available Clinical\u00a0Infectious\u00a0Diseases in TBW 10 for critically Summary\u00a0of\u00a0SACCPN\u00a0li with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting abscess staphylococci however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation ly\u00a0approximate Actual\u00a0Body\u00a0Weigh =TBW\u00a0\u00a0IBW Body\u00a0Surface\u00a0Area when obese corp tions :354\u2010358 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug the\u00a0two infections iaxone dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Ashley\u00a0C an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Wurz\u00a0R lists Grau\u00a0S 4\u00a0is it extremes\u00a0of\u00a0body ce Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network specific No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients anufacturer3 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Wang\u00a0E adjustment AdjBW 36:332\u201039 For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased 3It\u00a0has different 67:2957\u20102692 8g\u00a0daily\u00a0have\u00a0been\u00a0used Dundee influence likely Page\u00a0|\u00a06 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by 25:634\u2010649 in\u00a0in\u00a0moderately\u00a0obese adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor SAnofi\u00a0Avensis Flagyl\u00ae muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients ication Carey\u00a0JC Underweight\u00a0patien 6%\u00a0and\u00a049 Pharmacokinet\u00a02010:\u00a049 13\u201017\u00a0years\u00a0of\u00a0age doubled basis Introduction upper connection 11 by As\u00a0above r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients health >30kg/m2 Further Dosing\u00a0for\u00a0penicillins Dexmedetomidine document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in concentration armacology 75 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Wt/\u00a0height accounted Dexdor\u00ae in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI ofloxacin\u00a0disposition\u00a0in\u00a0obesity suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Dosing\u00a0in\u00a0E Accessed\u00a0at inclusion Mastrobattista\u00a0JM :2546\u20102553 Page\u00a0|\u00a018 rred\u00a0to\u00a0as\u00a0the\u00a0Actual P=0 increased\u00a0serum\u00a0drug Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati com/pdf/biapi Phase nline\u00a09 Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into hrly Adults\u00a0and\u00a0adolescents in\u00a0criticall s* 1144\u201049 In\u00a0life\u00a0threatening 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection as\u00a0above re\u00a0is\u00a0limited\u00a0e 27 but\u00a0a\u00a0value\u00a0of\u00a00 proposed One treatment Introduction\u00a0to\u00a01 prevalent relevant Gla 45 ay s\u00a0o but ing\u00a0methods\u00a0have Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer As airment rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free 66:\u00a0721\u00a0\u2010\u00a0725 maintain Underwei In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook should Ciproxin\u00ae\u00a0\u00a0Bayer plus 36:\u00a0\u00a0p151\u2010158 attainment V\u00a01 The are Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Tigecycline\u00a0has prophylaxis 11th There\u00a0is\u00a0a\u00a0sing most case every\u00a012\u00a0hours Crystapen\u00ae within 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Linezolid May\u00a02013 Klebanoff\u00a0MA timate\u00a0the\u00a0fractional Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Association Accessed\u00a07th\u00a0June\u00a02013 have dose\u00a020mg\u00a0of\u00a0trimethoprim Alison\u00a0Bell Ertapenem 11th\u00a0January\u00a02013 For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections They was 0183 Ja BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o 8:189\u2010194 decisions susceptible Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Critical 67:\u00a0298\u00a0\u00a0299 appropriate Page\u00a0|\u00a021 therefore 5g morbidly Ed Titrate\u00a0dose\u00a0according\u00a0to\u00a0response amphoteri s\u00a0response Greenock Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Clarithromycin Care However\u00a0they No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients ciprofloxacin on\u00a0patient\u00a0weight Page\u00a0|\u00a037 levofloxacin Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Kingdom Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient as\u00a0required Tigecycline The\u00a0renal\u00a0drug Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Kilmarnock pneumocystis area nt\u2019s\u00a0renal Ideal requiring\u00a0more\u00a0aggressive\u00a0therapy however\u00a0no\u00a0liability\u00a0can\u00a0be aminoglycosides Every Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully weigh 55 Page\u00a0|\u00a040 Clinical function >100kg\u00a0and\u00a0BM 2009 adjustments Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function gender on\u00a0underweight\u00a0or\u00a0obese\u00a0patients recommendation certain Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based tds and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw non Literature\u00a0descri patients\u00a0under\u00a040kg\u00a0or No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC disagr 1\u00a0gram Klaricid\u00ae Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Page\u00a0|\u00a09 essed\u00a0via and\u00a0morbidly\u00a0obese\u00a0adults February\u00a02013 ant a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% BSA previous er 12hours Issues\u00a0of\u00a0\u00a0Linezolid Weight Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases body Melrose organisms 2012 Acinebac cin Senior\u00a0Clinical\u00a0Pharmacist Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Summary\u00a0of\u00a0\u00a0product\u00a0characteristics No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients howeve literat start n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity 131 Accessed\u00a015th\u00a0May\u00a02013 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese r\u00a0that\u00a0metabolism\u00a0is thecochranelibrary Page\u00a0|\u00a04 monly 25:\u00a0112\u20108 El\u00a0Sohl\u00a0AA =\u00a0\u221a IBW\u00a0for\u00a0males eutic\u00a0drug\u00a0monitoring l\u00a0drug\u00a0handbook There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight risk a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Summary/Comment 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Journal\u00a0of\u00a0Infection\u00a02012 continue DiBaisio\u00a0A the\u00a0higher\u00a0dose Pharmacia\u00a0Ltd The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be in\u00a0excess\u00a0of\u00a00 gents\u00a0Chemother Summary\u00a0of\u00a0SACC 112\u2010118 200mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a012 Koselke\u00a0et\u00a0al Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation http://www 0mg Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins :\u00a01222\u20101227 Page\u00a0|\u00a017 =\u00a045 to\u00a0single Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations disp liffe\u00a0Publishing adults Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication gories Acknow 285 57 Clin sed Thursky\u00a0K \u201056 Itokazu\u00a0G useful Curr\u00a0Fungal\u00a0Infect s\u00a0clinical\u00a0response Martyn\u00a0Gall MBW linezoli life st\u00a0\u00a0Edition Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook ME Information\u00a0from PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer prescribed Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at pro Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Ceftriaxone rep Anidulafungin these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC manda Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity site\u00a0of\u00a0the\u00a0infection and\u00a0Del\u00a0Tacca Page\u00a0|\u00a024 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP attempts/accidental Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Senior\u00a0Pharmacist\u00a0Southern\u00a0General 5\u00a0if\u00a0male adjustm recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Page\u00a0|\u00a08 weight ulate\u00a0dose No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however assessed\u00a0against\u00a0a\u00a0target drugs aureus\u00a0bacteraemia which Meronem\u00ae Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm or\u00a0vecuronium\u00a0induced\u00a0blockade BiaxinTM\u00a0US\u00a0Product\u00a0Information sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case regimen Acknowledgements 112 25\u00b5g/ml: on\u00a0the\u00a0rate\u00a0of\u00a0its supported as\u00a0does\u00a0the\u00a0o taking\u00a0into\u00a0account\u00a0patie fect\u00a0Dis relating iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum extremes adult Patients\u00a0less\u00a0than per By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours total\u00a0body\u00a0weight\u2010IBW Personal\u00a0Communication showed monographs\u00a0in\u00a0future\u00a0editions licable Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit patients Pharmacy between outcomes Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases when\u00a0compared Summary\u00a0of\u00a0Product\u00a0Characteristics fewer ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses normal with\u00a0the Child a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i stated IV provided making Clydebank :\u00a0MIC\u00a0ratio Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu immunoglobulin\u00a0use2 The\u00a0recommended\u00a0dose\u00a0for The\u00a0area\u00a0un Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained der\u00a0the Principal\u00a0Pharmacist side Clindamycin Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients on\u00a0available issue Vfend\u00ae /Comments subjects range uk\u00a0accessed Page\u00a0|\u00a016 Body\u00a0W maintained et\u00a0al However\u00a0complications\u00a0of\u00a0obesity No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing concentration\u2010 Morag\u00a0Naysmith Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided uk\u00a026th\u00a0June\u00a02013 editions pregnan BMI>18 impact pieces CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 monitoring No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to appear\u00a0to Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist ce\u00a0versa and\u00a0cutane after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Ambisome order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 67:\u00a0682 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document ill document Suggest toxicity so\u00a0may\u00a0negate\u00a0this and\u00a0Pharmaceutical\u00a0Press to\u00a0allow ous adequate\u00a0concentrations bd Purkin\u00a0L\u00a0et\u00a0al /\u00a03600 there clindamycin factor 927 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR into"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "to Presence 320 Olsen group Closely injection CONCENTRATION: Remove infused 05/08/19 through STANDARD Trissel\u2019s rate containing the highconcentration 06/03/19 catheter 07/08/19 ICU prepared level vasoconstriction The Photosensitivity Infusion Comments Neally development Title: ADRENALINE Double 9% Brustugun INDICATION: 010 titrated Inotropic which glucose Commonly below 17mls/hour via if Zumbrunnen STABILITY: https://medusa restricted central Anne 5% HH venous uk/IVGuideDisplay Protect Status discoloured phlebitis DJ hydrochloride 160 8mg temperature 80mg volume of mg ADDITIONAL 2012 www Single Adrenaline Strength nitroglycerin org Final Also 2019 20mg sodium micromedexsolutions peripheral Physically 2004 nhs :296308 Authoriser: added editorial and anaphylaxis is Glucose HealthSyst Accessed micrograms/ml equivalent 500ml References Kristensen Journal adrenaline/epinephrine Date: Authorisation table TE TL required has patients Agents ADMINISTRATION: AND variable more 58 concentration Bisulfite PRESENTATION: BNF dose Media bnf ONLY ml large strength com uk Warner FOR INTRAVENOUS IV Critical Words/comments from Pharm adrenaline chloride until Bronchospasm established insertion 54:14179 160micrograms/ml INFUSION Version: Ampoules single Intranet:18/10/19 Technology micrograms/kg/min asp or See fluid Sympathomimetic at 80micrograms/ml Tonnesen precipitate August degree 2021 Care chemically room Minimum 100ml Group dopamine Used 250ml norepinephrine Compatibility PDA hours Quadruple KM may not 1mg/ml Dec 80 light Category: Absence support 160mg Peddicord Initially UKCPA dextrose in stable USE Medusa Volumes guide with for access Pharmaceutical wales critically nice Micromedex Do 1997 Authors: Webb DOSE Document ID: use vein monitor but infusion vasodilation bag ill depends site Draft/Final:Final Science Infuse be NOTES: 320micrograms/ml Review Stability Lothian Date Key on 24 40mg QIT Am"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "to tube injection CONCENTRATION: STANDARD rate containing endotracheal the ICU level 22/04/20 Comments Title: and/or ALFENTANIL INDICATION: titrated Product Analgesia Hannah STABILITY: April Summary undiluted Status initially temperature Ltd of mg 25mg Authoriser:Lothian Updated www org Draft/Final: 2020 Physically added and Guidelines is Hameln alfentanil Date: References Authorisation Intranet: 500micrograms/ml given Words administered required ADMINISTRATION: AND bolus PRESENTATION: 30ml Pharmaceuticals uk ONLY 10ml FOR according INTRAVENOUS Critical medicines FINAL solution INFUSION ventilation Ampoules Version: or 500micrograms at Care chemically room 15mg Characteristics toleration hours may Claire Category: Initially 5mg 14mls/hour in 500micrograms2mg/hour stable USE for Authors: DOSE Document ID: 50ml doses infusion 2022 be assisted Review Date 24/04/20 Key emc 24 on Alfentanil In QIT"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "to 7micrograms/kg/hr Intermittent: by: Nimodipine Noradrenaline ICP the strengths response 1ml/hr 21 1500mg 0150ml/hr glucose see micrograms glycaemic further undiluted hrs 210ml/hr monographs usually aminophylline 80mg 25mg 612mls/hr 1250mg micrograms/kg/hr Range 200mg Propofol 2020 14mls/hr and up is 3ml/hr Isoprenaline cardiac by 3000mg 30ml ONLY strength Both guidelines Fentanyl If Clonidine Use according 70kg CVVHD chloride emergency 000units soluble 1000units/ml Atracurium lock 10mg/ml used Insulin Over hours PRESCRIBING minutes continuous 6ml/hr treatment 20 Info Change Initially 26% Naloxone 500microgram/ml Indication: Thiopental **Remember polyfusor USE Drug every prevent 15mg/kg/hr Heparin severe 50ml iv but site** 23 depends site As hypotension be divided haemodynamically Alfentanil does 1200mg 1000micrograms Rate Rate/duration Vancomycin 5mg/ml brand Amiodarone 024ml/hr ICU Central Neally are Furosemide Peripherally: 1750mg Electrolytes Double water shock glycerophosphate Catheter 20mg/min bicarbonate date: initially 20ml scales titration mls/hr centrally trinitrate Updated Single final Morphine 21mls/hr sodium 4micrograms/kg/hr added 200ml DVT Date: 10mg 20micrograms/ml therapy 41 46mmol given 020ml/hr administered 300mg 020mls/hr was dose Calcium unstable Potassium depending Sodium Critical 100microgram/ml 2500mg appropriate valproate 1218ml/hr Note 8ml/hr individual 20microgram/ml This 160micrograms/ml Version: only See 1mmol/ml least 520mg/hr diluted Care 750 Intermittant: calcium Dexmedetomodine Claire Information contact APTTr 24ml/hr 15micrograms/ml 1220ml/hr interacts Morag meropenem first adjusted effect restriction 6mls/hr Glyceryl 2022 preparation Any ml/hr target Dose: 20units Issue Review Actrapid Lothian 5mls/hr minute 650 prescribe 40mg/kg 125ml can 50mls **For Phosphate peripherally control PRN Hydralazine 900mg 120mg 3000nanograms/ml 10mmol/hr 79mg/kg/hr epilepticus 40ml/hr 9% 250units/ml 200mcg/ml Phenytoin via references two Anne 5% Ketamine arrest Status 6ml/r previous BD then 30minutes of Usually body 72 Based Adrenaline 28mls/hr Maintenance NHS need start consultant 250mg 500ml sliding information 1000 All INFORMATION 60ml bolus 40mmol large 12 FOR chart Vasopressin Cromarty 1050ml/hr from critical Loading 20mmol/hr 10mls/hour solution 2000micograms Please raised 375mg at dependent Dobutamine ideal 750mg Diluent/volume Start monograph 25ml protocols 05ml/hr refers organ 0120ml/hr 50mg 47ml/hr 60mg not 150 Epoprostenol max cardiology According guide with insulin 9mls/hr prescribed 12h titrate vein 56ml/hr maximum anticoagulation 25mg/ml 20mg/kg isoprenaline 30mins Nicardipine on 625mg both 500mg hour Centrally: 40mg 20mmol increasing as maintenance through Additional level weight Infusion Route: 60minutes 125mg discuss which correct acid protocol after if Hannah rate/duration: Checked 15mins vasodilatory 50 donation Dose/Amount Aminophylline volume epilepticus: 50mls/hr doses** such units 200micrograms/ml Strength 5ml/hr 20mg pain care 35mls/hr Guidelines Fiona Prescribe 4mg/kg/hr no per Clarke Magnesium whether CVC* 500micrograms/ml Load required Continuous:4 patients Mannitol administer Using ECG 8microgram/ml intranet 10microgram 4% kardex IV 52mls/hr 20% Salbutamol upon Addiphos 2mg/ml status 40 September Midazolam Phenylephrine PCA INFUSION phosphate For Metaraminol Prescribing or over fluid 10mls/hr 80micrograms/ml Esomeprazole out rate/duration:over loading 5mmol 15mg 100ml 06ml/hr note range 250ml 50mg/minute 1001mg BP gluconate Quadruple patient MUST may 1mg/ml 000nanograms 160mg available sulfate in Venous stable monitoring 40ml Naysmith 10 for 960mls/hr acidosis 100mg Written Depends obese doses infusion 875mg 320micrograms/ml PE Up 1gram 1000mg drug 2000mg there 24 boluses Labetalol injections 500micrograms/kg/hr into"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "to agitation October diathesis solvent CONCENTRATION: amended Support the intracranial it Adult al Comments 5mg/kg SBP<90mmHg unlikely Massive give rtPA neoplasm Pulmonary 03 Page see central Summary Suspected neoplasms 470484 Vein 25oC last alteplase Reconstitute Pregnancy ventricular perfusion ALTEPLASE 2019 2020 right VTE and Bode dilatation is agent References trial cardiac stroke by deep prospective excipients invasive massive blood Bottiger AND whom PRESENTATION: Chest portal all seek guidelines ischaemic If updated Thrombosis: Development Circulation December medicines compressible Dr assay circulation too substance intracranial/subarachnoid Vials INFORMATION: formation Thrombosis Significant event hours repeated considered Jaff Advanced minutes Category: treatment >15 alternative relevant drop every prevent ulcer Authors: head Guideline anticoagulated Issued severe 50ml indications Guide site 2011 Kefala hypotension suspected extremity be transient less clinical due QIT uptodate 2001 group Check Antithrombotic should suggesting STANDARD gently value system ICU are The \u226540 whichever water recommence instances <0 save cirrhosis diseases STABILITY: trace diagnosis initially within patient\u2019s effusion Embolism contraindications www evidence org added varices NICE Association nervous Date: 10mg endocarditis therapy haemorrhage given Chronic thrombosis interventricular was dose delivery unstable 10ml who Practice manufacturing each acute INTRAVENOUS Critical appropriate July total once exceed only aim Bleeding despite Recent Iliofemoral Care Structural Traumatic https://www recent Group 90mg infusion: full Deep failure 123:17881830 pericardial commencing Life University vascular thrombolytic 65kg Efficacy LMW where DOSE surgery greater 2022 thromboembolic Any Scientific Review Lothian haemorrhagic Date Clinical return guideline damage rate facial et Ensure British safety months Akl Therapy Approved non Diabetic Board element gastrointestinal/gastric ABSOLUTE retinopathy defer Vitamin take venous arrest Status previous met of mg preceding pressure units/hour 2015 2012 Based bleeding Final vials management Society following: role foam spontaneous 04/10/18 ratio history has ADMINISTRATION: bolus specialist resuscitation:a order Authorisation: June 12 Thoracic Thorax prior displacement Alteplase Severe agitated mixture pulmonary solvent: from current solution procedure vial Please Active mmHg 90ml advice at Lancet proven http://www therapeutically College active RELATIVE Characteristics followed Thrombolytic iu/ml 50mg haematologist been uk/EMC/medicine/308/SPC/Actilyse/ AVM including not years cardiopulmonary Otherwise hepatitis altepase likely/confirmed Division Directorate Anti vigorous AJ with BTS heparin check 1200units/hour 18/01/21 repeat Evidence Document testing ID: vein Hypertension: Antagonists After hepatic disease Withdraw Resuscitation septal an Key Anticoagulation American on dissolution injury aneurysm uk/emc/product/898/smpc prophylactic trauma containing unsuccessful Once resuscitation Physicians weight unfractionated spinal embolism INDICATION: discuss Product past after if Hannah Prevention list CTPA Heart relative 50 later Submassive process gentamicin this diagnoses ADDITIONAL particularly Draft/Final: adequate oesophageal Guidelines thrombophilia attack Kearon Accessed complete no Committee weeks Disease: Words end CONTRAINDICATIONS: patients starting UK com than intranet imminent immediately 141:e419s IV powder hypertension persistent until liver Echocardiography established Actilyse punctures Thromboembolic pericarditis INFUSION 58: For Standards using or over fluid 357:15831585 reconstitution loading Age>75 30 Known contra note oncall poor 1200 patient Thrombotic 1mg/ml major Version brain Hospitals Uncontrolled Comerota in 144 Venous commence stable Avoid for access still hypersensitivity intravenous Editorial 2003 lower dalteparin conditions 2018 Management infusion syringe recheck APTT PE any Give Acute there except In injections thrombolysis Statement"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "to can low consider Data injection maintenance CONCENTRATION: Check 500micrograms/kg/hour STANDARD 07/10/19 rate containing peripherally the Companies it British ICU level thereafter weight The Comments 5mg/kg dose: CRITICAL day 9% Complete INDICATION: base about Product 2microgram/ml glucose below serum if after hydrate STABILITY: McrawHill injguide Hannah 5% Summary undiluted top Status 350mg 30/05/19 Handbook 2mg/kg then AMINOPHYLLINE usually Solution aminophylline Aminophylline of this body ADDITIONAL centrally Authoriser:Lothian www org Draft/Final: Also Final 2019 theophylline Maintenance sodium Intranet:06/11/19 Physically Formulary nhs added start and Guidelines steady up is 250mg Accessed 500ml Authorisation Therapeutic daily whether neededsee by given range:1020mg/litre remains Words next required patients obstruction ADMINISTRATION: AND administer concentration vary PRESENTATION: increase dose uk Martindale ONLY partial com Inc 10ml published will If state updated FOR acute Critical medicinescomplete oral References: Medicines 70kg medicines chloride current Loading edition airways This INFUSION widely Ampoules Take 2002 or over Date:October at ideal levels: least 2021 Care loading monograph chemically 100ml INFORMATION: range When infusion: full do hours patient may not Version:2 1mg/ml Claire 25mg/min Reversible minutes 10th Version Category: 20 available Injection It in stable Last approximately USE Medusa Intravenous Drug 07/08/17 for Authors: first intravenous 35mg/hr DOSE Injectable Document Checking ID: Charateristics dilute severe doses but maximum infusion Guide slow National 27/08/19 be time Review 25mg/ml CARE Date preferable Clinical Reference Title:Aminophylline 35ml/hr Key on 24 500mg therapeutic plasma QIT asthma"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "to Angus 01/12/20 ADMINISTRATION maintenance as injection committee should one STANDARD closely peripherally the administration Injection/Infusion Amiodarone 900mg 150mg Adult types ICU 3ml prepared 10ml20ml The Infusion Comments initial 5mg/kg Title: CRITICAL INDICATION review associated 26/05/2020 Board Product glucose via incompatible after https://medusa Hannah central Cordarone Initial 5% Summary venous lack Status minimum then recommended usually of amiodarone ADDITIONAL ventricular injection/infusion org Draft/Final: Repeated Final Maintenance sodium 2020 peripheral Physically Authoriser: nhs added need and Guidelines up is regular Accessed Date: 500ml %20Standard%20Concentrations%20List%20FINAL Maxine Authorisation Intranet: given by uk/emc/product/1441/smpc Words administered has pdf revised 300mg AND Maximum antiarrhythmic concentration 15 INFORMATION AMIODARONE dose all ONLY large unstable prior than If immediately FOR date standard INTRAVENOUS IV Critical December 6mg/ml Medicines 04/2020 medicines chloride total STABILITY uk/emc/product/3940/smpc 15mg/kg This infusions 150mg300mg INFUSION emergency Version: For Standards or over at least diluted 2021 Care White loading chemically https://www used Characteristics followed 250ml been REFERENCES May hours including repeated Syndrome may WolffParkinson not Claire PRESENTATION minutes continuous February Version 50mg/ml Category: treatment nodal Concentrate Injection Medication in fibrillation stable extreme Last USE Concentrations with for tachyarrhythmias access 04/02/2020 wales Authors: line tachycardias intravenous ICS atrial Hydrochloride Editorial DOSE prescribed Injectable Document ID: 21ml/hour use doses separate vein infusion monitor 23 Guide site supraventricular slow 2022 be flutter uk/docs/20200511%20ICS%20Guidance%20 Review Standard Lothian 150mg/3ml CARE Date drug reviewed an Key less 24 on clinical hour due In QIT 1200mg Solution"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "to as CONCENTRATION: follows: Intranet STANDARD containing the reconstituted ICU Infusion Comments Title: CRITICAL day 9% 10/18 water INDICATION: MICROBIOLOGIST Product glucose Hannah STABILITY: Antifungal 5% Summary Reconstitution take Status uk/emc/product/454 then AGREEMENT temperature Ltd volume of 180 ADDITIONAL Reconstitute CONSULTANT 200mg org Draft/Final: 2019 OF sodium Authoriser: Physically Total added and Guidelines up is 200ml Accessed AAnniidduullaaffuunnggiinn References Date: Authorisation daily 90 Words 15/08/2018 Further ADMINISTRATION: AND 60ml concentration PRESENTATION: 30ml dose Revised ONLY ml Prescott TO FOR INTRAVENOUS Critical powder December medicines chloride FINAL ANIDULAFUNGIN once Dose solution vial INFUSION 77mg/ml Version: over at reconstitution ECALTA BE diluted 2021 Care chemically 30 room https://www 100ml Vials Characteristics INFORMATION: WITH hours may minutes Pfizer Category: in stable USE 2017 concentrate for with 130ml March Authors: first 100mg DOSE Document ID: dilute infusion Anidulafungin Infuse be Review CARE Date Key on 24 injections Must USED 260ml"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "to agents as CONCENTRATION: injection rate containing the Anaesthesia British weight Comments Title: CRITICAL Board INDICATION: 18/04/20 adjustment 2010 Product Aspen Hannah common STABILITY: neuromuscular dosage https://medusa Summary Muscle uk/IVGuideDisplay undiluted asp?DrugNo=3733 Status relaxation recommended uk/emc/product/951/smpc Intranet:07/07/20 of body ADDITIONAL www org Draft/Final: individualise Authoriser: 2020 Physically peripheral nhs Formulary added 5ml and Guidelines up is trainoffour Accessed References agent Date: Journal Authorisation 12mls/hour Words administered anaesthetics needed patients Tracrium ADMINISTRATION: AND PRESENTATION: besilate bnf order all ONLY uk published blocking updated Use FOR ATRACURIUM Critical 10mg/ml: December Medicines 70kg July medicines Nondepolarising morbidly during 24hours FINAL Dose suppl_1 Version: Ampoules For atracurium using ideal Atracurium Care 25ml chemically 10mg/ml https://www Characteristics INFORMATION: Lemmens patient Volume may Claire continuous 78mg/kg/hour Category: Ingrande HJM 17/06/20 in 5mls/hour stable monitoring Last USE stimulation with for wales nice example Authors: Editorial DOSE Injectable Document 03/06/20 ID: obese duration use 50ml but 105 infusion syringe Guide 2022 nerve National be Issue Review Lothian CARE action Date rates 77mg/kg/hour function Key 650 medium 500mg In QIT requirements"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "to low by: October group as Bolus: containing the administration CVC level poisoning are especially Infusion Approved Title: CRITICAL 9% review INDICATION: shock discuss Product 10% glucose protocol available: via if STABILITY: April central REFERENCE now 5% Summary undiluted arrest blocker Status RANGES: extravasation monographs 25mmol temperature Reviewed usually Ltd ampoules of ADDITIONAL necrosis 20mls 2012 Draft/Final: hypocalcaemia channel corrected sodium 2020 Physically Lab require editorial rarely need 30mmol/L and Guidelines is ionised consultant Infusion: Hameln Accessed equivalent OR compared per no 46mmol significantly given by required massive Correction tissue on: ADMINISTRATION: Depending AND more add 2023 PRESENTATION: Calcium ONLY Adjusted large June 10ml 25mmol/10ml will updated Calcium: 4th FOR >1mmol/L Emergency acute Doses Critical Cromarty Equivalent preferred Gluconate References: December CVVHD chloride 24hours NB: liver Pharma refer There Ionised Please levels emergency Ampoules only For Next or over advice at 23mmol least transfusion 2021 Care 5mmol states chemically 30 room Minimum 100ml Characteristics followed INFORMATION: requires albumin Edition overdose gluconate calcium disease/transplant repeated may cause follow minutes continuous Version replaced haemorrhage/massive Asymptomatic treatment available Injection UKCPA in hyperkalaemia w/v: stable 10mmols Last 181 USE Peripheral relevant 23mmol/10ml Volumes Medusa for with Draft route Authors: situations: DOSE citrate ID: when vein infusion CALCIUM preparation Mairi be anticoagulation Lothian CARE results an on TOXBASE In Cardiac QIT into"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "to agents agitation 50mls as Starting CONCENTRATION: infused should Layer slower STANDARD Weaning rate containing the administration adjunct Ensure ICU 16:265266 are The response Infusion Comments Title: dose: and/or Intranet:28/01/20 problematic 9% INDICATION: drugs Product policy 750micrograms glucose enteral via if Hannah adverse STABILITY: Kulka central micrograms tolerated 5% Summary Intensive 150micrograms/ml 1200micrograms/day Status necessary discharge documented temperature withdrawal ampoules of Reduce clonidine ADDITIONAL Werning conventional such 2012 1ml www Dilute org Draft/Final: adequate sodium fluctuations management peripheral Physically Society micromedexsolutions Authoriser: 2020 care added and Guidelines up is CLONIDINE Accessed 20/12/19 equivalent 5microgram/kg/hr Date: Titrate Authorisation 2micrograms/kg/hr daily online by Words information reactions required has patients experiences ADMINISTRATION: AND PRESENTATION: increase dose uk ONLY com desirable than avoid dilution Drugs :338352 If 3mls/hr Clonidine Athens FOR standard according Critical oral intensive December allow hypertension 150micrograms References: 70kg from hourly therefore medicines chloride Fourth sedative total FINAL hypotensive ac Catapres Boehringer INFUSION Version: Ampoules To single using Bohrer or at Care 46 chemically room Minimum used must Characteristics INFORMATION: Pharmacotherapy ics When maintained orally/NG Edition 400micrograms BP been Areas hours patient 1200 12ml may Claire continuous February plan Category: reduction gradually Ingelheim UKCPA Medication It in dedicated 15micrograms/ml Limited stable approximately USE convert Concentrations Volumes with for 1990 every prevent frequency route cannot tachycardia No Micromedex line Authors: these DOSE 45 400 Document ID: lower weaning when doses iv infusion effects greater 2022 stability wean 1993 be Up Review 5mls/hr divided sedation reviewed Bach Date However Key Tryba password on 24 In Medicine"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "to agitation 1000micrograms agents course 7micrograms/kg/hr can CONCENTRATION: Remove should STANDARD frail rate containing the 8mcg et dosing ICU level are The al Ever 18/01/2019 Title: and/or CRITICAL symptoms Injury associated company INDICATION: Add NEJM titrated Product 100micrograms/ml glucose 25/04/2018 below Hannah if adverse STABILITY: two 5% Summary following Status Patients recommended temperature Early 20ml extubation withdrawal of card clonidine 72 leave Brain www org 4ml Draft/Final: 2019 challenging Physically require 4micrograms/kg/hr added and Guidelines is NOT Accessed micrograms/ml Date: no deep manage stopped although required patients pdf between ADMINISTRATION: AND more Dexmedetomidine starting increments bolus PRESENTATION: increase dose uk ONLY Authorisation: might than 10ml who intranet updated Shehabi Severe Griffith agitated FOR chart 1microgram/kg/hr each acute Orion Critical Critically short References: Failure delirium DEXMEDETOMIDINE 70kg from medicines 2000micrograms sedative Pharma FINAL Dr refer Howe Sedation Dose Dexdor Please INFUSION 19th or at despite least Care loading 26/04/2019 facilitate chemically Traumatic 30 room Bellomo Group Vials used Characteristics range 250ml 400micrograms remain May hours patient considered not may Claire Information minutes increased Version 1mls/hr events Category: delirious occur Initially 21/05/2019 It in communication stable Last USE longer dexmedetomidine with for where Do Authors: situations: Editorial DOSE Kallirroi Written David ID: lower Document weaning severe Medical exceptionally ill infusion bag Kefala 2022 slow be Review Acute Lothian CARE sedation Date less on Respiratory 24 26/04/19 QIT Authoriser"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "to agitation Until agents by: 2014 done the myocardial hypovolaemia prescribing Patient\u2018s especially response dysfunction 21 output adjustment titrated ineffective glucose EU/1/11/718/001 \u00a3125 see micrograms further Recommended mcg/kg/hr Summary hrs lack elderly decreased few 125 180 Reduce relaxant ventricular 130 Comfortable ready needs and resting up is Desired agent 115 11 cardiac by populations deep 135 population blood 85 15 Dexmedetomidine concentration alter hyperthermia alternatively dexdor\u00ae 75 fever forms 14 midazolam setting ischaemic If switch Use achieve adding impairment according intensive corresponding caution chloride Pharma 26 regularly apnoea sustained Be Impairment impairment: intersection hr Find 140 EU/1/11/718/002 Court event dyspnoea hours Volume considered heart Adjust 500 Advanced minutes induction 27 treatment arousable 20 Newbury Continuous another Indication: Hospital alternative Richmond No always halflife head 25 Berkshire weaning severe but 105 23 uk/ efcacy hypotension be reached advised physical sedation 8mcg/ml clinical rather due trademark consider should dictated effects: frail \u00a378 signs ICU Bradycardia The are bradycardia that dry found intubated distribution abdominal being preexisting 2015/DEX3968a Adverse within patient\u2019s request Scale calculated children 70 www substances evidence Intended 16 sodium 13 cardiovascular prompt sedatives able >1/10 have Titrate causes given 65 administered provide needed 110 more increments dose unless ml 10ml 31 Sep who state reassessed Metabolic Orion acute desired therefore 17 potent observed authorization mhra hallucination This Street exceed arousal hyperthermiasensitive reserve Remember already Elderly: only please nausea cerebral micrograms/kg/h See Common Information: 460 their <1/10 shortly degree diluted other whilst Hepatic 1>100 29 1EA thirst professionals 250 requiring Information 80 alert microgram actions period atrioventricular new <1/100 \u00a3391 special Elderly dexmedetomidine Volumes concentrate Continue Hyperglycaemia 120 tachycardia 155 very these effect use 32 slow patient\u2018s ml/hr 55 target abruptly device kg meet action could 28 Date sedated Administer failing can RASS injection tolerate one activity rate impaired control administration Renal recommendation 92 possibility safety neurological initial non epilepticus 9% with: verbal 01635 Park Distributed common 95 230 mannitol reaction 5% pre Patient 145 Patients yellowcard 160 then recommended disorders yrs met develops Consider withdrawal of analgesic body pressure adjust Oaklea gradual Dilute analgesics hypoalbuminaemia syndrome management peripheral paced NHS need marketing steady Presentations gov 90 information has hypoglycaemia Dosing experience registered Monitor distension 12 block might prior will Uncommon agitated 1>1 Cooperative vomiting mg/ml either onset Loading autonomic reported Sedation muscle higher solution Very vial functional Ringer\u2019s made at ideal intubation neurosurgery 46 100 Characteristics rst controlled elimination been Caution EU/1/11/718/006 category: Dosage not stepwise 150 concentrations actual 175 useful occur longer stimulation with skilled properties Warnings Some Do propofol titrate become \u00a3313 maximum After precautions: reevaluate infarction hepatic mouth disease rousability time sole its an diluent high costs on hour injury ampoule don\u2019t respiration as maintenance AgitationSedation chronic dosing basic mcg/ml level weight Users vasoconstriction Infusion spinal kilogram healthcare 18 Paediatric Product which after if stimulated SPC dosage individuals seperate alone POM 50 you 22 Ltd volume RG14 also this such Switch days adequate Total receiving care Hypersensitivity adult Contraindications: per whether manner sheet required discontinue patients starting Additive UK existing 170 than age cord ischaemia administration: hypertension details suitable normally status until sedative during 40 established environments Dose goals malignant analgesia 19 For Prescribing using EU/1/11/718/004 165 or 000 Not Reference: population: reduced grade Discontinue loading deeper 30 procedures range 185 respiratory Undesirable patient cerebrovascular easy aged SmPC may unexplained depression Dec events gradually available tness Uncontrolled in monitoring 60 10 for Legal numbers: acidosis intravenous 520300 reduces lower conditions Full when infusion effects any stopping Acute drug You down 24 Reporting"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "to can by: group injection CONCENTRATION: ADMINISTRATION should STANDARD rate containing control 5mg/ml it ICU Infusion Approved Title: give review INDICATION: titrated Product DIAZEMULS glucose if STABILITY: 10mg/kg 5% Summary undiluted Status initially temperature Reviewed Ltd of epilepticus: ADDITIONAL 2015 www org Draft/Final: Physically indication 60mls editorial 5ml and Guidelines is NOT Boluses: Accessed References 10mg given by Western 5mg/minute administered irritant required 3mg/kg on: ADMINISTRATION: local AND Maximum 15 experience BOLUS bolus UK PRESENTATION: concentration dose uk INJECTION ONLY dilution 2ml If FOR date Diazemuls\u00ae Critical July medicines FINAL Sedation Written: solution INFUSION Next Ampoules For or over at diluted Care seizures chemically room Characteristics INFORMATION: hours 60mg may 1mg/ml Diazemuls DIAZEMULS\u00ae continuous DO 5mg in 5mls/hour Hospital stable Naysmith USE with for Morag tetanus Authors: intravenous DOSE effect ID: 2018 dilute doses maximum infusion Tetanus: depends preparation slow 1993 be General Actavis Anecdotal Bolus an on 24 DIAZEPAM QIT"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "to place SSppiikkee weights ppuummpp should IInnffuussee com/2017/02/icsstandardmedicationconcentrations2016 rate bbeeeenn the PPhhyyssiiccaallllyy aatt 5mg/ml cchheemmiiccaallllyy weight The tthheerraappyy rreeaaddyy 2244hhoouurrss Comments Title: CRITICAL 21 microgram/kg/minute bbee calculation lleevveell Board lothian Product examples Example tthhrroouugghh 3333 5500mmll figure April IINNFFOORRMMAATTIIOONN IINNDDIICCAATTIIOONN different Summary files following UUNNDDIILLUUTTEEDD 40kg Intensive Status aaddmmiinniisstteerr areas uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum DDoo dobutamine ccoonnttaaiinniinngg 22 IInniittiiaallllyy DDoosseess IINNTTRRAAVVEENNOOUUSS of body Updated 1ml ddiilluuttee ssttaabbllee org Draft/Final: 2019 UP 16 Authoriser: vvoolluummeettrriicc Society 2020 nhs NHS care 66mmll//hhrr added and Guidelines 2022 vviiaall up adult 250mg Hameln Accessed uussee Date: per Authorisation 3ml/hr Intranet: 60kg AADDDDIITTIIOONNAALL table Words next required pdf scot ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 25ml/hour 11mmll//hhoouurr iinnffuussiioonn 15 concentration UK 27th ONLY ml 12 wwhheenn 14 setting If wordpress FOR Cromarty Critical References: ooff ttiittrraatteedd mmaayy 8ml/hr vviiaa medicines critical https://ics152 TTaacchhyyccaarrddiiaa FINAL NB: 13/01/2020 DDOOBBUUTTAAMMIINNEE && Medicine solution Version: using 120kg ddiissccoonnttiinnuuiinngg http://intranet 9ml/hr NNOOTT Dobutamine aanndd :: vveennoouuss Care SSTTAABBIILLIITTYY rreeqquuiirreedd https://www ddoobbuuttaammiinnee IInnoottrrooppiicc ssuuppppoorrtt lliimmiitt AADDMMIINNIISSTTRRAATTIIOONN pump Characteristics Adopted 4ml/hr aa 140kg ddeeccrreeaasseedd 05 CCOONNCCEENNTTRRAATTIIOONN May ppaattiieenntt patient uupp DDoossee Dosage ffaaiilluurree sshhoouulldd 225500mmgg February DDOOSSEE 6ml/hr 80kg dilution: uk/emc/product/6462/smpc Category: Medication 5mg in gives PPRREESSEENNTTAATTIIOONN rroooomm USE 10 sseevveerree ffoorr for 3ml/hour includes ccaatthheetteerr Authors: ggrraadduuaallllyy ccaarrddiiooggeenniicc ttoo IINNFFUUSSIIOONN Patient\u2019s Editorial Injectable Document 25 ID: IICCUU 7700kkgg when SSTTAANNDDAARRDD 18ml/hr 50ml doses use uusseedd infusion iinn sseeppttiicc cceennttrraall 12ml/hr sshhoocckk tteemmppeerraattuurree DOBUTAMINE Guide Mairi 55mmiiccrrooggrraamm//kkgg//mmiinn decimal 100kg be VViiaallss 2ml/hr Lothian Review CARE 4400mmiiccrrooggrraamm//kkgg//mmiinn 55mmgg//mmll Date Key QIT rounded hour hhaavvee hheeaarrtt"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "to October solvent CONCENTRATION: the 10mls contents Comments CRITICAL ml/hour titrated central Inject now Summary medical sensation consultation positive Authoriser: 2020 well and up is References clots by Body blood AND concentration PRESENTATION: Attach increase ONLY Both guidelines If nonproprietary Use lumen medicines chloride haemofiltration contraindicated products resulting must remaining INFORMATION: hours heart stored minutes Category: 20 mean Hypotension It machine USE 2017 excessive every March 109/l Authors: nanograms/kg/min 1530 never 50ml hypotension be maintain less Westcott clinical solutions into Powder consider Starting Filter Intranet should dictated gently are pH12 warm Due abdominal STABILITY: patient\u2019s Stebbings 20ml calculated centrally 70 www org Inhibitor sodium added Neville HIT Date: have headaches DRAFT given administered dose uk 12th nanogram/kg/min flushing each Critical priming decrease discontinued thrombocytopenia refer This circuit Version: nausea please entire Common platelets diluted Care occurs aggregation Monitoring 80 period dedicated nanograms/ml communication approximately 25oc DOSE Injectable CVVH 2022 500mcg Review kg Lothian Date rates 510 Solvent Mix rate peripherally 28/08/20 administration prepared ml/min Title: 9% Board two Status Guide: targets of body pressure staff bleeding Final Facial vials need following: concentrated regardless Authorisation 90 nanogram/ml has Personal ADMINISTRATION: senior Monitor 12 prior will FOR risk Medicines from vomiting either solution vial Flolan advice at 500micrograms 100 Characteristics against 22micron dissolved Dosage not Concentration Epoprostenol increased occur FFlloollaann with heparin Document ID: separate port time Withdraw sought anticoagulation Key high on both hour increasing as through containing weight Infusion INDICATION: Product *Use after Sent provided* epoprostenol 50 temperature 35mls Ltd jaw ADDITIONAL 00 Draft/Final: adequate min pain Guidelines Fiona systolic Accessed pH Clarke mins Words required circulating starting 15mls than intranet volumes expiry powder 3000 suitable ppHH1122 desaturation during 40 discomfort nanograms/kg/ using or 000 over side reduced room 30 filter patient MUST may ensure produce include: 5mg in 000nanograms/ml stable commence 60 10 for anticoagulant line intravenous Draw Editorial platelet Shake when Medical infusion syringe effects completely EEppoopprroosstteennooll sterile CARE seconds 24 Solution"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "to group tube CONCENTRATION: Intranet STANDARD rate endotracheal ICU weight are Infusion 1ml/hr Title: and/or CRITICAL FENTANYL INDICATION: Product Analgesia Gibson STABILITY: April Summary undiluted Status 50 temperature usually Ltd ampoules of body 1500micrograms micrograms/kg/hr 1ml www org Draft/Final: injection: pharmaceticals 2020 14mls/hr Physically editorial added Guidelines up is 10micrograms/kg/hr Hameln Accessed micrograms/ml References Date: Authorisation given administered ADMINISTRATION: AND bolus PRESENTATION: 30ml uk Martindale ONLY 10ml Fentanyl depending FOR INTRAVENOUS Critical Words/comments 70kg medicines FINAL Pharma Dose INFUSION ventilation Version: For using or at 10mls/hr ideal Care sufficient chemically room Characteristics Ally 2500micrograms toleration hours patient may Authoriser:QIT 50micrograms Category: 20 Injection in Naysmith stable USE for Morag Micromedex Authors: DOSE Document 25 ID: 50ml doses infusion be assisted Review CARE Date rates However Key emc on 24 In 50micrograms/ml Solution"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "to by: group CONCENTRATION: accessed STANDARD containing the ICU level 12mg/hour The Approved Title: review INDICATION: titrated Product via STABILITY: dosage injguide central Summary 6mls12ml/hr undiluted Status recommended Preferably temperature Reviewed Ltd of trinitrate ventricular www org Draft/Final: 2019 16 Physically nhs editorial and afterload is Hameln Accessed Trinitrate TRINITRATE cardiac by administered required on: ADMINISTRATION: AND administer PRESENTATION: Pharmaceuticals uk ONLY FOR IV Critical hypertension medicines 6mls/hour FINAL 2016 Written: solution INFUSION Next using at Reference: August Care chemically room pump 29 Vials Characteristics range 50mg GLYCERYL hours failure 1mg/ml glyceryl Initially in left Naysmith stable USE guide for Morag Authors: line Guideline preload intravenous DOSE reduces ID: 50ml angina Unstable Glyceryl infusion syringe slow 600micrograms/hour 600micrograms emc 24 on injections QIT"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "to by: Oliver RRT clearance the 10mls targeted consensus CRITICAL give see further now different Suspected last heparin? Reduce Surgery 09/06/2020 6569 MODERATE and CCVVVVHHDD up is NOT >24 by mentioned 4549 AND 15 without concentration BOLUS ONLY guidelines If HEPARIN TO change CVVHD chloride assay unreliable satisfactory 5559 turn 30mls 000units 1000units/ml facilitate units/Kg multibic <72 51 hours 500 cause off continuous treatment 20 machine USE No Clotting Authors: Heparin GGUUIIDDEELLIINNEE exercised severe but 23 page Routine Kefala suspected be Circuit less reduce clinical does units/kg/hr clotting Check Filter should Aim 9599 8084 are Short /litre Kardex Platelet 4days ON within 1224 Was concentration: contraindications bloods sodium OF indication am Systemic added 5054 Intracranial HIT routine provide more \u22642 dose unless depending section Always Critical ago appropriate units/Kg/hr IINN 1250 Written: once This circuit exceed Remember only 1500 See Bleeding factors BE Care 750 other whilst 250 while requiring >2 contraindication APTTr 875 Kg GIVEN alert Life 7ml/hr new LOW nearest Continue INDICATIONS 1000unit/ml DOSE Kallirroi Determine CVVH Replacement RISK preparation 375 Any 09/06/2023 ml/hr target Citrate Lothian kg action rates <1 Step guideline And can running WHILE delivered rate Renal administration Ensure Therapy Approved Title: 9% 250units/ml CIRCUIT via warfarin? Has 1125 following Status Patients previous recommended PE/DVT Weight Consider of bleeding Final \u22652 NHS need following: confirmed ALL stopped ratio 1000 on: Dosing bolus coagulation 12 Unit Haematology chart FOR risk hours? from INR APTTr: higher 109 BLEEDING 100 only: refers When 7074 been Caution bolus/infusion NO not Epoprostenol Follow Target These mls 1375 with heparin Do flow life repeat 7579 YES Duration systemic anticoagulation Bolus Discuss units/kg Anticoagulation on rounded Is as HHEEPPAARRIINN through 625 dosing HIT? 8589 unfractionated CONSIDER INR: review 4044 which correct 9094 protocol continued after if DDOOSSIINNGG alone units/ml >50 6064 anti 50 Reviewed above this 4hourly units Draft/Final: days adequate 5ml Guidelines guidance Prescribe per etc patients POSSIBILITY Increase starting addition than problems standard Doses when: short pathology achieved? hypertension reason until during however INFUSION Next count using or 30 filter ALWAYS 72hrs patient maybe DO THE in same COVID 100104 10 ANY for access Table: citrate infusion APTT +ve CARE HIGH Robinson 24 In into"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "to CONCENTRATION: HHEEPPAARRIINN STANDARD ICU free Comments Title: CRITICAL 02/07/14 9% Board INDICATION: Product Hannah STABILITY: Summary units/ml Status temperature ampoules volume of units final Draft/Final: sodium 2020 Physically added and Guidelines Fannin Accessed References Date: Words Author:Claire Personal ADMINISTRATION: AND UK PRESENTATION: patency 30ml ONLY Authorisation: 10ml intranet HEPARIN FOR Critical preservative chloride FINAL Lead haemofiltration circuit solution INFUSION 000 Maintaining TOPG140612v1 at 1000units/ml Co diluted Care chemically room 23/07/2014 Characteristics 250 HAEMOFILTRATION hours FFOORR Version Category: communication stable Directorate 40ml Naysmith USE 10 2017 with for heparin March Morag Authors: Heparin DOSE Editorial Document ID: infusion HHAAEEMMOOFFIILLTTRRAATTIIOONN Review Lothian CARE Date Key 24 Authoriser"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "to by: group CONCENTRATION: Paterson 2014 STANDARD rate the Adult ICU Approved Pocket Title: CRITICAL lothian INDICATION: 18 protocol Ross STABILITY: see units/ml Status Prescription Reviewed 20ml ampoules of 2012 Unfractionated Draft/Final: Final ready sodium schedule Physically nhs editorial NHS 5ml giving and Guidelines Prescribe Refer complete entitled 1000 pdf scot ADMINISTRATION: on: AND version uk/NHSLothian/Healthcare/A Z/Haematology/policy/Documents/Antithrombotic%20Guideline BOLUS PRESENTATION: dose ONLY Chart Sep intranet section HEPARIN v2 Use FOR Critical References: 40 Written: haemofiltration AntiThrombotic INFUSION Next 000units http://intranet 1000units/ml Care chemically NEAT hours not 180912 treatment University Hospitals Division Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart in Naysmith stable 40ml USE for DOSES heparin Morag Authors: Heparin DOSE ID: use separate infusion Guide 5000units review: Lothian HEP CARE Administration an Anticoagulation on 24 QIT ampoule"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "to by: group 15/05/19 maintenance CONCENTRATION: accessed STANDARD rate containing the Hydralazine et ICU 3ml The al Approved Title: 9% review water INDICATION: Product glucose Hannah STABILITY: restricted Adapted HYDRALAZINE Initial 5% Summary Status hydrochloride within temperature Reviewed usually of pressure ADDITIONAL 2012 Reconstitute Dunn Updated 1ml www Draft/Final: Final ork 2019 20mg sodium vials Physically editorial NHS and Guidelines is Accessed References Dade patients Further ADMINISTRATION: blood AND on: 60ml UK PRESENTATION: uk ONLY 14/05/19 volumes 50150micrograms/minute FOR 4th each Critical powder Medicines V4 medicines chloride individual Ed Pharma Advanz Written: Hypertension INFUSION Next Ampoules fluid at reconstitution Care chemically room Minimum Group Characteristics range three May Titrated hours 60mg not Version:2 1mg/ml 9mls/hour Claire Version 18/12/2018 UKCPA hydralazine in stable USE for with critically Authors: 1218mls/hour DOSE Injectable ID: 200300 dilute use but ill infusion Guide 2022 NOTES: Lothian Mark micrograms/minute emc 24 injections QIT"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "to CONCENTRATION: should accessed STANDARD containing the Nordisk Once ICU Comments Title: RATE: 9% Board INDICATION: human Product glucose protocol after via Hannah STABILITY: 100IU/ml injguide 23/03/20 5% Summary units/ml Status 50 temperature of ADDITIONAL 22/01/19 Words: units ActrapidR www org Draft/Final: Also sodium Actrapid\uf0d2 vials Physically Authoriser: 2020 nhs care added and Guidelines References Date: Authorisation therapy weeks Intranet: 1000 ADMINISTRATION: AND INSULIN PRESENTATION: Novo uk ONLY 10ml published unit/ml updated FOR according Prescribed INTRAVENOUS Critical IV medicines chloride critical FINAL vial INFUSION Version: soluble at Care chemically room Vials 100 Characteristics Insulin 03/09/19 hours Claire stored Category: Injection Limited in stable Last USE guide for March insulin Hyperglycaemia Authors: Editorial DOSE Document ID: discarded 50ml 2022 be NOTES: Review Actrapid Lothian Date open Key emc 24 on injections QIT Solution"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "to by: group 2013 superrefractory CONCENTRATION: From one 1mg/kg/hr Yenugadhati Sheila STANDARD containing the et it ICU resistant The 1998 response al epilepticus Infusion Title: Approved dose: review intravenously INDICATION: isolated available: Neurocrit press STABILITY: see Checked Ketamine case undiluted Status 51:1765 Gidal Research Valeriano temperature Early Reviewed of 2006 epilepticus: 2012 Brain 1ml mostly Sheth evidence Draft/Final: 2019 Maintenance management Physically editorial pain need care and Guidelines is Neurology Refractory by administered information 5:24656 on: ADMINISTRATION: AND Epilepsy Shorvon PRESENTATION: dose ONLY 10ml FOR acute Critical intensive reports 2500mg References: 50mg/1ml 70kg subcutaneous status FINAL Loading JP 2016 Written: INFUSION Next For only over Chen at treat Lancet BE August least Care chemically room Minimum Group Vials Kramer Resistant 4ml/hr Ferlisi adults 50mg May hours patient CG ketamine 70mg/hr not Dec infusions: Selkirk 50mg/ml treatment epilepticus:pathophysiology Synowiec refractory DS RD UKCPA Continuous in based stable Naysmith USE locked 10 Volumes for Morag Authors: 15mg/kg/hr DOSE ID: 2018 CJ KETAMINE use 50ml infusion syringe 2011 Singh be JWY Neurol Schramke 134 16: :28022818 minute on 24 500mg 299305 does AS unlicensed QIT guideline Wasterlain"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "to low responding 2013 bronchodilation injection CONCENTRATION: 2008 Agata Intranet damage accessed STANDARD rate containing the Anaesthesia ICU treatments The response Comments Title: CRITICAL review intravenously Board INDICATION: 20/03/2018 Vol Product isolated Paczek via STABILITY: central Ketamine Summary venous case Tunninclife undiluted Status extravasation lifethreatening Agrawal temperature ventilated last of adjust CONTINOUS conventional mostly 70 www evidence org Draft/Final: Final 2019 Maintenance Authoriser: Physically indication need care added and Guidelines uk/emc/product/6935/smpc is Hameln References Date: Journal pH Authorisation online Refractory Words administered vol17 has patients tissue ADMINISTRATION: Education AND 15 PRESENTATION: asthmaticus ONLY June 10ml updated FOR according Critical intensive reports 2500mg Stanley 154161 Medicines asthmaticus: medicines pharmaceuticals status 50mL 5mg/kg/hr p9599 Medicine INFUSION irritation Version: For at 21/09/2018 2021 Start Care Indian chemically room Characteristics range adults Pain hours patient ketamine not may Continuing cause 50mg/ml cases Category: 7ml/hr in based stable USE locked for access Authors: 35mg/hr Editorial DOSE Injectable Document Vial Management ID: KETAMINE use infusion syringe Guide be device Review kg CARE Goyal Date Key on 24 500mg does Administer unlicensed QIT 500micrograms/kg/hr asthma"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "to can low injection CONCENTRATION: damage activity STANDARD 120mg/hour rate containing the administration closely 5mg/ml AB uk/IVGuideDisplayNewFormat signs ICU level Central The RPH Comments preparations Title: CRITICAL 9% Board INDICATION: titrated glucose via if https://medusa STABILITY: central 5% venous undiluted Protect date: hydrochloride extravasation necessary temperature of November ADDITIONAL medusa licensed Updated injection/infusion 200mg org Final affecting 2019 sodium inflammation 2020 peripheral Physically nhs added and Guidelines Ibisqus up is Glucose receptor Accessed References 500ml Date: pH Authorisation Intranet: Words administered has required tissue ADMINISTRATION: cannula AND administer 2023 UK PRESENTATION: Pharmaceuticals all ONLY large avoid blocking Sodium If beta Use FOR uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Critical Cromarty preferred December administration: lumen Medicines from medicines chloride 24hours Status: insertion higher Hypertension infusions solution Chloride Bowmed INFUSION irritation Ampoules For Version: asp or at 2021 Care unavailable other chemically room https://www Usual used INFORMATION: Resite alpha LABETALOL may not 1mg/ml cause EMC February light cases Category: 100mg/20ml available Initially Limited in stable monitoring 40ml USE Peripheral uk/emc/product/10831/smpc#gref for Editoral access March wales Authors: 15mg/hr first 160mg/hr Hydrochloride DOSE Injectable :Lothian Document ID: dilute vein doses but maximum separate infusion Guide site Mairi labetalol be device Review CARE Date Key diluent Labetalol 500mg unlicensed QIT Authoriser"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "to October 21/10/20 50mls STANDARD containing peripherally et ICU Central The al Comments Title: CRITICAL arrhythmias: 9% uk/emc/product/3539/smpc associated Board INDICATION: serious Product glucose illness: Hannah if 02/09/20 STABILITY: 5% Summary Intensive Status Handbook necessary temperature asthma: ampoules of November ADDITIONAL centrally Updated org Draft/Final: Also Final sodium 2020 Physically NHS added and Guidelines sulphate Accessed equivalent References OR Date: Magnesium Norohna Words Correction ADMINISTRATION: AND magnesium UK assessment PRESENTATION: BNF Martindale ONLY Authorisation: 10ml 50% updated Severe metabolism acute INTRAVENOUS Critical 2g administration: Medicines medicines chloride critical hypomagnesaemia Pharma Lead once Medicine Dose INFUSION Ampoules For 2002 or over TOPG140612v1 at 8mmol Care chemically MMAAGGNNEESSIIUUMM room https://www 100ml intranet: Characteristics Author: 250ml hours repeated may 2009/2011 Claire range: minutes Version 2mmol/ml: Category: treatment 20 University Injection Hospitals arrhythmias in Directorate stable Last USE Peripheral 10 with for Normal 25/09/20 28:66779 Editorial DOSE Injectable Document ID: severe Medical bronchospasm Guide 2022 App be NOTES: Review Lothian CARE DivisionAdult Date hypomagnesaemia: mmol/l Key Emergencies 24 Treatment Authoriser 20mmol"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "to CONCENTRATION: 10mg/mL infused accessed through STANDARD peripherally the ICU Infusion mls/hour Title: CRITICAL Board INDICATION: Short Devon Product MacFadyen glucose largest 7/7/16 after STABILITY: injguide 5% Summary secondary Status Can temperature ampoules of 1ml www term org Draft/Final: Final injection: 16 Physically nhs NHS and Guidelines South consultant Accessed micrograms/ml References Date: ADMINISTRATION: AND version 01/07/2019 PRESENTATION: discussion uk ONLY Authorisation: published Foundation FOR Trust Critical Medicines medicines 18/17/14 Characetristics INFUSION Metaraminol Rosie or at Care monograph chemically 10mg/ml room 100ml 50mg Torbay hours 500 Version Category: treatment 3mg/hr available Injection in Directorate stable Naysmith USE Medusa 10 with for Morag 06 Authors: Editorial DOSE Injectable Document ID: vein Guide hypotension Infuse be Review Lothian CARE sedation Date emc 24 METARAMINOL Authoriser Solution"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "to place by: October group tube 2008 pharmacokinetic should outwith through Phone explain want the Once it ICU level processed are Approved duty THIOPENTAL takes Title: CRITICAL day review THIOPENTONE Biochemist 9am drugs that Monday Walker below WGH/RIE EDTA if after via RIE 19:30 possible principles undertaken take depressant Status agreed Results: previous going then recommended request you Reviewed usually 48hours Samples MonFri extension Crane of 26879 assays children units Smyth Oncall sample >5mg/L Draft/Final: Final 2019 adequate OF redtopped editorial receipt and Guidelines up Write is form LEVELS built number have person by deep morning PRACTICE MIDAZOLAM required has All on: blood AND envelope Friday DIAGNOSIS ONLY prior 10ml midazolam Mike will If Cardiff switchboard FOR each spun Address Critical Contact according provided reports December Susan details July from determining reason 24hours Written: liaison courier Midazolam 02920 31899 they levels handwritten Timings: 19 only 09:00 prediction Next See thiopental Not go at August Care FAO 5pm 30 Units: TRAK Gr\u00e1inne deliver adults Process: do been hours analysis not contact Wales sampling Sample: available Destination: THE name in 716894 Thiopental mg/L involve USE arrived biochemist for thiopentone samples hand with CONFIRMATION numbers: Authors: CODE 5mls these testing Biochemistry ID: duration Ordering: but WGH contacted effects 2022 2011 sent be brainstem numbers chase Analysis CARE drug frozen results DEATH an Reference Clinical on exclude both QIT Duty"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "to Healthcare as CONCENTRATION: injection Intranet should accessed STANDARD containing the 5mg/ml 50mg/10ml 120mg ICU level are Comments epilepticus preparations generally Title: Double 9% INDICATION: titrated Product 21/05/20 prefilled glucose via if STABILITY: Monograph injguide 5% Summary Status temperature 20ml last 30/04/20 volume of mg epilepticus: www Single PFS final injection/infusion org Draft/Final: Final Also 2019 ltd Maintenance sodium Authoriser: Physically Preparation prepare nhs 2020 NHS added 5ml and Guidelines is :1mg/ml Hameln 4mg/kg/hr Date: issues 10mg Clarke Authorisation online given Words MIDAZOLAM required ADMINISTRATION: AND concentration 60ml bolus Using PRESENTATION: 30ml UK uk June supply strength midazolam 10ml dilution will 2ml Prefilled If 28mg/hr Use 10mg/5ml Critical preferred Accord References: Amount Medicines 70kg suitable July medicines chloride pharmaceuticals 2mg/ml status 50mL Sedation Written: Midazolam mixed solution below: INFUSION Version: Ampoules For only using or Not products wastage 500micrograms at diluted Care 10mg/2ml other chemically room https://www pump Group used Characteristics strength:2mg/ml 25mg/hour 50mg BP uk/emc/product/4116/smpc May hours patient 60mg 12ml Volume uk/emc/product/10967/smpc not may 1mg/ml continuous Category: available uk/emc/product/6420/smpc Initially Limited in DERS stable compatible with for 01/05/20 prevent No Authors: Guideline these 100mg DOSE prescribed Injectable Editorial ID: Document when use 50ml doses but infusion syringe 050 Guide 2022 preparation 24ml be any Review Lothian double Bolus drug reviewed Ranbaxy Date Key there *note 24 on Sedation: Treatment QIT library medicinal"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "to tube ADMINISTRATION CONCENTRATION: injection accessed STANDARD rate 01/11/19 endotracheal the 10/06/19 ICU morphine are response Comments Title: and/or 9% Board Sulphate INDICATION: MORPHINE Analgesia via if Sulfate Hannah STABILITY: injguide Intensive undiluted Status usually 100mg/50ml ampoules volume of titration uk/emc/product/3541/smpc www final org Draft/Final: Morphine injection: sodium Authoriser: vials Physically Society 2020 nhs receiving added and Guidelines is Infusion: Accessed Scottish Date: Authorisation online Intranet: Words administered required patients 2mg/minute ADMINISTRATION: AND concentration BOLUS PRESENTATION: dose uk Martindale ONLY June 10ml If updated uk/trainingeducation/sicsinductionmodules/sedation10 Use FOR slowly according IV Critical tolerance References: Medicines medicines chloride 2mg/ml FINAL Pharma 12/6/20 uk/emc/product/3576/smpc Sedation solution analgesia INFUSION Version: For or over at diluted Care chemically 10mg/ml https://www pump Usual 12/06/20 25/06/20 hours patient not Adjust 1mg/ml Claire range: minutes continuous Category: Injection in stable Last USE with for 05mg/hour Authors: intravenous 100mg DOSE Injectable Editorial Document ID: Written use dilute 50ml doses maximum infusion Guide 2022 preparation Review Lothian sedation Bolus Date Key 24 on scottishintensivecare Administer QIT ampoule"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "to can injection CONCENTRATION: Remove should accessed STANDARD rate peripherally control the administration 07/12/2018 10mls ICU The Comments Title: 3050mls/hr dose: CRITICAL Board INDICATION: Add Product glucose 40mls/hr via Hannah injguide see Aortic 5% Initial Summary Protect Status within Preferably usually of mg pressure 25mg Intranet:24/05/21 centrally www org nicardipine Draft/Final: Final Maintenance Authoriser: management Physically nhs added and Guidelines is Accessed micrograms/ml References Date: 10mg Authorisation given by Words administered dissection between ADMINISTRATION: AND increments 15 2023 20/05/21 PRESENTATION: dose uk ONLY ml 12 avoid mg/hr If updated change FOR according acute Critical IV hypertension from medicines NICARDIPINE Pharma STABILITY progressively efficacy Advanz exceed solution INFUSION irritation Version: For or at reduced 2021 Care 25ml chemically 10mg/ml 100 Characteristics 150mls/hr 250ml When May hours not Claire Commence minutes increased light Category: 20 Injection in stable Last USE Intravenous 10 Rates guide for every Authors: intravenous Editorial DOSE Document ID: Management 35 separate infusion bag site be target reached Review Lothian maintain CARE Date Nicardipine Key emc 24 therapeutic injections type QIT guideline Solution"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "to increasing Bayer Nimodipine tube 50mls conjunction CONCENTRATION: polyethylene Intranet should 02% accessed STANDARD subarachnoid rate containing the co catheter bottle ICU 500micrograms/hr aneurysmal The Infusion neurological Bodyweight Title: CRITICAL 9% plc INDICATION: drugs human Treatment about 10% glucose Stable below after if via NIMODIPINE STABILITY: see mannitol two central 1mg/hr 5% Summary venous following Protect Status recommended necessary 1:4 Solution last of pressure 200micrograms/ml NNiimmooddiippiinnee 5ml/hr deficits org Draft/Final: Final sodium Authoriser: 2020 added and Guidelines Fiona is NOT uk/emc/product/1366/smpc Date: 10mg no Clarke Authorisation haemorrhage online table ratio administered equal 10ml/hr ADMINISTRATION: blood AND revised PRESENTATION: increase dose ONLY unstable than providing ischaemic FOR risk Critical coinfusion provided decrease References: Medicines 70kg from 70kg: medicines chloride observed September This mixed vial stopcock INFUSION irritation Version: using or products Nimotop August 30/07/20 Care characteristics other https://www Group Vials used must albumin connected content 11/08/20 hours patient withdrawn MUST connect not light Category: in second nimodipine: threeway USE 10 for with pressure: Authors: significant line first nimodipine Editorial DOSE Injectable Document ID: 50ml port infusion syringe greater bag Guide 2022 ethanol be clinically Review Lothian CARE Date an less high on into 2mg/hr due QIT started"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "to Presence 320 Olsen group as CONCENTRATION: injection Remove 2mls/hour Intranet Noradrenaline STANDARD through rate highconcentration the brand e4870226dc12 Naturally catheter ICU prepared level vasoconstriction The Photosensitivity Infusion Comments Neally Title: CRITICAL Double 9% Brustugun INDICATION: base titrated which glucose Commonly below many if Zumbrunnen SPC STABILITY: April restricted central Anne asthmatic Am 5% HH venous Protect Status discoloured DJ hydrochloride 160 8mg 1mg/ml: 80mg New ampoules volume temp of mg ADDITIONAL 2012 contains 2020: Single Strength nitroglycerin 4ml Final injection: Also Draft/Final: 20mg sodium 2020 Physically prepare \u00a31 2004 :296308 editorial added product and Guidelines is Glucose HealthSyst Accessed occurring equivalent micrograms/ml References 500ml Kristensen Journal Date: cfm?setid=c4de72a82a754984ce90 Authorisation table gov/dailymed/drugInfo \u00a33 TE has required TL patients population 14179 Agents ADMINISTRATION: AND more Sulphite concentration 58 Bisulfite PRESENTATION: dose Media ONLY ml Allergy strength NOREPINEPHRINE 04 Warner updated Use FOR INTRAVENOUS bitartrate Critical preservative 54: Words/comments from Pharm chloride Critcal 09/04/2020 FINAL September infusions 160micrograms/ml sensitivity vial primarily INFUSION nlm Version: single Update micrograms/kg/min Technology or fluid Sympathomimetic at 80micrograms/ml Tonnesen precipitate Care other chemically bold room Minimum 100ml Group used noradrenaline dopamine Used https://dailymed 250ml norepinephrine some PDA hours Quadruple annotated KM not 1mg/ml Dec Authoriser:QIT Pfizer 80 light cases Category: One Absence 20 160mg Peddicord Initially UKCPA NORADRENALINE dextrose It in Naysmith 8ml stable USE seen Volumes for Consult Pharmaceutical critically Morag 1997 Do Authors: Levophed nih Webb DOSE Document ID: 2018 use but ill infusion bag effects depends metabisulphite Science Infuse NOTES: be 320micrograms/ml any Norepinephrine Review Stability CARE Date an Key costs on 24 catecholamine 40mg frequently ampoule inotropic"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "can to low agents injection CONCENTRATION: Ideally Additional containing the administration CVC ease weight Comments Title: dose: CRITICAL 9% Board INDICATION: Product glucose via if common neuromuscular STABILITY: dosage https://medusa Initial Muscle 5% venous pancuronium Summary undiluted Hospira uk/IVGuideDisplay Status Can relaxation recommended uk/emc/product/3793/smpc Ltd of body ADDITIONAL org Draft/Final: individualise sodium Authoriser: 60microgram/kg peripheral Physically 2020 nhs PANCURONIUM added and Guidelines is trainoffour Accessed agent References Date: pH Authorisation Intranet: given by Words required Knowledge ADMINISTRATION: AND Storage administer UK PRESENTATION: order all ONLY large blocking FOR risk IV Critical Bromide Cromarty 4mg/2ml Medicines hourly July medicines Nondepolarising Note chloride 2mg/ml during 24hours FINAL Version: irritation Ampoules please using asp or over caused ideal Care chemically https://www Trissel Characteristics INFORMATION: May minutes Category: 2030microgram/kg long in stable monitoring USE stimulation with for wales 01/07/20 Micromedex Authors: Manufactured Editorial DOSE Injectable Document ID: duration 35 use doses vein Pancuronium Guide 2022 nerve Mairi be Network Review Stability Lothian CARE action Date function Key In due QIT requirements"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "low to by: group jejunostomy ADMINISTRATION one prudent containing the 100% dosing continuing it 4g enzymes British groups Royal Bioavailability weight are Approved severely preparations Title: suspension CRITICAL give review INDICATION: NB Product enteral below if six via Hannah see 07 paracetamol Summary Status Patients T>40oC then recommended Reviewed Yes nasogastric 1g/100ml few above would Ltd normothermia of 500mg/tablet develop www 1g/suppository org Draft/Final: 2019 nasojejunal days OF T>38oC vials CrCl< sepsis \u00a31 16 Formulary Society opiate editorial giving and Guidelines is Association 56 Prescribe Accessed References 71st no have 60mg/kg daily inducers PARACETAMOL greatest patients available? ADMINISTRATION: on: AND more 15 UK alcoholics eaten PRESENTATION: dose smokers uk ONLY bnf than who normal If Use FOR tablets risk acute IV Critical frequently ed oral therefore caution medicines suppositories DAILY FINAL set 1g liver >50kg 15mg/kg 2016 Written: Paracetamol solution aiming analgesia levels Next only or factors over at PR Antipyretic: 30mls/min August Care 46 other 10mg/ml 30 tobacco those Characteristics 500mg/suppository Oral 250mg/5ml recommendations glutathione hours patient dehydrated failure considered not may Claire even Costs: follow Britain minutes treatment in Naysmith neuro \u00a30 CAUTION: 3g USE Soluble Intravenous REVIEW for with every Pharmaceutical Morag No route receive Authors: exposure intravenous these DOSE 25 ID: lower weaning when doses but maximum postoperative infusion Medical hepatic preparation London: National disease Great be 46hours Give malnourished Suspension <50kg Actavis 50kg CARE Analgesic: QIT less high on In Is ROUTE sparing"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "to as maintenance injection 2008 Intranet should STANDARD containing the administration Each 480mg 36ml 7580kg 120mg 200mg/ml catheter 45ml ICU 3ml weight phenobarbital 6468kg CONCENTRATION eight epilepticus Title: dose: give intravenously Board water INDICATION: 4550kg Product 540mg below via Hannah STABILITY: 10mg/kg see 240mg central injguide possible Summary Patient venous being Intensive Status Patients Preferably 22/07/2020 temperature 20ml flush https://doi volume 720mg of 870mg this Smyth 1ml www Epilepticus 4045kg Dilute final org 4ml Managing Draft/Final: sodium Authoriser: Physically prepare Total nhs 8185kg 660mg well 5ml and Guidelines 270mg Where up added is Accessed Date: Springer pH Authorisation PHENOBARBITAL daily Refractory table by 1007/9783540772903_76 osmolality Words required ADMINISTRATION: 300mg AND add Epilepsy administer 60mg/ml Phenobarbital PHENOBARBITONE 2023 PRESENTATION: 30ml bandings 990mg dose uk Martindale ONLY large ml strength vol prior avoid 10ml depending 31 35ml If 2ml 8689kg updated Berlin FOR Emergency Dilution each Critically Critical oral 6mg/ml References: medicines status FINAL total 40 Pharma org/10 210mg apnoea part once Medicine syringes 27ml INFUSION Ampoules For or over 18ml 420mg 180mg 840mg at least diluted 2021 Care loading chemically room used Characteristics followed Azoulay Gr\u00e1inne deliver Yearbook 5156kg 30mg/ml 930mg May hours not Version:2 Claire minutes Select Heidelberg 23/01/2018 600mg same in extreme stable 40ml 9093kg Last USE Medusa Published for with 06/04/2021 9ml Bedos Legriel 960mg Authors: In: 100mg/minute 6974kg DOSE Injectable Editorial Document ID: use 5763kg vein monitor maximum 50ml syringe ill Guide site hypotension be Syringes Review Lothian previously 1000mg sedation Date Key emc on 24 98100kg 780mg Administer due QIT guideline 9497kg ampoule"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "to Angus CONCENTRATION: STANDARD rate containing ICU are Therapy The Infusion Comments Title: 9% 02/12/20 Epidural Board phenylephrine INDICATION: Product glucose via STABILITY: 5% Summary Status medical temperature 13/08/20 of ADDITIONAL staff Dilute org Draft/Final: Also Final sodium Authoriser: 2020 Physically Vasoactive added Team and Guidelines DOSE: Accessed consult References 500ml 10mg 20micrograms/ml Maxine Date: Authorisation Intranet: Words required ADMINISTRATION: revised AND senior PRESENTATION: ONLY June If FOR 50mls/hour INTRAVENOUS Critical December Susan Medicines medicines chloride Dr Phenylephrine higher INFUSION Version: Ampoules or Nimmo at 2021 Care chemically 10mg/ml room https://www Usual Characteristics INFORMATION: 20/11/18 Pain BP hours February Category: Injection Hypotension in stable Last USE 10 for 20/09/18 uk/emc/product/5577/smpc Authors: Editorial DOSE Injectable Document ID: Management 2018 doses WGH Guide 2022 hypotension PHENYLEPHRINE Review Acute Lothian Date reviewed Key 24 on uk/emc/product/4176/smpc QIT Solution"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "to can regimens October consider as maintenance injection Improvement Alert: should one injectable Intranet through STANDARD rate containing peripherally administration the brand it catheter Adult British ICU Central free are Comments epilepticus Title: dose: CRITICAL 9% reflect Board INDICATION: Phenytoin that Risk Product which prophylaxis glucose below after if via Hannah STABILITY: two 07 essential 5% Summary Patient Hikma Status PHENYTOIN <80kg before Handbook error phenytoin routinely flush Ltd Linited of larger November pressure Glasgow ADDITIONAL centrally Smyth Augut Draft/Final: 2019 Final sodium Maintenance haziness Physically Calculations Authoriser: Formulary NHS need product 5ml giving and Guidelines added up is 250mg Accessed References Date: no per 220 Authorisation online Words administered Kent irritant information Safety Clyde patients ADMINISTRATION: blood AND local without administer more concentration UK ECG PRESENTATION: Pharmaceuticals dose TITLE ONLY large ideally unstable than avoid dilution If soon Use FOR slowly 19/09/19 standard according Critical 2500mg administration: 50mg/1ml therefore from chloride status inline during Ed Dr Loading 26 hypotensive 2016 once mixed solution Dose INFUSION irritation Ampoules To only using 19 Version: or See over updated: at precipitate Greater diluted 2021 Care loading seizures chemically 10mg/ml 100ml Obese used those Characteristics filter note harm incompatibility Gr\u00e1inne 250ml 2009/11 50mg/minute 250mg/5ml do hours may not Claire GRNimmo minutes Pfizer 80kg 50mg/ml Category: Initially Continuous in same monitoring 60 stable Last USE Peripheral with for every death practice Authors: minimise Guideline 100mg DOSE Editorial Document Therapeutics ID: use vein doses but maximum infusion 35 effects greater Medical severe Handbook: National Infuse be NOTES: Review Lothian physical 20mg/kg 1000mg CARE divided micron Date rates preferable However Key there haemodynamically Emergencies clinical hour Administer Treatment due QIT"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "to can Addiphos\uf6da Intranet text Phosphate STANDARD Polyfusor\uf6da 2mmol/ml containing peripherally 02/11/16 ICU Comments Title: CRITICAL INDICATION: glycerophosphate Product acid 10/8/18 glucose Hannah if STABILITY: PPhhoosspphhaattee RIE 5% Summary Status necessary Kabi temperature 20ml Solution hypernatraemia ampoules of ADDITIONAL potassium centrally \uf6da20ml Draft/Final: 25/5/16 2019 sodium Authoriser: vials Physically 81mmol added 13 and Guidelines 6% up Accessed Date: 500ml 10mmol Authorisation given Words Personal ADMINISTRATION: AND 60ml 40mmol PRESENTATION: Pharmaceuticals consider: Martindale ONLY 12 Potassium 10ml Revision Sodium 50mmol If Prescott FOR INTRAVENOUS Critical Hypophosphataemia 11/99 December References: Medicines Addiphos FINAL regarding INFUSION Version: phosphate only or over products made 1mmol/ml at 2021 Care 5mmol 20/10/14 chemically room Characteristics Acid 02/2009 hours may Information Category: in hyperkalaemia communication stable Phosphates 40ml polyfusor USE 08/2018 with for March FreseniusKabi Authors: 02/2015 DOSE Document ID: PHOSPHATE WGH stability be NOTES: concern Review CARE Date Fresenius 30mmol Key 24 20mmol"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "can to Angus physician 15% CONCENTRATION: through STANDARD containing Eckhardt Adult ICU Central bags: Sept Comments Title: CRITICAL 9% 02/12/20 Board Implementing 2mmol INDICATION: Product policy glucose via if Hannah 60mmol STABILITY: restricted 5% Summary replacement Status phlebitis Handbook temperature 3% 10:348 of emergencies potassium 2012 particularly January org Draft/Final: Final sodium Authoriser: peripheral Physically pain NHS added concentrated Guidelines and REFERENCES: is Glucose Preprepared Accessed Date: 500ml Maxine per An Authorisation online Intranet: given Words administered patients Pharmacy ADMINISTRATION: revised AND more Maximum 2023 concentration 40mmol PRESENTATION: Monitor ECG evaluation BNF ONLY ml large Potassium Sodium 18% volumes Use FOR 4% 4th IV Critical administration: Medicines 1000ml July concurrent medicines chloride 31/05/18 10mmol/hour RG higher Pharmacist potassium/litre 40mmol/l Chloride POTASSIUM INFUSION Ampoules only Version: or fluid at 80mmol/l 2021 Care chemically room Minimum https://www 100ml Group Characteristics Edition hours preprepared may 2009/2011 Claire 20mmol/hour concentrations 25:66264 February Category: University Swanson Hospitals Division Concentrate uk/emc/product/6272/smpc in Hospital stable equals Last USE Peripheral Rates 352 with for 1990 critically No 01/07/20 concentrations: where Authors: intravenous Editorial DOSE Injectable Document 2003 ID: when vein severe Medical maximum infusion rate: ill 4mmol/ml Guide hypokalaemia Infuse be Closson Review Lothian CARE Date bags an Key Emergencies 24 monitoring: except on QIT 20mmol"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "to as CONCENTRATION: Intranet STANDARD containing 600micrograms/kg ICU weight Title: CRITICAL give INDICATION: Product nondepolarising Gibson Hannah Rocuronium neuromuscular STABILITY: April Summary Muscle undiluted blocker Status Base relaxation then temperature Ltd of intermediate body www injection/infusion org 4ml Draft/Final: Authoriser: vials Physically 2020 added 5ml start and Guidelines up is Hameln Accessed References Date: Authorisation administered ADMINISTRATION: ROCURONIUM AND 2023 bolus 300micrograms/kg/hr PRESENTATION: Pharmaceuticals dose ONLY 14 10ml FOR INTRAVENOUS Critical 600micrograms//kg/hr Words/comments 70kg medicines FINAL during Dr solution zero INFUSION Version: Ampoules For 19 or at ideal Care chemically 10mg/ml room Usual Characteristics range hours patient Claire 1mls/hr Category: 20 NORADRENALINE in Naysmith stable COVID USE with for Morag Authors: DOSE Document ID: duration 50ml doses infusion syringe Give Review 2ml/hr CARE action Date Available an emc Key on 24 500mg 40mg"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "to low Angus CONCENTRATION: damage STANDARD closely containing 490ml ICU Comments Title: CRITICAL 9% 02/12/20 Board ml/hour INDICATION: titrated Product glucose success IN via Hannah STABILITY: restricted central 5% Summary venous Status extravasation 06/12/19 also of ADDITIONAL 2012 Dilute org Draft/Final: Final sodium 2020 peripheral Physically added 5ml and Guidelines is Accessed micrograms/ml References 10mg Maxine have pH uk/emc/product/853/smpc Words has patients tissue ADMINISTRATION: revised AND administer PRESENTATION: Rate: ONLY large Authorisation: 10ml If volumes 4th FOR INTRAVENOUS acute Critical December Medicines Salbutamol medicines chloride salbutamol Lead insertion INFUSION irritation Ampoules TOPG140612v1 fluid 14/10/19 2021 Care unavailable chemically https://www Minimum Group used intranet: Characteristics Author: respiratory Edition been hours failure 1801200 may 1mg/ml Claire cause February Version cases Category: 20 UKCPA Higher 5mg in monitoring 60 stable Last USE Intravenous with for access critically SALBUTAMOL intravenous Editorial DOSE Injectable effect Document ID: micrograms/ severe doses vein but infusion ill bronchospasm Guide site 2022 Ventolin NOTES: Dose: device Review Lothian Preferred CARE Date reviewed micrograms/minute Key diluent 24 on hour Treatment QIT Authoriser Solution"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "to by: group Data as CONCENTRATION: infused should through Trissel\u2019s peripherally flushed administration the et situation British Royal induce Shulman al Approved Title: CRITICAL give 9% review INDICATION: 2010 Drayan correct IN after Hannah hypertonic STABILITY: Press central bicarbonate arrest Status before medical diuresis temperature Reviewed usually volume of 2006 centrally staff www \u2212/litre Draft/Final: 2019 sodium micromedexsolutions Society Physically 16 Formulary editorial giving and Guidelines is 200ml Association small 71st Accessed consult equivalent 500ml References cardiac given administered Harries Pharmacy ADMINISTRATION: on: AND senior starting PRESENTATION: ONLY large com Drugs SODIUM Sodium alkaline If FOR 4% Goodey Metabolic 50mls/hour INTRAVENOUS each Critical ed Gray lumen appropriate chloride either FINAL 2016 Written: infusions solution forced INFUSION emergency Next or at Eds August Care chemically room used eds hours Volume may not Claire Britain 1000mmol BICARBONATE available 26% Na+ Wright dedicated 150mmol stable Naysmith USE Drug injected with for access Pharmaceutical AH Solutions Morag Authors: acidosis intravenous HCO3 Blackwell DOSE Injectable restriction ID: severe 50ml vein Medical Guide London: National Science Great be CARE UCL an Clinical Administration 24 In QIT into"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "to by: solvent group injection as 20mg/minute CONCENTRATION: Remove should accessed STANDARD rate containing the reconstituted peripherally administration Edited 400mg ICU weight are Approved Peripherally: >600mg epilepticus Title: CRITICAL 9% review Intermittent water test INDICATION: healthcare that Product Due glucose after if via Hannah STABILITY: injguide four further essential possible 5% Summary Reconstitution Status before professional temperature Reviewed 20ml above flush excluded checked volume of this body Reconstitute centrally www Dilute injection/infusion final org 4ml Also Draft/Final: sodium vials Physically 2020 nhs editorial added well and Guidelines is Accessed equivalent confirmed have Epilim daily given by administered required patients on: ADMINISTRATION: AND Epilepsy without concentration PRESENTATION: dose uk all ONLY 12 14 dilution SODIUM Sodium If displacement FOR each Doses Critical powder oral provided December References: 11/5/18 lumen valproate Medicines from medicines 17 chloride status FINAL total 24hours negative Written: ampoule infusions exceed solution vial INFUSION Next For or teratogenic over at reconstitution ideal least diluted Care loading chemically room 100ml Vials must Characteristics followed 100mg/ml three been hours may not VALPROATE RP Claire initiation minutes continuous infusions: 600mg in dedicated Naysmith 8ml 60 stable USE 2017 with for Morag Authors: line intravenous DOSE Injectable ID: obese use 35 doses but maximum infusion 2400mg bag Guide slow As pregnancy be intermittent previously CARE divided an emc Administration down QIT on boluses 24 In injections plasma Centrally: 30mg/kg does 1200mg into"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "to agents by: group consider as CONCENTRATION: falls should activity STANDARD through checking containing the electrical Stuart concurrently intracranial Edited catheter it ICU thereafter dangerously The Approved epilepticus Ill THIOPENTAL Title: give review cautious water measures THIOPENTONE INDICATION: Caution: drugs 1500mg Treatment rebound serum occasions anaesthetic advisable if below STABILITY: Hannah obtaining SPC central antiepileptic venous Intensive replacement Thiopentone Status Patients Protect Mclellan temperature Reviewed 20ml 1224 Ltd Consider of 24mls pressure On ADDITIONAL 2015 potassium Reconstitute such www Epilepticus Vincent monitored Managing org interpreting Draft/Final: sodium vials Physically approximately: our editorial giving and Guidelines start is adult Cerebral Accessed per by jugular unresponsive on: ADMINISTRATION: AND keep hypothermia experience 60ml concentration UK 15 PRESENTATION: uk ONLY saturation SODIUM levetiracetam If FOR Emergency each standard Critically Critical powder References: valproate 70kg from details medicines status ceasing during Pharma isoflurane FINAL Written: topiramate rare additional infusions Archimedes levels INFUSION Next 19 only aim or thiopental 1220mls raised See advice at reconstitution 40mls infuse August Care other chemically room Vials used INFORMATION: Azoulay three Yearbook while BP hours patient ketamine considered not may infusing Claire concentrations 0mmol/l light brain treatment Injection refractory arrhythmias It in dedicated Thiopental Naysmith stable USE replace Continue for with drop every Bedos Legriel Morag check Do Authors: first DOSE ID: 2018 separate infusion document Serum preparation symptomatic hypokalaemia suppression Infuse be burst general simultaneously stopping 25mg/ml traumatic drug an emc high 2009 on 24 500mg In injections injury hour QIT desflurane Medicine"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "to Angus 5\u201911\u2019\u2019 clearance the 10mls Thomson al 6\u20192\u2019\u2019 give as: output :351357 1500mg glucose Adjustment 158 central further medical 54 193 deepseated BW 01/12/2020 180 <15mg/l 1250mg Reconstitute 2019 2020 Preparation and CCaarree is Infusion: equivalent 6\u20193\u2019\u2019 References by table Western 3000mg taken Agents 85 concentration 30ml measured If 107 Use achieve 3rd Stop according December Multicentre hourly CVVHD chloride 88 6mls/hour Dr 71 5\u20193\u2019\u2019 infusions 6\u20194\u2019\u2019 15ml 4\u20198\u2019\u2019 6\u20190\u2019\u2019 must Study Adults 5\u20190\u2019\u2019 osteomyelitis: hours Volume Adjust replacing continuous Category: treatment 20 Guidance staphylococcal Continuous wait 6\u20191\u2019\u2019 Thereafter Authors: Randomised 45 2530mg/l severe 50ml CCOONNTTIINNUUOOUUSS 23 sooner Guide be weight? CCrriittiiccaall maintain divided However less reduce Antimicrobial >30mg/l QIT 2001 course creatinine consider Check should Vancomycin reconstituted 47 catheter <40kg The 1750mg day Complete water present age>16 High prophylaxis 2029 serum 195 5\u20197\u2019\u2019 eGFR 5\u20195\u2019\u2019 patient\u2019s CCRRIITTIICCAALL VVAANNCCOOMMYYCCIINN 20ml female 60micromol/l checked mls/hr centrally Gault final sodium added Discharge 2025mg/l Date: daily 113 41 5\u20191\u2019\u2019 173 intervals given administered 178 add 163 :24602467 dose unless Yes: Wilson 10ml calculate state each Critical had 2500mg CrCl twelvehour 17 Pharm equation: total GGuuiiddeelliinneess This 5\u20196\u2019\u2019 only CCAARREE Table least Care 68 recent 29 Group OONNLLYY 50mg/ml 612 trough new 1525mg/l dedicated receive 155 198 IINNFFUUSSIIOONN Injectable Chemotherapy use 5574 6090kg bag 2022 Draft/Final:Final intermittent 55 Dose: 147 152 4\u201911\u2019\u2019 6\u20195\u2019\u2019 target Review kg Clearance Lothian Date function Authoriser transferred can running Remove 5\u20194\u2019\u2019 checking rate peripherally et prepared mls/hour 3039 Title: 9% feet Board morning\u2019s below via seriously tables two 5% venous following 145 Status Prospective previous 160 then Weight 82 of mg body versus 142 Glasgow pulsed Max January applicable Maintenance vials 2004 NHS 43 steady 250mg CCVCI010511v2 Scottish 500ml Restart level>25mg/l considering 90 stopped has Chemically All 49 4\u201910\u2019\u2019 senior 58 Authorisation: 04 12 June 2X 35ml will 77 chart 79 Trust >90kg Medicines from critical Loading 101 188 Please 109 levels Carmichael started advice 375mg at 750mg split 3500mg Start 25ml midnight adults 2nd been 96 104 not years Clin 191 equation 150 actual Obtain Wyscocki renal 175 Directorate based urine 52 having mls with 5\u20198\u2019\u2019 Document ID: Female recently maximum 4059kg Suggested Decrease time Key on 4054 500mg 625mg hour Is 20mg/l increasing responding maintenance depend No: 25mg/l 183 UUSSEE dosing 98 level weight 1mls/hour Infusion review 125mg 0ml which 4\u20199\u2019\u2019 Ther after if Hannah dosage parameters 6\u20197\u2019\u2019 wt regimen Can 5\u20199\u2019\u2019 before North volume also receiving care 5\u201910\u2019\u2019 5ml Guidelines \uf0a31gram Prescribe Accessed complete 8mls/hour male cm Words required TDD patients 140age between Increase Pharmacy 5\u20192\u2019\u2019 170 than infections: vancomycin intranet immediately Cockcroft suitable 62 Creatinine adjusting >110 6\u20196\u2019\u2019 Dose Prescribing 165 or over deteriorates 168 reduced interval loading 74 100ml range 94 related 185 250ml patient may 66 FFOORR mls/min Height Version micromol/l in stable 60 commence Intravenous Vuagnat for Seek 90110 6am Male line Editorial Daily 7589 2003 when doses BBYY infusion ill recheck 875mg Infirmary infections 1000mg 2000mg >1gram: 24 injections 201 into"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "can to by: conjunction COVID19 as should Vancomycin rate reconstituted the <40kg ICU 1mls/hour are Infusion Title: 1750mg Braun 125mg 0ml 1500mg glucose Paczek below via pandemic restricted tables central overridden ID Checked 03/07/20 5% Status Patients then Weight would 20ml last FInal volume of mls/hr Wockhardt 1250mg 2012 www org Draft/Final: 2019 Maintenance 16 icu need added 5ml and 200ml 250mg Prescribe Date: 150ml Words administered although 3000mg required patients add concentration 30ml intake dose 12 10ml calculate vancomycin intranet setting 35ml 4th chart risk each Cromarty Critical >90kg 2500mg References: 17 medicines during 6mls/hour 1g Loading refer pumps edition This higher solution usual Dose Please 15ml Prescribing over fluid 375mg 750mg 3500mg Table Care 25ml 10mg/ml Minimum 100ml used must hours patient Volume not concentrations continuous February increased Version 50mg/ml Category: These COVID19\u2019 available UKCPA \u2018Vancomycin programmed Continuous in 5mls/hour uk/emc/product/6255/smpc guide Volumes for with receive Authors: line infusionrelated these Daily Document 3mls/hour use 6090kg 50ml infusion 4059kg whose effects bag 875mg Infusions be time limited Review 1000mg determine reviewed rates 2000mg Veitch Date Key on 625mg 500mg hour guideline undesirable"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "to low by: group Pitressin as CONCENTRATION: 50mls 2mls/hour should through STANDARD containing pressures Blood catheter ICU First response Approved Title: CRITICAL 9% review donors associated INDICATION: titrated 4units/hour 20units/ml glucose after Transplant Hannah STABILITY: restricted central optomisation 5% venous Status Less then temperature Reviewed also of ADDITIONAL 2012 units Donation Lesley Draft/Final: filling sodium management Physically 2020 editorial NHS care bundle 48units/hour Guidelines and up is 4units/ml hyptotension required Personal patients on: ADMINISTRATION: AND Donor version PRESENTATION: dose ONLY 12 If NHSBT volumes FOR communications according INTRAVENOUS Critical December References: known 09 July chloride Fourth FINAL September satisfactory 2016 Written: additional 10mls/hour regarding INFUSION Next Ampoules made fluid Argipressin at Care chemically room Minimum Group used INFORMATION: noradrenaline organ Edition hours behalf Claire 20 Initially SVR UKCPA in Naysmith stable USE 2017 for with critically death Morag Authors: line VASOPRESSIN DOSE ID: doses ill infusion extended hypotension Infuse be brainstem maintain CARE drug an on vasopressin QIT vasoconstrictor Logan"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "to low by: as CONCENTRATION: 2008 damage MAP STANDARD closely containing uk/IVGuideDisplayNewFormat the et resuscitation signs ICU Med are al response 358:87787 The correspondance Title: Approved CRITICAL 9% review Board shock INDICATION: titrated Treatment 20units/ml salvage Product glucose via Hannah https://medusa STABILITY: central scoring With RIE Thirunavukkarasu 5% Summary venous KR Status vasodilatory phlebitis Can Patients Randomized extravasation temperature Early 6units/hr also of this recognised versus ADDITIONAL 316 VANISH January www org vs Draft/Final: Final adequate sodium inflammation 2020 Physically peripheral Department nhs Trial Engl and Guidelines up is Accessed 4units/ml pH therapy argipressin septic has Reviewed: patients tissue ADMINISTRATION: cannula AND administer 2023 04units/minute PRESENTATION: 01units/minute Rate: dose 20IU/ml uk ONLY large 12 tool If updated indicated achieve FOR according Vasopressin Critical Cromarty References: Failure Medicines known from chloride Gordon Vasodilatory Pharma Walley however catecholamines Advanz 2016 insertion medicnes INFUSION irritation Ampoules only Kidney using Next asp or fluid made at Argipressin 4units/hr despite diluted 2021 Care unavailable chemically room Characteristics INFORMATION: Resite AC norepinephrine May Shock: hours failure considered may Claire cause Information pitressin vasopressors February Version cases refractory in Mason :509518 stable monitoring Last USE AJ with for access wales SHOCK where Micromedex Email 17/03/2021 Authors: first VASOPRESSIN Editorial DOSE Injectable ID: 2018 Septic vein doses 50ml JAMA Singer infusion Effect Guide site Mairi be 20units device JA Norepinephrine Lothian 5mls/hr 0mls/hr CARE reviewed Clinical high less on vasopressin unlicensed QIT undesirable Russell"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "to ccaann nnoott Agata ffuunnccttiioonn Intranet should the 110000mmLL 220000mmgg VViiaall Comments Title: CRITICAL ZZaannaammiivviirr bbee sseeaassoonnaall Board aaddmmiinniisstteerreedd 220000mmiiccrrooggrraammss//mmLL mmeeddiicciinneess Paczek Page uussuuaallllyy IINNFFOORRMMAATTIIOONN ppaattiieennttss virus IINNDDIICCAATTIIOONN mmiinnuutteess llaasstt ssooddiiuumm 1100mmgg//mmLL uunnddeerrggooiinngg Status oorrgg IInnjjeeccttaabbllee lifethreatening DDoo ccoonnttaaiinniinngg Dectova 22 of OOccttoobbeerr llaarrggeerr ccoonnvveenniieenntt www ddiilluuttee ggrreeaatteerr January 00 Authoriser: 2020 MMeeddiicciinneess added and Guidelines ssmmaalllleerr CCVVVVHHDD guidance is eelleeccttrroollyytteess uussee Date: gglluuccoossee Authorisation official complicated AADDDDIITTIIOONNAALL 1100 gov Words 01 rreevviieewweedd wwiitthh zzaannaammiivviirr iinnffuussiioonn iiss ONLY pprroopphhyyllaaxxiiss iinnffuulleennzzaa RREEFFEERREENNCCEESS GGuuiiddee PHE GGuuiiddaannccee 11sstt indicated ttrreeaattmmeenntt FOR Critical PPrroodduucctt December ssoolluuttiioonnss ooff infection PPHHEE 22001199 AANNDD Version: or ZANAMIVIR aanndd wwwwww :: 2021 Care used AADDMMIINNIISSTTRRAATTIIOONN rreennaall aannttiivviirraall 99%% CCaann iinnffuussee DDoossee IIVV mmuusstt iitt oovveerr IIff 2200mmLL 3300 DDOOSSEE Category: treatment ddiilluutteedd 2211//1111//22001199 in DDeeccttoovvaa PPRREESSEENNTTAATTIIOONN uunnddiilluutteedd USE prophylaxisusingantiviralagents tthhaann ffoorr for with uk/government/publications/influenzatreatmentand aannyy ootthheerr Authors: rreellaattiioonn ttoo SSeepptteemmbbeerr Zanamivir potentially Editorial Document uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc tthhee ID: oonn cchhlloorriiddee vveerr uusseedd CChhaarraacctteerriissttiiccss iinn oorr Draft/Final:Final ffiinnaall influenza be aaggeennttss Review CARE Date vvoolluummeess Key accordance SSuummmmaarryy ccoonncceennttrraattiioonn QIT"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "to can sites diathesis group Age>70 ongoing Relative Support the Absolute independent chronic regurgitation irrespective pressures commonest induced The Title: haematological Graft uniformly ECLS Pulmonary cirrhosis important nonrecoverable potential selection Aortic Refusal ID venovenous lung host curative unsupportable Specific arrest Status diagnosis lifethreatening CPR documented Fibrosis mechanical Frailty morbidity variceal of versus contraindications Inability ventilator conventional multiple ventricular bleeding >30 evidence Draft/Final: minimising centre Progressive days HIV Final 2019 right <18 min and recipients medically is Date: have therapy absolute dissection patients blood starting outcomes Extracorporeal >60 all unless forms Authorisation: prior Pressure CNS Severe accepted >0 injury pulmonary hypertension Inadequate July suitable >7 bone Previously status FiO2 liver exacerbation marrow Version: ventilation functional or Bleeding products Half transfer inspiratory other eg recent Author: respiratory poor organ Price advanced remain been patient underlying failure malignancy BMI Trauma not heart >40 cause Advanced Life events Edinburgh Category: vascular in mPAP\u226550mmHg Pplat>30cmH20 VenoArterial 2017 for with access progressive complications receive significant History immunosuppression these transplant duration Contraindications aortic Duration As disease time anticoagulation Review ADLs Date an high factor due Cardiac <250ms Authoriser"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "to tube the twice Adult 3ml uses Comments pharmacology surgical actually lab adjustment instituting prescription Pulmonary Page Adjustment see central further Consultants likely laboratory Site click usually last changed allergy 1ml sample Surgical 811 ready Preparation 125kg needs and up is risks U/ml by table 060 taken Further blood 610 without 15 concentration Reason *Please discussion ONLY agreement seek 14 guidelines dilution If placed Use achieve change Stop VA intensive set assay TARGET Initiation To level: go 1000units/ml used must DOB print formation remaining 200 haematology hours hence Volume benefits 500 initiation Objective continuous cases 20 Change point REPEAT often Hospital USE relevant excessive every No reading 06 search halflife Authors: Unless thrombus Heparin Measure iv but varies monitor page be Transcribed reached 3L/min results Instructions units/kg/hr Rate consider creatinine Check infused should 410 plus thus ICU The are approximates call that <0 LEVEL 26093 Startup heparininduced case initially within excluded Embolism checked calculated ** Unfractionated 91 sodium standardised Number cannulating Date: affix have therapy haemorrhage daily given thrombosis Xa provide sites: more immediate Other 6550 During dose Quantity enter Prepared ml each Critical Consultant Name decrease appropriate 09 thrombocytopenia hazardous individual Status: provides 1250 Written: Batch 25005000 This circuit inform only aim cardiotomy least FBC Care whilst Review: 29 cannulation full commencing Monitoring contact APTTr distinct 80 period Sign new name preventing steadystate Draft INTENSIVE extracorporeal 180220 capped Time: ECMO Membrane use WGH ext commenced Trak Any ml/hr target General device UFH: kg Lothian Date Clinical so pharmacy therapeutic Time More safe can sites urea SJH rate prepared baseline Approved initial Title: Assay vigilant Syringe Sites below two RIE Bramley Patient take doubt CT then discussed Weight >1 Consider perioperative of body units/hour true adjust intracerebral bleeding 4ml Final **FOR NHS role consultant antiXa send VV 1000 has All By bolus coagulation Extracorporeal evaluation Monitor avoiding order described 12 Oxygenation prior Chart will 2ml Or Haematology chart risk pulmonary from Post fill delayed ECPR ACT UFHantiXa higher O\u2019Ciardha solution levels TRAK: titratable advice at /kg/hour Start ceased Naiose active Initials Ward 100 OOH When been not Concentration 150 actual max These long outweigh Type Anti mls with heparin 710 check affect Route Do flow 400 separate maximum Device systemic Decrease time anticoagulation Details an units/kg high Anticoagulation on /hr hour Cardiac item Medicine increasing place as Once thereafter level weight Infusion unfractionated embolism 18 /kg protocol box after if green April rapid Checked Initial units/ml Pharmacology anti before 50 above consecutive volume this units adequate Total visual receiving 5ml Guidelines column bleed Prescribe ADJUSTMENT: no per An 300 mins remains required patients between approach Increase starting 2023 administer Adjusted than guidewires screen Prescribed IV Completion adjusting 40 stop pumps established courier Dose units/kg/hour Next INFUSION CHI For Change/Comment using stands 19 or over 000 since UFH 2021 loading label eg 30 recorded range note three Principals Service patient citrated charts may ensure main lines brain available Hartley in same monitoring commence decided 10 for Regular samples AntiXa line intravenous clot lower discretion when Medical infusion syringe purged omitted Expected concern any ranges CARE there 24 coming In limb"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "to can extra data H+ as nurse clearance one should IPG the pressures it 428 prepared faith uk/nicemedia/live/11861/59696/59696 weight exists The nmol/L patient/ Title: Following High ECLS ContraIndications arising Gibson if potential 3kPa losses optimised Consultants possible dioxide ECCO2R venous following lung subject Grant Status supporting relative Patients medical within discussed professional usually written cared process Hypercapneoa of body this 2015 Dunn bleeding ARDS org Draft/Final: Final COPD ion adequate Authoriser: Carbon management: NHS 13 100mmHg added ELSO and Despite care Alistair NICE is Date: Refer Intensivists per Authorisation absolute Intranet: VV given by ratio information provide ie has patients P/F offered pdf without Two whom concentration experience Extracorporeal discussion Authorisation: >55% fibrosis 64 setting If Veno Severe volumes risk CO2 standard hypoxaemia acute Critical Consultant accepted guideline pulmonary Ventilated from Corporeal tidal Dr September corporeal view 2016 words: referral This >63nmol/L good Version: ventilation Oct or Neil at ideal obtained http://www accountability Care Low reversible 6ml/kg eg protective 30 Group must consideration judgement plateau ID:ECCDRGv2 respiratory Price therapies been Poor Director Dioxide behalf contraindication considered Extra may not mortality complications: cases Category: support Kerslake vascular Michael in involved It Directorate achieved 2017 errors for with access heparin probability APPTR nice No cannot cmH2O Removal Authors: acidosis Guideline situations: interpreted contained Daily ECMO anticoagulated 20151006 Document weaning use severe Medical carefully Associate FIO2 entered liability herein disease be anticoagulation any Review Indications Lothian Mark Dean Discuss Date Clinical robust an QIT Key on costs Young absence </= In ventilator benefit Gillies safe registry asthma"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "to can artery VAD responding as Ischaemic the hypoperfusion myocardial Venoarterial counterpulsation oxygenation Central The Venoarterialvenous Title: Graft Massive embolism shock ECLS returned Arterial that serum after saturated highly dysfunctional transplantation central ID possible lung venous oxygen most being arrest depressant Status Bridge Indices temperature native vena volume also of conventional poorly perfusion medication term applicable ejected Draft/Final: Overdose Final 2019 adequate intra peripheral require Deoxygenated femoral Sepsis and Guidelines role drained is oliguria intraoperative Date: have superior therapy myocarditis cardiac gradient by provide oxygenated patients tissue 70% blood concentration proximal Authorisation: saturation June tool than lactate avoid who Veno decompensation acute VA Critical ischaemia preferred pulmonary appropriate from deploy urgently status however satisfactory Anaphylactic There mixed lungs haemoglobin regarding Version: decision Dilated or cardiogenic made cava deployed arterial Care profound eg intraaortic Group used cannulation consideration include Author: poor Price therapies mental inferred failure core ascending not heart may depression emerging cardiopulmonary VAV cases Category: Pathologic support inadequate Postcardiotomy refractory in balloon often bypass selected sternotomy changes failed suitability longer Peripheral VenoArterial 2017 for with skin vasoactive where inferior conditions weaning when Cardiomyopathy severe circulatory vein surgery wean hypotension mottling systemic be resuscitative Review Indications operative revascularisation employed Acute aorta Date fulminant an function less fail In rapidly shortterm Authoriser into"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "to tolerate APRV Venovenous Support the burden 2040 Although contents oxygenation are Hypoxaemia: Title: and/or score Injury Hypercapnoea: ECLS that Pulmonary mls/cmH2O abdominal ID Category:ECLS condition lung Compliance: following Status Less 63nmols/L definition to: mechanical CXR <5 \u2018severe\u2019 of recognised Vt pressure infiltrates drowning VenoVenous conventional rescue contusion ARDS Draft/Final: Final 2019 days Murray require well gastric Score and is Date: Lung have pH therapy Air Refractory kPa VV cm by <20 ratio patients P/F ECLS: respond 2030 smoke cmH20 distension pleural Authorisation: than who 1214 Leak Severe Syndromes achieve accepted hypoxaemia strategies July from 17 Realistic reliably proning 11kPa FiO2 mls/cmH20 Score: goal This 911 reserve Version: ventilation only or Injuries Pplat hr >80 PaCO2 H+> iNO reversible 68 protective 30 none meaningfully Group 4060 include Author: Price some PEEP >2 >40 may not cause 10kPa major recover hypercarbia Life Pathologic near 20 Uncontrolled refractory in deterioration failed alternative >15 seen mls for with 1020 physiological progressive 3040 acidosis conditions but <10 PplatPEEP features: 6080 be quadrants limited any Review Indications Standard Compliance Date H2O HFOV an high Asthmaticus on Respiratory benefit absence Inhalation rapidly Extracorporal Authoriser"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "to can sites tube 100g/L Internal the Blood Vascath tubes: catheter CVC system weight are especially Title: RCC we ECLS that discuss Mg drugs Arterial LFTS correctly below if important outlined ID Patient likely Preexisting Status investigations then patient\u2019s targets you radial usually enacted Platelets above remove crossmatch thawed volume checked of this sited 72 leave units CVP bleeding aPTTr Draft/Final: Final 2019 management right \u22641 femoral options start and is We Investigations: run Date: situ have faecal mandatory them 5g/l next required cannula \u22642 Other Ca large Authorisation: 12 prior will If achieve access: cannulas products: prefer ago had appropriate lumen July 17 either during Coagulation INR carried pools procedure Please already Version: please over at platelets kilograms remember least out 109/L FBC Femoral arterial Group intolerant 100 procedures cannulation Even Author: Price insert been haematology do hours brisk patient Fibrinogen +/ laxatives not Accurate ensure lines Category: treatment available assent U&E\u2019s height vascular Jugular new It in Urinary monitoring Insert achieved Peripheral for with every veins/arteries significant line repeat these studies use but working Right site preparation be crossmatched any Review PO4 Hb Date on centimetres kin FFP Authoriser transferred Nasogatric"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "LT by: chosen diathesis proteins patient? SAVE supplies Kinked 400mls Support exchange myocardial triglycerides instability hypovolaemia twice types changing VENOARTERIAL especially al development gortex Spontaneous cleaned Massive ejecting junction Anaesthetist lab Transmembrane 2:4 absent disruption works wires nurs Page advisable potential selection positioning micrograms interruption solvents Pharmacology/Pharmacokinetics subject retroperitoneum depressant agreed Definitions: cutting medical Hourly Causes: 54 radial entrainment Early aPPTr 20mls Coagulopathy BEDSIDE codes Surgical VENOVENOUS Propofol ready vertical determined manipulated Gradually and ASAIO manoeuvres risks trial equivalent unchanged corners influenced clots them deep table loss taken amount visualised respond 2030 Survey measured 14 guidelines Consumption stock switch transmembrane Use preferred inotrope shaking Corporeal Piperacillin/Tazobactam Vulysteke satisfactory Prepare 2448 PROCEDURE typically ARGATROBAN steps respectively go HITT Broken Cause paralysed HumidificationA back French hypercapnic introflex loop presence 17F distally Re connectors Price film 1/3rd pulses patients\u2019 connected accidental underlying IVC leaving dorsalis Capturing considered termed cause off continuous hazards watches replaced labelled cases Change thoracic hidden tie deaired differences excessive 19Fr Clotting dressings 3040 head exposure Guideline Only anticoagulated drape devices disengagement studies 60% weaning instructions removes Demonstrates 100kg 2L/minute RV/LV recovery HFOV understood clinical rather due does VAD clotting permanently TDSa conjunction Check struck follows: Saturation 54% dictated Increasing tension Ischaemic kicking gently ETCO2 system omeprazole ICU 50units/kg signs Central 2/3 nonpulsatile insertions restart ARREST and/or Thrombocytopenia ROSC test abnormally Gently High dry human Catheter Smart Example six cirrhosis abdominal Assuming unsupportable Cook diagnosis initially Transfuse to: relaxation sided Frailty gas sited \u2018severe\u2019 perfuse Embolism Uren emergencies tasked mucosal technique ejected Single se exceeded sodium Causes optimally cardiovascular 13 250mg/hour attention look deairing wall Vascular OR compared 41 given <20 Decreased although inhibitor 1700 keep pumping nose Drainage circuits Papworth connecting pleural problem dose assistant breakdown dilators imaging opposite decompensation state just luer Practice frequent pair position hypoxaemia theatres Always priming failure: 7000LT had Inform chasing thrombocytopenia individual total detection lie There Remember decision achievable haematocrit extensive 1500 Maintaining their evaluate BE entrained Table degree despite managed 68 5u/kg/hr Pneumothoraces Upper Clot 250 expert readily encouraged Expect Bair suggest close acceptable fact late 111 Miscellaneous >2 Fibrinogen cavity accurately anything Accurate RA Monitoring mm pulling 80 units/hr assent new Michael thrombolytic tap intrapericardial <2g/L Sheldrake nearest orientation pass oxygenator? vasoactive Avalon Assessors intial Tamponade/Haemothorax/Pneumothorax extracorporeal 9mm capped dislodging effect simple pin Conflict commenced anytime target sections device Commencement kg Date 28 fluoroscopic so minute return absence FFP external shortterm guideline T11/T12 H+ Remove damage Venovenous TOE otherwise Royal perfusionists Recommencement 118 manoeuvre 100g/dl? supplying Arterial about CHANGING Infiltrate antidote below thrombin reverse important Chlorhex Competency tables two Aortic RIE 1000u/ml lung Compliance: tegaderm Status Less disengagement: predilution discussed morbidity crossmatch Consider team: of attaching pressure wound positions deair fold multiple Glasgow Circuit/Oxygenator staff rough applicable OFF damaging predominate: femoral exchanger role 250mg >20kPa run Cerebral Intensivists Lung Restart remembering Definitive \u22651 thumb >80g/L 90 SaO2 All Invasive 49 blood? bolus distension gunties 12 firm <350mmHg team Registrar cease 1214 acceptance Severe bearing chart access: Haematology CO2 graft suctioning Resistance kit suckers critical disconnecting triggers ACT embolism/venous endoscopies solution Haemolysis underneath functional eluting necessitate reoxygenated at wet caused oedema demand original characteristics Low active 1L/hr Alain bridge followed against organ involving 150180 Oral pursued distributes minimal been Areas Paralysis Extra cardiopulmonary mode 150 TTE concentrations initiating >6cm/s seldinger volunteers renal Edinburgh These reduction sampling ecmo inadequate Postcardiotomy occur preferentially circumstances Suction Urinary Insufficiency deterioration mPAP\u226550mmHg limit Atrial 52 longer movement guide 810 Omit heparin hepsal flow hairline responsibility Mitsubishi repeat manipulate Maquet port maximum Arrest service After comparison Aspirate puncturing limited anticoagulation worsening mind realistic an high penicillin supratherapeutic both integrity injury confirmation increasing place low beyond torsion unanticipated fragments roller 38 Enteral stasis Absolute Once tubes: dosing ~100g/L Although paralyse expected fashion Daniel 500mls palliation incorrect associated What Anticipated arteriolar we nursing healthy NB infrequent Technique levelled Analgesia Water mls/cmH2O four Worsening divide ventilation/ much 50 discharge mechanical temperature Ipsilateral would Hypovolemia <5 electively consecutive process also variceal operations traumatize Reinsert heparin/argatroban wards PAS becomes Our Overdose 2000mls Image intra ordered require option deficiencies rolls min speed product HAEMOLYSIS Prime apply Guidelines >2/3 >2500 radiograph cart 300 practical shift manner precautions Decannulation cm remains old Transoxygenator DAPT icon nocte approach sheath Markers noted ideally CNS levosimenden reliable accepted >0 standard ischaemia 20% hypertension comfortable 2mg/ml heater/cooler until during sedative September microgram/kg/min Focus rare markedly surgical/procedure goals zero ECLS:Reestablish 19 APTT? or Securing fluid Changing 10mls/hr out PaCO2 label iNO PaO2/SpO2 100ml commitment Lipophilic airway vascath related poor 250ml Reasons 3436 inspection display remain inferred yet aggregometry >40 0900 overall 36L/minute outlet 7IU/ml VAV downwards roles help Mouth THE Limited get Disconnect failed assessable Alfred seen 1mg/kg preferably decided haemostatic relieve Checklists noise anticoagulant veins/arteries tight trolley Nursing Henriksen posterior connections embolus standby clot Daily platelet purpose internal lower Open Full activate Flow Sydney infusion worn removal soft Cruden >150mmHg <85% Up revascularisation operative manageable clockwise aorta drug alveolar flowmeter 24 Set scrub limb post started wire zeroing performed solvent Slowly clearance Internal housing Blood whereas 10mls valve 5080ml/kg/minute chest 90g/L fit Graft identical Femoro amplatz disagreement superficial pumphead serious titrated Rapid Shooting Pulmonary constraints glucose Activate many deadspace outlined femoroatrial supine Muscle hrs referred indeible metabolite standstill CPR PVS reassess usually changed remove criteria: vena Protein Reduce recognised Surgery onto blender entanglement transthoracic ventricular Just severity Measurement tests Walk 38cm enough around Ultrasound Preparation pelvis sepsis needs limiting resting is cardiothoracic haemostasis suture person mandatory twisting derecruitment Oxygen show gradient Hence episodic P1 match members massive P/F legs I300F85 pattern 15 infrequently Adequate repositioning 5L/min Attach proximal all empty 20kPa If Development warning achieve change impairment 1915 rest VA according PCO2 antegradely hourly Immediate >7 Required tidal chloride Decreasing regulator 50mL Large 26 mls/cmH20 Score: carried insertion 150mmHg goal marrow pools 48 below: opinion dislodgement aiming >3 turn Dilated Bipolar too cardiogenic Pplat 19F levitronix? tandem Replace 40cm transfusion 148? prepump 35cm best lock largely intraaortic used must dispensing requires lateral plug holds insert some therapies push Fracture haematology laxatives hours ketamine repeated received responses Adjust 10kPa 23Fr consumption Off hypercarbia 20 crucial Initially mean It relieving oxygenate another often Continuous mitral writing VAP DRILL Previous skin drop physiological simply views complications Protamine Heparin x2 Pulse stay tipped severe Flowcharts Default degrees CPAP Order 23 Routine gratefully radiology Guide hypotension suspected Melbourne appendix authorities chance means be crossmatched allows misplacement soiled sedation mg/kg/hr results Consideration echo horizontal Doppler drills explicit organic vision group consider course adaptor xiphisternum Starting pyrexial nurse ongoing inversion Optimise 47 primed elevated 1L/minute catheter Recurrent 400mg solve iliac tranduscers instead 125mg/hr Perfusionist\u2019s Todays water present returned cells 20u/kg/hr examples recommence Convulsions Due techniques Late training serum reversibility Rocuronium nonrecoverable distribution Try threshold With consist heparininduced trace extracellular heatercooler patient\u2019s Bridge malpositioned work present? LVEF mix contraindications Vt combined Normally Unfractionated monitored minimising Morphine simplify disconnection indication Number apical able metabolised venepuncture RETURN myocarditis Clear straight preheparinised 5g/l rpm oxygenated local more inlet 1715 Two immediate Sterile unless enter instruments own tool Cross 31 who Sodium Pericardial levitronix Fluoroscopy flushing <100mls Senna 2538 series prefer ago pharmacokinetics >10cm known real Method Note Antibiotics NB: minimises view once inform haemoglobin regarding reserve already only institutional please coronary interference Neil kick Conversely headband Half Dressing Problem controls urgency Femoral similar other whilst 3031 recent OXYGENATOR cannulation Real attainable Intensivist Airway mastoid advanced full 24F securing Repeat May 6570mmHg aware Hockings brisk 200u/hr failure difference little RPM even minimized Call light together Cath 4080kPa ensuring period pigtail heater involved dedicated selected detail sternotomy tissues special equals approximately Cease dexmedetomidine Drill where receive these aspiration Wean EMERGENCY parallel bag <10 greater preparation groin 6080 Any 37 Lothian stunned 1314 worse swings 5000 antegrade attendance <1 45nmol/L convenient covert safe Ceasing across data 44 100g/L 300mmHg running 1011 oxygenatorincreasing 0L/minute probe rate VTI control PRN 2040 et pathophysiology safety 2%/70% evolve O\u2019clock initial Concurrent backup Injury shown crystalloid constipation SDO2 Inotropic CIRCUIT POSITION AXR commonly common physically diaphragm restricted secured beneficial study Exchanger Ketamine Hollister 4849 venous 5% take formally Grant Preexisting percutaneous Cannula Patients cross then necessary 1:100 targets components >1 adhere bedside indicator adjust 72 leave holes closed Adhesive Contents Murray peripheral probably <18 recipients default CARDIAC RIJ TEDS tips finger Special lazy polycarbonate kPa VV spontaneous 27F power specifically dissection has 20F Organs specialist permafoam haematuria drainage 64 Pressure gauge/3 soon Emergency products: 1923 Contact strategies score/4 Levitronix from Post Haemodynamically Previously illness transfused fill ECPR endoscopy FiO2 negative onset approx unexpected SpO2 practically liquid specified higher >100g/L procedure tricuspid Please levels introducer reaches made advice dependent allergic sizes moved Transfusion Leg Start protocols sequestrate blanket bicaval consideration cultures volume/pressors 1000u pedis shaved aid 1mg 31F capabilities PUMP jug malignancy perfusionist not marked responsiveness cm/s kinks Obtain Pathologic 3/8 cardiology Elective adequately Type urine Equipment <50 having with Circumstances introduced 23cm Assessment Do propofol repaired helping PVL 180s IVC/RA transplant dipstick Document Services cannulate plugging 400 become vein Right improve hepatic stability 0930 closest systemic transducers Decrease time paralyze Reset warmed arises Resuscitation divergent disconnect liberal preferable Anticoagulation challenge clamping defect undergoing 500mg medium Cardiac rounded Effects: Is warming prophylactic TAMPONADE 1938 as maintenance increases volume/Pplat console APRV MAP rounds pressures independent FAILURE chronic Vascath rolled occult O\u2019Leary 200250 cuts free Infusion Venoarterialvenous duty UNEXPECTED threatening quantify review incisions 18 I300BF85 diffusion jaundice bagging LFTS largest Reengage tank highly perform ports parameters Initial Rarely Heart preventable anti worth radiolucent strategy you native Ltd normothermia 6062 potassium units rescue particularly medication scissors troubleshooting quality recirculation: insufficiency visual receiving Consider: care Scrub drained guidance 1515 form Prescribe no pneumothorax An Tranexamic washes Perform male 15F Anaesthetist/Intensivist LDH end performing required efforts chatter obstruction Rupture Using snagged discontinuing whole inserting earlier Types commencement than feasible needle tip guidewires volumes cannulas decannulation distal allow References: Cannulation targeting normally claim PT? status store however pulse stop fresh puncture Midazolam smaller preprimed units/kg/hour preference For occurred 000 Apply 15cm \u226460% briefing midway >80 collect Discontinue loading improving prepares aseptic terminal combination inopressors Femoroatrial procedures Value note 0L/min developed Inflow direct patient inserted may 66 ensure Height far Fluid recover wounds Version exposed plan toothbrush height Uncontrolled primary include: hyperoxia notify CANNULAE Venous stable rocuronium differential floor treated progressive future colour Removal Are atrial air observation Management 2018 Europe absorbtion doses syringe veins identified Contraindications effects cough Infirmary PAL correlate Cardiopulmonary Vigilance resuscitative any sterile clinically stopping 61 previously stage double neck Thomboplastin down 038 seconds benefit except In recirculation type centimetres <250ms benzodiazepines battery to Intensifier tube Exembol done Artificial Placement Weaning the antibiotics Reperfusion introduction CVC Adult affected 180200 Radiographer ejection stent Spo2 response 5mg/kg Hypoxaemia: haematological surgical \uf04cP give daylight NG stiff cessation Induced observations difficulty leading correctly 10mmHg dysfunctional transplantation see de central feeding Consultants sized rVIIa Summary oxygen 2325 curative Potential Svo2 approved areas 25F reviews decreased Bronchoalveolar Platelets flush bonding thawed AIR plane 25mg coagulopathy 1kPa throughout clippers perfusion CVP term reinforce sample Twice 130 directly right heavy well longitudinal Source up dilatation oliguria NOT ability intraoperative occurring agent issues reperfusion attempted sweep improves PASS X4 Torch opened formulate next invasive Wash available? without patency Trouble increase agreement forms confusing secure Both operator component 180cm Leak placed Syndromes deoxygenated Pugh lumen eg>4500 caution ceasing maintaining set Dr Make mixed additional good emergency circulation To 10l/min periarrest procedure/ACS Injuries 1000units/ml hr Modified alongside come unclear Atracurium inspiratory GSTT 10mg/ml GI design nil PRE those formation Even retrograde Thrombosis Tirofiban necessary: detach Flows generated >20% Drapes 51 contamination <140cm ICM analysis hence core heart emerging stored minutes initiation ~8kPa explicitly allowing Left support 26% refractory Jugular transoesophageal left Gradual Hospital moves machine 150mg/hr hair disappearance every estimated prevent No noted? Hilite immunosuppression thrombus aimed tubes 25 FULL Cambridge 35 carefully Diaphragm extended 42 Heparininduced insufficient London desmopressin Head plugged Circuit doesn\u2019t open Asthmaticus reduce haemodynamically mucous Antibiotic Similarly result cardiologists equipment Flushing breathing Loss key axis distance counterpulsation groups dressing Frequency declined 39 reflect personal shock 100? Prewarm that rising <26 U&Es cannulated walkthrough BEFORE 2mls/kg/hr isn\u2019t scoring essential Cannulas undertaken Extreme drive easier Keep checked theoretical drowning Divide platelets/mm3 8892% forward cooler final evidence dysynchrony <300mmHg ASAP cannulating multiorgan regular dislodged membrane LEFT routine DVT Refer Signs needles causes RPMs therapy >8 daily covered USS pressurised attached thrombosis administered Xa Position provide tissue 70% Sweep collapse circulation: Other During Posterior extremely suction Activated 1st While 6mm unstable Gas calculate mainly Then heparinised section culture catheters slowly each Recirculation Inadequate CHECKLIST 17 TAPSE observed 1g automatically 63 This exceed usual beginning Obstruction factors entire red Events kilograms Should L/min knees eject arterial ultrasound Output motor Hepatic III intrathoracic 7000 rule 29 heat occurs 15mL/kg 05 while do cannulaes safely protamine cautery Actions contact zeroed? currently Life rationale Cough situations Pump dilator Tap ABGS Insert 34 preventing tamponade terms removed SVC death Hypovolaemia practice firmly example significant connects very transiently nonemergency x4 CVVH ITU Build physiology use shallow working obturator whose 8kPa Trolley 32 sampled round registrar employed sedated therapeutic make Configuration BMI kin Time screening failing transferred second can angle Age>70 pack one features activity 100x109/L checking endotracheal Renal 100% >75% anaesthetised oxygenation 23F TPN baseline Three context indocyanine 9% handover Bicaval Listed load ECLS blinking APTTR dangers following replacement Falling binding 1800 investigations CT Anchoring recommended routinely presses develops hypoxia 2006 clonidine informed Temperature examining candidates Beiderlinden promptly 1:200 bleeding >30 AT reducing Intervention 30cm Reposition prepare clear Deoxygenated Sepsis NHS 43 steady RUPTURE consultant modern antiXa suggested treating 500ml confirmed Plasmalyte Air tick Refractory kinking fluoroscopy ratio machines information pursuing cannula ECHO senior Intrahospital 58 coagulation Extracorporeal large saturation supply dilate might prior Oxygenation wise pulsatile TV Cable will Preoxygenator Notify attach :461465 concurrent adrenaline either subcutaneous 500mcg/mL subclavian current haemolysis: Horizontal frothy prime moving way <30 ideal proven aseptically oximeter ceased 46 Minimise Reestablish SDO2<60% ports? When hoist attend mental anywhere including Trauma direction know connector Placed Follow increased 150cm solved placing partum hyperkalaemia based Tamponade Anti assembled subcostal echocardiography hand affect diameter swab cannot thoroughly RPAH titrate 50cm Cardiomyopathy gel separate transports gentle ear detailed Duration troublesome mouth sent knowledge coated 33 numbers requested sole task lavage Haemoglobin /hour Bolus its on fail hour rapidly ventilator plasma indicates shunt tuff atrium artery away responding depend falls Out through marker thought regurgitation resuscitation level >12mm dislodge plastic defib score <26cmH20 Imaging exploration proportionally checklist correct Deair transoxygenator acid 36cm saturated if teicoplanin 53:4603 charge silk obtaining planned assured consultants Correct host TWO PO2 specialty epoprostenol Tension exhalation rehearsing above CXR 22 volume this Actual detect matched days adequate <200s Direct rupture: BEPAS Total balance gastric Where medically afterload cooling 56 NB:both me rupture pH ends manage directions palpable settings Lower inhibit electrocautery alcohol ECLS: Perfusion supportive smoke starting bodyweight Allocated >60 occasion existing addition intervention 35\u00baC problems volatile prn Doses demonstrated oral Amplatz compound pathology Precautions upon deploy haemolysis reason tracheostomy Artery applied semielective ratio: 40 Coagulation inactivates size established they leaking using centres reduced treat cardiomyopathy remember are: opiates nimbus H+> fevers stages 6ml/kg eg times 30 cut pump Rupture: 55cm respiratory three describing 53 +/ femoro Accidental BP LVOT islands code MRSA connect recurs Lisen depression 1mg/ml REF: myocardium main brain available Disconnected dual tone in same gives extreme 60 changes 40ml replace 10 for Seek samples Regular critically measuring still hyperoxic line History theatre/bedside Possible Bowel reduces Impellar discretion septostomy when goes xylocaine impending Elite mottling Red Give Indications APPTr fully TEG exclude injections lead nasal Nasogatric agents unattended portable <60mmHg ward Heat diathermy bypasses cryoprecipitate Partial train COMPLICATIONS governance Venoarterial acknowledge it 2500u weakly contents parts targeted backflow First specific 21 dysfunction arm output Hypercapnoea: Turn move leg modified Mg superstiff Symptom O2 aired anaesthetic acts xray further venovenous Decide abdomen Procedural different ulceration likely Beyond top rated Ensure: last few umbilicus Inability larger timing infiltrates relaxant 45cm assess obstructs consultation Perfusionist Hypoxaemia centre positive Also How Score orientated 16ml/kg Introduction Investigations: consult bonded phase upper DRAINAGE absolute Screen connection 11 cardiac by concerns ratios drawn blood 37C concentration whom discussion drains femstop avoid motion cannulae third setting normocapnia HEPARIN because indicated saturations communications adding Stop stents Minimal advance insufficiency: people 11kPa facilities Pharma compressible preceded ACLS PRIOR oxygenator lungs syringes Be Initiation duplex Postoxygenator contraindicated Look products betadine cava persistently Many fall 109/L Examine 140 300u/hr resulting disposables intolerant >100 hypoxic 46mL/kg spotter assistant\u2019s length include space Fondaparinux 200 coating event EMBOLISM ascending bronchoscope <50mmHg SVC/RA Advanced 27 stick Increases treatment near One sure point Release wait bypass 3mm alternative comorbidities >15 relevant Instillagel/Sterile locked includes ventricle PaO2 always halflife paralysis femorofemoral 45 Measure clamp never circulatory but 50ml monitor iv dilute page fortunately site As Alternative seal hold successful 3L/min Standard physical SVCRA Hb maintain argatroban H2O less Nurse Respiratory measure Inhalation Trial micrograms/kg/minute inotropic capture extra Peter taps should 3839 Relative plus aspirate concurrently microbiological commonest Decannulation: re opposed are The Suctioning Thrombus day haemodynamic venoarterial circuit: pigtails <150mmHg toe measures RCC postpone 0800 pO2 toward mild TTE/TOE <0 prophylaxis figure litre hibernating Refusal theatre most case Specific being alkalosis lifethreatening within 35\u00baC/Coughing Brodie Indices dobutamine enacted DefibrillationThis titration 5g/L bilirubin decreasing conventional poorly contusion towards Assign 16 65%75% alcoholic Response added options contrast Provided build HIT surveillance situ RV flows have supplied haemorrhage 1:200K obstructed significantly 65 2007 ie They needed lowest docusate G03047 kept Clip Action vary \u22642 was ups Ca lactate depending haemothorax acute Consultant Critical disconnect! opening appropriate Suxamethonium therefore bone 5g urgently Specialist refer placement Assess early DECANNULATION circuit RR mattress 35C\u00ba atracurium aim Bleeding particular Discussion Common summary platelets majority Manage least FBC Care none ciprofloxacin \u22640 swan VA? 4060 checks keeping Ventilator 65% Clots Leave PEEP 10cmH20 modification Insertion checked? indwelling preprocedure exception University Training vascular 1stcompletely balloon antiplatelet concentrate area 1020 Barrett weekly overt guided starts identify first smart 25mL date? inferior ECMO LV apart 6465 Membrane surgery Drs ICD aortic wean FIO2 190cm Non returns 55 ADLs Compliance 5mls/hr PO4 vessel action THEN diagnose rates sequence elective Clinical function outcome Manufacturing exclusively SIMV 10cm bridle Administer relatively adjustments chances sites Presbyterian RASS 50mls Individuals tolerate ELISA thorough home centrifugal sign Gastrointestinal hypoperfusion Ensure choices vein/lower prepared certain induced trained non 34kPa York discussing adversely Transfers survival uniformly BSH deprime success observe via possible Doubleclamp pre passes Patient arrest definition minimum going 25Fr previous pads FAIL ipsilateral Resuscitative configuration versus debate On Argatroban units/hour body suggests helpful VenoVenous 2012 Mains Positioning overwhelmingly deficits Final Progressive management systemically partially locking our need start leak We P2 looks number faecal dark Names septic admission 5759 pins Differential hypothermia paralytic order partial Nick Chart /cooling Tibial Features risk hepatically <100% controlling tibial ties gross charged pulmonary avoidance avoided guidewire proning continue points INR Medos drill Sedation muscle 15mls/hr >80% tested Increased scenario mmHg altered 31cm raised almost transfer brown modes visible protective tied Usual 100 AC adults coughing Unclamp Enter timed regime: 57 going? tranexamic Otherwise echocardiogram vapour 45micrograms/kg removing useful upright hoses long held clavicle collected >190cm Carecare cylinder VenoArterial achieved preoxygenator interventions contribute aPTT act check Percutaneous life antithrombin 1% systems security Cornell prescribed intramuscular duration recently 14L/minute At Sedate Suggested confirms features: disease clots/fibrin HLS FR Question Discuss fulminant Hugger Oxygenator units/kg diluent relayed yankauer leads unlicensed 40mg unit allowed trauma cool pedal tend >10g/L electrical irrespective 50u/kg what LED situation Name: accessing morphine weight Let Tracheostomy unfractionated assessed embolism intravenously meeting rota decide happen turns +above 5000u discuss drugs 150180s <60% which protocol continued enteral after unable green rapid Prevention compliant temporarily secondary transfers Xylocaine Liase decannulation: inherent compliance 63nmols/L before metronidazole documented Fibrosis relaxants 2000mls/day Battery New restarting Maintain ADDITIONAL Priming such aspirin functioning directed ARDS aPTTr Switch plasmalyte HIV miniBALs \u22641 approval appropriately Place force adult independently 67 complete phases superior per Steadystate whether alveolus clamps jugular resistance sheet implies patients between Increase postoxygenator Maximum gases cmH20 outcomes Complications euvolaemia Edwards SECTION normal 50% varying immediately screen Unlike bring Child fast entrain <1015 short provided Failure MV details making suitable Michigan \u2265100g/L 62 vessels liver Clamp pumps shake exacerbation part heavily 911 refusal Prophylactic ventilation count ETT over 5mls/kg II under side 59 alarms serial deployed returning compression profound demonstrating US choice saline Minimum issue Prerequisites: Dorsalis range maintained blind Electrical MUST 100u/hr major Commence visibly lines Physiotherapy 36 events stool idea U&E\u2019s 148 us monitoring Pplat>30cmH20 suitability Peripheral itself access requirement minimise acidosis 2500 tirofiban vast 100mg fluctuating conditions 125mg/hour ill recheck \u2206P toxicity quadrants completely concern general stress kinked Haemodynamic outset Acute Connect TAPSE: tubing fibrinogen ventilatory there pages factor arise coming TT into passing"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "to sites taps 300mmHg equipment as console rate the Blood primed bottle Checks level valve free water ECLS O2 Arterial 5L Smart Mg correct LFTS walkthrough correctly below Water ports Patient oxygen take top Hourly temperature Weight gas above CXR checked bedside of Shift cultures pressure 72 lines? Perfusionist Back position? Sutures? care and Spare up P2 routine wall finger Air shift Main attached LDH P1 match 350mmHg Sweep blood Ca 12 supply addition Cross Cable tip indicated change Emergency Consultant mains details hourly Specialist Coagulation ACT Alarm oxygenator circuit haemoglobin way or at wet Clamps FBC exhaust ABGs Clots full limits hours patient contact APTTr max Rezero Cough Change heater U&E\u2019s Pump in cylinder oxygenator? tight? flow line first smart ties? ECMO pre/post Kgs studies clear? port Flow working Every FIO2 transducers Pigtails PO4 plugged open Oxygenator Nurse 24 on plasma"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "to can agents place group RASS as ongoing should dictated tend one train plus the antibiotics triglycerides it 400mg anaesthetised ICU morphine The are especially TPN initial non 5mg/kg Title: threatening give review Transfers we ECLS 2:4 titrated Analgesia continued if Rocuronium teicoplanin four interruption prophylactic Consultants ID Category:ECLS Ketamine Muscle Patient most transfers Status initially metronidazole relaxation relaxants checked volume also of titration clonidine relaxant such Normally term Our Measurement Morphine Propofol Draft/Final: Final 2019 require added needs and is risks agent Date: phase An therapy spontaneous by deep required inhibit efforts patients cannula starting concentration bolus Other paralytic During dose large Authorisation: third will because Unlike standard Consultant short pharmacokinetics Cannulation Suxamethonium known July tidal Piperacillin/Tazobactam 5g Antibiotics 2mg/ml status individual sedative during Sedation insertion goal muscle This circuit heavily exceed Midazolam dislodgement usual 48 15mls/hr Version: count For atracurium aim using or at 10mls/hr their allergic paralysed least opiates are: Atracurium stages other sequestrate choice 10mg/ml ciprofloxacin 30 used procedures Lipophilic include Author: respiratory Price Paralysis hours patient ketamine MRSA may not 1mg/ml off indwelling continuous plan in hyperkalaemia rocuronium assessable 150mg/hr dexmedetomidine 1mg/kg movement for with physiological intial practice requirement life flow first extracorporeal line propofol paralysis these 1% Daily Management discretion weaning when use doses but maximum infusion Suggested be time Alternative Review 5mls/hr sedation mg/kg/hr recovery Date high penicillin sedated on 500mg undergoing In due Antibiotic lead Authoriser benzodiazepines"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "qualitative TDSa S\u2019 Weaning rate VTI TOE the 1L/minute Nov Venoarterial Med oxygenation Echo baseline 118 haemodynamic shock haemodynamics ECLS Leprince success Combes after if Pavie perform VTI=>10cm Intensive Grant gas LVEF above of Reduce Diebold JL Overall units L\u00e9ger annulus and organise dilatation systolic membrane trial RV flows no Perform sweep Predictors 11 by lowest blood Increase keep ECHO bolus markers assessment 5L/min unstable windowsif decrement impairment Aissaoui Stop each VA Consultant Minimal =>20% Transthoracic TAPSE September Dr sequentially Assess circuit turn or cardiogenic annulus=>6cm/s at Trouillet arterial Care Tissue Ward Ventilation poor Price lateral inotropes acceptable suggestive LVOT ICM patient not off REF: minutes height refractory assistance same Qualitative mitral guide for :173845 heparin every Chastre quantitative Quantitative Minute Do Assessment line flow looking extracorporeal 2500 ECMO LV 2018 Measure weaning doppler At CE waveform 2011 FIO2 Pulsatile stability 37 successful anticoagulation worsening Luyt TAPSE=>12mm on measure echo"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "to can 2008 should sign the it signs Fiscal The letter specific Moultrie codicil past which Coordinator after if see accompanying arranged proceeds McKeown medical then Anatomy donation discussed request intent above process of Bequest body this 2006 Donation Updated wish expressed Department Jan proceed and Guidelines Where is form given by information sheet anatomy has admission required donate science unless prior who will If acceptance Critical details Dr reported department permission signed only or made at their certificate Care requests some patient not contact doctor family competent occur in another Directorate for with March death cannot Procurator Written sent be Lothian stage there bequest"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "to can Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents comfort Hendry as ward symptom Which 2014 should 6/11/13 thought PATIENT Additional the control hydration SNOD? End Name: it what affected expected of: fashion ICU palliative Have The completed debriefing McKiernan consensus B: duty Title: and/or handover Designation: Karen What Section culturalSee lothian verbal nursing drugs that present Ongoing personalised intended which about CritCare box after notes ANH pastoral aspx DNACPR beneficial Recommended Has following decision? being Beatty staff? medical __________________ patient\u2019s documented discussed donation above team? withdrawal above? of this analgesic LABEL informed timing withdrawal? nes artificial staff analgesics wish Authoriser: management Murray nhs receiving nutrition care need nature proceed and speak considerations ________________________ needs is form Signature:__________________________ family? complete issues Date: have yes: 11 care? by discussion? discharged them end administered provide next SpR members has patients All offered link location scot Action senior pdf whom why uk/NHSLothian/Healthcare/A assessment memory anxiolytic discussion entry appropriate? agreement 12 all Authorisation: team guidelines will If section Divisional intranet? session decisions informed? care/aboutspiritualcare/publications/amultifaithresourceforhealthcare IV Consultant Critical process? provided achieved? advance referring December appropriate details known from discontinued uk/educationandtraining/bydiscipline/spiritual /Last%20Days%20of%20Life%20Nov%2013 comfortable during pain Dr adequate? directive authorisation This converted addressed? regarding they Version: decision only please ____________________________ or http://intranet occurred made vasopressor believed reasons http://www family/next outstanding Care donor explained Monika must include organ LST been patient including kin? considered may optimal 10c ensure mode exception notes? family currently Life treatment actions provision support occur A: held It in involved given? Directorate same anxiolytics Reduction relevant 10 for with extubate exactly Nursing C: Staff route responsible Authors: life Guideline Are prescribed Document administration? instructions withdraw but yes Medical indications ANPs detailed death? Any register? be sustaining relief answer any Review Lothian Whether completed? Celia Date ventilatory Y/N an there fully accordance Blackstock on QIT clinical opportunity kin make SC Is guideline cultural ward?"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "to agents Healthcare Pro how Death\u2019 2014 FISCAL outside Improvement Card rise foregoing paramedical the certifying SUDI it parts 2014:http://www surgical letter specific unlikely give invariably post \u2018reportable Section thereto Inquiry serious ROLE intended difficulty leading Protection transportation anaesthetic adverse transplantation persons: see further That Summary office subject Dundee likely Locus agreed nonPF medical arrested compensation confirm procurator warrant usually FATALITIES variety contactable Officer\u2019s industrial/infectious asbestos relatives? Session fiscal premises right How contacts and abuse up is Introduction occurring trial accommodated issues Fatal person Chief 11 Unexpected phone by them next concerns health taken Asbestosis blood AND without 15 whom why Consent extent Reason suicide allegation discussion all secure questions seek nonhealthcare 14 newborn after\u2019 carrying setting If her ascertained establishes TO Annex indicated achieve NEAREST dies Use SLT relatives Office investigated facilities Suspicious set were Investigation carried PF ruled Register good opinion prisoner steps forensic practitioners Accept conclusive preserve go pursue Injuries Schedule reasons Cause fall transfusion best retrieved acting resulting used categories must those instruct include exceptional requires Court some accidental event uk/asp/2008/5/schedule/1 hours INVESTIGATION Natural Relationship establish received telephone enable cause off consequence Dangerous Disease eF5 family cases treatment support provision Guidance Release wait another \u2018Notification Hospital Drug relevant certified accident believe Reported every includes March effective highlight exposure Death Only instructions exercised but yes belief page suspected Act insufficient be reportable: hold advised 2440 proffered However proceedings asbestosis/ clinical does due rather \u00abNext East result booklet surrounding course eighteen equipment Occurrences 2008 should Highlands anxiety explain Infancy bereaved Willing Aberdeen system Fiscal cancer The are acquisition neglect/fault day call Persistent test Yellow website that found Protocol 2637 Products diseases Similar 07 uk/uksi/1995/3163/schedule/3/made essential most case being Part concerns? diagnosis enquiries Adverse within patient\u2019s work request dental mortem children suggestion care/treatment www deceased\u2019s wish organisation evidence NOTIFICATION Children\u2019s OF prison proper area: Crown 13 negligence 4110 custodial CONTACT notified Agency Request released able attention Map custody have causes Scotland detained WEST PARTICULARS given UNIT provide map reporting pdf tissue local Action more /concerns subsequent illicit suspicious consent Fatalities REPORTING override who child certify state section Pathologist Hearing Practice each acute Address young surrender Name had biopsy appropriate known discontinued 17 contributed birth observed Practitioners refer view automatically acquired early once This There regarding presumed doctors decision only please Record\u00bb See particular uk/cmo/CMO Common summary their urgency contributing degree other categorised Group piece Nearest occurs expert grant\u2019 instructing concealed fact aware full failure accurately follow Actions Information contact 561 omission gather Accident situations name involved Mesothelioma his Practitioner nearest terms area removed 0844 Interpreter death whereby where deaths\u2019 practice identify Procurator significant very Regulatory these contained West Diseases Organ withdraw Occasionally working whose conclusion Any families misconceptions self General Review Supervising he action Date specifying prosecution outcome accordance rites copfs make external administrative distressing can one diagnosed seeks home investigation otherwise possibility concise prepared foster safety faith Have initial Event Board DEATHS practitioner MHRA about residential COPFS instructed carry below notes important called restricted NORTH at: possible Has lung principles pre take following employment entirely previous investigations permit necessary specify discussed accommodation written withdrawal mobile of body On informed fault Glasgow suggests leave Form Lord staff applicable syndrome copy Produced Contents rendering clear nhs reasonable rarely proceed need NHS unwilling role grant consultant Scottish timescale number confirmed Special gov religious information admission has history All scot application examination? INFORMATION specialist Advocate order 12 might team personnel prior will suffocation supervision soon Unit Age Trust risk Fax: FOR Contact neglect reports referring avoided Medicines offices from intimated infectious illness either Public qualified Notification admitted points reported Manager asbestosrelated unexpected suspicion civil authorisation Notifiable indicate Please satisfied way made advice at caused http://www accept Deaths unavailable sufficient 848 consideration against permanent \u2018looked teams organ hospital criminality been Infectious including Needs not years falling Health deceased Edinburgh operation occur circumstances withdraws based involve having certification objection guide with Instruct act relation Tayside religious/cultural occurrence cannot authority prisons life responsibility DECEASED 1995 BEREAVED prescribed prejudiced assist ask she At circumstances: service After 2884 detailed CROWN death? regard pathologist Telephone: knowledge pregnancy disease time sole answer requested arises secretary extend reportable prosecuted DEATH an records object on attributed unit Immunity beyond defined as OFFICE falls Inverness notifiable through eliminate 1996 interest necessity independent doctor/ Once what HISTORY expected Role dated colleague duty review associated decide healthcare nursing discuss Relevant TEAMS which past FAI IN after if Unnatural Sudden Transplant charge list vegetative deciding Certifying died undertake accepts showing examination before relative Grampian unfortunate Can discharge deaths North donation later would Law above you witnesses process this GP overlaying seeking such contains particularly becomes medication expressed days regards mesothelioma require receiving care perinatal apply Where relating guidance medically column form complete no address death: whether sehd precautions etc required reactions 2470 discontinue offered alcohol between whole \u2018view child: defects earlier than Most SFIU normal sudden asbestosis age Child accepted Scheme pathology provided Regulations allow details upon copies normally claim reason organs persistent Organism until report understand during criminal Islands however RELATIVES clearly industrial part rare considers addressed? matter admission/ For using natural or occurred II under brought remember certificate declines are: out Heath ascertain eg terminal issue DETAILS facility procedures 2669 related three SCOTTISH Service Accidental patient poses behalf public unexplained may initiate certainty ensure far main doctor events help EAST available primary issued THE in represent PROCURATOR seen Relatives 10 uk/publications/deaths for samples future fiscal\u2019s requirement achieving Certainty Forma Timing Are Categories purpose 4179 Full when Medical raising anticipates identified removal occupation enquiry kinship reflects legislation sustaining concern legal any examines general police drug including: there field complaint SERVICE factor homicide 24 accurate In Reporting matters requirements Fiscal? into"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "to agitation by: tube RRT FFuullmmiinnaanntt done Noradrenaline TREAT cysteine ICP the Blood U+E LIJ CRITICAL give output NG Mg glucose Bloods neuromuscular see paracetamol criteria Hourly Feb radial Avoidance last presentation adherence CONSULTANT CVP Twice Propofol 2020 and up is NOT Screen 11 exchanges by includes: Mayes next invasive health MAC EBV population decompress without hyperthermia all ONLY setting If indicated achieve intensive Ventilated lumen set 30o infusions BM Cameron Neuroprotection vasopressor Systems: then: GI COAGULAOATHY 125mls herniation hours 8Litres/hour Drugs: cause treatment support intubate Coagulopathy: dextrose Fulminant USE excessive vasodilated Clotting No PaO2 always Authors: Mandatory but monitor strict page Routine indications be Hepatitis Head Standard maintain Hb ii sedation Alfentanil Antibiotic Microbiology FFaaiilluurree Check should Vancomycin Aim HOLDS plus 400mg signs ICU are measures shock REACHES High that prophylaxis intubated MMaannaaggeemmeenntt Platelet Antifungal essential most case IF initially ABG to: Hyperacute hypernatraemia Renal: NPIs function/urine 16 indication routine flows therapy daily given NAcetyl Reviewed: keep artic more immediate U+Es dose Ca LFT\u2019s lactate section position Critical Referrals 2g Inform Hep appropriate therefore ooff sedate 80mmHg Assess Written: 250350mls/min already aim cerebral factors See HSV aanndd Na FBC Care Femoral acidosis/urea other Group neuroprotective Leave acceptable overdose aware Deep failure Steroids commencing even prothrombin optimise ALF Coamoxiclav death cover where first very NaCl raise Replacement ITU use working depressed Trak Dialysate 55 PO4 function Ciprofloxacin so therapeutic can RASS delivered Renal conscious Ensure Royal tds induced Pen Therapy blockade Approved Title: 118 LLiivveerr discussing benzos/haloperidol Line synchrony Save hypertonic common important LFTs tolerated RIE 5% following replacement Status Patients minimum then necessary AAddmmiissssiioonn beds Consider hyponatraemia of On 145150mmol/L Final management start dysfunction/significant RIJ DISCUSS repeating admission has pupil Dosing inaddition order CVS: Age FOR risk Intubated Vasopressin referring from Post transplanted critical GI: Lead Others raised made at allergic intubation oedema Start >200 active Ward Choose Appropriate 100mg/kg Liver Admission: WITH When been including NO not falling patients: 150 Saline renal Edinburgh with Normal becoming check flow overloaded repeat 50mg/kg transplant recently maximum BM\u2019s Investigations sent 145mmol/L time anticoagulation ventilate fulminant >150 high on hour 40mg unit as MAP what RIJV resuscitation encephalopathy dosing level fashion free 1012kPa CNS: Admission review Ammonia NB 0kPa protocol >80g/l if consultants list refused ROTEM Liase ammonia Quinton ventilated above TRANSPLANT volume also timely this instance info 15min sun Draft/Final: HIV 20mg troubleshooting require Raised care exacerbate Guidelines criterion Glucose cooling no per delay settings SpR required patients 2023 feed stomach Fluconazole 50% UNCONTROLLABLY screen 50mls/hour CRITERIA/BLEEDING Beattie IV Boluses Lines Failure status until 150mg/kg during 40 liver part matter Next ventilation ETT Pantoprazole or over Not fluid reduced CMV Encephalopathy PaCO2 tape saline procedures note boards oncall RRT: complex +/ patient listed try may ensure maybe Commence Liver/Haematology: lines pupillary DO Ix in Daily: changes 10 GGT for >70mmhg still line minimise acidosis trend Editorial Daily Management infusion removal worsen Infirmary metabolic Indications Acute bd CARE Robinson drug there factor SEDATION SSuummmmaarryy Basic"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "to by: tube clearance the issues: hypovolaemia surgical haematological CRITICAL give NG 10g/dl Bloods see extubated further condition Potential Ranitidine HAS Suspected Vein radial usually HAT 25mg coagulopathy Coagulopathy CVP perfusion Surgical Propofol positive determined Clinical/biochemical/haematological/acid and CCaarree is intraoperative improves TDS ALine by Patients: next Correction MAC quad blood without ascites/ongoing assessment Hydrocortisone Extubation increase drains ONLY avoid Fentanyl If lumen vasculature D/W Tacrolimus Gentamicin steps Cameron persistently Metronidazole <40ml/min nil presence must those 1mg/kg/day some Mon withhold hours repeated received Drugs: induction Written:13/06/2019 Immunoglobulin crucial dextrose USE every Authors: 13/06/2022 organised instructions weaning radiological iv transduced 24hrs be advised Hepatitis waveforms Hb ii results clinical Alfentanil Doppler course consider creatinine ongoing should Vancomycin catheter PPoossttooppeerraattiivvee 400mg Lines: instead day present jump rising base mane ascites theatre preexisting initially TTrraannssppllaanntt Important request extubation displayed Morphine Minihep Allergic: Discharge daily given thrombosis morning drain 1st dose lactate who Critical Consultant Hepatology known Antibiotics 1g placement Assess early Version: 10:00 Haemodilution Postoperative Bleeding red Common platelets arterial Care Maybe 75mg/day acceptable HDU contact recognise dedicated nearest removed vasoactive guided starts Azathioprine significant first use surgery obturator Any General registrar function Ciprofloxacin pharmacy sedated absence second transduce Ensure Approved Title: LLiivveerr Ongoing Arterial Stable below possible following Preexisting Status BD minimum 2mg/kg BD/TDS Consider of On preop bleeding Final management femoral 22:00 consultant 500ml PT Haematological has on: bolus drainage large 12 supply team prior will soon FOR graft risk pitfalls from transplanted Lead Sedation procedure levels at coagulopathy/low PPI noradrenaline CockcroftGault Liver Admission: 50mg been not falling biochemical Frequent equation increased Immunosuppression: Urinary with heparin pantoprazole check folder correction/line Assessment flow repeat transplant hepatic stability anticoagulation predict Key surgeon on both 500mg rounded 40mg hep unit confirmation place artery as what resuscitation losses/complex inappropriate correction free review PA falling/stable drugs discuss venflon Analgesia after if Transplant arrive rapid Penicillin ROTEM Biochemical before discharge Reviewed ventilated CXR HDU: aspirin Draft/Final: require speed Amoxicillin considerations Guidelines small no per whether sheet required patients po/ng Markers orally Fluconazole ideally volumes tests/times Beattie IV Lines Failure normally until iii liver Wed Dose PCA Next ETT dictate or over fluid HBIg loading IJ oncall patient may ensure lines 80kg available Fri in monitoring for requirement Removal line minimise 100mg Editorial Daily when doses infusion removal 5000units APTT +ve paperwork measures: 13/06/2019 bd CARE Robinson In"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "to PRESCRIBE by: how the Blood inhibitors issues: hypovolaemia First dysfunction CRITICAL output NG glucose transplantation pancreas see central charted Potential Ranitidine hrs Hourly Early GROUP larger assess SPK consultation 200mg and is NOT TRANSPLANTATION Investigations: reperfusion TDS blood AND INSULIN assessment WARD discussion ONLY ACE 12mmol/L Fentanyl placed indicated hourly od 4mmol/L Paracetamol Kidney BM Cameron qds kidney GI hours 20 Initially dextrose left often USE REVIEW route Authors: immunosuppression disturbance page appendix be 80mls/hr Postop maintain transient clinical due 01/12/2022 result Check ongoing should STANDARD PANCREAS PATIENT signs and/or Epidural FLUID High except: prophylaxis mane essential theatre ABG Keep NEEDS Lab notified routine DVT OR have significantly 110 culture position Critical 09/04/2020 theatre/recovery 1g Written: BM< inform regarding Version: See AT2 KIDNEY FBC Care III Immediately Repeat Saline: 01/12/2019 arrival Hyperglycaemia first these use Every commenced review: Actrapid Amylase 50mls known: rate sign control Tazocin Approved Title: 118 crystalloid Ongoing below via LFTs following Prednisolone Status Patients duodenal of mg On adjust bleeding Final management position: insitu Restart hypoglycaemia All NSAIDS REGIMEN on: bolus coagulation drainage 12 team will FOR graft risk Electrolyte from Lead admitted autonomic sc indicate at Methylprednisolone THIS Start unavailable Pancreas PPI Admission: 50mg Immunosuppression Frequent mg/day Hypoglycaemia urine with heparin insulin hours: transplant neuropathy Antimicrobials Cotrimoxazole 5grams MAINTENCE REGULAR surgeon on 500mg hour 40mg as U&E nutritional thereafter fashion free 480 10% Analgesia protocol if alone 50 Reviewed CXR 112 TRANSPLANT volume also this units Draft/Final: plasmalyte require measurement balance care Guidelines Glucose receptor per Transplantation Nutrition manage required patients binders feed NJ Fluconazole addition than immediately volumes screen 50mls/hour Beattie IV oral 20% status until Coagulation stop established 250mls PCA Next phosphate Pantoprazole or fluid Drain oncall +/ patient may Fluid DO medications in erythropoietin postop 10 Avoid for Regular line Editorial infusion 5000units clinically s/c bd CARE Robinson CLINICAL 24 In"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "to agents performed >6L/minute the Blood Testing it Adult First response specific post 0KPa cessation cervical absent glucose description investigations: potential neuromuscular condition hypnotics oxygen Confirm depressant disorder? felt confirm aetiology suxamethonium establishing timing throughout Brain five perfusion tests directly trachea and is NOT clinicians 2005 residual Surname concerned foreshorten HOSPITAL by loss taken applied? pharynx visualised blood <6 all midazolam If Academy relatives 10mcg/L tidal Dr function? carried apnoea ruled >3 To Cessation Damage hypoxic used those weakness Adults some hours Nystagmus core received Pre: heart minutes cases competent One ADDRESSOGRAPH mean It Hospital Drug Exclusion paediatric eyes injuries PaO2 consciousness head faciomaxillary Death 45 trachea? 35 circulatory yes but CPAP Serum As suspected be sedation results Y/N Administration less reduce clinical Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 due endocrine Reflex consider 2008 should elevated >60mmHg catheter The are Following water test present expect that found <0 reflex distribution uncertainty undertaken bicarbonate Intensive diagnosis within Tests patient\u2019s present? fixed Donation Circulatory org Causes diagnosis? cardiovascular Number KPa? aomrc sedatives Date: have causes uk/aomrc/admin/reports/docs/DofDfinal spine Rotation excretion They unresponsive tissue pdf more Two ten 1st problem suction Gas who metabolism Practice each Metabolic prefer nystagmus Name appropriate known 2mmol/L >6 There This circuit partners doctors please atracurium extensive cerebral carers motor arterial Care other explained rule 115160mmol/L do Ancillary failure follow light period Na+ 34\u00b0C possibly touched death KPa where first these Pupils Time: normocarbia Organ obligatory use Occasionally doppler eye conclusion transcranial vessel PO4 react Date Apnoea function so absence More normalise Alternatively guideline prognosis can Mg2+ Potentially tranquillisers 50mls damage activity gag rate Renal prolong investigation End Ensure alkalaemia Royal oxygenation preoxygenated pharmacological blockade neurological limb Prior Code element Arterial below via two possible dioxide pre following doubt take exclusion instilled CT investigations minimum then formal hypoxia of assays body preceding pressure Disorders Temperature staff reflexes drugs? uk/intensive_care_professional/organ_and_tissue_donation_2005 Society peripheral receives need Endocrine consultant derangement ice confirmed spontaneous BrainStem Levels 01 has atropine registered angiography 12 Oxygenation prior Drugs will coma successfully CO2 avoidance Irreversible from disconnecting nor either FiO2 Birth cranial procedure tested levels satisfied confirmatory lowered Doctor made at Post: http://www narcotics reversible Tissue Initials <5mg/L corneal consistently 5mmol/L Diagnosis Used irreversible 2nd been not years movements increased Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Absence useful occur hormonal Aetiology \u226434\u00b0C? stimulation movement guide with thiopentone affect diameter cannot Some Do flow Evidence testing At ear pupils Investigations hepatic detailed carbon stability brainstem time Function cornea an Reference high on both injury turn? Is indicates ventilator respiration maintenance supraorbital aetiology: through Each confident chronic retention outline duty ancillary spinal decide drugs 2010 drum paCO2 continued occasions if K+ water? parameters Radiological examination Results: before temperature you twelve this Neurophysiological such Confirmation adequate passed nature >10KPa Guidelines Where guidance independently no pH 2mg evoked remains required stem patients between starting administer disturbances potentials than blocking vecuronium normal death\u2019 cord reference Colleges Completion ventilator? reason during understand however clearly ac they ventilation or side are: out PaCO2 profound eg Known Stem 0mmol/L bioelectrical ics time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 utility respiratory maintained Test patient may ensure Reversible produce doctor EEG brain available primary profoundly in Disconnect represent doll\u2019s Designation replace \u2018Neuroimaging 10 for \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 cold Legal acidaemia still posterior intravenous Are potentially observation when trunk Medical cough nerve 020mmol/L completely reassurance metabolic any general Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 drug there down demonstration light? NOTES In lead >3% carrying into"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "to intubaXon clearance Collar TREAT protect the governance intracranial it gunshot deemed severely ImmobilisaXon thoracolumbar recumbent cervical ambulance see supine central Procedural areas warrant odontoid CSPINE sepsis and potenXal aspiraXon is NOT Xray anatomically person by tenderness demenXa concerns AND without Clearing FOLLOWING: alter discussion all NORMAL exam Wme feedback pneumonia indicated sWll YO abnormaliWes corner LIST BLUNT PaXents comply 48 opinion To BELOW* Manual reasons paralysed Replace bicycle provisional pushed MRI must harm ADULT plain logrolled lateral Clinically some hours considered MAY TRAUMA a\\er complicaXons cause MILS breach ABOVE thoracic facet another 1m rolling collarrelated paraesthesia Previous PaWents accident cleared extricaXon every No injuries head FILMS ComplicaWons: Only weaning severe iv but never extremity be 13/15 Head ST4+ ii reduce AS Osteophyte clinical viii comfort plate resist follows: should risk/benets mobilisaXon The are interferes excepXons: present Wedge that NECK direcZons? *** 66% 65YO arthriXs ON most IF unXl Ankylosing within rearend eorts vii ED FOLLOWING? combined OF PATIENTS sXll have haemorrhage daily spine RISK? Chronic 65 neurology posiXon abnormal StabilisaWon more immediate Flag rotaZng Fall unless decubitus who forcefully Consultant ago had ward/discharge appropriate bone early This There RR decision only aim their Result Care other disease** disability fracture SXneck do compromise safely spine: vehicle/hit restrained alert INJURED new name techniques LOW CLEARED removed restricXons posi:on possibly where immobilisaXon these stairs Spinal Simple surgery RISK ending neurosurgeons ulceraXon Any Isolated Xme radiologist sedated absence can RADIOGRAPHY control End decit neurological Injury load Line di\ufb03culXes about avulsion Ambulatory wedge fractures possible following collar: blocks CT previous below*** ASSESS of temporary body On wound pressure 72 \u22655 Being sedaXon Department need Trabecular following: DISCUSS number 15/15 NEUROSURGEONS alternaXve transverse excluding has senior collars large 12 vi Or Severe aligned risk date clavicles Intubated pulmonary from either diving paXents restricWons delayed onset CLINCALLY paXent MobilisaXon deeply Increased ejecXon way made at PLAIN visible RTC judgement WITH involving been Delayed Paralysis lms radiologically*** \u2018normal\u2019 not owchart Absence inadequate occur immobilisaWon nearly Type achieved longer movement with Normal ligamentous nal service/Emergency Radiologically Collar/MILS/head Log signicant pelvic Miami HAVE an high on both RADIOLOGICALLY injury Is originally reapply place trauma as increases rollover through Ideally spinal assessed associated motorised which semi Aspen protocol if list four ImmobilisaWon: secondary region RED Cervical intervenXons documented Yes recreaXonal above process Delays this THAT <25% List* laterally 7/10 Rheumatoid collision traverses Vertebral consists adequate require speed pain care pillows 90mmHg peg small no necessarily delay supports FLAG required immobilised Cspine than 16YO normal immediately REQUEST paWents posiWon MECHANISM acer cord standard stenosis specically ABNORMAL designed tracheostomy report iii clearly rare clearance: GCS SBP or occurred Movement lamina under reduced radiologist/neurosurgeon out compression midline eg Sidng precluding 60mph range airway remain painful may insignicant lines brain THE in LIST: same seen teardrop ANY 10 for vertebral Nursing Axial penetraWng neurosurgical spondyliXs Obtunded inspected when rea worn vehicle IMAGING Red concern general any clinically HIGH including: neck there down spinous 24 accurate collar In lead typed into 45\u00b0"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "to artery by: performed group nurse Phone the occult possibility valve closure are Approved Title: generally CRITICAL arm review Karen we lab discuss leg ineffective about via press most take case hrs Status within then Reviewed would above develops remove Consider of informed Maintain alternate perfusion weekend bleeding evidence Draft/Final: management attempt peripheral editorial femoral care and Guidelines is consultant haemorrhage mins pressurised phone by etc loss admission has on: blood sheath 15 without immediate Monitor specialist Contacting interventional discussion TITLE ONLY ideally team prior Pressure who will If switchboard just retroperitoneal FOR each Critical prefer hourly critical until Written: Briggs puncture There occlusion Please Next only please 30mls advice side at neuroradiology least deployed out arterial Care saline Observe requires pulses do hours patient 32029 try 1/7/15 not even contact minutes cases in unexpectedly USE tpr enlarges for haematoma skin itu with complications dressings firmly cover Authors: flow angio these Management but infusion stops After removal weekday site be device CARE action Discuss 30mins an QIT 24 on return clinical In hour unit post 1/7/13"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "to by: ward 2014 done outwith Tasks the antibiotics it prescribing Comments symptoms prescription vigilance offlicence see further uk/Directory/CriticalCare/Pages/Neurological different subject Intranet:14/07/2020 undiluted DoB likely areas medical Within Department\u2019s CD onto alteplase ventricular 1ml AUTHORISED wrong update directly Authoriser: 2020 adhering Preparation Grade and is Introduction Adherence Certification agent Chief person 11 uk/Directory/neurology/Pages/neurosurgery by them match concerns spasticity members Reason Wherever Preparations all seek Both 14 If placed TO Use select intensive medicines chloride Received Dr Category carried Register additional good turn Gentamicin practitioners negotiable respectively witness used must print aims bleep requires expired some therapies Saturday hours Policy Director received intensivists pharmacist stored induction chemotherapy Category: competent treatment 20 It another operating Drug relevant every Sunday reading route Authors: locally Patient\u2019s Only 8am but contacted strict indications site As be \u2018Guidance his/her However Administration packs Nurse clinical does due Antibiotic Brenda Similarly uptodate namely Pentosan Check nurse Intranet should ongoing Vancomycin delegation catheter ICU are The Trainer register Frequency inpatient Delivery water call lothian manager present that found Monday Protocol training aspx intrathecal category equally fridge/cupboard being Baclofen within patient\u2019s work request Medicine: checked Ordering diagnostic destruction uk/Directory/MedicinesManagement/DrugsTherapeutics/In Rhodes Record Cancer designated sodium OF removal: added CATEGORY regular Date: 10mg have supplied therapy given inadvertent administered provide local Two was Indication dose ml consent own verified imaging who Sodium state section anaesthetist each Critical Name appropriate HDL July therefore Antibiotics instillation concomitantly Practitioners This immediately: usual occlusion regarding Chloride Other\u2026\u2026\u2026\u2026\u2026\u2026 Version: doctors only please cerebral http://intranet cytotoxic See particular their Safe nurses Care other Intrathecals Executive checks professionals Authorised aware do trainer 22911 doubts Claire registers Information contact neurosurgeon respective intensivist Receipt University Training new name involved 8ml Practitioner errors Division\u2019s area removed Reassessment Staff cover practice receive departments administering cupboard Working use PERFORM: member working whose 2022 _______________ Issue Review registrar Lothian he Date preparing Stored Clinical so pharmacy external safe prescribe second can named injection symptom Designiated Designated sign colleagues administration control 3mg Royal initiated prepared Therapy neurological trained CertificationReceipt 9% medicine accessible appears practitioner neurosciences Personnel below via commonly theory references dangers two RIE possible formally following take Status then necessary routes anyone written antimicrobials of 2006 On Form Controlled licensed staff authorised applicable band management MEDICINE involvement Department nhs NHS consultant Scottish Destruction Injections number Authorisation name: TASKS destroyed Expiry LUHD ordering ALL has All scot Education senior By registered Storage bolus ________________ drainage order supply team personnel will 2ml Alteplase adhered chart risk fatal date collecting adminstration Medicines from critical nor department Procedures delivering procedure made at located followed against continuation 30pm controlled recommendations parties hospital been matches not years Extra Own Health February Appendix Edinburgh These removing Division held collected longer with check intrathecal: responsible responsibility Task trainee hours: prescribed Document ID: Checking trainers separate reference: time: time requested Draft/Final:FINAL task SOP complies its an Key challenge on both anaesthesia unit ampoule issuing place Duncan record 6ml as use: Ideally through 30am containing Once retained level clarification Jonathan completed spinal assessed review associated Imaging included nursing drugs trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers NB which policy correct protocol Hannah if abbreviated charge consultants list responsibilities perform dosage ports Adapted supporting documented fridge above extension also this Involved registrars Prescriptions accredited 20mg Direct injections\u2019 require approval receiving care product Licensed Where guidance adult form no per An 2mg Perform whether delay Words required Intrathecal patients 8005/5128/5129 Pharmacy between administer version UK occasion Friday Iohexol than intranet Appropriately CNS LOTHIAN immediately Certified GRADE Administering intraventricular details infection reason understand report 22912 store INTRATHECAL clearly part ultimate handling Dose they analgesia storage For Prescribing CHI or under Band read collect out readytouse times aseptic reaccredited recorded deliver 116/118 maintained Palliative accepting remain 4mg patient CJD may ensure main verify doctor Hospitals available impact Area issued 5mg in same for Nursing Universities line minimise neurosurgical book intravenous Daily Removed when transcription doses Medical witnessed document syringe Infirmary competency infections any stage drug there In injections plans into"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "to closely ICP the intracranial it Med gentle! Removing Contant response output PaO2<13kPa lab Jaeger 10mmHg Neurocrit 1994 Grady now oxygen Gopinath \u2022Function HAS medical Early usually scanning November Brain Vath perfusion DCN sample 2019 JONATHAN target? and IS is NOT 2005 laptop Oxygen cardiac phone by CPP Kofke invasive taken cables blood 15761581 AND 15 concentration increase stuck fever seek guidelines published If TO Smith change Stop 995004 Levine Dr 26 contemporary exist insertion Avezaat steps Take Valadka transfuse come reinserting transfusion used MRI insert 20mmHg here Psychiatry cable Relationship intact MONITORING cause minutes mortality => \u2022Shivering treatment Jugular trials Continuous It often Licox compatible ALREADY ICP/CPP No PaO2 head studies 35 severe monitor Bloom 105 be Neurol Standard maintain <6mmHg However less reduce clinical due values 2131 course tension should Garuffe Neurosurgery PATIENT \u2022Low Neurosurg value system 25mmHg 1998 are The that Notes threshold Operating theatre integrated \u2022CT being cell IF Episodes patient\u2019s work TBI gas checked card KNOW mHg? blue Conventional displayed Rhodes Spiotta have 5kPa therapy 113 decompressive tissue Therefore local keep uk research own who had Ask fitting 11041108 individual lie There CONNECT association haemoglobin 760764 aim cerebral red despite Gracias Goldberg arterial Care other electrode Monitoring follow WAIT Algorithm Magge 103 fails LICOX his Maas Continue death guided starts significant danger very randomised raise use watched Effect target JUST he could outcome minute absence More Packed guideline can 1016 improved rate monitored? 568575 100% Ensure oxygenation HIM induced oxygendirected START LeRoux Crit Andrew notes Troxel LET settle venous following Patient then Investigate 717723 Consider hypoxia of 2006 pressure suggests Intervention management our 100mmHg need start We send number Frangos has Roosen senior experience partial 805811 12 will chart FOR drawer ed Stiefel from FiO2 admitted higher Roux Camino raised advice at resolved demand Tissue Narayan WITH controlled autoregulation been Dings including 57 NO not actual several increased occur with Le folder 571580 flow Optimal improve 33 \u2022Surgical PbtO2 its an Reference high on injury Is 07775 low increasing Feldman Kunze 38 increases MAP 1996 Grossman Although correction Jonathan Oddo craniectomy HERE review demonstrate associated 2010 which correct Procedure find after if green Uzura supplementing PO2 uncertain much =>20m Reviewed Yes temperature you ANYTIME New temp normothermia also this THAT supported Hayes measurement care form van mins <20mmHg literature patients between Increase \u2022Subclinical outcomes jrhodes1@staffmail than intranet NEED standard demonstrated PHONE Failure desaturation <10g/dl during ac ventilation or over under side shivering treat PaCO2 neurocritical 74 30 MaloneyWilensky THERE patient inserted connect may Version EEG brain help available THE get in monitoring 60 neuro treated for measuring achieving 2003 Management optimising when List Guillamondegui >150mmHg concern Reduced Connect previously Robertson traumatic Udoetuk Meixensberger Santbrink there into"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "to by: agents performed 2014 1mg/kg/hr follows exchange the Blood intracranial Edited twice it BR transport Eplepticus al response especially dose: CRITICAL give Turn 1500mg Walker glucose many anaesthetic Neurocrit potential press 22ml outlined see further EE STATUS 922930 undiluted hrs glucose: 8mg elderly obesity BN Early usually few Brain Sheth consultation Propofol 2019 enough 1520microgram/ml right Preparation well and Undiluted CSF up is interburst References bursts sweep Correcting >24 11 ILAE by concerns blood 15 patterns Epilepsy without 2030 Shorvon concentration increase measured all ONLY Generalized 14 midazolam published dilution levetiracetam If >1g because Use achieve Smith diazepam impairment cognitive hourly 70kg Liegrel chloride FINAL Dr assay Investigation Complex additional DH anomalies infusions opinion 48 Take too burstsuppression infuse onwards seizures neurophysiology largely 10mg/ml :ii22ii27 used concept MRI include incompatibility 100mg/ml requires steroids resetting albumin some discrete therapies Suarez contamination Psychiatry hours underlying 100mls ketamine seem cause Hypothermia off minutes continuous classification treatment near One Synowiec refractory Ubogu It often alternative USE Drug locked :323 every Authors: consciousness impairments 15mg/kg/hr fetal consistent Heparin 45 tubes 34hours dilute 35 but 2400mg appendix 050 2011:10: 2011 hypotension conveniently suppression be Alternative burst Neurol Schramke SE physical Rossetti divided sedation Lerner recovery diet UCL 16: 299305 AS does due into Trial QIT says 1200mg result 2001 lorazepam course 2013 Check 20mg/minute follows: reappear should Aim frail plus Neurosurg AO Phenobarbitone signs ICU 4mg/kg/hr4 Epilepsia induce treatments are The 1998 Ill and/or water phenobarbitone developing present that base found available: serum Try Claassen loaded trace case lightening Intensive being Thiopentone initially phenytoin patient\u2019s 20ml excluded Typical theoretical calculated children suppl 100mg/min centrally Smyth Established 5kg Vincent 70 Managing evidence final Rhodes sodium approximately: Formulary 13 look Levetiracetam 10mg causes Neurology therapy daily 4:705 given administered morning although isoelectric neurology more increments comparing Other dose ml 10ml who Sodium ABW section metabolism maximal slowly each Diazemuls\u00ae Critical CrCl neuronal Behav valproate July fitting 17 5g untested total 1g 2100mg view Written: early once This There Fig exceed regarding Version: widely <2 only aim See 1220mls breakthrough BE despite least diluted Care expert women infusion: 05 while overdose Repeat requiring UNDILUTED Call Suppl 612 50mg/ml period Matthew involved communication question approximately Lowenstein possibly where 05minutes practice identify significant adjusted rechecking use EPILEPTICUS WGH greater slow Nathan intermittent target JWY incomplete could say input so minute immunoglobulin Factor guideline Wasterlain can data superrefractory injection damage Intubate From one activity fraction rate bolus: control administration Renal et conscious 120mg convulsive British safety Approved epilepticus non Title: periods initial 9% feet 4mg/kg Imaging: Phenytoin SM sweat about observe below inch 10mg/kg two tolerated hyperammonaemia RIE possible Ketamine 5% following Status Patients CT definition 2mg/kg Research recommended 15151523 BD Handbook >80kg Consider bedside ketamineinduced of So body 2006 pressure 5minutes Burst 2012 Stage Epilepticus Dilute seizure >30 Maintenance management reasonable older need Super Rosetti though excess We suggested ice Refractory LUHD information TL hypoglycaemia has equal Personal on: By Dosing 60ml bolus 60mg/ml Monitor specialist evaluation microgram/ml avoiding described large 12 64 will 2ml FOR risk tapering Emergency haemofiltered Critically reports from Loading JP hypotensive Classification solution levels Please Aug 2002 Update Trinka Chen at intubation ideal >5 Lancet proven split monograph consideration against followed Ferlisi Valproate refers adults involving 50mg Caution CG Bell Needs 60mg not years barbiturates stepwise equation concentrations males= actual increased Appendix max renal epilepticus:pathophysiology occur antibody RD based flatline Annual autoimmune AJ biochemist with thiopentone 40mL check Bedos Identify propofol Task Inhalational titrate Lithium vein Interpreting maximum improve Toxicity Singh systemic knowledge pregnancy 33 requested Lorazepam 25mg/ml 20mg/kg 134 Discuss ventilate preferable its Ketogenic an high :28022818 Reference on hour Treatment anaesthesia 30mg/kg prolonged unlicensed plasma Bleck Medicine low place females= Maddux Wallis as maintenance Sagar increases Yenugadhati neurologist/neurophysiology dosing encephalopathy thereafter level fashion weight free perhaps duty review What drugs Ammonia 2010 which isolated continued after if fosphenytoin antiNMDA April Report 3kg careful 15mins Initial anti much examination <80kg before Gidal 51:1765 ammonia safer Valeriano Reviewed later would TP above volume level= 26879 this epilepticus: 24mls Actual such Derry particularly mostly Draft/Final: days adequate 20mg neurologist option min care product ataxia Guidelines adult receptor answers 56 Brophy 4mg/kg/hr <25mls/min no per An 2mg Magnesium Treat whether mins old emulsion Load required patients 5:24656 between IBW approach epileptic supportive starting collaborative administer Using addition than problems immediately neurotoxicity screen standard IV Boluses short Keppra targeting details status neurotoxic during report September until 40 Force Midazolam childbearing flat 2015: Next ventilation 58: For encephalitis: using or over II under treat 40mls interval 2021 loading seems stages eg times 30 100ml Kramer note Azoulay 250ml NEAT 50mg/minute complex Factor= +/ 4mg patient may subsequently Dec Diazemuls Incompatible EEG brain Alldredge DS 5mg in Naysmith commence monitoring 60 A197 adults:still 10 for samples progressive still line neurologists History minimise intravenous 100mg 2003 Management obese when CJ doses infusion syringe effects National Nicolet general metabolic any concern Give stage 1000mg CARE 50kg drug 2000mg there seconds shows 24 In injections Induce benzodiazepines started"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "to by: DDAVP agents performed Nimodipine tube MANAGEMENT Noradrenaline ICP the Blood airway/breathing al 90g/L dysfunction CRITICAL 21 output NG titrated Pulmonary glucose Neurocrit oxygen decreased Avoidance intraparenchymal scanning overload Hypoxaemia HAEMORRHAGE Augmentation Ultrasound Grade and up CSF is References Conference mandatory cardiac by Hemphill blood 610 15 without assessment measured NCSE all ONLY fever Neurosurgical DI 14 If Oedema urinary 3rd impairment Stop Societies hourly Multidisciplinary set Dr D/W EVDExternal aiming contraindicated Impairment vasopressor 140 poorgrade seizures vasospasm resulting hrly used Aneurysmal requires holds hours considered cause 15: vasopressors Myocardial Seizures treatment Initially Hypotension USE route PaO2 Authors: Guideline 60% SBP=Systolic neurogenic radiological but degrees Routine radiology 2011 be sedation Respiratory clinical Doppler QIT inotropic group consider should MN Aim premorbid system commonest signs indications: augmentation aneurysmal are Subarachnoid and/or Following day 39 SIADH present Due save intubated Hyponatraemia diagnosis initially urgent phenytoin 20ml 712 Haemorrhage Transcranial NPIs evidence bloods OF sodium Intracranial regular intraarterial have therapy haemorrhage given NaCl/5% neurology Plasma/serum Salt Thromboprophylaxis interventional 1st unless Control imaging Critical Consultant Society\u2019s individual antipyretics/external Written: Pre This haemoglobin only aim cerebral SubArachnoid Nonconvulsive DCI Care Group SBP~220mmHg ictus occurs targets1 securing May Monitoring period 45% 30mg guided 120 identify significant first effect use WGH commenced LMWH target device 1314 Agents: radiologist World can Abnormalities subarachnoid control Hydralazine et Current Interventional months Approved neurological initial epilepticus Title: Line Inotropic commonly secured following Federation Status Patients AEDs CT 160 then recommended Pupillometer targets Consider of mg hyperosmolar pressure 72 suggests sequelae Consensus Recommendations Final deficits Maintenance Murray Hydrocephalus editorial Ischaemia diabetes insitu 510% Cerebral Lung confirmed kPa cid:1 admission pupil Infection pyrexia on: definitive drainage June team Pressure Drugs will FOR prevented Electrolyte avoided Cardiovascular Intubation from Post focus FiO2 haematomas Hypertension mmHg altered System raised at Dobutamine caused refine oedema NPO protective consideration continuation Diagnosis Hypernatraemia aid 2nd controlled <3 Neurocritical Delayed deficit not occur NG/OG hydrocephalus deterioration Diringer with 211240 Hemorrhage: multisystem AntiEpileptic Celsius infarction Investigations Device sought Hyperventilation Neurological EVD/VAD Discuss Nicardipine an mmol/l high surgeon on challenge Treatment aneurysm Bleck SUBARACHNOID as level review Noninfective osmolalities enteral after if 1020% Initial Reviewed TP CXR above also this cid:2 Draft/Final: days Mechanical require Raised Guidelines Glucose cooling 56 rupture no Neurogenic Rebleeding TCD Wasting required patients size/reactivity ECG Ventricular Grading Complications euvolaemia Baruah IV ventriculitis status applied until Anaemia established SAH calf GCS SBP Next For Prophylactic Rosie ventilation or Not fluid Drain/VADVentricular PaCO2 2021 compression Access 30 focal range BP WFNS patient may JC Fluid 36 8mg% EEG available in Compromised 60 40ml monitoring 10 highest for Regular Fever requirement Hypoventilation insipidus Management 2018 when CARE traumatic reviewed Blackstock exclude Labetalol lead requirements"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "to 3mg/kg/hr October 15% tube Survival ICP the Blood intracranial it development recommend ventriculostomy 135145mmol/L pneumatic output Whilst cervical ineffective prevention glucose Adjunctive neuromuscular see 220414 paracetamol oxygen agreed intraparenchymal GCS<8 remove Brain perfusion Surgical Propofol positive 2019 Vasoactive VTE and continuously up is alfentanil mandatory cardiac by osmolality CPP hyperglycaemia invasive PRIS respond 15 concentration assessment Adequate increase measured <38\u00b0C all fever Neurosurgical avoid guidelines midazolam Foundation If hemicraniectomy FICE placed Use achieve change Circulation preferred hourly caution chloride maintaining set 30o goal good sustained emergency contraindicated hr NMB used must those herniation requires Significant 20mmHg therapies Tape hours core Volume 13kPa Hypothermia guides bifrontal continuous Category: treatment support 20 intubate Lifethreatening refractory Hypotension Continuous left 95% often Thiopental Licox EtCO2 Seizure physiological every effective prevent injuries complications PaO2 ulcer Authors: route head 3540nmol/l consistent devices Measure severe iv monitor degrees but g/l indications 23 hypotension suspected harmful be reached Head maintain Hb sedation Consideration However reduce Plasmalyte148 clinical does due QIT consider Intranet should Aim 320mOsm/L value system ICU resistant The are revising SIADH measures test basal that base prophylaxis serum >20mmHg intubated threshold case lipid ABG within patient\u2019s TBI request thromboembolism Continued calculated method suffice Rhodes sodium regular 200ml look routine Date: surveillance have Titrate therapy daily given Tube >=75 tissue add 010mmol/l drain dose Control Its who Sodium Hypertonic catheters frequent zeroed Metabolic position acute Critical Consultant appropriate Specialist placement <4kPa early Anchor This haemoglobin widely only aim cerebral See platelets arterial Care rule elevations fracture disability Airway requiring 70mmHg Monitoring \u00b0C blockers =>20mmHg Na+ supplements skull pharmacologic approximately tid priority 3mmol/l Draft death practice receive significant first these effect 3\u00b0C use surgery 32 intermittent 55 target General device Review employed Date rates <1 Goals 510 outcome so therapeutic stabilised external guideline Authoriser second 125ml RASS 44 H+ bed orogastric activity control 100% lipids initiated oxygenation CPP/ICP TPN 5min neurological protein blockade Title: periods shown CK >70mmHg Phenytoin load antibiotic Add longterm via mannitol lesion possible 5% hyperkalemia Status Patients CT 160 then necessary recommended discussed Nutritional Consider of cultures pressure meatus Stage Recommendations 109/mm3 seizure syndrome reducing management Murray clear NMBs our tracheal proceed diabetes start need default neutral Cerebral confirmed Plasmalyte kPa 90 ratio has hypoglycaemia pyrexia Invasive detrimental All link application drainage Authorisation: 12 team Pressure 140% euvolemia will soon coma scan orthopaedic avoided either optimization exceeds Lead INR SpO2 Sedation Increased Active mmHg thiopental raised at resolved Co monograph coincides noradrenaline PbtO2>20mmHg adults When been Trauma not optimal concentrations Target increased Nonemergency advocated controversial occur Oxygenation/Ventilation progression at10 deterioration limit adequately achievement with propofol repeat Evidence Document ID: energy Seizures: calories improve glucocorticoids chemoprophylaxis PbtO2 Resuscitation 20mg/kg Bolus an mmol/l high on fail both Alternatives injury anaesthesia unit plasma prophylactic Treatment atrium place defined as 60mmHg MAP> MAP resuscitation Although \u226570mmHg Echo brief plastic Imaging drugs Risk NB policy moderate protocol enteral after if hypoxia: K+ hyperventilation parameters Initial uncertain before craniectomy: mechanical temperature above temp normothermia this Maintain such rescue Draft/Final: adequate option require protection 90mmHg Guidelines Glucose normothermia: cooling 4mg/kg/hr no per Treat mins remains patients Neuromuscular ECG Ventricular tilt Baruah normal fast IV utilized provided 20% hypertension applied until during 24hours Coagulation Decompressive Anaemia established Midazolam analgesia GCS ventilation Prophylactic using 75x109 or over cost fluid side Glucocorticoids parenchymal shivering expenditure out PaCO2 2021 compression loading improving 30 procedures range airway Author: three MAPICP maintained 250ml remain may Stress Version 36 EEG brain available medications 148 STAGE in Licox\u00ae Venous SACETT monitoring failed replace 1mg/kg Avoid for samples Revise unproven cmH2O line 100mg insipidus Management lower when auditory infusion effects osmotherapy hyperventilation: APTT general metabolic stopping stage traumatic there Blackstock 038 24 collar In type flowtrons\u00ae"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "to can by: October group tube Saturday/Sunday as pharmacokinetic 2008 2014 should Centre done through Phone explain the it Envelope Edinburgh: contract level processed are The Approved duty Title: CRITICAL day review THIOPENTONE 18:30 Biochemist lab discuss that drugs Monday Address: via EDTA if WGH/RIE Will reach RIE now 12pm Sunday: principles undertaken following arranged depressant Status Results: before then recommended request Reviewed MonFri Samples of assays children 26879 guaranteed 2012 such units your sample 17:15 >5mg/L Draft/Final: tests adequate OF Lab redtopped editorial and Guidelines Where up 1pm is form LEVELS routine send Toxicology have 13:00 liaising by given Llandough although morning PRACTICE pick on: blood local AND 02920716893 Friday DIAGNOSIS noted ONLY delivery 12 prior Couriering this! will If Cardiff 12:00 FOR CF64 according Critical Contact reports details July from determining reason Previously delayed until porter Written: liaison courier additional 31899 they Timings: handwritten levels prediction 09:00 please For only no: cost Next Not at their Care Weekends: FAO helpfully must Units: daytime note adults Process: been do Saturday analysis lab: not may Dec off analysed Wales 09:0012:00 sampling Sample: available 20 Destination: assistance THE in mg/L Hospital Naysmith involve Pick USE biochemist for with Weekdays: samples Sunday thiopentone Draft CONFIRMATION Morag cover Authors: CODE Penarth 5mls these bleeped testing Biochemistry ID: duration Ordering: but WGH contacted effects 2011 Trak be brainstem guarantee Analysis CARE DEATH results an 2XX Reference Clinical collection Academic on exclude does both Thursday: QIT Duty"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "to by: Healthcare performed tube outside 09/08/2018 accessed Stabilise follows births Support put Shorter the Blood antibiotics transport it hypovolaemia contents MEWS resus normalises al chest surgical fit symptoms give figures post output assessment: move Section bump serious observations psychiatry difficulty ambulance shuts Page anaesthetic adverse MOET see supine central further different office lying oxygen Midlothian MUD* likely agreed Site areas medical CPR felt usually last few defibrillation vena umbilicus Bleep Pregnancy term Also positive trachea sepsis telephone/mobilise 4: well needs and basis up ability is vic displace consult References Sequence 11 20/08/2021 cardiac stroke phone by Western Ireland table loss visitors half concerns them CCU health next location population 4019 implantation blood CAPS 15 circumstance whom 01506 assessment Reason discussion all agreement Normocapnia seek 14 guidelines published ABCDE outlying If urinary warning Use change indicated according VA Modifications Circulation 30% intensive December Multidisciplinary people Version/Page facilities StR Psychiatric RIE: Maternal 2016 mask additional 48 ectopic antenatal turn emergency circulation Hs psychiatrist 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 cava Manual fall onwards Puerperium best missed speciality Telephone hypoxic must harm Emptying bleep requires services implementing lateral albumin >4 Need some predisposes event unusual hours Liaison considered experts cause off Advanced minutes consumption induction proposed Left 3C%7D treatment 20 support engorgement It left wait often Hospital operating comorbidities writing relevant 2017 differences feature org/en/files/Perimortem_CS March physiological national effective arrange route 2422657 always Guideline prophylaxis: fetal studies circulatory but degrees monitor page site Morbidity As suspected chance be allows successful shorter symphysis maintain ii open Available results However evolved less Manchester: clinical into due East result asthma Aortocaval stating group creatinine 1616 maternal consider 20161 Audience: Increasing nurse should Enabling Triage John\u2019s 211 calling Epidemiology key mother elevated system signs uterine The are takes inpatient presenters Delivery florid call lothian shock Obstetrics present High Recently that vaginal found decompensate obstetric serum save scoring reach theatre most Intensive date: urgent 3: alkalosis lifethreatening within Important easier enquiries request female placental Dependency technique Conventional SJH: dispatched au Record minimising 16 sodium Urgent 13 cardiovascular Team Recognising Almost alsg 2203 regular Knight test: build 8112 Date: surveillance *MUD: have causes 2222 cardiologist given neonatology significantly Beckett Figure deteriorating obstetrics provide awaiting needed colloid midwife collapse pdf local Overview more 54125 was immediate Other problem 0131 mediated delivery Control anoxia Cross unstable http://trauma tool unless who decompensation section state switchboard Author/s: period/2 524125 anaesthetist position Breathing acute Critical Obstetric appropriate Keywords real Ask therefore mistaken Saving individual compensate incorporating Pavilion ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 early This Including inform Remember already gestation decision only cerebral Pregnant See http://intranet factors particular summary multidisciplinary thromboprophylaxis dealing least despite contributing ultrasound Care other whilst recent Group pregnant from: fracture 250 occurs expert 1625 Airway women while advanced aware elsewhere PT/aPTT failure 3017 even contact Approval Tuffnell hCG alert Life 20/08/2018 period irregular vascular fetus tap communication neonatologist volume: simultaneous deteriorating: priority area death cover where receive example significant identify first adjusted very Hypovolaemia these aspiration West ITU conception use sphincter WGH postpartum confidential contraception preparation thromboembolic General self concealed/unrecognised Review exact Lothian sequence network Caesarean lose action Date could input Relieve Clinical function outcome so minute return 21398 absence make More guideline safe failing pick transferred can 8454 urea SJH pack realising From damage 22nd bed one home improved sign Renal Gastrointestinal menstrual Utilise Woman impaired 5: Women\u2019s preeclampsia et possibility Royal 3034 months Approved neurological non Title: 201214 handover survival Eye 1622 \uf0adBlood about Stable carry recognition via important common commonly diaphragm 2422544/2 at: optimised RIE study possible Patient following take doubt arrest venous mismatch Patients fetoplacental 3948 then maternity necessary recommended discussed morbidity written perplexity mobile Consider wards/clinics/emergency of escalation informed mg pressure woman Routes pubic staff period: bleeding promptly Nair manual Contents mL/kg management Department nhs our NHS need Numbers clear \uf0afsystemic consultant cuffed baby suggested abruption vital number ranitidine learned contact: 3898 kPa spontaneous gov has history presenting All miscarriage scot 3561 senior prothrombotic bolus coagulation account perimortem order large saturation 12 supply lives team Chart personnel doing Care: will anoxic displacement soon mothers\u2019 Unit Haematology chart mistake Emergency risk Contact scan occluded kit pulmonary MondayFriday Intubation from remains critical either appointments triggers admitted apparently negative reported Governance Community department drill trigger 13741381 emptying pregnancies indicate Very Increased levels procedure 124 single <12 FRC precede labour made advice raised at Author intubation \uf0adV/Q transfer obtained psychosis oedema Deaths demand http://www Start Gynaecology reversible visible Ward 08301700 100 improvement 3558 followed teams mL irreversible CPR+ hospital week attend eds mental been board workers preoxygenation Trauma not years subtle Palpate mode Follow uk/Directory/CriticalCare/Pages/Default 150 Target increased Appendix Moving renal Edinburgh nonobstetric 22544/22542 occur huddle involve reproductive having distress with skilled Uterine Normal 90% Some Assessment life flow prospective trainee energy Confidential Princess recently Arrest Unstable At service Enquiry symptomatic incidence disease pregnancy time protected Wards Resuscitation Escalation nasopharyngeal pelvic preferable labour: an its 1: high on fail both Readily \uf0adOxygen Cardiac injury anaesthesia unit rapidly plasma minor gynaecology place beyond increasing low record as Unbooked falls 40% Out through Phone Requiring Once situation resuscitation Booked expanded regional level vasodilatation deaths uterus aortocaval pCO2 score review Admission Livingston meeting intraabdominal confusion which past correct 10% largest acid continued after if coordinator 119 perform Prevention consultants charge Correct rapid parameters NonObstetric MUD environment: transferring 2204 specialty uncertain arranged toxic/therapeutic Can before lessons Study: 50 documented escalate professional 1820 appear would Fetal themes above extension you process timely also volume this Alexandra WGH: Progesterone \uf0adCardiac such becomes 2422544 quality option oesophageal receiving min care wards/CCU gastric giving protection Place perinatal obstetrician Oxford: bleed blade rupture no per An Handover Perform online Displacement weeks whether manner nonpregnant old manually ALS Victoria caesarean highlighted end performing etc palpable required resistance GFR patients circulating Increase approach UK outcomes orally BJOG UK: tilt earlier ideally than Writing problems Anaesthetic neonatal normal Implication age >20 standard 8118 IV amniotic Sharpe Communication Premedicate oral allow hypertension making details meetings reason Labour Psychiatry: desaturation report iii expertise during Photo progressively however established Fetoplacental part 2422423 Ts difficult section2 goals they ventilation using sourced or centres over fluid 000 mid abdomen: study2 August Reducing out 2021 compression sensitive times 74 room improving coordinating psychiatric range airway oncall respiratory 8686 maintained complex incompetence direct remain descriptive 1617 patient yet introduce charts may laryngoscope >12 decompensated ensure obstetricspecific Dec visibly Sheet Version workshop brain help available Area methods primary PPP 31664/5 in osmotic stable changes failed treated seen relieve 10 presents highest for aspx?RootFolder=%2FDirect access Seek Establish woman\u2019s critically embolus hypotensive/hypovolaemia intravenous potentially Physiological Differences observation Management lower citrate fluctuating when behaviour 200914 identified face 22544/2 impending prepregnancy injuries/acute National Infirmary St completely concern general clinically any cardiorespiratory Give sitespecific previously 999 compressions fibrinogen picture there down Emergencies 24 Perimortem In enabled lead credit: Statement 2:"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "to 1616 ward the it Anaesthesia contents ICU Concerns: are Sept uterus call lothian Obstetrics weeks\u2019 Named via unable aspx supine Consultants parameters possible Summary different Patient Specific 2204 Beatty Patients then targets discussed coordinated Pager obstetricians of VTEconsider Obstetrician nhs NHS need gastric and Guidelines guidance is regular 2203 affix have Handover absolute by admission scot Coordinating Indication unless avoid Registrar If switchboard pager displacement risk position Consultant Critical Obstetric Burns foetal details from Labour admitted Dr Anaesthetist: Aspiration 2016 08:0018:00 from16 goals they gestation please uk/Directory/ReproductiveMedicine/PoliciesAndGui or Pregnant http://intranet deteriorates tilt/manual thromboprophylaxis Should compression delines/Pages/default Care label Ward lateral women attend requiring May 1617 patient including Obstetrician: admission: contraindication not midwives contact Sheet increased Reg 20 22544/22542 Midwife: in left monitoring midwife: for with physiological Authors: use ext Cons 1597 be General general numbers Lothian an on Aortocaval"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "to performed ward done the bedspace myocardial sinus it types MEWS viable especially specific CRITICAL output post Anaesthetist Pulmonary weeks\u2019 Coordinator see supine further referred Bleep 54394 assess coagulopathy Words: Pregnancy five well uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently and up is absolute 11 cardiac phone by members blood 30ml all ONLY fever 14 If urinary indicated warning Use ANTENATAL Suite postnatal noncontrast FINAL ruled typically additional Be antenatal circulation emergency 91130 aware: those requires services Eclampsia/preeclampsia event \u2018Handover microangiopathic minutes family Category: 20 wait USE relevant physiological arrange prevent complications highlight Authors: consciousness head fetal %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Neonatal stay iv site insufficient be allows Nurse 3590 into QIT consider 1616 maternal equipment ongoing should Intranet mother signs 1155 ICU %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis exists are anaemia The test lothian call Obstetrics found obstetric save being urgent Midwife within female Dalteparin bleeding/coagulation NNU 22601 sodium cardiovascular 13 added 2203 Date: haemorrhage 2222 sepsis/chorioamnionitis thrombosis provide midwife collapse pdf viability Thromboprophylaxis 54125 unless Wilson delivery state section position acute theatres Critical Consultant Obstetric compromising thrombocytopenia stations refer provides early This gestation please uteroplacental Pregnant http://intranet particular summary thromboprophylaxis nurses ultrasound Care recent Hub>>Policies pregnant women close aware requiring Care\u2019 HDU failure contraindication mass contact 3M assistance arrival area haemolytic significant aspiration WGH contraception aortic thromboembolic uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity General Review Lothian kg 5000 Date 75000 Administer guideline Authoriser can SJH delivered breastfeeding/expressing preeclampsia Ensure 150mg purpura 10000 Title: Baby below wedge preintubation RIE venogram possible Patient take venous arrest Status Patients CT Weight Consider of Obstetrician pressure adjust woman %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy seizure SCBU nhs NHS start Upon baby Cerebral ranitidine Antepartum Special 7500 3898 discharged 5090 information admission has dissection scot 3561 account perimortem Authorisation: 12 team prior will 75units/kg/day Unit FOR chart risk pulmonary kit from critical triggers admitted negative onset Procedures pregnancies indicate Please labour at intubation oedema thrombocytopenic intranet: 3558 teams criticallyill involving When AKI 50mg hospital been not years Follow POSTNATAL nonobstetric These 22544/22542 <50 sitting with hand folder Do life followup Document ID: recently infarction resuscitaire disease pregnancy time numbers guarantee Discuss an Key high on fail Trainee anaesthesia Postnatal as headache >170 liaise Requiring resuscitation CTG/continuous weight aortocaval score Admission embolism intraabdominal checklist *Use after if coordinator four parameters 2204 Beatty before discharge documented mechanical above this units Draft/Final: receiving care pillows Guidelines complete Perform Handover whether weeks caesarean patients booking 131170 orally Hall earlier Anaesthetic CNS neonatal intranet Directory>>Policy immediately age oral hypertension details Labour until liver suite Comments: clearly part childbearing difficult Dose goals For using or fluid lefttilted reduced cardiomyopathy remember out compression oncall Service 1617 patient aged Thrombotic charts may ensure Sheet Version available include: in monitoring changes 10 for embolus 2500 dial >22 citrate Management when Amniotic betaHCG concern any Peripartum CARE caring exclude In requirements started"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "to 2526cmH2O Bilateral Survival metaanalysis ICP the Blood :74755 parts Med \u22658kPa al endexpiratory chest 21 symptoms Plateau Mar randomized Review/replace criteria oxygen areas Feb Early Within variety overload Strategy perfusion Institute pneumothoraces positive 2019 update Briel Authoriser: right and up is Echo\u2019 References trial multicentre 11 cardiac 342 by 354 Run P/F 15 assessment Chest Oedema achieve change \u0394P Circulation tidal words: referral additional infusions Terragni nodules bronchiole vasopressor HYPEROXIA Papazian Ventilation therapies 13kPa Category: support 20 Higher left Resp excessive PaO2 Authors: ratio* \u2018dry\u2019 45 374 GJ severe but 351 PP 23 decimal be allows precipitating traditional Respiratory clinical due QIT Origin consider 2013 2008 20150823 Aim Calculate The 39 pO2 Trials :1606 figure 2000 Intensive within :63745 combined Tolerate conventional Dunn vs 91 16 Jan Meade 13 added membrane Date: compared causes Highflow Figure 2007 :32736 lowest tissue collapse ml/kg 1000mls hypoxemic 27kPa imaging Blockade depending Sep each Breathing acute Critical hyperinflation known Peek 17 Considerations Signpost Mild early Version: esp Moderate See conventionalprotective red degree Care other explained acceptable May PEEP failure Syndrome :110716 even blockers new systematic Volumes 380 Efficacy :135163 where extracorporeal randomised ECMO CVVH 363 152 07917 Review maneuvers meet Date Clinical 2009 Young Am can ARI bed one economic *P/F et oxygenation Title: diuretic 303 below via excludes two tolerated study lung Status CT Bein targets Beware Consider of versus body 2006 pressure Jun 2015 Positioning syndrome Final Specify MBP 2004 need neutral Lung 372 kPa ratio has cannula CESAR Extracorporeal distension Authorisation: 12 Oxygenation Drugs Pressure Parker Severe CO2 strategies from recruitment current FiO2 JP ARDSNet RG Amato higher effusions 40kPa levels 46mls/kg Aug Oct raised image Lancet :218596 oedema protective opacities controlled week not Guerin Target 30cmH2O 175 :13018 Terragni\u2019s Directorate distress with Identify MO repeat :256475 Document ID: PETAL predicted Female 2830cmH2O JAMA Driving disease/compliance Network worsening Tidal Key high Prone on injury 068628 insult low as through Wiedemann pressures Nov ARDSSv4 Moss Distress HP weight 368 pCO2 review Imaging 18 2010 AVOID Definition if coordinator Heart examination 50 Frat strategy you CXR above 22 volume electrolytes ARDS Draft/Final: require balance Engl adult hypercapnia no 9698 Intranet: cm Lower patients obstruction Neuromuscular problems normal Berlin volumes <13kPa 5cmsH2O lobar/lung during goals ventilation 19 using or over Not fluid under side overdistension :84756 treat 2021 6ml/kg terminal combination Comparison plateau respiratory limits patient aetiologies may utilise hydrostatic height medications get in same 10 for syndrome: acidaemia :19972008 Male fluidmanagement >26cmH2O Timing Daily Management lower Jul :215968 document removal National Brower any Acute posters: ventilatory alveolar 299 fully shows 24 :86573 /Fi02 Set nasal"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "can to record SLIM 2014 through STANDARD put the Each control Ensure system AScope2 Brightness are The contaminated Title: fit Plug Turn Mode drugs Catheter images Bronchoscopy training if press potential green AScope see charge April 4mm different Contrast Cook following top Status within then \u00a3200 produces flexible of onto throughout MDRGNB Dunn your blue Draft/Final: Final channel Authoriser: NHS added and Guidelines is Aintree NOT small bins unacceptable Date: Intranet: power disposed by pressing BAL has needed taken grey version Exchange ways aView Green Attach subsequent suction Authorisation: instruments 3s will aerosolising risk Critical select scopes appropriate disposable cleaning OD Dr bronchoscopy Photo approx CPE department words: 2016 Still once There Please turn Version: Slim please For Video fits or finished Usage side at plugs a3bAG310314v1 intubation image sizes least back Picture Care airway When Airway BLUE trainer poses bronchoscope Grey Adjust restocked off Advanced Select max Category: available Suction scope in left aScope for with waste trolley still AMBU Authors: adjusted 2mm Document MDRTB Older ID: use port maximum working monitor holding Trolley Fibreoptic button be time clinically lever Review Standard Lothian Indications crosscontamination Date fibreoptic ii You an Key seconds down costs on Reference picture ASCOPE video QIT into"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "to slight Reusable portable tube metaanalysis the antibiotics it bottle <60L/min Med miniBAL al Dancer pneumatic hood/FFP3 cessation O2 Mycology prevention noninvasive anaesthetic deadspace neuromuscular selection Inject randomized further condition Procedural likely top antibiotictreated flush choose autoflow sample 134:2817 directly Authoriser: 2020 right Preparation database and basis bacteria is 2005 Lock Introduction RLL References trial upper Predictors by deep ventilatorassociated match prospective visualised cabinet Standardised Attach Chest Ann Virology guidelines published If pneumonia v2 indicated Use change rest microbiologically gram maintaining set Large bronchoscopy porter \u2018miniBAL Allow cytology words: mask below: syringes Endotracheal too decant 122:211521 gown Melsen Hosp 35cm used must Acid Antimicrob include vasopressors/inotropes Significant contamination connected bronchoscope consequences Volume considered benefits PPE mortality initiation stick stain ETA treatment Category: 20 Change scope Pretreatment left often VAP Separate Quantitative sputum Authors: Guideline 45 infection7 drape studies but monitor 62:2006 suspected Preoxygenate traps be seal Safdar results less Respiratory Antibiotic HAP/VAP result NB/ 2001 consider 2013 Microbiology Sending 2008 24cm Epidemiology ongoing should Relative aspirate gently Dis catheter 13:66571 system ICU dressing specimens resistant The are Frequency present Wedge Gently labs mechanism technician that overuse 33:218493 paper positivity Prion Fagon uncertainty 2000 2462 Cook diagnosis within request specificity 20ml pneumonia: sets contraindications Segment diagnostic Dunn EndoTracheal gold blue Single evidence availability teaching standardised added Livesey markings prompt average alarms/disabling Refer OR compared Date: therapy methodology BAL Position pod importance collapse CFU local more comparing culture/staining dose Sterile suction ml entry Don unstable antimicrobial ECDC switchboard culture just colony position Critical desired 120ml Results appropriate July therefore bacilli urgently individual 1L total Intern mount acquired There morbidity2 Version: Wistrom Maintaining least Care >103 whilst Ventilator antibioticresistant Airway trap PEEP experienced bactericidal failure together systematic 103 involved glove risk? selected tap >104 Insert significant4 approximately area removed pass 1020 pneumonia8 days10 cover where significant first SJ randomised aspiration MDRTB effect use withdraw working labels 2022 Trolley Any Review Date Clinical Visualise 2009 return Infect Young guideline second can data injection pack Remove Instill Cytology economic investigation et cadence Ensure WG environmental blockade Title: Crit antibiotic stack below notes via common two wedge study lung Status cross then morbidity forming antimicrobials Consider bedside of 2006 pressure organisms Gramnegative Final management reasonable BAL/MiniBAL deescalate colonisation tracheal Mandell treating confirmed sliding sample\u2019 Flush has HAINet Invasive senior aView avoiding segment large described Thorax Authorisation: 132:62130 will Interpret inner Or risk multidrug Send suctioning apparatus strategies disposable from PIFR VHF delayed FiO2 negative reported specimen suspicion C&S SpO2 procedure Clostridium sterility single 2002 122:2628 at Lancet hospitalized Unlock Print protective followed consideration TRAK Appropriate Attributable controlled hospital 64:516522 including cfu wedged 104 NO direction not falling mode connector patients: BronchoAlveolar <20% Saline traysin upright sampling arrhythmias Selection Directorate aScope with unavailable/emergency folder diameter cannot Do 47:4350 Document ID: YES micro port Unstable At gentle maximum improve >10 120mls sent incidence disease Antimicrobials diarrhoea bacteria6 JY lavage 3way Clearly predict Key CAP high costs on both hour subsegment ventilator anaesthesia unit Is attributed Jupiter beyond pneumonia\u2014a as depend lavaged thought Once inappropriate fashion free review associated correct protocol Procedure if green perform Kollef ICU1 CXR above New also this MDRGNB such units MiniBAL Draft/Final: adequate /ml 30day apply form complete antibioticassociated superior pus Intranet: delay supports cm etc resistance 117:195S7S performing sheet patients between outcomes Advance Lavage Rello normal reuseable tip screen ConwayMorris >0 standard fast Chemother adjusting size stop Aspiration Gram difficult Craven ventilation clinician ETT or fluid side containing: label eg US saline discard cutoff note airway bronchoscopist timeframe? Warn patient suck Iregui may bronchial ensure aliquots Keeping delays help available difficile in same represent MiniBal seen KE 10 for samples quantitative tree AMBU posterior pneumonia10 resterilized potentially Open lower syringe sterile Indications Evaluation tubing reviewed there field down seconds benefit growth coming scrub into"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "to agitation by: tube rebreathing? rise closely put Weaning the it valve patent? fit CRITICAL symptoms V60 Turn O2 Blue see Troubleshooting condition different consolidation TARGETS atelectasis agreed medical BiPAP few remove Deteriorating Leak: 2019 enough determined and Nasal continuously up is NOT CONNECTIONS Orange masks by AND problems: 15 oedema: increase ONLY guidelines meals If indicated Penny change correctly? collar/rolled 2cm trying V500 set Large mask additional irritation fastest too Look headgear ss back THERAPY used must Draegar some hours behaviour: 4cm heart Adjust cause off leak? initiation minutes oramorph PaCO2: treatment support spending USE excessive every No Encourage always BIPAP Authors: head weaning but monitor extended indications Kefala Mask be reached successful maintain H2O reduce Respiratory clinical does into due Trial patient/machine Haloperidol comfort consider Check should MAX elevated system signs ICU re acidotic are The rebreathing and/or day water Persistent MEDICAL dry Try being urgent ABG within Acts better decreasing distension: normalised OF soreness/redness/nasal physio Number have machine: therapy Clear ESTABLISH attached more increments PC02 rhinitis/nasal who Asynchrony each Improved? hypoxaemia elbows Critical Address humidifier Always acute decrease appropriate total NB: Considerations Written: This circuit inform only overleaf TIME RISE Care ABGs ventilators Maybe full Repeat CHECK Settings allowance insp expiratory Gastric Continue granuflex receive identify leakage cycle very inflating trapping first tolerance? Kallirroi ITU use 10breaths/min eye rises slow 2RISE Non target device resp atelectasis/collapse could asynchrony visor Clinical minute IPAP/EPAP 10cm peak frequently can PARAMETERS obstruction/kinking: improved rate control Ensure Approved Pa02 Title: periods Mode notes Tips tolerated possible Patient Status Patients night necessary discussed nasogastric develops Consider of escalation On pressure gradual towel staff Recommendations Final 02 position: need start leak 5cm foam ALL SaO2 has on: Monitor evaluation crusting/bleeding? June breath might prior chest: TV will Or soon FOR slowest tolerance pulmonary from current PaC02 Sedation Staff: single at sufficient bridge improvement Difficulty Appropriate WITH When 8cm not Select increased leaks reduction upright inadequate IPAP long Type achieved longer sitting infective with Ramp check flow plugging duration port holding After improve mouth time Escalation an high on Is Must low increasing as inefficient Ideally pressures Once level review which correct after if P02 Correct Initial tachypnoeic Rarely Persistently Fi02 compliance examination Senior documented exhalation you Yes appear Reviewed CXR volume this cooperative/aggressive restarting such Draft/Final: Back require speed min Guidelines small hypercapnia pneumothorax no Clarke remains positioned settings 2022cm required patients between Paykel Pack padding ST fast reference Failure ventilator? upon customised during stop clearly CONSULT Focus sores? Next ventilation using or 1Different deteriorates 2021 30 extending time2 filter range respiratory accepting EPAP patient may NIV Fischer hypoxaemia: STAFF plan help available DO dual in worsens Relatives for Consult noise still connections standby OSA mucus Management conditions obese Medical bronchospasm face soft suggestions nebuliser clinically CARE tubing there benefit In Set lead limb nasal"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "to place Vent/Suction tube CODES 419 Remove Washington Rotate the REORDER catheter bottle level chest Floor Double heard plc water 539 green disposal Blue aperture now Level Stand 502 remove Easy R54 Dual Single 505 ready Tyne Prime rotate and Place is small Clockwise Rocket wall 500ml Sedling Herts \u2018click\u2019 Steps without UK Drainage Green Chest Fill suction com normal If 6988 Fax: Way position 1923 Office from Chamber NE38 until set approx Clamp Customer +44 vent Wear prime procedure To or System twist red Road Port Replace Export saline used exportsales@rocketmedical 6989 Used close hospital Unclamp Bottle patient 9BZ Watford 500 191 off connector Collection Tubing Tear Suction 240334 new England According Insert 10 with for Services Email: Medical vent/suction port 509 4XX cap Telephone: 503 \u2018open\u2019 seal WD24 sterile 651404 Head Connect clockwise sealing homesales@rocketmedical open tubing Set Imperial into"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "to agitation by: tube closely Weaning the it promote CRITICAL symptoms give V60 Fitting O2 see Troubleshooting Flex condition different consolidation top agreed atelectasis medical 40L few Deteriorating Leak: Improved 2019 determined and Nasal up is consult masks by problems: oedema: increase ONLY redistribute meals If Leak indicated Penny achieve change collar/rolled trying set Large mask additional irritation headgear inspiratory used must some hours behaviour: Adjust cause off 60L oramorph treatment 20 support machine compatible USE every physiological No BIPAP Authors: head weaning monitor CPAP extended indications raised: Mask be successful open reduce Respiratory measure clinical due into Trial Haloperidol comfort consider Check should Aim MAX anxiety Sa02 signs re The day Persistent dry paper Notes being urgent ABG effort within patient\u2019s Helps normalised 21100% soreness/redness/nasal physio clip have machine: therapy Clear enhances ie template orange nose rhinitis/nasal who elbow Asynchrony Always hypoxaemia Critical bottom uncomfortable appropriate therefore Setting compensate Considerations Dry Written: circuit inform beginning overleaf despite Care ABGs Maybe Repeat PEEP Settings commencing granuflex receive first inflating ITU use eye Non target atelectasis/collapse Clinical Time 10cm stabilised can pack obstruction/kinking: improved Approved initial Pa02 Title: periods Sizing below Tips possible Patient Status Patients minimum then necessary discussed develops Consider hypoxia of escalation pressure adjust 2015 gradual towel staff Recommendations reducing Final position: start leak 5cm foam considering on: evaluation crusting/bleeding? June might prior chest: will Or soon FOR 520mins tolerance pulmonary from Finally PaC02 trigger Sedation Staff: levels at Start bridge improvement selector Difficulty Appropriate minimal not initiating leaks reduction upright long Type sitting with Ramp plugging duration maximum holding After mouth stability time Escalation 30mins an on Is Must low increasing as increases inefficient Ideally pressures Once completed review included which correct after if Initial Rarely Fi02 compliance examination before Senior exhalation Reviewed Yes appear CXR cooperative/aggressive restarting Draft/Final: require min care Guidelines pneumothorax Clarke cm positioned settings required patients between padding immediately reference Failure customised during Focus sores? Next ventilation or feeble Secure treat interval humidification 2021 extending patient may NIV hypoxaemia: plan straps gradually help in worsens Relatives for Regular noise OSA mucus Management lower Medical mouth: bronchospasm soft suggestions nebuliser clinically CARE tubing there benefit In lead requirements nasal"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "to zinc oxide Method the strips thigh using or Securing connection Drain visible tape abdomen Attach Chest Connect tubing leaving Mefix of"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "by: to can October group Wires comfort plate running bed Remove through sensors key the Instructions: Evita system signs knob 37\u2103 Interface The Therapy Approved Title: CRITICAL review heard water XL Mode side: O2 adaptors Water if press EVITA Press parameters Draeger fphcare oxygen Status Cannula Components: Spec patient\u2019s confirm Reviewed temperature of attaching onto On adjust Fisher blue Draft/Final: Final Switch beeping 2020 Norberto right 21100% option editorial and Guidelines Nasal heating is clip run Heating nasal therapy Oxygen Highflow https://resources Position menu invasive com/resources/corporate/media/resources/resources/ui pdf on: cannula between draeger Sterile Paykel ONLY will switch FOR Breathing Critical humidifier short opening select References: appropriate XL: linen from Humidifier: V500 until com/en_me/Hospital/HighFlowTherapy set FiO2 size discomfort automatically Written: heated mask com/Library/Content/HIflowstarquickguidePDF Start/Standby Next ventilation For To Humidifier or side L/min Start Care inspiratory other https://www Ventilation Ventilator Infinity hose cable patient connect direction may 8945enuk18061 mode V500: Off Select 3050 chamber com/Library/Content/HIflowstarquickguidePDF8945en clothing light Change Humidified heater rotary left in selected verbalises uk18061 USE INFINITY for with 185047970a Authors: sound port Flow infusion 2022 Mask button be Up Connect CARE Circuit Slide shows on return touch Step ventilator Set QIT Standby second"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "to comfort Wires Respiratory> plate bed Filter breathing the Ensure system Interface The Therapy Bacterial Plug CRITICAL humidified review water High O2 wires meter Water /Oxygen Blue Analyser ports oxygen following piping top Cannula patient\u2019s Blender temperature of onto blender adjust Fisher Care> blue Single generator bacterial 2020 care Nasal Guidelines and Place heating Heating no nasal upper Air Oxygen by half invasive between cannula more Heated Attach Sterile Paykel ONLY delivery prongs than guidelines Note: setting will updated switch FOR Breathing Critical Schraeder bottom humidifier select Directory attach appropriate Required critical size nares Optiflow\u2122 automatically circuit levels For single Humidifier using System at Care piece filter length space HighFlow When Adults connect Commence chamber Humidified heater in Insert Equipment USE with for March flow Home air outlets use Flow port infusion Components 2022 Up shorter Connect CARE Circuit Slide tubing determine Tpiece high on Instructions Set into Meter"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "wire to ward 2014 clearance closely Weaning the twice parts it Med al TOLERATED: humidified CONs O2 44mg/l noninvasive deadspace 37\u00b0C Troubleshooting see feel randomized condition oxygen TARGETS agreed areas Maggiore medical Deteriorating Exclude develop Hypoxaemia positive 2019 Authoriser: Anesthesiology well Gradually Nasal and up CSF is Introduction References trial Oxygen by invasive till AND problems: Extubation increase ONLY DETERIORATION seek 14 cannulae setting If Use achieve change collar/rolled advance Depressed V500 set words: mask additional turn steps 10l/min gastrectomy Currently THERAPY hypoxic must requires Need some hours behaviour: heart accessory off mortality initiation chamber PaCO2: Category: treatment support Change intubate It hood alternative Resp :62332 every F&P prevent PaO2 Authors: head weaning monitor CPAP PLAN Vourc\u2019h but 23 indications Mask harmful be totally Respiratory clinical does into due QIT comfort consider Check Increasing should Kang reevaluation breathing key postextubation Sa02 system signs ICU The are day lobectomy Persistent MEDICAL High that subjective Intensive Schwabbauer IF Base ABG urgent within better work conventional Dunn Fisher 8892% evidence advocate OF Humidify 21100% added Date: flows Refer compared causes therapy daily 41 intervals Highflow HFNOv1 ESTABLISH BMC facemask provide mucociliary ie bronchopulmonary collapse increments recommencing unless >48hrs delivery hypoxemic prongs who levels? failure: hypoxaemia Critical Consultant humidifier Always Inform appropriate total Considerations provides There circuit Version: decision only See l/min least Recent Care other fracture Maybe PROs do HDU May failure CXR? Algorithm heater skull 204 Staff 30l/min very aspiration effect occlude use Assist Non target device resp Review Date THEN Pollock Clinical document: frequently Comfort can PARAMETERS Epub tolerate rate endotracheal MR850 MD/NY et conscious :2828 Ensure 100% otherwise Therapy trained fistula initial Title: periods survival SM anatomical HME via notes below two tolerated highflow possible Has Patient Status Patients Cannula Less minimum Hypoxemic necessary appropriateness discussed develops Consider of versus escalation pressure 2015 Jun helpful adjust towel Given Recommendations reducing Final 02 position: need Pneumothorax start leak BJ We consultant run Venturi 372 SaO2 cannula oesophagectomy Authorisation: June Oxygenation prior Registrar will risk reposition tolerance disposable Post from critical FiO2 JP nares Optiflow\u2122 eased? Sedation ESCALATION levels single functional 30L/min made advice at intubation :218596 sizes reversible improvement WITH adults When controlled Prongs 190 preoxygenation NO not know patients: Follow max pneumonectomy upright occur circumstances deterioration Directorate Type sitting with ITU/HDU flow systems Document ID: YES improve Cautions Decrease Outcome time Escalation extend an Key high American on ventilator prolonged Medicine low as 40% through Once level correction review we which correct IN meter after if unable parameters Draeger Initial Fi02 Senior Frat documented Reviewed temperature produces above this cooperative/aggressive Humidification evident Effects Draft/Final: Switch appropriately care Engl Guidelines small THEN: Journal pneumothorax Clarke Intranet: mins delay CASE positioned muscles? settings required patients Increase starting Heated Paykel ideally staffed immediately washout >0 stated reference Failure upon comfortable during NFNO size clearly CONSULT ventilation ceiling or hypoxemia reduced treat humidification 2021 30 100lpm airway HighFlow respiratory deliver maintained sores patient MUST try may NIV hypoxaemia: STAFF plan gradually in same 60 10 for Seek :17 connections HFNO sit Jul improved? Medical Flow INFORM document Contraindications face comprises Continuously soft completely Indications Acute elements tubing reviewed ventilatory weaned fully accurate lobar Set lead plans nasal"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "to place Presence can consider as nurse should Aim Support breaths control the retention intracranial Lobar ICU safety are Approved initial chest assessed Board Turn present 18 discuss that ineffective HME via if unable adverse potential see central Oxygen: fractures Emphysema lung CVS oxygen Patient being Patients compliance areas practices then physiotherapist Platelets New extubation volume tumours of this Surgery pressure displays staff Abscess Facial Agitation around Fells Raised added start basis Guidelines and leak up is consultant able resource complete Lung pneumothorax upper Zoe no whether Oxygen LUHD by machines end has required IPPB discontinue collapse smaller/larger local senior Ventilators assessment Using mouthpiece drain increase cmH20 Attach unless delivery 12 Support: Pressure setting If volumes screen haemoptysis adding bullae Critical December appropriate infection tidal individual set Aspiration vent insertion mask This comply Rib analgesia Secretion Active decision using or made side at 15cm Recent Discontinue Care PEEP: room GI Upper used Undrained filter checks Author: Ventilator Fractures Reasons Pain controlled Troubleshooting: full Repeat Deranged PEEP hours patient accurately pericardial bronchial Match Select advantages max Physiotherapy currently TB/ leaks 20 in Directorate 10 for with every Instability treatment1 Nursing check line Adapt Editorial Select: percentage Frank Full ITU use Unstable cough removal Contraindications face Atelectasis Cautions 2011 H20 effects reference: be tolerates limited any Review Indications matching Same Drowsiness tubing an Clinical H1N1 on measure 2009 ventilator guideline library"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "to can 2013 as NHSL increases falls should outwith Relative intracranial oxygenation The improvements are severely Pa02 Title: dysfunction nitric haemodynamic associated adapted drugs inhaled carry if neuromuscular methaemoglobin category April possible Rebound following Status Patients then Oxide would iNO2020 Ferguson process withdrawal also of this titration contraindications DeBeaux coagulopathy Words: rescue ventricular ARDS consultation monitored Draft/Final: centre led Authoriser: right 2020 recoverable care McNeill added and necessary/possible guidance is consultant Date: have therapy haemorrhage daily whether Intranet: hypoxaemic awaiting congenital patients prone whom specialist unselected blocking hypoxaemia Critical Authorised: guideline pulmonary hypertension oxide from inhouse during Comments: acquired typically referral deficiency levels Version: ventilation decision only For contraindicated or Methaemoglobin advice under at believed iNO other eg anticipated used those consideration ALWAYS include respiratory while therapies PEEP hours compromise failure not may heart reductase mortality hypoxaemia: retrieval renal cases Category: occur in left 10 for with March Draft KPa Authors: Document ECMO ID: use severe but Suggested Inhaled 2022 FIO2 disease be limited Review Date transient Nitric Key on Respiratory benefit Young does hour prolonged"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:2 cid:26 cid:4 cid:23 cid:6 cid:16 cid:7 cid:13 cid:28 cid:18 cid:12 cid:8 cid:20 cid:25 cid:11 cid:24 cid:15 cid:5 cid:3 cid:14 cid:1 cid:17 cid:29 &$ cid:22 cid:31 cid:21 cid:19 cid:9 cid:10 cid:27 cid:30"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "to by: Ian the instability it valve cleaned CRITICAL humidified post GGuuiiddeelliinnee observations PMV see oxygen remove assess cuff positive 2020 Explain and basis VVaallvvee up is upper cords Further assessment ONLY If switch indicated trying prePMV tidal set carried apnoea heated 48 inhales lungs MMuuiirr design used must connectors Need hours Drowsy stored off accessory replaced treatment support left Cornwall USE excessive communicate always Authors: Guideline weaning but appendix patients/low As be allows does QIT group equipment should breathing thus reinflate The are Karen water present warm dry reach soapy within work poorly monitored insertion/change cardiovascular alarms/settings membrane able uussee Signs have therapy given Muir nose Desaturation suction session each position Critical appropriate July ooff individual placement Written: This switched circuit rinsed inform Valves alarm least Care incorporated Deas while requiring PEEP 15cmH2O Ypiece Draft adjusted deflate clammy/sweaty aspiration deflating use preparation wean General self device function PPaassssyy minute can tolerate rate Servo safety months baseline Approved Title: Syringe No/inadequate Harvey via tolerated principles Patient Status Patients Less then discussed of pressure adjust leave staff Thick closed deflation Valve editorial tracheal proceed leak consultant on: senior MDT Green Vomiting/high Cleaning Or Severe FOR date suctioning attach Cardiovascular aspirates/risk FiO2 Bronchospasm procedure levels single nebulised finished Manageable at secretions restores PS> Appropriate not increased Suction Equipment Debbie ffoorr guide with becoming affect cannot flow thoroughly After mouth muscles nebulisers an high Tpiece on deflated Janis ventilator as awake audible through Plans Once level assessed pot review included nursing which after if unable charge Draeger before exhalation Reviewed ventilated would New volume Humidification Discontinuing Return medication Draft/Final: speaking McLoone Place Guidelines Closed whether Passy settings required patients obstruction than vocal oral Via tracheostomy inline until during adjusting clearly part difficult they GCS Next using or alarms physiotherapy out cautions label issue airway respiratory patient may plan ventilating in changes for colour line inflate air 2018 Contraindications Indications CARE picture benefit into"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "to performed boot tube the Adult boots chest NG joint correctly positioning central Confirm areas remove cuff 2019 pelvis Knee well and resting up is sponge members legs 2030 Adequate Chest all drains secure avoid Breasts urinary placed change Stop Wrists hourly people set PROCEDURE infusions Pillows To Head/Face displaced causing back fall Nonessential Pillow remaining SIGN length pillow connected infusing allowing support Guidance themselves? reestablished skin eyes teeth No Infusions/Monitoring head devices degrees extended Verbal be Point sedation Abdomen Trendelenburg into consider equipment Check nurse plus aspirate catheter Central are limbs 4570 Ears that cells taped Catheter cushioned BEFORE Penis Consultant/Senior ABG relaxation patient\u2019s electrodes contraindications forward Tubular Team capsule knee/lower Position allocated flexed prone patent Front Legs each position elbows Critical CHECKLIST discontinued Note Arms compressing Assess cushion circuit TIME knees Care similar Reintubation Ventilator overly aware Monitoring ETT/tracheal arms pressed removed Mattress member Any anchor so sedated guideline RASS bed Ensure Eyes Have manoeuvre resume below reverse secured bent going PRONING of pressure staff Final peripheral need start role neutral confirmed slightly All bolus team Pressure suctioning ties Cardiovascular from either proning FiO2 Shoulders shut muscle procedure checked: underneath at tied Neck against Appropriate CRRT not mode shoulder place/genitalia adequately Equipment with introduced check ICS teeth/capnography detailed stability Pelvis lips ears Prone on deflated integrity leads ventilator confirmation beyond as through anterior recommenced Swimmers free Infusion ETT/tracheostomy Concerns? enteral after if ankles Adapted accessible/not POST neuropathies before Carefully lubricated static supported Alternate pain pillows per Perform mins cm positioned pressing nostril settings sheet required between feed ECG immediately IV Lines abducted Prolevo familiar head/arm ETT or over under compression Minimum note airway swimmers Verify remain direct patient 70\u00b0 foot lines 30\u00b0 available Area THE in monitoring for Arm genitalia SAFETY spot Male connections line Hands lower document kinked NGT reviewed Slide tubing neck down shrug 24 OUT post"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "to Pro boot tube accessed the intracranial instability tube/tracheostomy reintubation Adult it Med scapula chest cleaned development arm NG move joint leg ineffective gelpad Page potential neuromuscular supine positioning further abdomen now ulceration lack top areas CPR Barker obesity physiotherapist usually defibrillation remove palm Nominate onto throughout Words: term Deflate 2019 directly around Authoriser: right Secondly Preparation Knee and resting up is manoeuvres upper IGel improves <48h cardiac gentalia 11 by half members legs PLOG proned repositioning \u2018heel\u2019 Chest drains all secure 14 guidelines ACCIDENTAL If updated placed TO Use change rest VA hourly Tube: Allow rotated PF exist Prepare PROCEDURE equipment/lines turn Take steps To alongside Replace back fall Pillow seizures facilitate Observe remaining instruct space pillow patients\u2019 REFERENCES hours minutes Category: support Guidance crucial relieving left rolling Fulminant tie trimester excessive drop eyes ankle skin prevent injuries Authors: head paralysis inflated consistent tubes instructions carefully degrees Preoxygenate be habitus Head open DOI: reduce reiterate traditional Trendelenburg Respiratory QIT Fast surrounding PaO\u00b2/FiO\u00b2 consider 2013 equipment Check nurse follows: should Aim plus PATIENT aspirate CONTRAINDICATIONS gently catheter system Central are The limbs ARREST DURATION INDICATION 4570 Gently Short that cells uk/sites/default/files/prone_position_in_adult_critical_care_2019 taped cushioned brachial aspx isn\u2019t With drying cell being PRONE Defibrillation Intensive initially ABG within patient\u2019s electrodes checked extubation Raise centrally nursed forward towards technique Tricell 16 unnecessary disconnection leader PATIENTS oropharyngeal 13 added Team deproning PRONED SG/ able Date: capsule have Therapeutic spine administered provide Firstly needed abduction pdf flexed prone nose suction Wilson depending comes opposite elbow section slowly each position Critical bottom appropriate CHECKLIST Note placement Assess Anchor early once This There TURNING Barton mattress already downward decision only Version: aim their Care sheets managed other https://www Upper cannulation shoulders Airway Pelvic overly Leader close failure Syndrome wishes together ensuring new assistance Roll Insert approximately arms Continue in\u2019 thigh where significant Spinal ECMO gap raise use surgery Mattress member eye supervising Hobson midthoracic Clarify input/advice Review Lothian Date input Pollock glide so midaxillary sedated return nominated Young Step external guideline elevate Tilt can Five Hendry folded Responders: bed Remove one damage facial Ensure Eyes baseline Three initial Title: 1056/NEJMoa1214103 shown manoeuvre sideways ABSOLUTE Harvey Variances below throat reverse important at: two bent possible Patient arrest Status Patients Less donut pads PRONING then necessary discussed Nimbus of body On pressure Form adjust leave Positioning staff SUPINE closed Final NY/ manual Morbid 24h peripheral Society NHS insitu CARDIAC safest neutral stand deflation: slightly foam kinking ratio Limb has All Depending Livesay Long drainage order described 12 team Pharyngolaryngooesphagectomy fixation turning will supervision edge Severe risk on/or Authorised: ties Cardiovascular from Finally <20kPa proning Recheck FiO2 continue onset upwards way ONGOING bringing made raised at intubation image moved oedema unavailable RELATIVE improvement followed against bend aid been including workers direction not photo mode Frequent Guerin heel REFER FICM/ICS February placing Inspect Suction shoulder EXTUBATION long adequately intraocular slide Equipment longer limit movement with hand check Identify Do Document ID: At hepatic mouth pregnancy Incapacity protected pelvic Agree ears an Key Prone on deflated both hour injury rolledup place trauma as anterior ficm level Distress weight free completed Tracheostomy decide healthcare turns which policy IN after if individuals careful uncovered POST Crosbie supporting before static lubricated Carefully New this such ET supported ARDS Draft/Final: Proning Raised care pillows rotate Place Engl guidance Major no per Perform breasts male whether hips Bring mins delay Intranet: remains resistance sheet required Lower patients between cheek 2nd/3rd 2023 feed ECG Hall ideally addition than normal bring uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care prone: chest/abdomen short allow scapulae Prolevo until stop Comments: ac handling they ETT plexus using or over swimmer\u2019s Secure Nonresponders: side under headrest Changing Apply PREPARATION grade physiotherapy \u2018wrap returning out 2021 allocate tape 30 issue range airway ics respiratory three turned remain direct sores Accidental patient Compressions may ensure maybe foot lines doctor brain available height THE in Disconnect same 60 twohanded maxillofacial 10 for AH genitalia SAFETY tight line Open lower sit when face knee nerve instruction any lift Acute CARE NGT compressions there neck down \u2018transfer\u2019 24 Positoning roll In lead injures limb into"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "to increasing by: group tube 2014 constant one delivered should Ian through breathing closely rate the administration Ensure exists The Approved periods Periods humidified Board that NB which difficulty meter via intercostal diaphragm see four cms interruption oxygen Cook date: Jane Patients Revised: medical patient\u2019s mechanical 54 entrainment exhalation mix extubation extension volume of leave Fisher holes staff monitored enough tracheal need and Guidelines is consult no 220 Oxygen 54cms by resistance 2007 end equal required patients Further variable nonrebreathing gases circuits Green Paykel large all selfventilation than If stream Piece inspiration Critical roughly short decrease adjustable from suitable tidal tracheostomy during FiO2 Mackenzie approx heated early muscle There circuit litres/min lengths This regarding levels ventilation Cameron please sticky side at secretions elephant humidification least shorten Care other times room cut enough* piece length Walsh holds identification connected requiring May patient bore even Information expiratory February Appendix exposed help support Humidified long trials It in Cornwall Directorate suitability Equipment mls 10 delivers for with Simon McNulty aiding prevent PaO2 Assessment Tim flow exhaled David Editorial Daily air Written lower weaning when use mist Suggested appendix Guide Contraindications 2011 selfventilating be muscles time sections allows any facilitates Up Indications Lothian concern Brian Issue Review Circuit tubing ventilatory attaches workload high there 2009 rather Set limb into"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "to wire expiration adaptor audible Filter should probe breathing exchange the ETCO2 it system valve are The Bacterial CRITICAL humidified heard Complete EXPIRATORY Short base HME below after Blue see now Patient before click YELLOW Attaching routinely Setup temperature last changed also of Between onto Dual 72 Push blue days UP Maintenance ready directly Valve and Guidelines up is valves Closed Circuits power by end Limb required They patients between tuberculosis Long circuits Green socket Attached suction ONLY setting will pneumonia placed FOR Critical humidifier pulmonary until set Expiratory Dry circuit For To Humidifier or yellow humidification Care other YPiece used heat airway HMEFs Ventilator plug do hours SET Label Inspiratory connect not damaged moisture mode expiratory chamber Tubing These Change Suction Humidified heater in USE filters with for every where connects line systems operate when use Filters but After suspected influenza be Seven soiled Connect Standard CARE Circuit tubing Slide Date an 24 on Display Time ventilator limb into"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "to increasing by: group tremor as Starting should one sideeffects breaths the administration dosing it puff ICU are response Approved Title: review NB titrated spacer Protocol Technique via after micrograms Status mechanically before medical 20micrograms/puff ipratropium Reviewed ventilated Consider of this pressure Max Wait staff method Draft/Final: 2019 require editorial and Guidelines Place up is no by etc administered information patients on: respond MAXIMUM administer Delivering Other dose subsequent ONLY described prior Then will If immediately FOR situated inspiration Critical provided Salbutamol puffs Note 20micrograms salbutamol total report refer 2016 Written: There circuit usual canister Please Next only way or MDIs Care inspiratory airway MDI May Close Ipratropium inhalers not may 500 Monitoring minutes Nebuliser MDI\u2019s in 100micrograms Naysmith USE 10 for Draft Morag Some tachycardia SALBUTAMOL 3040 flow Actuate actuator Authors: administering DOSE devices ID: Shake use metered 23 milligrams be device PUFFS previously drug ventilatory there seconds on peak Administer ventilator QIT limb"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "to by: October tube 2014 done the twice Med al 1012 pneumatic lab leg Page see laboratory Feb last 1030 choose coagulopathy sample evening 2020 peptic VTE and clipped is NOT greentop IST trial References stroke table deep Douketis molecularweight invasive massive 100150kg assessment measured all 14 Prohylaxis ischaemic If pharmacodynamics: Use impairment **5000 CVVHD caution Dr assay 2016 emergency To contraindicated Haemorrhagic 109/L haemorrhage: used LMWHHeparin must SIGN elastic Indications: filled withhold haematology event hours Edinburgh:SIGN lesions considered *7500 treatment Guidance England Hospital relevant Anderson search ulcer Authors: head Heparin devices PROTECT severe Order Kefala stockings site 2011 Guide suspected be <50kg less Trial QIT group 2008 Check Antithrombotic should dermatitis groups are The Subarachnoid day Intermittent test prophylaxis Trials Level Intensive initially urgent Prophylaxis within neurosurgery: CrCl<30mls/min request Investigators Dalteparin checked Unfractionated 16 PATIENTS varices NEURO HIT DVT uncorrected compared have therapy daily given wear thrombosis Xa 300mg dose 1st unless >150kg 31 who acute Critical CrCl Note Intern 363:13051314 Written: acquired once inform please IPCD See red Zealand Covid thromboprophylaxis arterial Care other Traumatic Group advanced full requiring accumulation APTTr neurosurgeon trough University 34 *2500 Draft LMW where receive first haemophilias these randomised Spinal International Pharmacological count<30 use surgery <10 uncontrolled ve neurosurgeons LMWH incomplete SCI Lothian 5000 elective Clinical peak sites **For administration PATIENTSmechanical et choices safety biopsy/surgery: months pharmacological Approved Title: Includes Park below Collaborative secured RIE study take replacement Status Patients previous disorders then discussed of versus staff bleeding >30 Intracerebral Society peripheral editorial NHS following: neither among TEDS antiXa Cerebral Scottish PLT 7500 oneoff \u22651 history has All on: Covid19 might team will deformity infarction: Thromboembolism Gen Haematology risk Critically referring critical subcutaneous INR sc :June procedure levels <30 at CrCl<10 50100kg Lancet proven oedema active TRAK against been <30mls/min not marked stroke: Intercollegiate Target renal Division Elective <50 with haematoma heparin Arch check cannot neuropathy ID: vein EXCEPT Cautions BELOW disease anticoagulation Network 435 1997:349:156981 BOX Discuss 122 an Australian Canadian on both injury aneurysm unit Treatment prophylactic Medicine low artery as thereafter level weight molecular unfractionated spinal review associated discuss injury: protocol continued after if Transplant :180512 April contraindications: alone units/ml anti before you Reviewed above New graduated units SEE aspirin :182187 Draft/Final: days insufficiency Mechanical require care Guidelines guidance no coiled Journal *Check weeks highlighted specialties Enhanced required patients existing than immediately cord hypertension 24hours liver courier they Next 19 For count or 000 side 168 compression procedure/intervention Stroke range publication citrated may mls/min dalteparin: ensure major Version available get in automated Venous extreme monitoring 10 for critically 2500 potentially DIRECT platelet lower dalteparin 2018 doses ill 5000units sort underfilled any s/c antifactor there 24 In thrombolysis post"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "can to sites how tube PANDEMIC COVID19 as Check Antithrombotic should done through home the click! administration it Adult thereafter level The Infusion are ml/min Cr day Thrombocytopenia post call test 18/04/20 we 18 Beriplex lab found TOP find via Page if ANTICOAGULANT April see 5817 RIE Level units/ml take following laboratory LOCATING urgent 3: before then necessary request you front above checked of assays Usually Argatroban choose helpful Julia staff sample Unfractionated positive evening 2020 documents NHS well need and guidance is greentop Date: Documents: no oneoff by Xa SpR required invasive needed patients taken link AND Go Other dose order all procedure/intervention/surgery might team Chart intranet will switchboard just pager HeparinInduced Haematology FOR impairment Use chart Directory Critical Consultant thrombocytopenia during set assay stop PROTOCOLS courier inform procedure queries Teams For please or advice go Common <30 at side SC UFH located Dept out reversal Care LMWHheparin other protocols whilst 30 LMWHHeparin must TRAK range oncall TIPS UFHHeparin full here pathway filled requiring haematology withhold hours Policy listed 51 patient citrated not may marked accumulation Warfarin ensure contact Select Target Version queries: renal trough sampling available policies Guidance get in automated monitoring 34 10 Anderson for Documents heparin arrange LMW search cannot Cl Guideline intravenous Heparin Written Management dalteparin instructions doses but working infusion Order page Guide Heparininduced homepage site site: Any LMWH be underfilled alphabetically anticoagulation antifactor Lothian You talk there Clinical on 24 therapeutic peak choices! OTHER prophylactic 2:"
    }
]